0001437749-23-023314.txt : 20230811 0001437749-23-023314.hdr.sgml : 20230811 20230811160203 ACCESSION NUMBER: 0001437749-23-023314 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 69 CONFORMED PERIOD OF REPORT: 20230630 FILED AS OF DATE: 20230811 DATE AS OF CHANGE: 20230811 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CYANOTECH CORP CENTRAL INDEX KEY: 0000768408 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 911206026 STATE OF INCORPORATION: NV FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-14602 FILM NUMBER: 231163902 BUSINESS ADDRESS: STREET 1: 73-4460 QUEEN KAAHUMANU HWY STREET 2: SUITE 102 CITY: KAILUA KONA STATE: HI ZIP: 96740 BUSINESS PHONE: 8083261353 MAIL ADDRESS: STREET 1: 73-4460 QUEEN KAAHUMANU HWY STREET 2: SUITE 102 CITY: KAILUA-KONA STATE: HI ZIP: 96740 10-Q 1 cyan20230630_10q.htm FORM 10-Q cyan20230630_10q.htm
0000768408 Cyanotech Corp false --03-31 Q1 2023 11 64 0.01 0.01 10,000,000 10,000,000 0 0 0 0 0.02 0.02 50,000,000 50,000,000 6,291,086 6,291,086 6,271,971 6,271,971 1,000,000 2 2 2 19 1,000,000 2 2 10 0 500,000 3 1,000,000 00007684082023-04-012023-06-30 xbrli:shares 00007684082023-08-04 iso4217:USD 00007684082023-06-30 00007684082023-03-31 iso4217:USDxbrli:shares 00007684082022-04-012022-06-30 0000768408us-gaap:CommonStockMember2023-03-31 0000768408us-gaap:AdditionalPaidInCapitalMember2023-03-31 0000768408us-gaap:RetainedEarningsMember2023-03-31 0000768408us-gaap:CommonStockMember2023-04-012023-06-30 0000768408us-gaap:AdditionalPaidInCapitalMember2023-04-012023-06-30 0000768408us-gaap:RetainedEarningsMember2023-04-012023-06-30 0000768408us-gaap:CommonStockMember2023-06-30 0000768408us-gaap:AdditionalPaidInCapitalMember2023-06-30 0000768408us-gaap:RetainedEarningsMember2023-06-30 0000768408us-gaap:CommonStockMember2022-03-31 0000768408us-gaap:AdditionalPaidInCapitalMember2022-03-31 0000768408us-gaap:RetainedEarningsMember2022-03-31 00007684082022-03-31 0000768408us-gaap:CommonStockMember2022-04-012022-06-30 0000768408us-gaap:AdditionalPaidInCapitalMember2022-04-012022-06-30 0000768408us-gaap:RetainedEarningsMember2022-04-012022-06-30 0000768408us-gaap:CommonStockMember2022-06-30 0000768408us-gaap:AdditionalPaidInCapitalMember2022-06-30 0000768408us-gaap:RetainedEarningsMember2022-06-30 00007684082022-06-30 0000768408us-gaap:RevolvingCreditFacilityMembercyan:FirstFoundationBankMember2023-03-31 0000768408us-gaap:RevolvingCreditFacilityMembercyan:FirstFoundationBankMember2023-06-22 0000768408us-gaap:RevolvingCreditFacilityMembercyan:RelatedParty1Member2023-06-30 0000768408us-gaap:RevolvingCreditFacilityMembercyan:RelatedParty1Member2023-03-31 0000768408us-gaap:RevolvingCreditFacilityMembercyan:RelatedParty1Membersrt:MaximumMember2023-06-30 0000768408cyan:UnsecuredSubordinatedLoanFromSkywordsMember2019-04-30 0000768408cyan:UnsecuredSubordinatedLoanFromSkywordsMember2023-06-30 0000768408cyan:UnsecuredSubordinatedLoanFromSkywordsMember2023-03-31 0000768408cyan:FirstFoundationBankMember2023-04-012023-06-30 0000768408us-gaap:RevolvingCreditFacilityMembercyan:RelatedParty1Member2023-04-012023-06-30 xbrli:pure 0000768408us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember2023-04-012023-06-30 0000768408us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember2022-04-012023-03-31 0000768408us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMembercyan:CustomerNumber1Member2023-04-012023-06-30 0000768408us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMembercyan:CustomerNumber2Member2023-04-012023-06-30 0000768408us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember2022-04-012022-06-30 0000768408us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2023-04-012023-06-30 0000768408us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMembercyan:CustomerNumber1Member2022-04-012022-06-30 0000768408us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMembercyan:CustomerNumber2Member2022-04-012022-06-30 0000768408us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMembercyan:TwoCustomersMember2023-04-012023-06-30 0000768408us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMembercyan:TwoCustomersMember2022-04-012023-03-31 0000768408cyan:PackagedAstaxanthinMember2023-04-012023-06-30 0000768408cyan:PackagedAstaxanthinMember2022-04-012022-06-30 0000768408cyan:PackagedSpirulinaMember2023-04-012023-06-30 0000768408cyan:PackagedSpirulinaMember2022-04-012022-06-30 0000768408cyan:PackagedProductsMember2023-04-012023-06-30 0000768408cyan:PackagedProductsMember2022-04-012022-06-30 0000768408cyan:BulkAstaxanthinMember2023-04-012023-06-30 0000768408cyan:BulkAstaxanthinMember2022-04-012022-06-30 0000768408cyan:BulkSpirulinaMember2023-04-012023-06-30 0000768408cyan:BulkSpirulinaMember2022-04-012022-06-30 0000768408cyan:BulkProductsMember2023-04-012023-06-30 0000768408cyan:BulkProductsMember2022-04-012022-06-30 0000768408cyan:ContractExtractionAndRDServicesMember2023-04-012023-06-30 0000768408cyan:ContractExtractionAndRDServicesMember2022-04-012022-06-30 0000768408us-gaap:EquipmentMember2023-06-30 0000768408us-gaap:EquipmentMember2023-03-31 0000768408us-gaap:LeaseholdImprovementsMember2023-06-30 0000768408us-gaap:LeaseholdImprovementsMember2023-03-31 0000768408us-gaap:FurnitureAndFixturesMember2023-06-30 0000768408us-gaap:FurnitureAndFixturesMember2023-03-31 00007684082023-01-012023-06-30 0000768408cyan:LineOfCreditExcludingRelatedPartyMember2023-06-30 0000768408cyan:LineOfCreditExcludingRelatedPartyMember2023-03-31 0000768408cyan:LineOfCreditRelatedPartyMember2023-06-30 0000768408cyan:LineOfCreditRelatedPartyMember2023-03-31 0000768408cyan:LongtermDebtExcludingRelatedPartyDebtMember2023-06-30 0000768408cyan:LongtermDebtExcludingRelatedPartyDebtMember2023-03-31 0000768408cyan:UnsecuredSubordinatedLoanMember2023-06-30 0000768408cyan:UnsecuredSubordinatedLoanMember2023-03-31 0000768408us-gaap:RevolvingCreditFacilityMembercyan:FirstFoundationBankMember2016-08-30 0000768408us-gaap:RevolvingCreditFacilityMembercyan:FirstFoundationBankMemberus-gaap:PrimeRateMember2203-06-30 0000768408us-gaap:RevolvingCreditFacilityMembercyan:FirstFoundationBankMemberus-gaap:PrimeRateMember2023-03-31 0000768408us-gaap:RevolvingCreditFacilityMembercyan:FirstFoundationBankMemberus-gaap:PrimeRateMember2023-01-012023-06-30 0000768408cyan:FirstFoundationBankMembersrt:MinimumMember2023-06-30 0000768408us-gaap:RevolvingCreditFacilityMembercyan:FirstFoundationBankMember2023-06-30 0000768408cyan:TermLoanAgreementMaturingOnAugust142032Member2012-08-132012-08-14 0000768408cyan:TermLoanAgreementPromissoryNoteOneMember2012-08-132012-08-14 0000768408cyan:TermLoanAgreementPromissoryNoteTwoMember2012-08-132012-08-14 utr:M utr:Y 0000768408cyan:TermLoanAgreementMaturingOnAugust142032Member2023-06-30 0000768408cyan:TermLoanAgreementMaturingOnAugust142032Member2023-03-31 0000768408cyan:TermLoanAgreementMaturingOnAugust142032Membersrt:MinimumMember2012-08-132012-08-14 0000768408cyan:TermLoanAgreementMaturingOnAugust142032Member2022-04-012023-03-31 0000768408cyan:TermLoanAgreementMaturingOnAugust142032Member2023-06-21 0000768408cyan:SkywordsNoteMembercyan:UnsecuredSubordinatedLoanMember2019-04-30 0000768408cyan:SkywordsNoteMembercyan:UnsecuredSubordinatedLoanMember2021-04-30 0000768408cyan:SkywordsAmendedNoteMember2021-04-30 0000768408cyan:SkywordsNoteMember2021-04-012021-04-30 0000768408cyan:SkywordsNoteMembercyan:UnsecuredSubordinatedLoanMember2023-06-30 0000768408cyan:SkywordsNoteMembercyan:UnsecuredSubordinatedLoanMember2022-03-31 0000768408cyan:SkywordsNoteMember2023-06-30 0000768408cyan:SkywordsNoteMember2023-03-31 0000768408cyan:SkywordsNoteMemberus-gaap:PrimeRateMember2021-04-012021-04-30 0000768408cyan:SkywordsNoteMembersrt:MinimumMemberus-gaap:PrimeRateMember2021-04-012021-04-30 0000768408cyan:SolarLeaseForBuildingsMember2023-06-30 0000768408cyan:The2004DirectorsPlanMember2023-06-30 0000768408cyan:The2016PlanMember2023-06-30 0000768408cyan:The2014DirectorsPlanMember2023-06-30 0000768408us-gaap:EmployeeStockOptionMembersrt:MaximumMember2023-04-012023-06-30 0000768408us-gaap:EmployeeStockOptionMembercyan:EmployeesMember2023-04-012023-06-30 0000768408us-gaap:EmployeeStockOptionMembercyan:EmployeesMember2022-04-012022-06-30 00007684082022-04-012023-03-31 0000768408us-gaap:EmployeeStockOptionMembercyan:EmployeesMember2023-06-30 0000768408us-gaap:EmployeeStockOptionMembercyan:EmployeesMember2023-03-31 0000768408us-gaap:EmployeeStockOptionMember2023-06-30 0000768408us-gaap:EmployeeStockOptionMember2023-04-012023-06-30 0000768408us-gaap:RestrictedStockMemberus-gaap:ShareBasedPaymentArrangementNonemployeeMembercyan:TwoBoardMembersMember2023-04-032023-04-03 0000768408us-gaap:RestrictedStockMemberus-gaap:ShareBasedPaymentArrangementNonemployeeMembercyan:TwoBoardMembersMember2023-04-012023-06-30 0000768408us-gaap:RestrictedStockMemberus-gaap:ShareBasedPaymentArrangementNonemployeeMembercyan:TwoBoardMembersMember2022-04-012023-03-31 0000768408us-gaap:RestrictedStockUnitsRSUMembercyan:EmployeesMember2023-04-012023-06-30 0000768408us-gaap:RestrictedStockUnitsRSUMembercyan:EmployeesMember2022-04-012022-06-30 0000768408us-gaap:RestrictedStockUnitsRSUMember2023-03-31 0000768408us-gaap:RestrictedStockUnitsRSUMember2023-04-012023-06-30 0000768408us-gaap:RestrictedStockUnitsRSUMember2023-06-30 0000768408us-gaap:RestrictedStockUnitsRSUMembercyan:EmployeesMember2023-06-30 00007684082022-12-31 0000768408cyan:CommonStockOptionsAndRestrictedStockUnitsMember2023-04-012023-06-30 0000768408cyan:CommonStockOptionsAndRestrictedStockUnitsMember2022-04-012022-06-30 0000768408cyan:SkywordsNoteMembercyan:UnsecuredSubordinatedLoanMember2020-03-31 0000768408cyan:SkywordsNoteMembercyan:UnsecuredSubordinatedLoanMemberus-gaap:PrimeRateMember2019-04-012020-03-31 0000768408cyan:ConversionOfSkywordsNoteIntoRevolvingLoansMember2021-04-122021-04-12 0000768408cyan:SkywordsAmendedNoteMember2021-04-12 0000768408cyan:SkywordsAmendedNoteMember2021-04-122021-04-12 0000768408cyan:SkywordsNoteMember2021-04-122021-04-12 0000768408cyan:SkywordsAmendedNoteMemberus-gaap:PrimeRateMember2021-04-122021-04-12 0000768408cyan:SkywordsAmendedNoteMember2022-12-14 0000768408us-gaap:SubsequentEventMember2023-08-10
 

Table of Contents



 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

 

FORM 10-Q

 

 

Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For Quarterly Period Ended June 30, 2023

Or

 

Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the Transition Period From               to               

 

Commission File Number 0-14602

 

CYANOTECH CORPORATION

(Exact name of registrant as specified in its charter)

Nevada

91-1206026

(State or other jurisdiction of incorporation or organization)

(IRS Employer Identification Number)

 

73-4460 Queen Kaahumanu Hwy. #102, Kailua-Kona, HI 96740

(Address of principal executive offices)

(808) 326-1353

(Registrant’s telephone number)

Not Applicable

(Former name, former address and former fiscal year, if changed since last report)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, $0.02 par value per share

CYAN

NASDAQ

 

Indicate by check mark whether the registrant (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act of 1934 during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒  No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes ☒  No ☐ 

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one): 

Large accelerated filer ☐

 

Accelerated filer ☐

Non-accelerated filer ☐

 

Smaller reporting company 

  

Emerging growth company 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes   No ☒

 

As of August 4, 2023, the number of shares outstanding of the registrant’s common stock was 6,308,010

 

  

 

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

This Report and other presentations made by Cyanotech Corporation (“CYAN”) and its subsidiary contain “forward-looking statements,” which include statements that are predictive in nature, depend upon or refer to future events or conditions, and usually include words such as “expects,” “anticipates,” “intends,” “plan,” “believes,” “predicts”, “estimates” or similar expressions. In addition, any statement concerning future financial performance, ongoing business strategies or prospects and possible future actions are also forward-looking statements. Forward-looking statements are based upon current expectations and projections about future events and are subject to risks, uncertainties and the accuracy of assumptions concerning CYAN and its subsidiary (collectively, the “Company”), the performance of the industry in which CYAN does business, and economic and market factors, among other things. These forward-looking statements are not guarantees of future performance. You should not place undue reliance on forward-looking statements.

 

Forward-looking statements speak only as of the date of the Report, presentation or filing in which they are made. Except to the extent required by the Federal Securities Laws, we undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Our forward-looking statements in this Report include, but are not limited to:

 

 

Statements relating to our business strategy;

 

 

Statements relating to our business objectives; and

 

 

Expectations concerning future operations, profitability, liquidity and financial resources.

 

These forward-looking statements are subject to risk, uncertainties and assumptions about us and our operations that are subject to change based on various important factors, some of which are beyond our control, including those factors described in Item 2 of Part I of this quarterly report and in Item 1A of Part I of the Company’s Annual Report on Form 10-K filed on June 27, 2023. Additionally, the following factors, among others, could cause our financial performance to differ significantly from the goals, plans, objectives, intentions and expectations expressed in our forward-looking statements:

 

 

The added risks associated with or attributed to the current local, national and world economic conditions, including but not limited to, the volatility of crude oil prices, inflation and currency fluctuations;

 

 

Access to available and reasonable financing on a timely basis;

 

 

The Company’s inability to generate enough revenues to meet its obligations or repay maturing indebtedness; and

 

 

Failure of capital projects to operate as expected or meet expected results.

 

It is not possible to predict or identify all potential risks and uncertainties and the above referenced factors and list do not comprise a complete list of all potential risks and uncertainties. Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in any forward-looking statement contained in this report. All forward-looking statements speak only as of the date of this report and are expressly qualified in their entirety by the cautionary statements included in or incorporated by reference into this report. Except as is required by law, the Company expressly disclaims any obligation to publicly release any revisions to forward-looking statements to reflect events after the date of this report. Throughout this report, Cyanotech Corporation, together with its subsidiary, are referred to as “the Company.”

 

 

 

CYANOTECH CORPORATION

FORM 10-Q

INDEX

 

PART I.  FINANCIAL INFORMATION

     

Item 1.

Financial Statements

4

 

Condensed Consolidated Balance Sheets as of June 30, 2023 and March 31, 2023 (unaudited)

 
 

4

 

Condensed Consolidated Statements of Operations for the three months ended June 30, 2023 and 2022 (unaudited)

5

 

Condensed Consolidated Statements of Stockholders’ Equity for the three months ended June 30, 2023 and 2022 (unaudited)

6

 

Condensed Consolidated Statements of Cash Flows for the three months ended June 30, 2023 and 2022 (unaudited)

 
 

7

 

Notes to Condensed Consolidated Financial Statements (unaudited)

8

Item 2.

Managements Discussion and Analysis of Financial Condition and Results of Operations

18

Item 4.

Controls and Procedures

22

     

PART II.  OTHER INFORMATION

     

Item 1.

Legal Proceedings

23

Item 1A

Risk Factors

23

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

23

Item 3.

Defaults upon Senior Securities

23

Item 5.

Other Information

23

Item 6.

Exhibits

24

     

SIGNATURES

25

 

  

 

PART I.  FINANCIAL INFORMATION

Item 1.  Financial Statements

 

CYANOTECH CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

 

(In thousands, except per share amounts)

(Unaudited)

 

  

June 30,
2023

  

March 31,
2023

 

ASSETS

        

Current assets:

        

Cash

 $648  $974 

Accounts receivable, net of allowance for credit losses of $11 as of June 30, 2023 and $64 as of March 31, 2023

  1,794   1,331 

Inventories

  10,506   10,707 

Prepaid expenses and other current assets

  378   484 

Total current assets

  13,326   13,496 
         

Equipment and leasehold improvements, net

  11,065   11,366 

Operating lease right-of-use assets, net

  4,656   4,776 

Other assets

  85   90 

Total assets

 $29,132  $29,728 
         

LIABILITIES AND STOCKHOLDERS’ EQUITY

        

Current liabilities:

        

Accounts payable

 $1,721  $1,021 

Accrued expenses

  821   1,101 

Customer deposits

  77   89 

Operating lease obligations, current portion

  494   483 

Line of credit

  1,770   1,540 

Line of credit – related party

  750   500 

Current maturities of long-term debt

  3,313   3,369 

Total current liabilities

  8,946   8,103 
         

Long-term debt, less current maturities

  1,000   1,000 

Long-term operating lease obligations

  4,146   4,275 

Other long-term liabilities

     3 

Total liabilities

  14,092   13,381 
         

Commitments and contingencies

          
         

Stockholders’ equity:

        

Preferred stock of $0.01 par value, authorized 10,000,000 shares; no shares issued and outstanding

      

Common stock of $0.02 par value, authorized 50,000,000 shares; issued and outstanding 6,291,086 shares at June 30, 2023 and 6,271,971 shares at March 31, 2023

  126   125 

Additional paid-in capital

  33,917   33,856 

Accumulated deficit

  (19,003

)

  (17,634

)

Total stockholders’ equity

  15,040   16,347 

Total liabilities and stockholders’ equity

 $29,132  $29,728 

 

See accompanying notes to condensed consolidated financial statements

 

 

 

CYANOTECH CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except per share amounts)

(Unaudited)

 

   

Three Months Ended
June 30,

 
   

2023

   

2022

 
                 

Net sales

  $ 5,146     $ 6,716  

Cost of sales

    3,614       4,398  

Gross profit

    1,532       2,318  
                 

Operating expenses:

               

General and administrative

    1,274       1,329  

Sales and marketing

    1,276       1,168  

Research and development

    191       246  

Total operating expenses

    2,741       2,743  
                 

Loss from operations

    (1,209

)

    (425

)

                 

Interest expense, net

    (160

)

    (44

)

                 

Loss before income taxes

    (1,369

)

    (469

)

                 

Income tax expense

          3  
                 

Net loss

  $ (1,369

)

  $ (472

)

                 

Net loss per share:

               

Basic

  $ (0.22

)

  $ (0.08

)

Diluted

  $ (0.22

)

  $ (0.08

)

                 

Shares used in calculation of net loss per share:

               

Basic

    6,290       6,204  

Diluted

    6,290       6,204  

 

See accompanying notes to condensed consolidated financial statements

 

 

 

CYANOTECH CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

(Unaudited)

 

Three months ended June 30, 2023 and 2022

 

  

Common
Stock
Shares

  

Common
Stock

Amount

  

Additional
Paid-in
Capital

  

Accumulated
Deficit

  

Total
Stockholders
Equity

 
  

(in thousands, except per share data)

 

Balances at March 31, 2023

  6,271,971  $125  $33,856  $(17,634

)

 $16,347 

Issuances of common stock to Directors in lieu of cash

  17,672   1   15      16 

Issuances of vested shares of restricted stock

  2,278      (1

)

     (1

)

Shares withheld for tax payments

  (835

)

            

Share-based compensation expense

        47      47 

Net loss

           (1,369

)

  (1,369

)

Balances at June 30, 2023

  6,291,086  $126  $33,917  $(19,003

)

 $15,040 
                     

Balances at March 31, 2022

  6,202,223  $124  $33,557  $(14,194

)

 $19,487 

Issuances of vested shares of restricted stock

  2,277      (3

)

     (3

)

Shares withheld for tax payments

  (857

)

            

Share-based compensation expense

        22      22 

Net loss

           (472

)

  (472

)

Balances at June 30, 2022

  6,203,643  $124  $33,576  $(14,666

)

 $19,034 

 

See accompanying notes to condensed consolidated financial statements

 

 

 

CYANOTECH CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Dollars in thousands)

(Unaudited)

 

   

Three Months Ended
June 30,

 
   

2023

   

2022

 

CASH FLOWS FROM OPERATING ACTIVITIES:

               

Net loss

  $ (1,369

)

  $ (472

)

Adjustments to reconcile net loss to net cash (used in) provided by operating activities:

               

Depreciation and amortization

    407       417  

Amortization of debt issue costs and other assets

    10       13  

Amortization of operating leases right-of-use assets

    120       105  

Share-based compensation expense

    47       22  

Provision for doubtful accounts

    11        

Net (increase) decrease in assets:

               

Accounts receivable

    (474

)

    463  

Inventories

    201       (1,233

)

Prepaid expenses and other assets

    104       168  

Net increase (decrease) in liabilities:

               

Accounts payable

    744       (509

)

Accrued expenses

    (264

)

    (75

)

Customer deposits

    (12

)

    (85

)

Operating lease obligations

    (118

)

    (110

)

Deferred rent and other liabilities

    (3

)

    (3

)

Net cash used in operating activities

    (596

)

    (1,299

)

CASH FLOWS FROM INVESTING ACTIVITIES:

               

Investment in equipment and leasehold improvements

    (150

)

    (376

)

Net cash used in investing activities

    (150

)

    (376

)

CASH FLOWS FROM FINANCING ACTIVITIES:

               

Net draws (payments) on line of credit

    230        

Net draws on line of credit – related party

    250        

Principal payments on long-term debt

    (59

)

    (174

)

Taxes paid related to net share settlement of restricted stock units

    (1

)

    (3

)

Net cash provided by (used in) financing activities

    420       (177

)

Net decrease in cash

    (326

)

    (1,852

)

Cash at beginning of period

    974       2,589  

Cash at end of period

  $ 648     $ 737  
                 

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:

               

Cash paid during the period for:

               

Interest

  $ 151     $ 65  

Income taxes

  $     $  

 

See accompanying notes to condensed consolidated financial statements 

 

 

CYANOTECH CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

June 30, 2023

(Unaudited)

 

 

1.

ORGANIZATION AND BASIS OF PRESENTATION

 

Cyanotech Corporation (the “Company”), located in Kailua-Kona, Hawaii, was incorporated in the state of Nevada on March 3, 1983, and is listed on the NASDAQ Capital Market under the symbol “CYAN”. The Company is engaged in the production of natural products derived from microalgae for the nutritional supplements market.

 

The Company is an agricultural company that produces high value natural products derived from microalgae grown in complex and intricate open-pond agricultural systems on the Kona coast of Hawaii.  The Company's products include Hawaiian Spirulina Pacifica®, a superfood with numerous benefits, including boosting the immune system and overall cellular health; and BioAstin® Hawaiian Astaxanthin®, a powerful antioxidant shown to support and maintain the body's natural inflammatory response.

 

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information pursuant to the instructions to Form 10-Q and Regulation S-X of the Securities and Exchange Commission (“SEC”). These interim condensed consolidated financial statements are unaudited and, in the opinion of management, include all adjustments (consisting of normal recurring adjustments and accruals) necessary to present fairly the Condensed Consolidated Balance Sheets, Condensed Consolidated Statements of Operations, Condensed Consolidated Statements of Stockholders’ Equity and Condensed Consolidated Statements of Cash Flows for the periods presented in accordance with GAAP.

 

Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. The results of operations for the interim periods are not necessarily indicative of the results to be expected for the full fiscal year. The Condensed Consolidated Balance Sheet as of March 31, 2023 was derived from the audited consolidated financial statements. These condensed consolidated financial statements and notes should be read in conjunction with the Company’s audited consolidated financial statements for the year ended March 31, 2023, contained in the Company’s annual report on Form 10-K as filed with the SEC on June 27, 2023. 

 

Liquidity and Going Concern

 

The accompanying condensed consolidated financial statements as of and for the three months ended June 30, 2023 and 2022, and as of March 31, 2023, have been prepared assuming the Company will continue as a going concern. The going concern assumption contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The Company sustained operating losses and negative cash flows from operation for these same periods. Further, as discussed below, the Company was not in compliance with a debt covenant requirement at March 31, 2023 and First Foundation Bank (the “Bank”) instituted a freeze on additional advances from the Revolving Credit Agreement (“Credit Agreement”). These conditions raise substantial doubt about the Company’s ability to continue as a going concern. The condensed consolidated financial statements do not include any adjustments to the carrying amounts and classification of assets, liabilities, and reported expense that may be necessary if the Company was unable to continue as a going concern.

 

As of June 30, 2023, the Company had cash of $648,000 and working capital of $4,380,000 compared to $974,000 and $5,393,000, respectively, as of March 31, 2023. The Company has a Credit Agreement with the Bank that provided for borrowings up to $2,000,000 on a revolving basis, however, as part of the covenant waiver at March 31, 2023, the borrowings under this line of credit were frozen at the outstanding balance on June 22, 2023, at $1,770,000. As of March 31, 2023, the Company had outstanding borrowings of $1,540,000 on the line of credit.  The line of credit is subject to renewal on August 30, 2023, and the Company intends to renew or replace it with another line of credit on or before the expiration date.

 

The Company also has a loan facility with a related party that allows the Company to borrow up to $1,000,000 on a revolving basis (the “Revolver”). At June 30, 2023 and March 31, 2023, the Company had $750,000 and $500,000, respectively, outstanding borrowings on the Revolver, which were included in line of credit – related party on the Condensed Consolidated Balance Sheets. The Revolver expires on April 12, 2025 (see Notes 5 and 12). On June 30, 2023, the Company and Skywords Family Foundation, Inc. (“Skywords”) executed a letter of intent to commence drafting and negotiating a definitive Second Agreement to the Amended and Restate Promissory Note, dated as of April 12, 2021, as amended on December 14, 2022, to which the revolving amount that the Company may borrow from time to time would increase from $1,000,000 to $2,000,000, with all other terms of the Amendment remaining the same.

 

8

 

As of June 30, 2023, the Company had $3,402,000 of debt (“Term Loans”) payable to the Bank that require the payment of principal and interest monthly through August 2032. Pursuant to the Term Loans and the Credit Agreement, the Company is subject to annual financial covenants, customary affirmative and negative covenants and certain subjective acceleration clauses. As of March 31, 2023, the Company debt service coverage ratio fell short of the Bank’s annual requirement. On June 22, 2023, the Bank provided the Company with a letter waiving the covenant violation as of March 31, 2023, but noting that the Bank reserved its right to declare a default in the future if any covenants remain out of compliance at applicable measurement dates. In addition, the Bank’s letter implemented an immediate freeze on any and all further advances of the Credit Agreement through the maturity date.

 

In April 2019, the Company obtained a loan in the amount of $1,500,000 from a related party. The proceeds were used to pay down accounts payable and for general operating capital purposes. On April 12, 2021 and December 14, 2022, the Company amended this loan (see Notes 5 and 12). As of both June 30, 2023 and March 31, 2023, the Company had $1,000,000 outstanding on the related party note. The loan matures on April 12, 2025.

 

The Company continues to experience a loss from operations resulting in net cash outflows from operating activities of $596,000 for the three months ended June 30, 2023. The impacts from the macroeconomic environment continued to lead to lower sales across all of the Company's products.  Since the second quarter of fiscal year 2023, the Company drew a net of $1,770,000 on its line of credit and $750,000 on the Revolver.  To address the resulting cash flow challenges, the Company continues to monitor cost savings initiatives implemented in fiscal year 2023, including stopping or slowing production of inventory in alignment with current customer demand, maintaining a reduced headcount and compensation, primarily through attrition and furloughs, respectively, and eliminating certain discretionary selling, general and administrative expenses.

 

Funds generated by operating activities and available cash are the Company’s most significant sources of liquidity for working capital requirements, debt service and funding of maintenance levels of capital expenditures.  The Company has developed its operating plan to produce the cash flows necessary to meet all financing requirements.  Although the Company has a history of either being in compliance with debt covenants, or obtaining the necessary waivers, execution of it operating plan is dependent on many factors, some of which are not within the control of the Company. However, no assurances can be provided that the Company will achieve its operating plan and cash flow projections for this fiscal year or its projected consolidated financial position as of June 30, 2024. Such estimates are subject to change based on future results and such change could cause future results to vary significantly from expected results.

 

 

2.

SIGNIFICANT ACCOUNTING POLICIES

 

Consolidation

 

The accompanying condensed consolidated financial statements include the accounts of Cyanotech Corporation and its wholly owned subsidiary, Nutrex Hawaii, Inc. (“Nutrex Hawaii” or “Nutrex”, collectively the “Company”). All intercompany balances and transactions have been eliminated in consolidation.

 

Use of Estimates

 

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosures of any contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the periods reported.  Management reviews these estimates and assumptions periodically and reflects the effect of revisions in the period that they are determined to be necessary.  Actual results could differ from those estimates and assumptions.

 

Cash

 

Cash primarily consists of cash on hand and cash in bank deposits.

 

Concentration Risk

 

A significant portion of revenues and accounts receivables are derived from a few major customers. For the three months ended June 30, 2023, two customers individually accounted for 32% and 18% of the Company’s total net sales, and for the three months ended June 30, 2022, two customers individually accounted for 24% and 17% of the Company’s total net sales. Two customers accounted for 72% and 46% of the Company’s accounts receivable balance as of June 30, 2023 and March 31, 2023, respectively.

 

Accounts Receivable

 

Accounts receivable balances are recorded at the invoiced amount and do not accrue interest. Credit is extended base on evaluation of the customer’s financial condition. Collateral is not required. The allowance for credit losses reflects management’s best estimate of expected credit losses inherent in the accounts receivable balance. Management determines the allowances based on historical experience, specifically identified nonpaying customers and other currently available evidence, including the likelihood of each customer not being able to pay, due to the Company’s small customer and recurring customer base. Management reviews its customer account balances monthly with a focus on significant individual past due balances over 90 days. All other balances are reviewed on a pooled basis. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. The Company does not have any off-balance sheet credit exposure related to its customers or otherwise.

 

9

 

Revenue Recognition

 

The Company records revenue based on the five-step model which includes: (1) identifying the contract with the customer; (2) identifying the performance obligations in the contract; (3) determining the transaction price; (4) allocating the transaction price to the performance obligations; and (5) recognizing revenue when the performance obligations are satisfied. Substantially all of the Company’s revenue is generated by fulfilling orders for the purchase of its microalgal dietary supplements to retailers, wholesalers, or direct to consumers via online channels, with each order considered to be a distinct performance obligation. These orders may be formal purchase orders, verbal phone orders, e-mail orders or orders received online. Shipping and handling activities for which the Company is responsible under the terms and conditions of the order are not accounted for as performance obligations but as fulfillment costs. These activities are required to fulfill the Company’s promise to transfer the goods and are expensed when revenue is recognized. 

 

Revenue is measured as the net amount of consideration expected to be received in exchange for fulfilling a performance obligation. The Company has elected to exclude sales, use and similar taxes from the measurement of the transaction price.  The amount of consideration expected to be received and revenue recognized includes estimates of variable consideration, which includes costs for trade promotion programs, coupons, returns and early payment discounts.  Such estimates are calculated using historical averages adjusted for any expected changes due to current business conditions and experience. The Company reviews and updates these estimates at the end of each reporting period and the impact of any adjustments are recognized in the period the adjustments are identified. In assessing whether collection of consideration from a customer is probable, the Company considers the customer's ability and intent to pay that amount of consideration when it is due. Payment of invoices is due as specified in the underlying customer agreement, typically 30 days from the invoice date, which occurs on the date of transfer of control of the products to the customer. Revenue is recognized at the point in time that control of the ordered products is transferred to the customer. Generally, this occurs when the product is delivered, or in some cases, picked up from one of the Company’s distribution centers by the customer. Revenue from extraction services is recognized when control is transferred upon completion of the extraction process.

 

Customer contract liabilities consist of customer deposits received in advance of fulfilling an order and are shown separately on the consolidated balance sheets. During the three months ended June 30, 2023 and 2022, the Company recognized $16,000 and $91,000, respectively, of revenue from deposits that were included in contract liabilities as of March 31, 2023 and 2022, respectively. The Company’s contracts have a duration of one year or less and therefore, the Company has elected the practical expedient of not disclosing revenues allocated to partially unsatisfied performance obligations.

 

Disaggregation of Revenue

 

The following table represents revenue disaggregated by major product line and extraction services for the:

 

($ in thousands)

 

Three Months
Ended

June 30,

2023

  

Three Months
Ended

June 30,

2022

 

Packaged sales

        

Astaxanthin packaged

 $2,809  $3,524 

Spirulina packaged

  1,574   1,511 

Total packaged sales

  4,383   5,035 
         

Bulk sales

        

Astaxanthin bulk

  299   494 

Spirulina bulk

  363   1,093 

Total bulk sales

  662   1,587 
         

Contract extraction and R&D services revenue

  101   94 

Total net sales

 $5,146  $6,716 

 

10

 

Recently Accounting Pronouncements

 

In June 2016, the FASB issued ASU 2016-13,Financial Instruments Credit Losses” (“Topic 326”), which was subsequently amended in November 2018 through ASU 2018-19,Codification Improvements to Topic 326, Financial Instruments Credit Losses” (“CECL”). CECL requires entities to estimate lifetime expected credit losses for trade and other receivables, net investment in leases, financing receivables, debt securities and other instruments, which will result in earlier recognition of credit losses. The guidance is effective for interim and annual periods beginning after December 15, 2022. The Company adopted this standard as of April 1, 2023, however, due to the relatively short-term nature of its accounts receivable and history of limited bad debt expense, the impact of this guidance was not significant to the Company’s consolidated financial statements and related disclosure. The Company will continue to evaluate the impact of CECL going forward.

  

 

3.

INVENTORIES

 

Inventories are stated at the lower of cost or net realizable value. Cost is determined by the first-in, first-out method. Inventories consist of the following as of:

 

  

June 30,

2023

  

March 31,

2023

 
  

(in thousands)

 

Raw materials

 $1,736  $1,887 

Work in process

  1,872   2,049 

Finished goods

  6,574   6,502 

Supplies

  324   269 

Inventories

 $10,506  $10,707 

 

The Company recognizes abnormal production costs, including fixed cost variances from normal production capacity, fixed production overhead costs, idle facilities, freight handling costs and spoilage, as an expense in the period incurred, without adjusting overhead absorption rates. Normal production capacity is defined as the production expected to be achieved over a number of periods or seasons under normal circumstances, taking into account the loss of capacity resulting from planned maintenance. The Company expensed abnormal productions costs of $133,000 and $0 to cost of sales for the three months ended June 30, 2023 and 2022, respectively.

 

Beginning in fiscal year 2021 through fiscal year 2023, cultivation of astaxanthin was completed in the first six months of the fiscal year during the most productive months of the year due to the best growing conditions, compared to year-round production in the prior fiscal years. In fiscal year 2024, cultivation of astaxanthin will be year-round in order to manage staffing constraints. The Company calculates total production costs for the year based on normal capacity of production expected to be achieved in a year under normal circumstances. These costs are then allocated into inventory based on the period of production, not including abnormal production costs. Allocating fixed and overhead costs requires management’s judgement to determine when production is outside of the normal range of expected variation in production.

 

Other non-inventoriable fixed costs of $189,000 and $35,000 were expensed to cost of sales for the three months ended June 30, 2023 and 2022, respectively.

  

 

4.

EQUIPMENT AND LEASEHOLD IMPROVEMENTS

 

Equipment and leasehold improvements consist of the following as of:

 

  

June 30,

2023

  

March 31,

2023

 
  

(in thousands)

 

Equipment

 $21,711  $21,649 

Leasehold improvements

  15,064   15,038 

Furniture and fixtures

  407   407 
   37,182   37,094 

Less accumulated depreciation and amortization

  (26,354

)

  (25,947

)

Construction-in-progress

  237   219 

Equipment and leasehold improvements, net

 $11,065  $11,366 

 

Management has determined that no asset impairment existed as of June 30, 2023. Depreciation and amortization expense were approximately $407,000 and $417,000 for the three months ended June 30, 2023 and 2022, respectively.

 

11

  
 

5.

LINE OF CREDIT AND LONG-TERM DEBT

 

Total debt consists of the following as of:

 

  

June 30,

2023

  

March 31,

2023

 
  

(in thousands)

 

Line of credit

 $1,770  $1,540 

Line of credit – related party

  750   500 

Long-term debt

  3,402   3,461 

Long-term debt - related party

  1,000   1,000 

Unamortized debt issuance costs

  (89

)

  (92

)

Less current maturities

  (5,833

)

  (5,409

)

Total long-term debt, net of current maturities

 $1,000  $1,000 

 

Line of Credit and Term Loans

 

On August 30, 2016, the Credit Agreement, which the Company entered into with the Bank on June 3, 2016, became effective after the Company and the Bank received the necessary approvals from the State of Hawaii to secure the lien on the Company’s leasehold property in Kona, Hawaii. The Credit Agreement allows the Company to borrow up to $2,000,000 on a revolving basis. Borrowings under the Credit Agreement bear interest at the Wall Street Journal prime rate (8.25% at June 30, 2023 and 8.0% at March 31, 2023) plus 2%, floating, provided that at no time shall the annual interest rate be less than 5.25%.

 

At June 30, 2023 and March 31, 2023, the outstanding balance under the Credit Agreement was $1,770,000 and $1,540,000, respectively, was included in current liabilities on the Condensed Consolidated Balance Sheets. The line of credit, which is subject to annual renewal, was renewed on August 30, 2022 and will be subject to renewal upon expiration on August 30, 2023.

 

The Credit Agreement grants the Bank the following security interests in the Company’s property: (a) a lien on the Company’s leasehold interest in its Kona facility; (b) an assignment of the Company’s interest in leases and rents on its Kona facility; and (c) a security interest in all fixtures, furnishings and equipment related to or used by the Company at the Kona facility. Each security interest is further subject to the terms of the Credit Agreement.

 

In 2012, the Company executed a loan agreement with a lender providing for $5,500,000 in aggregate credit facilities (the “2012 Loan”) secured by substantially all the Company’s assets, including a mortgage on the Company's interest in its lease at the National Energy Laboratory of Hawaii Authority, pursuant to a Term Loan Agreement dated August 14, 2012 (the “2012 Loan Agreement”). The 2012 Loan is evidenced by promissory notes in the amounts of $2,250,000 and $3,250,000, the repayment of which is partially guaranteed under the provisions of a United States Department of Agriculture (“USDA”) Rural Development Guarantee program. The proceeds of the 2012 Loan were used to acquire processing equipment and leasehold improvements at its Kona, Hawaii facility.

 

The provisions of the 2012 Loan required the payment of interest only for the first 12 months of the term; thereafter, and until its maturity on August 14, 2032, the obligation fully amortizes over nineteen (19) years. Interest on the 2012 Loan accrues on the outstanding principal balance at an annual variable rate equal to the published Wall Street Journal prime rate (8.0% and 7.5% at June 30, 2023 and March 31, 2023, respectively) plus 1.0% and is adjustable on the first day of each calendar quarter and fixed for that quarter, provided that at no time shall the annual interest rate be less than 5.5%. The balance under the 2012 Loan was $3,402,000 and $3,461,000 at June 30, 2023 and March 31, 2023, respectively, and was included in current maturities of long-term debt in the debt table above. See Loan Covenants, Violations and Waiver below.

 

The 2012 Loan included a one-time origination and guaranty fees totaling $214,500 and an annual renewal fee payable in the amount of 0.25% of the USDA guaranteed portion of the outstanding principal balance as of December 31 of each year, beginning December 31, 2012. The USDA has guaranteed 80% of all amounts owing under the 2012 Loan. The balance in unamortized debt issuance costs was $89,000 and $92,000 at June 30, 2023 and March 31, 2023, respectively, and was included in current maturities of long-term debt in the debt table above. See Loan Covenants, Violations and Waiver below.

 

12

 

Loan Covenants, Violation and Waiver

 

The Company’s Credit Agreement and the 2012 Loan are subject to annual debt service and other financial covenants, including covenants which require the Company to meet key financial ratios and customary affirmative and negative covenants.  As of March 31, 2023, the Company was not in compliance with the required debt service coverage ratio, however, was in compliance with the two other covenants. Due to this violation, the Bank would be contractually entitled to require immediate repayment of the outstanding term loans and the outstanding line of credit balance. However, on June 22, 2023, the Bank issued the Company a letter waiving the covenant violation as of March 31, 2023, and implemented an immediate freeze on any and all further advances of the Credit Agreement through the maturity date, with an outstanding balance in the amount of $1,770,000 as of June 21, 2023. The next remeasurement date will be March 31, 2024.

 

Line of Credit and Debt Related Party

 

In April 2019, the Company obtained a loan in the amount of $1,500,000 and the interest was payable quarterly.  The loan was originally due in April 2021. In April 2021, the Company amended the loan, which extended the expiration to April 2024, converted $500,000 into the Revolver, adjusted the interest rate to reflect a floor of 5%, and granted a security interest in substantially all of the Company’s personal property assets, subject to limited exceptions. Concurrently, with the amendment and conversion of the original loan, the Company repaid in cash the principal amount of $500,000 plus accrued interest to date of $1,900 (see Note 12).  In December 2022, the Company amended the loan to extend the expiration to April 2025 and increase the Revolver to $1,000,000. At both June 30, 2023 and March 31, 2023, the balance under this loan was $1,000,000, which was included in long-term debt in the debt table above. At June 30, 2023 and March 31, 2023, the balance under the Revolver was $750,000 and $500,000, respectively, which was included in line of credit – related party in the debt table above. Interest accrues on the outstanding principal balance and the Revolver at an annual variable rate equal to the published Wall Street Journal prime rate (8.0% and 7.5% at June 30, 2023 and March 31, 2023, respectively) plus 1.0% and is adjustable on the first day of each calendar quarter and fixed for that quarter, provided that at no time shall the annual interest rate be less than 5.0%.

 

Future principal payments under the loans at June 30, 2023 are as follows:

 

Fiscal year payments due

 

(in thousands)

 

Remainder of 2024

 $3,402 

2026

  1,000 

Total principal payments

 $4,402 

  

 

6.

OPERATING LEASES

 

The Company leases facilities, equipment and land under non-cancelable operating leases expiring through 2037. One of its facility leases contains price escalations and a renewal option for five years. Right-of-use assets represent the right to use an underlying asset for the lease term and lease liabilities represent the obligation to make lease payments arising from the lease. Right-of-use assets and liabilities were recognized at April 1, 2019 based on the present value of lease payments over the lease term, using the Bank’s incremental borrowing rate based on the information available at recognition, and the Company has elected to exclude non-lease components. The Company also leases two 84-month solar leases for two of its buildings, which are included in the right-of-use assets and liabilities. At June 30, 2023, the weighted average remaining lease terms of all operating leases was 9.6 years, the weighted average discount rate was 7.3%, and for the three months ended June 30, 2023 and 2022, the operating lease costs were $203,000 and $171,000, respectively.

 

Supplemental balance sheet information related to leases consist of the following as of:

 

Operating leases

Balance Sheet Classification

 

June 30, 2023

  

March 31, 2023

 
   

(in thousands)

 

Right-of-use assets

Operating lease right-of-use assets

 $6,149  $6,149 

Accumulated lease amortization

Operating lease right-of-use assets

  (1,493

)

  (1,373

)

          

Total right-of-use assets

 $4,656  $4,776 
          

Current lease liabilities

Operating lease obligations

 $494  $483 

Non-current lease liabilities

Long-term operating lease obligations

  4,146   4,275 
          

Total lease liabilities

 $4,640  $4,758 

 

13

 

Maturities of lease liabilities at June 30, 2023 are as follows:

 

Payments

 

(in thousands)

 

Remainder of 2024

 $609 

2025

  817 

2026

  794 

2027

  801 

2028

  591 

Thereafter

  2,854 

Total undiscounted lease payments

  6,466 

Less: present value discount

  (1,826

)

Total lease liability balance

 $4,640 

  

 

7.

ACCRUED EXPENSES

 

Accrued expenses consist of the following as of:

 

   

June 30, 2023

   

March 31, 2023

 
   

(in thousands)

 

Bonus and profit sharing

  $ 143     $ 143  

Wages

    79       215  

Vacation

    384       393  

Interest and legal

    47       30  

Other accrued expenses

    168       320  

Total accrued expenses

  $ 821     $ 1,101  

  

 

8.

COMMITMENTS AND CONTINGENCIES

 

From time to time, the Company may be involved in litigation and investigations relating to claims and matters arising out of its operations in the normal course of business. There were no significant legal matters outstanding at June 30, 2023.

  

 

9.

SHARE-BASED COMPENSATION

 

The Company has share-based compensation plans, which are more fully described in Note 10, Share-Based Compensation, to the Consolidated Financial Statements included in the Company’s annual report on Form 10-K for the fiscal year ended March 31, 2023 as filed with the SEC on June 27, 2023.

 

As of June 30, 2023, the Company had two equity-based compensation plans: the 2016 Equity Incentive Plan (the “2016 Plan”) and the 2014 Independent Director Stock Option and Restricted Stock Grant Plan and Amendment (the “2014 Directors Plan”). The Company has also issued stock options, which remain outstanding as of June 30, 2023, under an equity-based compensation plan which has expired according to its terms: the 2004 Independent Director Stock Option and Stock Grant Plan (the “2004 Directors Plan”). This plan allowed the Company to award stock options and shares of restricted common stock to eligible employees, certain outside consultants and independent directors. No additional awards will be issued under the 2004 Directors Plan.

 

The following table presents shares authorized, available for future grant and outstanding under each of the Company’s plans:

 

  

As of June 30, 2023

 
  

Authorized

  

Available

  

Outstanding

 
             

2016 Plan

  1,300,000   873,737   310,756 

2014 Directors Plan

  650,000   205,534   12,000 

2004 Directors Plan

        6,000 

Total

  1,950,000   1,079,271   328,756 

 

14

 

Stock Options

 

All stock option grants made under the equity-based compensation plans were issued at exercise prices no less than the Company’s closing stock price on the date of grant. Options under the 2016 Plan, 2004 Directors Plan and 2014 Directors Plan were determined by the Board of Directors or the Compensation Committee of the Board of Directors in accordance with the provisions of the respective plans.  The terms of each option grant include vesting, exercise, and other conditions set forth in a Stock Option Agreement evidencing each grant. No option can have a life in excess of ten (10) years. The Company records compensation expense for employee stock options based on the estimated fair value of the options on the date of grant using the Black-Scholes option-pricing model. The model requires various assumptions, including a risk-free interest rate, the expected term of the options, the expected stock price volatility over the expected term of the options, and the expected dividend yield. Compensation expense for employee stock options is recognized ratably over the vesting term. Compensation expense recognized for options issued under all Plans was $26,000 and $17,000 for the three months ended June 30, 2023 and 2022, respectively.

 

A summary of option activity under the Company’s stock plans for the three months ended June 30, 2023 is presented below: 

 

Option Activity

 

Shares

  

Weighted
Average
Exercise

Price

  

Weighted

Average
Remaining
Contractual
Term (in
years)

  

Aggregate
Intrinsic
Value

 

Outstanding at March 31, 2023

  253,000  $2.88   7.5  $ 

Outstanding at June 30, 2023

  253,000  $2.88   7.2  $ 

Exercisable at June 30, 2023

  144,666  $2.97   6.8  $ 

 

The aggregate intrinsic value in the table above is before applicable income taxes and represents the excess amount over the exercise price optionees would have received if all options had been exercised on the last business day of the period indicated, based on the Company’s closing stock price of $0.86 and $0.88 at June 30, 2023 and March 31, 2023, respectively.

 

A summary of the Company’s non-vested options for the three months ended June 30, 2023 is presented below:

 

Nonvested Options

 

Shares

  

Weighted
Average
Grant-Date
Fair Value

 

Nonvested at March 31, 2023

  141,667  $1.55 

Vested

  (33,333

)

  1.77 

Nonvested at June 30, 2023

  108,334  $1.48 

 

As of June 30, 2023, total unrecognized stock-based compensation expense related to all unvested stock options was $103,000, which is expected to be expensed over a weighted average period of 1.4 years.

 

Restricted Stock 

 

To reduce the Company’s ongoing cash expenses, the Nominating and Corporate Governance Committee of the Board of Directors adopted a resolution allowing each director to elect to receive his or her quarterly director fees in the form of restricted stock in lieu of cash. Two Board members elected to receive shares of restricted stock in lieu of cash for the third fiscal quarter of 2023. On April 3, 2023, 17,672 shares of fully vested restricted stock were issue to the two Board members. For the three months ended June 30, 2023, there was no compensation expense related to the issuance of this stock, as it was earned and recognized in fiscal year 2023 in the amount of $15,500.

 

Restricted Stock Units (RSUs) 

 

RSUs are service-based awards granted to eligible employees under the 2016 Plan. Compensation expense recognized for RSUs issued under the 2016 Plan was $21,000 and $5,000 for the three months ended June 30, 2023 and 2022, respectively.

 

15

 

The following table summarizes information related to awarded RSUs:

 

Nonvested Restricted Stock Units

 

Shares

  

Weighted
Average
Grant Price

 

Nonvested restricted stock units at March 31, 2023

  70,334  $3.04 

Granted

  7,900   0.94 

Vested

  (2,278

)

  2.39 

Forfeited

  (200

)

  0.94 

Nonvested restricted stock units at June 30, 2023

  75,756  $2.85 

 

As of June 30, 2023, total unrecognized stock-based compensation expense related to unvested restricted stock units was $114,000, which is expected to be expensed over a weighted average period of 2.1 years.

  

 

10.

INCOME TAXES

 

The Company utilizes its estimated annual effective tax rate to determine its provision or benefit for income taxes for interim periods. The income tax provision or benefit is computed by multiplying the estimated annual effective tax rate by the year-to-date pre-tax book income (loss). The Company recorded no income tax expense and $3,000 of income tax expense for the three months ended June 30, 2023 and 2022, respectively. The Company’s effective tax rate was (0.7%) for the three months ended June 30, 2022. The effective tax rates differ from the statutory rate of 21% as a result of state taxes (net of federal benefit) and the net change in valuation allowance against the net deferred tax asset the Company believes is not more likely than not to be realized.  The Company continues to carry a full valuation allowance on its net deferred tax assets.

 

The Company is subject to taxation in the United States and eight state jurisdictions. The preparation of tax returns requires management to interpret the applicable tax laws and regulations in effect in such jurisdictions, which could affect the amount of tax paid by the Company. Management, in consultation with its tax advisors, files its tax returns based on interpretations that are believed to be reasonable under the circumstances. The income tax returns, however, are subject to routine reviews by the various taxing authorities.  As part of these reviews, a taxing authority may disagree with respect to the tax positions taken by management (“uncertain tax positions”) and therefore may require the Company to pay additional taxes. Management evaluates the requirement for additional tax accruals, including interest and penalties, which the Company could incur as a result of the ultimate resolution of its uncertain tax positions. Management reviews and updates the accrual for uncertain tax positions as more definitive information becomes available from taxing authorities, completion of tax audits, expiration of statute of limitations, or upon occurrence of other events.

 

As of June 30, 2023 and 2022, there was no liability for income tax associated with unrecognized tax benefits. The Company recognizes accrued interest related to unrecognized tax benefits as well as any related penalties in interest income or expense in its Consolidated Condensed Statements of Operations, which is consistent with the recognition of these items in prior reporting periods.

 

With few exceptions, the Company is no longer subject to U.S. federal, state, local, and non-U.S. income tax examination by tax authorities for tax years before 2019. 

  

 

11.

EARNINGS PER SHARE

 

Basic earnings (loss) per share is computed on the basis of the weighted average number of common shares outstanding. Diluted earnings (loss) per share is computed on the basis of the weighted average number of common shares outstanding plus the potentially dilutive effect of outstanding stock options using the treasury stock method.

 

16

 

Reconciliations between the numerator and the denominator of the basic and diluted (loss) income per share computations for the three months ended June 30, 2023 and 2022 are as follows:

 

  

Three Months Ended June 30, 2023

 
  

Net Loss

  

Shares

  

Per Share

 
  

(Numerator)

  

(Denominator)

  

Amount

 
  

(in thousands)

     

Basic and diluted loss per share

 $(1,369

)

  6,290  $(0.22

)

 

  

Three Months Ended June 30, 2022

 
  

Net Loss

  

Shares

  

Per Share

 
  

(Numerator)

  

(Denominator)

  

Amount

 
  

(in thousands)

     

Basic and diluted loss per share

 $(472

)

  6,204  $(0.08

)

 

Basic and diluted per share amounts are the same in periods of a net loss because common share equivalents are anti-dilutive when a net loss is recorded. Diluted earnings per share does not include the impact of common stock options and restricted stock units totaling 3,000 and 12,000 for the three months ended June 30, 2023 and 2022, respectively, as the effect of their inclusion would be anti-dilutive. Restricted stock units become dilutive within the period granted and remain dilutive until the units vest and are then included in the calculation of basic earnings per share.

  

 
 
 

12.

RELATED PARTY TRANSACTIONS 

 

In April 2019, the Company obtained an unsecured subordinated loan from Skywords in the principal amount of $1,500,000 pursuant to a Promissory Note (the "Skywords Note”) executed by the Company in favor of Skywords. Skywords is controlled by the Company’s Chairman of the Board of Directors and largest stockholder. The Skywords Note bore interest at a rate of 1% plus the prime rate (as published by the Wall Street Journal), which was recalculated and payable on a quarterly basis. The principal amount and any accrued and unpaid interest were due and payable on April 12, 2021. The proceeds of the Skywords Note were used to pay down accounts payable and for general operating capital purposes.

 

On April 12, 2021, the Company entered into an Amended and Restated Promissory Note (the “Skywords Amended Note”) with Skywords. The Company and Skywords agreed to amend, restate, replace and otherwise modify without novation, the Skywords Note in order to convert $500,000 of the outstanding principal amount into revolving loans that may be prepaid and reborrowed from time to time in principal amounts not to exceed $500,000, extend the maturity date by three years, adjust the interest rate to reflect a floor of 5% and secure Skywords’ interest by granting a security interest in substantially all of the Company’s personal property assets, subject to limited exceptions (the “Collateral”). On April 12, 2021, concurrently with the conversion, the Company repaid in cash to Skywords, the principal amount of $500,000 plus accrued interest to date of $1,900. The Skywords Amended Note bears interest at a rate of 1% plus the prime rate (as published by the Wall Street Journal), which will be recalculated and payable on a quarterly basis, provided that at no time shall the annual interest rate be less than 5%. The Company may prepay the Skywords Amended Note at any time without penalty.

 

On April 12, 2021, in connection with the grant of a security interest in the Collateral, the Company also entered into an Intercreditor and Subordination Agreement with the Bank and Skywords. The Company is indebted to the Bank pursuant to two Term Loans and a Credit Agreement, each of which granted the Bank a security interest in substantially all of the Company’s personal property assets. The Bank’s security interest in the Company’s personal property assets ranks senior to Skywords’ security interest in the Collateral, and the Intercreditor and Subordination Agreement generally governs the relationship between the Bank and Skywords as secured lenders to the Company and includes customary terms.

 

On December 14, 2022, the Company entered into a First Amendment (the “Amendment”) to the Skywords Amended Note. The Amendment extends the maturity date to April 12, 2025 and increases the revolving amount that the Company may borrow from time to time under the Skywords Note from $500,000 to $1,000,000. All other terms of the Skywords Note remain the same.

 

At both June 30, 2023 and March 31, 2023, the Skywords Note principal balance was $1,000,000, and was included in long-term debt on the Condensed Consolidated Balance Sheets. At June 30, 2023 and March 31, 2023, the balance on the Revolver was $750,000 and $500,000, respectively, and was included in line of credit – related party on the Condensed Consolidated Balance Sheets. At June 30, 2023 and March 31, 2023, the interest rates were 8.0% and 7.5%, respectively.

 

On June 30, 2023, the Company and Skywords executed a letter of intent to commence drafting and negotiating a definitive Second Agreement to the Amended and Restate Promissory Note, dated as of April 12, 2021, as amended on December 14, 2022, to which the revolving amount that the Company may borrow from time to time would increase from $1,000,000 to $2,000,000, with all other terms of the Amendment remaining the same. Entry into this Second Amendment is subject to the completion of definitive documentation and the other terms and conditions specified in the letter of intent.  On August 10, 2023, the Company received approval from First Foundation Bank and the USDA to move forward with the Second Agreement.

 

 

13.

SUBSEQUENT EVENTS

 

On August 10, 2023, the Company was notified by Nasdaq that the Company is not in compliance with Nasdaq's Listing Rule 5550(a)(2), as the minimum bid price of the Company's common stock had been below $1.00 per share for 30 consecutive business days.  Under Nasdaq's rules, the notification of noncompliance had no immediate effect on the listing or trading of the Company's common stock on Nasdaq under the symbol "CYAN".  Under Nasdaq's rule, the Company was given 180 days, or until February 6, 2024, to achieve compliance with the minimum bid price requirement.  To regain compliance, the minimum bid price of the Company's stock must meet or exceed $1.00 per share for a minimum of ten consecutive business days prior to the expiration of the 180-day grace period.  Failure to regain compliance during this period could result in delisting.

 

The Company had no additional subsequent events, other than those mentioned above and in Note 12 regarding the Bank and USDA approval.

 

   

 

Item 2.

Managements Discussion and Analysis of Financial Condition and Results of Operations

 

Overview:

 

We are an agricultural company and a world leader in the production of natural products derived from microalgae grown in complex and intricate agricultural systems on the Kona coast of Hawaii. Incorporated in 1983, we are guided by the principle of providing beneficial, quality microalgal products for health and human nutrition in a sustainable, reliable and environmentally sensitive operation. We are Good Manufacturing Practices (“GMP”) certified by the Merieux NutriSciences, reinforcing our commitment to quality in our products, quality in our relationships (with our customers, suppliers, employees and the communities we live in), and quality of the environment in which we work. Our products include:

 

 

BioAstin® Hawaiian Astaxanthin® - a powerful dietary antioxidant shown to support and maintain the body’s natural inflammatory response, to enhance skin, and to support eye, joint and immune health*. It has expanding applications as a human dietary supplement and dietary ingredient; and

 

 

Hawaiian Spirulina Pacifica® - a nutrient-rich dietary supplement used for extra energy, a strengthened immune system, cardiovascular benefits and as a source of antioxidant carotenoids*

 

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

 

Microalgae are a diverse group of microscopic plants that have a wide range of physiological and biochemical characteristics and contain, among other things, high levels of natural protein, amino acids, vitamins, pigments and enzymes. Microalgae have the following properties that make commercial production attractive: (1) microalgae grow much faster than land grown plants, often up to 100 times faster; (2) microalgae have uniform cell structures with no bark, stems, branches or leaves, permitting easier extraction of products and higher utilization of the microalgae cells; and (3) the cellular uniformity of microalgae makes it practical to control the growing environment in order to optimize a particular cell characteristic. Efficient and effective cultivation of microalgae requires consistent light, warm temperatures, low rainfall and proper chemical balance in a very nutrient-rich environment, free of environmental contaminants and unwanted organisms. This is a challenge that has motivated us to design, develop and implement proprietary production and harvesting technologies, systems and processes in order to commercially produce human dietary supplement products derived from microalgae.

 

Our production of these products at the 96-acre facility on the Kona Coast of the island of Hawaii provides several benefits. We selected the Keahole Point location in order to take advantage of relatively consistent warm temperatures, sunshine and low levels of rainfall needed for optimal cultivation of microalgae. This location also offers us access to cold deep ocean water, drawn from an offshore depth of 2,000 feet, which we use in our Ocean-Chill Drying system to eliminate the oxidative damage caused by standard drying techniques and as a source of trace nutrients for microalgal cultures. The area is also designated a Biosecure Zone, with tight control of organisms allowed into the area and free of genetically modified organisms (“GMO”). We believe that our technology, systems, processes and favorable growing location generally permit year-round harvest of our microalgal products in a cost-effective manner.

 

Results of Operations

 

The following tables present selected consolidated financial data for each of the periods indicated ($ in thousands):

 

   

Three Months Ended

 
   

June 30,

 
   

2023

   

2022

 

Net sales

  $ 5,146     $ 6,716  

Net sales decrease

    23.4

%

    25.1

%

Gross profit

  $ 1,532     $ 2,318  

Gross profit as % of net sales

    29.8

%

    34.5

%

Operating expenses

  $ 2,741     $ 2,743  

Operating expenses as % of net sales

    53.3

%

    40.8

%

Operating loss

  $ (1,209

)

  $ (425

)

Operating loss as % of net sales

    (23.5

)%

    (6.3

)%

Income tax expense

  $     $ 3  

Net loss

  $ (1,369

)

  $ (472

)

 

 

Comparison of the Three Months Ended June 30, 2023 and 2022

 

Net Sales (in thousands)

                               
   

Three Months Ended

                 
   

June 30,

       

%

 
   

2023

   

2022

   

Change

   

Change

 

Packaged sales

                               

Astaxanthin

  $ 2,809     $ 3,524     $ (715

)

    (20.3

)%

Spirulina

    1,574       1,511       63       4.2

%

Total Packaged sales

  $ 4,383     $ 5,035     $ (652

)

    (12.9

)%

                                 

Bulk sales

                               

Astaxanthin

  $ 299     $ 494     $ (195

)

    (39.5

)%

Spirulina

    363       1,093       (730

)

    (66.8

)%

Total Bulk sales

  $ 662     $ 1,587     $ (925

)

    (58.3

)%

                                 

Contract extraction revenue

  $ 101     $ 94     $ 7       7.4

%

                                 

Total sales

                               

Astaxanthin

  $ 3,108     $ 4,018     $ (910

)

    (22.6

)%

Spirulina

    1,937       2,604       (667

)

    (25.6

)%

Contract extraction and R&D services revenue

    101       94       7       7.4

%

Total sales

  $ 5,146     $ 6,716     $ (1,570

)

    (23.4

)%

 

Net Sales The net sales decrease of 23.4% for the current quarter compared to the same period last year was driven by a decrease in astaxanthin packaged sales and astaxanthin and spirulina bulk sales. During the period, we continued to experience overall lower demand resulting from higher inflation as consumers shift their spending from goods to experiences and services. For our packaged sales, in addition to the macroeconomic impacts, noted above, there was a decrease in sales due to the timing of shipments to a few customers.

 

Gross Profit Gross profit as a percent of net sales for the first quarter of fiscal 2024 decreased by 4.7 percentage points compared to the same period last year, which was the result of higher costs related to lower production volumes.

 

Operating Expenses Operating expenses of $2.7 million for the first quarter of fiscal 2024 compared to the prior year same quarter, remained relatively flat. Sales and marketing expenses increased slightly primarily due to higher selling fees, offset by lower general and administrative and research and development costs.

 

Income Taxes We recorded no income tax expense for the first quarter of fiscal 2024 compared to an income tax expense of $3,000 for the same period last year. We continue to carry a full valuation allowance on our net deferred tax assets.

 

 

Liquidity and Going Concern

 

The accompanying condensed consolidated financial statements as of and for the three months ended June 30, 2023 and 2022, and as of March 31, 2023, have been prepared assuming we will continue as a going concern. The going concern assumption contemplates the realization of assets and satisfaction of liabilities in the normal course of business. We sustained operating losses and negative cash flows from operation for these same periods. Further, as discussed below, the Company was not in compliance with a debt covenant requirement at March 31, 2023 and the Bank instituted a freeze on additional advances from the Credit Agreement. These conditions raise substantial doubt about our ability to continue as a going concern. The condensed consolidated financial statements do not include any adjustments to the carrying amounts and classification of assets, liabilities, and reported expense that may be necessary if we were unable to continue as a going concern.

 

As of June 30, 2023, we had cash of $0.6 million and working capital of $4.4 million compared to $1.0 million and $5.4 million, respectively, at March 31, 2023. We have a Credit Agreement with the Bank that provided for borrowings up to $2.0 million on a revolving basis, however, as part of the covenant waiver at March 31, 2023, the borrowings under this line of credit were frozen at the outstanding balance on June 22, 2023, at $1.8 million. As of March 31, 2023, we had outstanding borrowings of $1.5 million on the line of credit. The line of credit is subject to renewal on August 30, 2023, and we intend to renew or replace it with another line of credit on or before the expiration date.

 

 

We also have a loan facility with a related party that allows us to borrow up to $1.0 million on the Revolver. At June 30, 2023 and March 31, 2023, we had $0.8 million and $0.5, respectively, outstanding borrowings on the Revolver, which were included in line of credit – related party on the Condensed Consolidated Balance Sheets. The Revolver expires on April 12, 2025 (see Notes 5 and 12 in the notes to our condensed consolidated financial statements). On June 30, 2023, the Company and Skywords executed a letter of intent to commence drafting and negotiating a definitive Second Agreement to the Amended and Restate Promissory Note, dated as of April 12, 2021, as amended on December 14, 2022, to which the revolving amount that we may borrow from time to time would increase from $1,000,000 to $2,000,000, with all other terms of the Amendment remaining the same.

 

As of June 30, 2023, we had $3.4 million in Term Loans payable to the Bank that require the payment of principal and interest monthly through August 2032. Pursuant to the Term Loans and the Credit Agreement, we are subject to annual financial covenants, customary affirmative and negative covenants and certain subjective acceleration clauses. As of March 31, 2023, our debt service coverage ratio fell short of the Bank’s annual requirement. On June 22, 2023, the Bank provided us with a letter waiving the covenant violation as of March 31, 2023, but noting that the Bank reserved its right to declare a default in the future if any covenants remain out of compliance at applicable measurement dates. In addition, the Bank’s letter implemented an immediate freeze on any and all further advances of the Credit Agreement through the maturity date.

 

In April 2019, we obtained a loan in the amount of $1.5 million from a related party. The proceeds were used to pay down accounts payable and for general operating capital purposes. On April 12, 2021 and December 14, 2022, we amended this loan (see Notes 5 and 12 in the notes to condensed consolidated financial statements). As of both June 30, 2023 and March 31, 2023, we had $1.0 million outstanding on the related party note. The loan matures on April 12, 2025.

 

We continue to experience a loss from operations resulting in net cash outflows from operating activities of $0.6 million for the three months ended June 30, 2023. The impacts from the macroeconomic environment have continued to lead to lower sales across all of our products.  Since the second quarter of fiscal year 2023, we drew a net of $1.8 million on our line of credit and $0.8 million on the Revolver.  To address the resulting cash flow challenges, we continue to monitor cost savings initiatives implemented in fiscal year 2023, including stopping or slowing production of inventory in alignment with current customer demand, maintaining a reduced headcount and compensation, primarily through attrition and furloughs, respectively, and eliminating certain discretionary selling, general and administrative expenses.

 

Funds generated by operating activities and available cash are our most significant sources of liquidity for working capital requirements, debt service and funding of maintenance levels of capital expenditures. We have developed our operating plan to produce the cash flows necessary to meet all financing requirements.  Although we have a history of either being in compliance with debt covenants or obtaining the necessary waivers, execution of our operating plan is dependent on many factors, some of which are not within the control of the Company.  However, no assurances can be provided that we will achieve our operating plan and cash flow projections for this fiscal year or our projected consolidated financial position as of June 30, 2024. Such estimates are subject to change based on future results and such change could cause future results to vary significantly from expected results.

 

Cash Flows The following table summarizes our cash flows for the periods indicated ($ in thousands):

 

   

Three Months Ended

June 30,

 
   

2023

   

2022

 

Total cash provided by (used in):

               

Operating activities

  $ (596

)

  $ (1,299

)

Investing activities

    (150

)

    (376

)

Financing activities

    420       (177

)

                 

Decrease in cash

  $ (326

)

  $ (1,852

)

 

Cash used in operating activities for the three months ended June 30, 2023 was the result of a net loss of $1.4 million, an increase of $0.5 million in accounts receivable, offset by non-cash charges of $0.6 million and lower inventories.

 

Cash used in investing activities for the three months ended June 30, 2023 primarily includes costs for capital improvements at our Kona facility.

 

Cash provided by financing activities for the three months ended June 30, 2023 consists primarily of draws on the line of credit of $230,000 and on the related party line of credit of $250,000 offset by debt service payments of $59,000.

 

Sources and Uses of Capital

 

As of June 30, 2023, our working capital was $4.4 million, a decrease of $1.0 million compared to March 31, 2023. There was a decrease in inventories in the first quarter of fiscal 2024 as we manage our production in line with sales demand, offset by the start-up of astaxanthin cultivation in April.

 

Our results of operations and financial condition can be affected by numerous factors, many of which are beyond our control and could cause future results of operations to fluctuate materially as it has in the past. Future operating results may fluctuate as a result of changes in sales volumes to our largest customers, weather patterns, increased competition, increased materials, nutrient and energy costs, government regulations and other factors beyond our control.

 

A significant portion of our expense levels are relatively fixed, so the timing of increases in expenses is based in large part on forecasts of future sales. If net sales are below expectations in any given period, the adverse impact on results of operations may be magnified by our inability to adjust spending quickly enough to compensate for the sales shortfall. We may also choose to reduce prices or increase spending in response to market conditions, which may have a material adverse effect on financial condition and results of operations.

 

 

Outlook 

 

This outlook section contains a number of forward-looking statements, all of which are based on current expectations. Actual results may differ materially.

 

Our strategic direction has been to position as a world leader in the production and marketing of high-value natural products from microalgae. We are vertically aligned, producing raw materials in the form of microalgae processed at our 96-acre facility in Hawaii, and integrating those raw materials into finished products. Our primary focus is stabilizing our production volume, rationalizing market channel participation, and leveraging our centers of core competence. We will continue to place emphasis on our Nutrex Hawaiian consumer products while exploring further opportunities for bulk sales orders for Spirulina and Astaxanthin, both domestically and internationally. Extraction services to third party customers utilizing our 1,000 bar super critical CO2 extractor process are expected to generate additional income throughout the year. We will leverage our experience and reputation for quality, nutritional products which promote health and well-being. The foundation of our nutritional products is naturally cultivated Hawaiian Spirulina Pacifica® in powder and tablet form; and BioAstin® Hawaiian Astaxanthin® antioxidant in extract and softgel form. Information about our Company and our products can be viewed at www.cyanotech.com and www.nutrex-hawaii.com. Consumer products can also be purchased online at www.nutrex-hawaii.com.

 

Gross profit margin percentages going forward can be impacted by lower production volumes along with pressure on input costs as well as greater competition in the market place. This could cause margins to decline in future periods. We will continue to focus on higher margin consumer products that promote health and well-being and strive for continuous improvements in processes and production methods to stabilize costs and production levels for the future. However, significant sales variability between periods may occur based on historical results.

 

Producing the highest quality microalgae is a complex biological process which requires balancing numerous factors including microalgal strain variation, temperature, acidity, nutrient and other environmental considerations, some of which are not within our control. An imbalance or unexpected event can occur resulting in production levels below normal capacity. The allocation of fixed production overheads (such as depreciation, rent and general insurance) to inventories is determined based on normal production capacity. When our production volumes are below normal capacity limits, certain fixed production overhead costs cannot be inventoried and are recorded immediately in cost of sales. In addition, when production costs exceed historical averages, we evaluate whether such costs are one-time-period charges or an ongoing component of inventory cost.

 

To manage our cash resources effectively, we will balance production with sales demand, minimizing the cost associated with inventory levels when appropriate and manage our expenses judiciously. We could experience unplanned cash outflows and may need to utilize other cash resources to meet working capital needs. A prolonged downturn in sales could impair our ability to generate sufficient cash for operations and hamper our ability to attract additional capital investment which could become necessary to maintain optimal production levels and efficiencies.

 

Our future results of operations and the other forward-looking statements contained in this Outlook, in particular the statements regarding revenues, gross margin and capital spending, involve a number of risks and uncertainties. In addition to the factors discussed above, any of the following could cause actual results to differ materially: business conditions and growth in the natural products industry and in the general economy; changes in customer order patterns; changes in demand for natural products in general; changes in weather conditions; changes in health and growing conditions of our astaxanthin and spirulina products; competitive factors, such as increased production capacity from competing spirulina and astaxanthin producers and the resulting impact, if any, on world market prices for these products; government actions and increased regulations both domestic and foreign; shortage of manufacturing capacity; and other factors beyond our control. Risk factors are discussed in detail in Part II, Item 1A of this quarterly report and in Part I, Item 1A of our Form 10-K report for the year ended March 31, 2023.

 

We believe that our technology, systems, processes and favorable growing location generally permit year-round harvest of our microalgal products in a cost-effective manner. However, previously experienced imbalances in the highly complex biological production systems, together with volatile energy costs and rapidly changing world markets, suggest a need for continuing caution with respect to variables beyond our reasonable control. Therefore, we cannot, and do not attempt to, provide any definitive assurance with regard to our technology, systems, processes, location, or cost-effectiveness.

 

Off-Balance Sheet Arrangements

 

As of June 30, 2023, we had no off-balance sheet arrangements or obligations.

 

 

Impact of Inflation

 

Inflationary factors such as increases in the costs of materials, utilities and labor affected our operations in fiscal year 2023. In the first quarter of fiscal year 2024, we have seen stabilization in our underlying costs. We are also experiencing overall lower demand as consumers are feeling the impacts of higher inflation and are re-allocating their spending from goods to experiences and services. Given the lower demand, our bulk customers have higher than normal inventory levels. The exact impact on our results is difficult to isolate and quantify given the macroeconomic environment. Most of our leases provide for cost-of-living adjustments and require us to pay for insurance and maintenance expenses, all of which are subject to inflation. Additionally, our future lease cost for new facilities may include potentially escalating costs of real estate and construction. There is no assurance that we will be able to pass on increased costs to our customers.

 

Depreciation expense is based on the historical cost of fixed assets and is therefore potentially less than it would be if it were based on current replacement cost. While property and equipment acquired in prior years will ultimately have to be replaced at higher prices, it is expected that replacement will be a gradual process over many years.

 

Critical Accounting Policies and Estimates

 

Our critical accounting policies and estimates are disclosed in the “Management’s Discussion and Analysis of Financial Condition and Results of Operations” section of our Annual Report on Form 10-K for the fiscal year ended March 31, 2023, filed with the SEC on June 27, 2023. In the three months ended June 30, 2023, there were no changes to the application of critical accounting policies previously disclosed in our most recent Annual Report on Form 10-K.

 

 

Item 4.

Controls and Procedures

 

Disclosure Controls and Procedures 

 

Under the supervision and with the participation of our management, including our chief executive officer (“CEO”) and chief financial officer (“CFO”), we have evaluated the effectiveness of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15(d)-15(e) of the Exchange Act as of the end of the period covered by this Report. Based on that evaluation, our CEO and CFO have concluded that our disclosure controls and procedures are effective to provide reasonable assurance that information we are required to disclose in reports we file or submit under the Exchange Act is (1) recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and (2) accumulated and communicated to our management, including our CEO and CFO, as appropriate to allow timely decisions regarding required disclosures.  

 

Managements Report on Internal Control over Financial Reporting 

 

The Company’s management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act). The Company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. Our management evaluated the effectiveness of our internal control over financial reporting as of June 30, 2023. In making this assessment, our management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission in “Internal Control - Integrated Framework” (2013 Framework). Based on our assessment, using those criteria, management concluded that our internal control over financial reporting was effective as of June 30, 2023. 

 

Changes to Internal Control Over Financial Reporting 

 

There were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the three months ended June 30, 2023, that has materially affected, or was reasonably likely to materially affect, our internal control over financial reporting.

 

Limitations on the Effectiveness of Controls 

 

Our management, including our CEO and CFO, do not expect that our disclosure controls and procedures or our internal controls over financial reporting will prevent all errors and all fraud. A control system no matter how well designed and implemented, can provide only reasonable, not absolute, assurance that the control system’s objectives will be met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs.

 

The inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of simple errors or mistakes. Controls can also be circumvented by the individual acts of some persons, or by collusion of two or more people. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected. 

 

This Form 10-Q should be read in conjunction with Item 9A “Controls and Procedures” of the Company’s Form 10-K for the fiscal year ended March 31, 2023, filed June 27, 2023.

 

 

  PART II.  

OTHER INFORMATION

 

Item 1.

Legal Proceedings

 

From time to time, the Company may be involved in litigation and investigations relating to claims and matters arising out of its operations in the normal course of business. There were no significant legal matters outstanding at June 30, 2023.

 

Item 1A.

Risk Factors

 

For a discussion of the risk factors relating to our business, please refer to Part I, Item 1A of our Form 10-K for the year ended March 31, 2023, which is incorporated by reference herein.

 

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

 

None.

 

Item 3.

Defaults upon Senior Securities

 

None.

 

Item 5.

Other Information

 

None.

 

 

Item 6.

Exhibits

 

 

31.1*

Certifications of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 signed as of August 11, 2023

     
 

31.2*

Certifications of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 signed as of August 11, 2023

     
 

32*

Certifications of Chief Executive Officer and Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 signed as of August 11, 2023

     
 

99.1*

Press Release dated August 11, 2023

     
 

101

The following financial statements from Cyanotech Corporation’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2023, formatted in Inline XBRL (eXtensible Business Reporting Language): (i) the Condensed Consolidated Balance Sheets, (ii) the Condensed Consolidated Statements of Operations, (iii) the Condensed Consolidated Statements of Cash Flows, and (iv) Notes to Condensed Consolidated Financial Statements.

     
 

104

Cover Page Interactive Data File (Formatted as Inline XBRL and contained in Exhibit 101)

     
   

*Included herewith. Other exhibits were filed as shown above.

 

 

SIGNATURES

 

In accordance with the requirements of the Securities Exchange Act of 1934, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

   

CYANOTECH CORPORATION

   

(Registrant)

     
     

August 11, 2023

 

By:

/s/ Matthew K. Custer

(Date)

   

Matthew K. Custer

     

President and Chief Executive Officer

       
       

August 11, 2023

 

By:

/s/ Felicia Ladin

(Date)

   

Felicia Ladin

     

Chief Financial Officer, Vice President — Finance &
Administration, and Treasurer

     

(Principal Financial Officer)

 

 

 

EXHIBIT INDEX

 

Exhibit Number

 

Description

31.1*

 

Certifications of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 signed as of August 11, 2023

     

31.2*

 

Certifications of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 signed as of August 11, 2023

     

32*

 

Certifications of Chief Executive Officer and Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 signed as of August 11, 2023

     

99.1*

 

Press Release dated August 11, 2023

     

101

 

The following financial statements from Cyanotech Corporation’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2023, formatted in Inline XBRL (eXtensible Business Reporting Language): (i) the Condensed Consolidated Balance Sheets, (ii) the Condensed Consolidated Statements of Operations, (iii) the Condensed Consolidated Statements of Stockholders’ Equity, (iv) the Condensed Consolidated Statements of Cash Flows, and (v) Notes to Condensed Consolidated Financial Statements

     

104

 

Cover Page Interactive Data File (Formatted as Inline XBRL and contained in Exhibit 101)

     
   

*Included herewith.  Other exhibits were filed as shown above.

 

26
EX-31.1 2 ex_553363.htm EXHIBIT 31.1

 

Exhibit 31.1

 

Certification Pursuant

To 18 U. S. C. Section 1350,

As Adopted Pursuant To

Section 302 of the Sarbanes-Oxley Act of 2002

 

I, Matthew K. Custer, Chief Executive Officer certify that:

 

1.

I have reviewed this quarterly report on Form 10-Q of Cyanotech Corporation;

 

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

 

4.

The registrant’s other certifying officer and I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15 (e) and 15d-15 (e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and we have:

 

 

a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiary, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

   

 

 

b)

Designed such internal control over financial reporting or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

   

 

 

c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

   

 

 

d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.

 

5.

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent function):

 

 

a)

All significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

   

 

 

b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

 

Date: August 11, 2023

/s/ Matthew K. Custer

 

Matthew K. Custer

 

President and Chief Executive Officer

 

 
EX-31.2 3 ex_553362.htm EXHIBIT 31.2

 

Exhibit 31.2

 

Certification Pursuant

To 18 U. S. C. Section 1350,

As Adopted Pursuant To

Section 302 of the Sarbanes-Oxley Act of 2002

 

I, Felicia Ladin, Chief Financial Officer certify that:

 

1.

I have reviewed this quarterly report on Form 10-Q of Cyanotech Corporation;

 

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

 

4.

The registrant’s other certifying officer and I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15 (e) and 15d-15 (e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and we have:

 

 

a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiary, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

   

 

 

b)

Designed such internal control over financial reporting or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

   

 

 

c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

   

 

 

d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.

 

5.

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent function):

 

 

a)

All significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

 

b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

 

Date: August 11, 2023

/s/ Felicia Ladin

 

Felicia Ladin

 

Chief Financial Officer; Vice President

Finance &
Administration, and Treasurer 

 

(Principal Financial Officer)

 

 
EX-32 4 ex_553361.htm EXHIBIT 32

 

Exhibit 32

 

Certification of CEO and CFO

Pursuant to 18 U.S.C. Section 1350,

As Adopted Pursuant to Section 906

of the Sarbanes-Oxley Act of 2002

 

In connection with the Quarterly Report of Cyanotech Corporation (the “Company”) on Form 10-Q for the period ended June 30, 2023 (the “Report”) as filed with the Securities and Exchange Commission on the date hereof, each of the undersigned certifies that:

 

1)

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act (15 U.S.C. 78m or 78o (d)); and

 

2)

The information contained in the Report fairly presents, in all material aspects, the financial condition and results of operations of the Company.

 

 

Date: August 11, 2023

/s/ Matthew K. Custer

 

Matthew K. Custer 

 

President and Chief Executive Officer

   
   

Date: August 11, 2023

/s/ Felicia Ladin

 

Felicia Ladin

 

Chief Financial Officer; Vice President

Finance &
Administration, and Treasurer

 

(Principal Financial Officer)

 

 
EX-99.1 5 ex_553360.htm EXHIBIT 99.1
 

 

Exhibit 99.1

 

image01.jpg

 

 

News Release 

Contact: Bruce Russell

(310) 346-6131

brussell@cyanotech.com

 

Cyanotech Reports Financial Results for the First Quarter of Fiscal 2024

 

 

KAILUA KONA, Hawaii (August 11, 2023) — Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health dietary supplement products, announced financial results for the first quarter of fiscal year 2024, ended June 30, 2023.

 

Commenting on the first quarter fiscal year 2024 results, Cyanotech’s President and Chief Executive Officer, Matthew K. Custer, said:

 

“This quarter we continue to see the impact of consumers shifting their spend from goods to experiences and services and reallocation of spending related to the high cost of living.  Due to these shifting consumer trends, we have added a new position to the Company, Chief Strategic and Commercial Officer, to oversee and drive market strategy and revenue opportunities.”

 

“Our production is performing efficiently, and we are managing production volumes in line with sales demand to control costs.”

 

“I am optimistic about the Company's future as we continue to build brand awareness to our naturally derived high value nutritional products.”

 

First Quarter Fiscal 2024

Cyanotech reported net sales of $5,146,000 for the first quarter of fiscal 2024 compared to $6,716,000 for the first quarter of fiscal 2023, a decrease of 23.4%. Gross profit was $1,532,000, with gross profit margin of 29.8%, compared to gross profit of $2,318,000, with gross profit margin of 34.5%. Operating loss for the first quarter of fiscal 2024 was $1,209,000 compared to operating loss of $425,000 in the same period of the prior year. Net loss for the current fiscal quarter was $1,369,000, or $0.22 per diluted share, compared to net loss of $472,000, or $0.08 per diluted share, for the same period of the prior year.

 

Trailing Twelve Months

For the trailing twelve months ended June 30, 2023, compared to the trailing twelve months ended June 30, 2022, net sales were $21,607,000 compared to $33,720,000, respectively.  Gross profit was $6,473,000, with gross profit margin of 30.0%, compared to $12,212,000 and 36.2%.  Net loss was $4,337,000, or $0.69 per diluted share, compared to net income of $1,161,000, or $0.19 per diluted share.

 

 

73-4460 Queen Kaahumanu Highway, #102 ~ Kailua-Kona, Hawaii 96740

(808) 326-1353 fax (808) 329-3597 ~ www.cyanotech.com

 

1

 
image01.jpg

 

 

Please review the Company’s Form 10-Q for the period ended June 30, 2023 for more detailed information.

 

---------------

 

— Cyanotech will host a virtual broadcast at 8:00 PM EST on Monday, August 14, 2023 to respond to questions about its operating results and other topics of interest. Interested parties are asked to submit questions to questions@cyanotech.com before 12 p.m. (noon) EST on Monday, August 14, 2023. The Company will respond only to relevant questions relating to the Company’s first quarter fiscal 2024 financial performance and will not be accepting any questions or comments during the broadcast.

 

To join the broadcast, please browse http://cyanotech.com/meet approximately five minutes prior to the start time.

 

---------------

 

About Cyanotech Cyanotech Corporation, a world leader in microalgae technology for more than 30 years, produces BioAstin® Hawaiian Astaxanthin® and Hawaiian Spirulina Pacifica®. These all-natural, dietary ingredients and supplements leverage our experience and reputation for quality, building nutritional brands which promote health and well-being. The Company’s mission is to fulfill the promise of whole health through Hawaiian microalgae. Cyanotech’s BioAstin® offers superior antioxidant activity which supports skin, eye and joint health, as well as recovery from exercise*. Cyanotech's Spirulina products offer nutrition that supports cardiovascular health and immunity*. All Cyanotech products are produced from microalgae grown at our 96-acre facility in Kona, Hawaii using patented and proprietary technology and are Generally Recognized as Safe (“GRAS”) for use in food products. Cyanotech sells its products direct to consumers at retail locations in the United States and online at www.nutrex-hawaii.com and also distributes to dietary supplement, nutraceutical and cosmeceutical manufacturers and marketers. The Company is regulated by the Food and Drug Administration. Visit www.cyanotech.com for more information.

 

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

 

“Safe Harbor Statement under the U.S. Private Securities Litigation Reform Act of 1995 Besides statements of present fact and historical fact, this press release may contain forward-looking statements. Forward-looking statements relate to the future and are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Our actual results may differ materially from those contemplated by forward-looking statements. We caution against relying on forward-looking statements. Important factors that could change actual, future results include: changes in sales levels to our largest customers, weather patterns in Hawaii, production problems, risks associated with new products, foreign exchange fluctuations, and availability of financing, as well as national and global political, economic, business, competitive, market and regulatory conditions. Other factors are more fully detailed in the Company’s annual Form 10-K filings with the Securities and Exchange Commission.

 

 

Financial Tables Follow: The following tables do not contain footnotes or other information contained in the Company’s Form 10-Q for the first quarter fiscal 2024 ended June 30, 2023, which can be found on the Cyanotech website (www.cyanotech.com) under Investors>Investor Filings upon filing. As such, the following Financial Tables are provided only as a guide and other factors are more fully detailed in the Company’s annual Form 10-K filings with the Securities and Exchange Commission.

 

 

73-4460 Queen Kaahumanu Highway, #102 ~ Kailua-Kona, Hawaii 96740

(808) 326-1353 fax (808) 329-3597 ~ www.cyanotech.com

 

2

image01.jpg

 

CYANOTECH CORPORATION 

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except per share amounts)

(Unaudited)

 

   

June 30,
2023

   

March 31,
2023

 

ASSETS

               

Current assets:

               

Cash

  $ 648     $ 974  

Accounts receivable, net of allowance for credit losses of $11 as of June 30, 2023 and $64 as of March 31, 2023

    1,794       1,331  

Inventories

    10,506       10,707  

Prepaid expenses and other current assets

    378       484  

Total current assets

    13,326       13,496  
                 

Equipment and leasehold improvements, net

    11,065       11,366  

Operating lease right-of-use assets, net

    4,656       4,776  

Other assets

    85       90  

Total assets

  $ 29,132     $ 29,728  
                 

LIABILITIES AND STOCKHOLDERS’ EQUITY

               

Current liabilities:

               

Accounts payable

  $ 1,721     $ 1,021  

Accrued expenses

    821       1,101  

Customer deposits

    77       89  

Operating lease obligations, current portion

    494       483  

Line of credit

    1,770       1,540  

Line of credit – related party

    750       500  

Current maturities of long-term debt

    3,313       3,369  

Total current liabilities

    8,946       8,103  
                 

Long-term debt, less current maturities

    1,000       1,000  

Long-term operating lease obligations

    4,146       4,275  

Other long-term liabilities

          3  

Total liabilities

    14,092       13,381  
                 

Commitments and contingencies

               
                 

Stockholders’ equity:

               

Preferred stock of $0.01 par value, authorized 10,000,000 shares; no shares issued and outstanding

           

Common stock of $0.02 par value, authorized 50,000,000 shares; issued and outstanding 6,291,086 shares at June 30, 2023 and 6,271,971 shares at March 31, 2023

    126       125  

Additional paid-in capital

    33,917       33,856  

Accumulated deficit

    (19,003

)

    (17,634

)

Total stockholders’ equity

    15,040       16,347  

Total liabilities and stockholders’ equity

  $ 29,132     $ 29,728  

 

73-4460 Queen Kaahumanu Highway, #102 ~ Kailua-Kona, Hawaii 96740

(808) 326-1353 fax (808) 329-3597 ~ www.cyanotech.com

 

3

 
image01.jpg

 

CYANOTECH CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

 

(In thousands, except per share amounts)

(Unaudited)

 

   

Three Months Ended
June 30,

 
   

2023

   

2022

 
                 

Net sales

  $ 5,146     $ 6,716  

Cost of sales

    3,614       4,398  

Gross profit

    1,532       2,318  
                 

Operating expenses:

               

General and administrative

    1,274       1,329  

Sales and marketing

    1,276       1,168  

Research and development

    191       246  

Total operating expenses

    2,741       2,743  
                 

Loss from operations

    (1,209

)

    (425

)

                 

Interest expense, net

    (160

)

    (44

)

                 

Loss before income taxes

    (1,369

)

    (469

)

                 

Income tax expense

          3  
                 

Net loss

  $ (1,369

)

  $ (472

)

                 

Net loss per share:

               

Basic

  $ (0.22

)

  $ (0.08

)

Diluted

  $ (0.22

)

  $ (0.08

)

                 

Shares used in calculation of net loss per share:

               

Basic

    6,290       6,204  

Diluted

    6,290       6,204  

 

 

73-4460 Queen Kaahumanu Highway, #102 ~ Kailua-Kona, Hawaii 96740

(808) 326-1353 fax (808) 329-3597 ~ www.cyanotech.com

 

4
EX-101.SCH 6 cyan-20230630.xsd XBRL TAXONOMY EXTENSION SCHEMA 000 - Document - Document And Entity Information link:calculationLink link:definitionLink link:presentationLink 001 - Statement - Condensed Consolidated Balance Sheets (Current Period Unaudited) link:calculationLink link:definitionLink link:presentationLink 002 - Statement - Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) link:calculationLink link:definitionLink link:presentationLink 003 - Statement - Condensed Consolidated Statements of Operations (Unaudited) link:calculationLink link:definitionLink link:presentationLink 004 - Statement - Consolidated Statements of Stockholders' Equity (Unaudited) link:calculationLink link:definitionLink link:presentationLink 005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:calculationLink link:definitionLink link:presentationLink 006 - Disclosure - Note 1 - Organization and Basis of Presentation link:calculationLink link:definitionLink link:presentationLink 007 - Disclosure - Note 2 - Significant Accounting Policies link:calculationLink link:definitionLink link:presentationLink 008 - Disclosure - Note 3 - Inventories link:calculationLink link:definitionLink link:presentationLink 009 - Disclosure - Note 4 - Equipment and Leasehold Improvements link:calculationLink link:definitionLink link:presentationLink 010 - Disclosure - Note 5 - Line of Credit and Long-term Debt link:calculationLink link:definitionLink link:presentationLink 011 - Disclosure - Note 6 - Operating Leases link:calculationLink link:definitionLink link:presentationLink 012 - Disclosure - Note 7 - Accrued Expenses link:calculationLink link:definitionLink link:presentationLink 013 - Disclosure - Note 8 - Commitments and Contingencies link:calculationLink link:definitionLink link:presentationLink 014 - Disclosure - Note 9 - Share-based Compensation link:calculationLink link:definitionLink link:presentationLink 015 - Disclosure - Note 10 - Income Taxes link:calculationLink link:definitionLink link:presentationLink 016 - Disclosure - Note 11 - Earnings Per Share link:calculationLink link:definitionLink link:presentationLink 017 - Disclosure - Note 12 - Related Party Transactions and Balances link:calculationLink link:definitionLink link:presentationLink 018 - Disclosure - Note 13 - Subsequent Events link:calculationLink link:definitionLink link:presentationLink 019 - Disclosure - Note 2 - Significant Accounting Policies (Tables) link:calculationLink link:definitionLink link:presentationLink 020 - Disclosure - Note 3 - Inventories (Tables) link:calculationLink link:definitionLink link:presentationLink 021 - Disclosure - Note 4 - Equipment and Leasehold Improvements (Tables) link:calculationLink link:definitionLink link:presentationLink 022 - Disclosure - Note 5 - Line of Credit and Long-term Debt (Tables) link:calculationLink link:definitionLink link:presentationLink 023 - Disclosure - Note 6 - Operating Leases (Tables) link:calculationLink link:definitionLink link:presentationLink 024 - Disclosure - Note 7 - Accrued Expenses (Tables) link:calculationLink link:definitionLink link:presentationLink 025 - Disclosure - Note 9 - Share-based Compensation (Tables) link:calculationLink link:definitionLink link:presentationLink 026 - Disclosure - Note 11 - Earnings Per Share (Tables) link:calculationLink link:definitionLink link:presentationLink 027 - Disclosure - Note 1 - Organization and Basis of Presentation (Details Textual) link:calculationLink link:definitionLink link:presentationLink 028 - Disclosure - Note 2 - Significant Accounting Policies (Details Textual) link:calculationLink link:definitionLink link:presentationLink 029 - Disclosure - Note 2 - Significant Accounting Policies - Revenue By Product (Details) link:calculationLink link:definitionLink link:presentationLink 030 - Disclosure - Note 3 - Inventories (Details Textual) link:calculationLink link:definitionLink link:presentationLink 031 - Disclosure - Note 3 - Inventories - Components of Inventory (Details) link:calculationLink link:definitionLink link:presentationLink 032 - Disclosure - Note 4 - Equipment and Leasehold Improvements (Details Textual) link:calculationLink link:definitionLink link:presentationLink 033 - Disclosure - Note 4 - Equipment and Leasehold Improvements - Components of Equipment and Leasehold Improvements (Details) link:calculationLink link:definitionLink link:presentationLink 034 - Disclosure - Note 5 - Line of Credit and Long-term Debt (Details Textual) link:calculationLink link:definitionLink link:presentationLink 035 - Disclosure - Note 5 - Line of Credit and Long-term Debt - Summary of Line of Credit and Long-term Debt (Details) link:calculationLink link:definitionLink link:presentationLink 036 - Disclosure - Note 5 - Line of Credit and Long-term Debt - Future Payments (Details) link:calculationLink link:definitionLink link:presentationLink 037 - Disclosure - Note 6 - Operating Leases (Details Textual) link:calculationLink link:definitionLink link:presentationLink 038 - Disclosure - Note 6 - Operating Leases - Supplemental Balance Sheet Information (Details) link:calculationLink link:definitionLink link:presentationLink 039 - Disclosure - Note 6 - Operating Leases - Operating Leases Maturities (Details) link:calculationLink link:definitionLink link:presentationLink 040 - Disclosure - Note 7 - Accrued Expenses - Components of Accrued Expenses (Details) link:calculationLink link:definitionLink link:presentationLink 041 - Disclosure - Note 9 - Share-based Compensation (Details Textual) link:calculationLink link:definitionLink link:presentationLink 042 - Disclosure - Note 9 - Share-based Compensation - Shares Authorized, Available for Future Grant and Outstanding Under Each Plan (Details) link:calculationLink link:definitionLink link:presentationLink 043 - Disclosure - Note 9 - Share-based Compensation - Summary of Option Activity Under Stock Plans (Details) link:calculationLink link:definitionLink link:presentationLink 044 - Disclosure - Note 9 - Share-based Compensation - Summary of Non-vested Options (Details) link:calculationLink link:definitionLink link:presentationLink 045 - Disclosure - Note 9 - Share-based Compensation - Restricted Stock Units (Details) link:calculationLink link:definitionLink link:presentationLink 046 - Disclosure - Note 10 - Income Taxes (Details Textual) link:calculationLink link:definitionLink link:presentationLink 047 - Disclosure - Note 11 - Earnings Per Share (Details Textual) link:calculationLink link:definitionLink link:presentationLink 048 - Disclosure - Note 11 - Earnings Per Share - Summary of Reconciliations Between the Numerator and the Denominator of the Basic and Diluted Earnings Per Share Computations (Details) link:calculationLink link:definitionLink link:presentationLink 049 - Disclosure - Note 12 - Related Party Transactions and Balances (Details Textual) link:calculationLink link:definitionLink link:presentationLink 050 - Disclosure - Note 13 - Subsequent Events (Details Textual) link:calculationLink link:definitionLink link:presentationLink EX-101.CAL 7 cyan-20230630_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 8 cyan-20230630_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 9 cyan-20230630_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Document And Entity Information Note To Financial Statement Details Textual Note 2 - Significant Accounting Policies us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Remainder of 2024 Note 3 - Inventories us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo 2025 Note 4 - Equipment and Leasehold Improvements Note 5 - Line of Credit and Long-term Debt Note 6 - Operating Leases Note 7 - Accrued Expenses Note 9 - Share-based Compensation Note 11 - Earnings Per Share Note 2 - Significant Accounting Policies - Revenue By Product (Details) Income Tax Disclosure [Text Block] Note 3 - Inventories - Components of Inventory (Details) Note 4 - Equipment and Leasehold Improvements - Components of Equipment and Leasehold Improvements (Details) Note 5 - Line of Credit and Long-term Debt - Summary of Line of Credit and Long-term Debt (Details) Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] Note 5 - Line of Credit and Long-term Debt - Future Payments (Details) Other assets us-gaap_ShareBasedCompensation Share-based compensation expense Share-Based Payment Arrangement, Nonemployee [Member] us-gaap_LiabilitiesCurrent Total current liabilities Note 6 - Operating Leases - Supplemental Balance Sheet Information (Details) Schedule of Maturities of Long-Term Debt [Table Text Block] Note 6 - Operating Leases - Operating Leases Maturities (Details) Note 7 - Accrued Expenses - Components of Accrued Expenses (Details) Note 9 - Share-based Compensation - Shares Authorized, Available for Future Grant and Outstanding Under Each Plan (Details) Note 9 - Share-based Compensation - Summary of Option Activity Under Stock Plans (Details) Note 9 - Share-based Compensation - Summary of Non-vested Options (Details) us-gaap_DebtConversionOriginalDebtAmount1 Debt Conversion, Original Debt, Amount Note 9 - Share-based Compensation - Restricted Stock Units (Details) Note 11 - Earnings Per Share - Summary of Reconciliations Between the Numerator and the Denominator of the Basic and Diluted Earnings Per Share Computations (Details) Notes To Financial Statements Debt Conversion Description [Axis] Notes To Financial Statements [Abstract] Debt Conversion, Name [Domain] Operating expenses: Share-Based Payment Arrangement, Option, Activity [Table Text Block] Issuances of common stock to Directors in lieu of cash (in shares) Represents the number of shares issued during the period with respect to director stock grants. Issuances of common stock to Directors in lieu of cash Represents the value of stock issued during the period with respect to director stock grants. Granted, weighted average grant price (in dollars per share) Vested, weighted average grant price (in dollars per share) Forfeited, weighted average grant price (in dollars per share) us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue Nonvested restricted stock units, weighted average grant price (in dollars per share) Nonvested restricted stock units, weighted average grant price (in dollars per share) us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod Forfeited (in shares) us-gaap_LesseeOperatingLeaseTermOfContract Lessee, Operating Lease, Term of Contract (Month) us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Nonvested restricted stock units (in shares) Nonvested restricted stock units (in shares) Schedule of Nonvested Share Activity [Table Text Block] cyan_LongTermDebtAndCapitalLeaseObligationsCurrentAndNoncurrent Long-term Debt and Capital Lease Obligations, Current and Noncurrent Sum of the carrying values as of the balance sheet date of both current and noncurrent portions of long-term debt and capital lease obligations. Unsecured Subordinated Loan From Skywords [Member] Represents the unsecured subordinated loan from Skywords Family Foundation, Inc. Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares) Depreciation and amortization Depreciation, Depletion and Amortization us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod Vested (in shares) us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation Shares withheld for tax payments (in shares) us-gaap_LongTermDebtCurrent Long-term Debt, Current Maturities, Total Less current maturities 2014 Directors Plan [Member] Represents the "2014 Directors Plan." Schedule of Nonvested Restricted Stock Units Activity [Table Text Block] us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Exercisable, weighted average exercise price (in dollars per share) us-gaap_AssetsCurrent Total current assets us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 Exercisable, weighted average remaining contractual term (Year) us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Exercisable, aggregate intrinsic value us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Exercisable (in shares) Line of credit Line of Credit, Current us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 Outstanding, weighted average remaining contractual term (Year) us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Outstanding, aggregate intrinsic value us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue Vested (in dollars per share) us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue Nonvested (in dollars per share) Nonvested (in dollars per share) us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares Vested (in shares) Common stock of $0.02 par value, authorized 50,000,000 shares; issued and outstanding 6,291,086 shares at June 30, 2023 and 6,271,971 shares at March 31, 2023 us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares Nonvested (in shares) Nonvested (in shares) Adjustments to reconcile net loss to net cash (used in) provided by operating activities: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Outstanding, weighted average exercise price (in dollars per share) Outstanding, weighted average exercise price (in dollars per share) Line of Credit Excluding Related Party [Member] Line of Credit Excluding Related Party. Line of Credit, Related Party [Member] Represents line of credit, related party. Common stock, shares authorized (in shares) Common stock, shares issued (in shares) us-gaap_ContractWithCustomerLiabilityCurrent Customer deposits Common stock, par value (in dollars per share) Accrued expenses Total accrued expenses The 2016 Plan [Member] Represents the 2016 Cyanotech Equity Incentive Plan (the “2016 Plan”). Statistical Measurement [Domain] Maximum [Member] Minimum [Member] Lessee, Operating Leases [Text Block] Accounts payable Revolving Credit Facility [Member] us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Outstanding (in shares) Outstanding (in shares) Product and Service [Axis] Product and Service [Domain] Statistical Measurement [Axis] Bonus and profit sharing Credit Facility [Axis] Credit Facility [Domain] Preferred stock of $0.01 par value, authorized 10,000,000 shares; no shares issued and outstanding us-gaap_OtherAccruedLiabilitiesCurrent Other accrued expenses Preferred, issued shares (in shares) Interest Interest Paid, Excluding Capitalized Interest, Operating Activities Wages us-gaap_PolicyTextBlockAbstract Accounting Policies Vacation cyan_LeasesNumberOfLeaseProperties Leases, Number of Lease Properties Represents number of lease properties under lease agreement. Property, Plant and Equipment Disclosure [Text Block] Property, Plant and Equipment [Table Text Block] Preferred, authorized shares (in shares) Inventories Inventories Available (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant (in shares) Preferred stock, par value (in dollars per share) Customer [Axis] us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period (Year) Customer [Domain] Authorized (in shares) Grantee Status [Domain] Shares used in calculation of net loss per share: Grantee Status [Axis] Income taxes Current liabilities: us-gaap_PaymentsForCapitalImprovements Investment in equipment and leasehold improvements Operating lease obligations us-gaap_Assets Total assets SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION: Plan Name [Axis] Plan Name [Domain] us-gaap_OperatingLeaseExpense Operating Lease, Expense us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount CASH FLOWS FROM OPERATING ACTIVITIES: us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Year) Statement [Line Items] Accounts receivable, allowance for doubtful accounts Accounts receivable, net of allowance for credit losses of $11 as of June 30, 2023 and $64 as of March 31, 2023 Furniture and Fixtures [Member] Additional paid-in capital Share-Based Payment Arrangement [Text Block] Shares withheld for tax payments Shares withheld for tax payments Stockholders’ equity: Leasehold Improvements [Member] Packaged Astaxanthin [Member] Refers to information regarding packaged Astaxanthin. Bulk Products [Member] Refers to information regarding bulk products. Long-Lived Tangible Asset [Axis] Packaged Products [Member] Refers to information regarding the packaged products. Long-Lived Tangible Asset [Domain] Business Description and Basis of Presentation [Text Block] Award Type [Domain] Bulk Spirulina [Member] Refers to information regarding bulk Spirulina. Bulk Astaxanthin [Member] Refers to information regarding bulk Astaxanthin. Packaged Spirulina [Member] Refers to information regarding packaged Spirulina. Current assets: Award Type [Axis] Net loss Net income (loss) Net loss us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash at beginning of period Cash at end of period Restricted Stock Units (RSUs) [Member] us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Net decrease in cash First Foundation Bank [Member] Represents information about First Foundation Bank. Restricted Stock [Member] us-gaap_Liabilities Total liabilities us-gaap_NetCashProvidedByUsedInFinancingActivities Net cash provided by (used in) financing activities Commitments and contingencies Related Party 1 [Member] Represents related party from loan agreement. Line of credit – related party Lines of Credit, Related Party, Current Carrying amount as of the balance sheet date of lines of credit with related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer). Net draws on line of credit – related party Proceeds from Lines of Credit, Related Parties The cash inflow from a line of credit made with related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. us-gaap_OperatingIncomeLoss Loss from operations us-gaap_NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities Net cash used in operating activities us-gaap_ContractWithCustomerLiabilityRevenueRecognized Contract with Customer, Liability, Revenue Recognized Share-Based Payment Arrangement, Option [Member] Prepaid expenses and other current assets us-gaap_NetCashProvidedByUsedInInvestingActivities Net cash used in investing activities Antidilutive Securities [Axis] Antidilutive Securities, Name [Domain] us-gaap_GrossProfit Gross profit Cost of sales Commitments and Contingencies Disclosure [Text Block] us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Less accumulated depreciation and amortization us-gaap_PropertyPlantAndEquipmentNet Equipment and leasehold improvements, net Equipment and leasehold improvements, net Equipment and leasehold improvements, gross Solar Lease for Buildings [Member] Represents solar lease for buildings. Common Stock Options and Restricted Stock Units [Member] Represents common stock options and restricted stock units. Construction-in-progress Long-Term Debt, Type [Axis] Long-Term Debt, Type [Domain] us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation Taxes paid related to net share settlement of restricted stock units Unsecured Subordinated Loan [Member] Information pertaining to the unsecured subordinated loan. Skywords Note [Member] Information pertaining to the Skywords Note. Long-term Debt, Excluding Related Party Debt [Member] Information pertaining to long-term debt excluding related party debt. Current maturities of long-term debt Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Excludes line of credit. CASH FLOWS FROM INVESTING ACTIVITIES: Schedule of Supplement Balance Sheet Information for Operating Lease [Table Text Block] Tabular disclosure of supplemental balance sheet information for operating lease. Retained Earnings [Member] Net loss per share: Earnings Per Share [Text Block] Net sales Title of Individual [Domain] Interest and legal Represents current accrued interest and legal liabilities. Title of Individual [Axis] Additional Paid-in Capital [Member] Common Stock [Member] Related Party Transactions Disclosure [Text Block] Income tax expense Income Tax Expense (Benefit) us-gaap_IncreaseDecreaseInAccruedLiabilities Accrued expenses Equity Components [Axis] Equity Component [Domain] us-gaap_LongTermDebt Total principal payments us-gaap_IncreaseDecreaseInAccountsPayable Accounts payable us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Loss before income taxes us-gaap_OperatingExpenses Total operating expenses us-gaap_DebtInstrumentTerm Debt Instrument, Term (Year) General and administrative Cash Cash and Cash Equivalents, at Carrying Value Skywords Amended Note [Member] Represents information related to Skywords Amended Note. us-gaap_DeferredFinanceCostsNet Unamortized debt issuance costs us-gaap_DeferredFinanceCostsCurrentNet Debt Issuance Costs, Current, Net Conversion of Skywords Note Into Revolving Loans [Member] Represents convert Skywords Note into revolving loans. Disaggregation of Revenue [Table Text Block] us-gaap_AllocatedShareBasedCompensationExpense Share-Based Payment Arrangement, Expense us-gaap_RepaymentsOfLongTermDebt Repayments of Long-term Debt, Total Deferred rent and other liabilities Equipment [Member] cyan_DebtInstrumentFloorInterestRate Debt Instrument, Floor Interest Rate Represents floor interest rate for debt instrument. Document Quarterly Report Amendment Flag Entity Incorporation, State or Country Code Long-term debt us-gaap_DebtInstrumentCarryingAmount Long-Term Debt, Gross us-gaap_UnrecognizedTaxBenefits Unrecognized Tax Benefits Accounting Policies [Abstract] Significant Accounting Policies [Text Block] Document Transition Report City Area Code Entity Interactive Data Current us-gaap_RepaymentsOfSecuredDebt Principal payments on long-term debt us-gaap_IncreaseDecreaseInContractWithCustomerLiability Customer deposits us-gaap_SharesOutstanding Balance (in shares) Balance (in shares) Security Exchange Name Common stock, shares outstanding (in shares) Preferred outstanding, shares (in shares) Title of 12(b) Security us-gaap_DebtInstrumentInterestRateDuringPeriod Debt Instrument, Interest Rate During Period Current Fiscal Year End Date us-gaap_DebtInstrumentBasisSpreadOnVariableRate1 Debt Instrument, Basis Spread on Variable Rate Net increase (decrease) in liabilities: us-gaap_DebtInstrumentInterestRateStatedPercentage Debt Instrument, Interest Rate, Stated Percentage us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Prepaid expenses and other assets us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent Document Fiscal Period Focus Document Fiscal Year Focus Document Period End Date us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1 Operating Lease, Weighted Average Remaining Lease Term (Year) Entity File Number Two Board Members [Member] Represents two board members. Entity Emerging Growth Company us-gaap_DebtInstrumentFaceAmount Debt Instrument, Face Amount Document Type Customer Number 1 [Member] Information pertaining to customer number 1 accounting for a percentage of accounts receivable. us-gaap_AssetImpairmentCharges Asset Impairment Charges Entity Small Business Entity Shell Company Two Customers [Member] Information pertaining to two customers accounting for a percentage of accounts receivables. Customer Number 2 [Member] Information pertaining to customer number 2 accounting for a percentage of accounts receivable. Contract Extraction and R&D Services [Member] Represents Contract extraction and R&D services. Document Information [Line Items] Document Information [Table] Entity Filer Category Debt Instrument [Axis] Entity Current Reporting Status Debt Instrument, Name [Domain] Employees [Member] Refers to information regarding employees. Variable Rate [Domain] Prime Rate [Member] cyan_SharebasedCompensationArrangementBySharebasedPaymentAwardNumberOfSharesOutstanding Outstanding (in shares) Number of options and equity instrument other than options outstanding. us-gaap_SharePrice Share Price (in dollars per share) Schedule of Long-Term Debt Instruments [Table Text Block] us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares) Variable Rate [Axis] Diluted (in shares) us-gaap_ConcentrationRiskPercentage1 Concentration Risk, Percentage cyan_NonInventoriableFixedCosts Non Inventoriable Fixed Costs Represents the non-inventoriable fixed costs incurred during the period. us-gaap_IncreaseDecreaseInAccountsReceivable Accounts receivable Share-based compensation expense cyan_InventoryAbnormalProductionCosts Inventory Abnormal Production Costs Represents the amount of abnormal production costs charged to cost of sales. Entity Tax Identification Number Entity Central Index Key Entity Registrant Name us-gaap_ProceedsFromLinesOfCredit Proceeds from Lines of Credit Term Loan Agreement, Maturing on August 14, 2032 [Member] Represents the term loan agreement that are maturing on august 14, 2032. Entity [Domain] Customer Concentration Risk [Member] Term Loan Agreement, Promissory Note One [Member] Term loan agreement, promissory note one [member] Legal Entity [Axis] Term Loan Agreement, Promissory Note Two [Member] Term loan agreement, promissory note two [member] Statement [Table] cyan_DebtInstrumentInterestPaymentPeriod Debt Instrument Interest Payment Period (Month) Represents the period for which interest is payable. Entity Address, Address Line One cyan_DebtInstrumentAmortizationPeriod Debt Instrument Amortization Period (Year) Represents the period over which obligation under the debt instrument fully amortizes. Statement of Financial Position [Abstract] Diluted (in dollars per share) cyan_DebtInstrumentReferenceRate Debt Instrument Reference Rate Represents the reference rate used to compute the variable rate on the debt instrument. Basic (in shares) Accounts Payable and Accrued Liabilities Disclosure [Text Block] Entity Address, City or Town cyan_NumberOfMajorCustomers Number of Major Customers Represents the number of major customers accounting for 10% or more of the specified concentration risk benchmark, which includes, but not limited to, sales revenue, accounts receivable, etc cyan_WorkingCapitalDeficit Working Capital (Deficit) The difference between the current assets and current liabilities that is used as a financial metric for operating liquidity. cyan_DebtInstrumentOneTimeOriginationAndGuarantyFees Debt Instrument One Time Origination and Guaranty Fees Amount of one-time origination and guaranty fees on the debt instrument. us-gaap_EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent Entity Address, Postal Zip Code cyan_DebtInstrumentAnnualRenewalFeePayablePercentage Debt Instrument Annual Renewal Fee Payable Percentage Represents the percentage of annual renewal fee payable on the debt instrument. cyan_DebtInstrumentGuaranteedPortion Debt Instrument Guaranteed Portion Represents the guaranteed portion of the debt instrument. Basic (in dollars per share) Entity Address, State or Province Concentration Risk Type [Axis] Net draws (payments) on line of credit Concentration Risk Type [Domain] Statement of Cash Flows [Abstract] cyan_OperatingLeaseRightofuseAssetBeforeAccumulatedAmortization Right-of-use assets Amount of lessee's right to use underlying asset under operating lease, before accumulated amortization. cyan_OperatingLeaseRightofuseAssetAccumulatedAmortization Accumulated lease amortization Amount of accumulated amortization of lessee's right to use underlying asset under operating lease. Entity Common Stock, Shares Outstanding us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear Remainder of 2024 Lease Contractual Term [Domain] Statement of Stockholders' Equity [Abstract] Lease Contractual Term [Axis] Income Statement [Abstract] us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree 2026 Revenue Benchmark [Member] Accounts Receivable [Member] us-gaap_ProceedsFromIssuanceOfDebt Proceeds from Issuance of Debt Schedule of Accrued Liabilities [Table Text Block] us-gaap_IncreaseDecreaseInInventories Inventories Trading Symbol Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Domain] cyan_DebtCovenantFurtherAdvancesOfCreditAgreementImmediateFreeze Debt Covenant, Further Advances of Credit Agreement, Immediate Freeze Represents an immediate freeze on any further advances of Credit Agreement. Local Phone Number Schedule of Share-based Compensation Shares Authorized Available and Outstanding by Plan [Table Text Block] Tabular disclosure of shares authorized, available for future grant and outstanding under each stock-based compensation plan. us-gaap_TableTextBlock Notes Tables Issuances of vested shares of restricted stock (in shares) us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity Line of Credit Facility, Maximum Borrowing Capacity Issuances of vested shares of restricted stock Provision for doubtful accounts CASH FLOWS FROM FINANCING ACTIVITIES: us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Other long-term liabilities Sales and marketing Line of Credit Facility, Lender [Domain] cyan_NumberOfShareholderApprovedSharebasedCompensationPlans Number of Shareholder Approved Share-based Compensation Plans Represents the number of shareholder approved plans under which shares were available for equity based awards. Raw materials Supplies Lender Name [Axis] us-gaap_LiabilitiesAndStockholdersEquity Total liabilities and stockholders’ equity Finished goods Work in process The 2004 Directors Plan [Member] The 2004 directors plan. cyan_NasdaqMinimumBidPrice Nasdaq Minimum Bid Price (in dollars per share) Represents the minimum bid price on the NASDAQ Stock Exchange. Accumulated deficit Research and development Debt Disclosure [Text Block] us-gaap_InterestExpense Interest expense, net Net (increase) decrease in assets: us-gaap_StockholdersEquity Total stockholders’ equity Balance Balance Amortization of operating leases right-of-use assets Amortization of debt issue costs and other assets us-gaap_DisclosureTextBlockAbstract Notes to Financial Statements Inventory Disclosure [Text Block] Subsequent Event [Member] Long-term operating lease obligations Non-current lease liabilities Schedule of Inventory, Current [Table Text Block] Class of Stock [Axis] Long-term debt, less current maturities Total long-term debt, net of current maturities Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] us-gaap_OperatingLeaseLiability Total lease liability balance Total lease liabilities Subsequent Event Type [Axis] Operating lease obligations, current portion Current lease liabilities Subsequent Event Type [Domain] Subsequent Events [Text Block] Operating lease right-of-use assets, net Total right-of-use assets us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue Total undiscounted lease payments us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Less: present value discount us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree 2026 us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour 2027 us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive 2028 us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Thereafter EX-101.PRE 10 cyan-20230630_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 11 image01.jpg begin 644 image01.jpg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end XML 12 R1.htm IDEA: XBRL DOCUMENT v3.23.2
Document And Entity Information - shares
3 Months Ended
Jun. 30, 2023
Aug. 04, 2023
Document Information [Line Items]    
Entity Central Index Key 0000768408  
Entity Registrant Name Cyanotech Corp  
Amendment Flag false  
Current Fiscal Year End Date --03-31  
Document Fiscal Period Focus Q1  
Document Fiscal Year Focus 2023  
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Jun. 30, 2023  
Document Transition Report false  
Entity File Number 0-14602  
Entity Incorporation, State or Country Code NV  
Entity Tax Identification Number 91-1206026  
Entity Address, Address Line One 73-4460 Queen Kaahumanu Hwy. #102  
Entity Address, City or Town Kailua-Kona  
Entity Address, State or Province HI  
Entity Address, Postal Zip Code 96740  
City Area Code 808  
Local Phone Number 326-1353  
Title of 12(b) Security Common Stock, $0.02 par value per share  
Trading Symbol CYAN  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   6,308,010
XML 13 R2.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
Jun. 30, 2023
Mar. 31, 2023
Current assets:    
Cash $ 648,000 $ 974,000
Accounts receivable, net of allowance for credit losses of $11 as of June 30, 2023 and $64 as of March 31, 2023 1,794,000 1,331,000
Inventories 10,506,000 10,707,000
Prepaid expenses and other current assets 378,000 484,000
Total current assets 13,326,000 13,496,000
Equipment and leasehold improvements, net 11,065,000 11,366,000
Operating lease right-of-use assets, net 4,656,000 4,776,000
Other assets 85,000 90,000
Total assets 29,132,000 29,728,000
Current liabilities:    
Accounts payable 1,721,000 1,021,000
Accrued expenses 821,000 1,101,000
Customer deposits 77,000 89,000
Operating lease obligations, current portion 494,000 483,000
Line of credit 1,770,000 1,540,000
Line of credit – related party 750,000 500,000
Current maturities of long-term debt 3,313,000 3,369,000
Total current liabilities 8,946,000 8,103,000
Long-term debt, less current maturities 1,000,000 1,000,000
Long-term operating lease obligations 4,146,000 4,275,000
Other long-term liabilities 0 3,000
Total liabilities 14,092,000 13,381,000
Commitments and contingencies
Stockholders’ equity:    
Preferred stock of $0.01 par value, authorized 10,000,000 shares; no shares issued and outstanding 0 0
Common stock of $0.02 par value, authorized 50,000,000 shares; issued and outstanding 6,291,086 shares at June 30, 2023 and 6,271,971 shares at March 31, 2023 126,000 125,000
Additional paid-in capital 33,917,000 33,856,000
Accumulated deficit (19,003,000) (17,634,000)
Total stockholders’ equity 15,040,000 16,347,000
Total liabilities and stockholders’ equity $ 29,132,000 $ 29,728,000
XML 14 R3.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - USD ($)
$ in Thousands
Jun. 30, 2023
Mar. 31, 2023
Accounts receivable, allowance for doubtful accounts $ 11 $ 64
Preferred stock, par value (in dollars per share) $ 0.01 $ 0.01
Preferred, authorized shares (in shares) 10,000,000 10,000,000
Preferred, issued shares (in shares) 0 0
Preferred outstanding, shares (in shares) 0 0
Common stock, par value (in dollars per share) $ 0.02 $ 0.02
Common stock, shares authorized (in shares) 50,000,000 50,000,000
Common stock, shares issued (in shares) 6,291,086 6,271,971
Common stock, shares outstanding (in shares) 6,291,086 6,271,971
XML 15 R4.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands
3 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Net sales $ 5,146,000 $ 6,716,000
Cost of sales 3,614,000 4,398,000
Gross profit 1,532,000 2,318,000
Operating expenses:    
General and administrative 1,274,000 1,329,000
Sales and marketing 1,276,000 1,168,000
Research and development 191,000 246,000
Total operating expenses 2,741,000 2,743,000
Loss from operations (1,209,000) (425,000)
Interest expense, net (160,000) (44,000)
Loss before income taxes (1,369,000) (469,000)
Income tax expense 0 3,000
Net loss $ (1,369,000) $ (472,000)
Net loss per share:    
Basic (in dollars per share) $ (0.22) $ (0.08)
Diluted (in dollars per share) $ (0.22) $ (0.08)
Shares used in calculation of net loss per share:    
Basic (in shares) 6,290 6,204
Diluted (in shares) 6,290 6,204
XML 16 R5.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance (in shares) at Mar. 31, 2022 6,202,223      
Balance at Mar. 31, 2022 $ 124 $ 33,557 $ (14,194) $ 19,487
Issuances of vested shares of restricted stock (in shares) 2,277      
Issuances of vested shares of restricted stock $ 0 (3) 0 (3)
Shares withheld for tax payments (in shares) (857)      
Shares withheld for tax payments $ 0 0 0 0
Share-based compensation expense 0 22 0 22
Net income (loss) 0 0 (472) (472)
Shares withheld for tax payments 0 0 0 0
Net loss $ 0 0 (472) (472)
Balance (in shares) at Jun. 30, 2022 6,203,643      
Balance at Jun. 30, 2022 $ 124 33,576 (14,666) 19,034
Balance (in shares) at Mar. 31, 2023 6,271,971      
Balance at Mar. 31, 2023 $ 125 33,856 (17,634) 16,347
Issuances of common stock to Directors in lieu of cash (in shares) 17,672      
Issuances of common stock to Directors in lieu of cash $ 1 15 0 16
Issuances of vested shares of restricted stock (in shares) 2,278      
Issuances of vested shares of restricted stock $ 0 (1) 0 (1)
Shares withheld for tax payments (in shares) (835)      
Shares withheld for tax payments $ 0 0 0 0
Share-based compensation expense 0 47 0 47
Net income (loss) 0 0 (1,369) (1,369)
Shares withheld for tax payments (0) (0) (0) (0)
Net loss $ 0 0 (1,369) (1,369)
Balance (in shares) at Jun. 30, 2023 6,291,086      
Balance at Jun. 30, 2023 $ 126 $ 33,917 $ (19,003) $ 15,040
XML 17 R6.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended
Jun. 30, 2023
Jun. 30, 2022
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (1,369,000) $ (472,000)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:    
Depreciation and amortization 407,000 417,000
Amortization of debt issue costs and other assets 10,000 13,000
Amortization of operating leases right-of-use assets 120,000 105,000
Share-based compensation expense 47,000 22,000
Provision for doubtful accounts 11,000 0
Net (increase) decrease in assets:    
Accounts receivable (474,000) 463,000
Inventories 201,000 (1,233,000)
Prepaid expenses and other assets 104,000 168,000
Net increase (decrease) in liabilities:    
Accounts payable 744,000 (509,000)
Accrued expenses (264,000) (75,000)
Customer deposits (12,000) (85,000)
Operating lease obligations (118,000) (110,000)
Deferred rent and other liabilities (3,000) (3,000)
Net cash used in operating activities (596,000) (1,299,000)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Investment in equipment and leasehold improvements (150,000) (376,000)
Net cash used in investing activities (150,000) (376,000)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Net draws (payments) on line of credit 230,000 0
Net draws on line of credit – related party 250,000 0
Principal payments on long-term debt (59,000) (174,000)
Taxes paid related to net share settlement of restricted stock units (1,000) (3,000)
Net cash provided by (used in) financing activities 420,000 (177,000)
Net decrease in cash (326,000) (1,852,000)
Cash at beginning of period 974,000 2,589,000
Cash at end of period 648,000 737,000
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:    
Interest 151,000 65,000
Income taxes $ 0 $ 0
XML 18 R7.htm IDEA: XBRL DOCUMENT v3.23.2
Note 1 - Organization and Basis of Presentation
3 Months Ended
Jun. 30, 2023
Notes to Financial Statements  
Business Description and Basis of Presentation [Text Block]

1.

ORGANIZATION AND BASIS OF PRESENTATION

 

Cyanotech Corporation (the “Company”), located in Kailua-Kona, Hawaii, was incorporated in the state of Nevada on March 3, 1983, and is listed on the NASDAQ Capital Market under the symbol “CYAN”. The Company is engaged in the production of natural products derived from microalgae for the nutritional supplements market.

 

The Company is an agricultural company that produces high value natural products derived from microalgae grown in complex and intricate open-pond agricultural systems on the Kona coast of Hawaii.  The Company's products include Hawaiian Spirulina Pacifica®, a superfood with numerous benefits, including boosting the immune system and overall cellular health; and BioAstin® Hawaiian Astaxanthin®, a powerful antioxidant shown to support and maintain the body's natural inflammatory response.

 

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information pursuant to the instructions to Form 10-Q and Regulation S-X of the Securities and Exchange Commission (“SEC”). These interim condensed consolidated financial statements are unaudited and, in the opinion of management, include all adjustments (consisting of normal recurring adjustments and accruals) necessary to present fairly the Condensed Consolidated Balance Sheets, Condensed Consolidated Statements of Operations, Condensed Consolidated Statements of Stockholders’ Equity and Condensed Consolidated Statements of Cash Flows for the periods presented in accordance with GAAP.

 

Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. The results of operations for the interim periods are not necessarily indicative of the results to be expected for the full fiscal year. The Condensed Consolidated Balance Sheet as of March 31, 2023 was derived from the audited consolidated financial statements. These condensed consolidated financial statements and notes should be read in conjunction with the Company’s audited consolidated financial statements for the year ended March 31, 2023, contained in the Company’s annual report on Form 10-K as filed with the SEC on June 27, 2023. 

 

Liquidity and Going Concern

 

The accompanying condensed consolidated financial statements as of and for the three months ended June 30, 2023 and 2022, and as of March 31, 2023, have been prepared assuming the Company will continue as a going concern. The going concern assumption contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The Company sustained operating losses and negative cash flows from operation for these same periods. Further, as discussed below, the Company was not in compliance with a debt covenant requirement at March 31, 2023 and First Foundation Bank (the “Bank”) instituted a freeze on additional advances from the Revolving Credit Agreement (“Credit Agreement”). These conditions raise substantial doubt about the Company’s ability to continue as a going concern. The condensed consolidated financial statements do not include any adjustments to the carrying amounts and classification of assets, liabilities, and reported expense that may be necessary if the Company was unable to continue as a going concern.

 

As of June 30, 2023, the Company had cash of $648,000 and working capital of $4,380,000 compared to $974,000 and $5,393,000, respectively, as of March 31, 2023. The Company has a Credit Agreement with the Bank that provided for borrowings up to $2,000,000 on a revolving basis, however, as part of the covenant waiver at March 31, 2023, the borrowings under this line of credit were frozen at the outstanding balance on June 22, 2023, at $1,770,000. As of March 31, 2023, the Company had outstanding borrowings of $1,540,000 on the line of credit.  The line of credit is subject to renewal on August 30, 2023, and the Company intends to renew or replace it with another line of credit on or before the expiration date.

 

The Company also has a loan facility with a related party that allows the Company to borrow up to $1,000,000 on a revolving basis (the “Revolver”). At June 30, 2023 and March 31, 2023, the Company had $750,000 and $500,000, respectively, outstanding borrowings on the Revolver, which were included in line of credit – related party on the Condensed Consolidated Balance Sheets. The Revolver expires on April 12, 2025 (see Notes 5 and 12). On June 30, 2023, the Company and Skywords Family Foundation, Inc. (“Skywords”) executed a letter of intent to commence drafting and negotiating a definitive Second Agreement to the Amended and Restate Promissory Note, dated as of April 12, 2021, as amended on December 14, 2022, to which the revolving amount that the Company may borrow from time to time would increase from $1,000,000 to $2,000,000, with all other terms of the Amendment remaining the same.

 

As of June 30, 2023, the Company had $3,402,000 of debt (“Term Loans”) payable to the Bank that require the payment of principal and interest monthly through August 2032. Pursuant to the Term Loans and the Credit Agreement, the Company is subject to annual financial covenants, customary affirmative and negative covenants and certain subjective acceleration clauses. As of March 31, 2023, the Company debt service coverage ratio fell short of the Bank’s annual requirement. On June 22, 2023, the Bank provided the Company with a letter waiving the covenant violation as of March 31, 2023, but noting that the Bank reserved its right to declare a default in the future if any covenants remain out of compliance at applicable measurement dates. In addition, the Bank’s letter implemented an immediate freeze on any and all further advances of the Credit Agreement through the maturity date.

 

In April 2019, the Company obtained a loan in the amount of $1,500,000 from a related party. The proceeds were used to pay down accounts payable and for general operating capital purposes. On April 12, 2021 and December 14, 2022, the Company amended this loan (see Notes 5 and 12). As of both June 30, 2023 and March 31, 2023, the Company had $1,000,000 outstanding on the related party note. The loan matures on April 12, 2025.

 

The Company continues to experience a loss from operations resulting in net cash outflows from operating activities of $596,000 for the three months ended June 30, 2023. The impacts from the macroeconomic environment continued to lead to lower sales across all of the Company's products.  Since the second quarter of fiscal year 2023, the Company drew a net of $1,770,000 on its line of credit and $750,000 on the Revolver.  To address the resulting cash flow challenges, the Company continues to monitor cost savings initiatives implemented in fiscal year 2023, including stopping or slowing production of inventory in alignment with current customer demand, maintaining a reduced headcount and compensation, primarily through attrition and furloughs, respectively, and eliminating certain discretionary selling, general and administrative expenses.

 

Funds generated by operating activities and available cash are the Company’s most significant sources of liquidity for working capital requirements, debt service and funding of maintenance levels of capital expenditures.  The Company has developed its operating plan to produce the cash flows necessary to meet all financing requirements.  Although the Company has a history of either being in compliance with debt covenants, or obtaining the necessary waivers, execution of it operating plan is dependent on many factors, some of which are not within the control of the Company. However, no assurances can be provided that the Company will achieve its operating plan and cash flow projections for this fiscal year or its projected consolidated financial position as of June 30, 2024. Such estimates are subject to change based on future results and such change could cause future results to vary significantly from expected results.

 

XML 19 R8.htm IDEA: XBRL DOCUMENT v3.23.2
Note 2 - Significant Accounting Policies
3 Months Ended
Jun. 30, 2023
Notes to Financial Statements  
Significant Accounting Policies [Text Block]

2.

SIGNIFICANT ACCOUNTING POLICIES

 

Consolidation

 

The accompanying condensed consolidated financial statements include the accounts of Cyanotech Corporation and its wholly owned subsidiary, Nutrex Hawaii, Inc. (“Nutrex Hawaii” or “Nutrex”, collectively the “Company”). All intercompany balances and transactions have been eliminated in consolidation.

 

Use of Estimates

 

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosures of any contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the periods reported.  Management reviews these estimates and assumptions periodically and reflects the effect of revisions in the period that they are determined to be necessary.  Actual results could differ from those estimates and assumptions.

 

Cash

 

Cash primarily consists of cash on hand and cash in bank deposits.

 

Concentration Risk

 

A significant portion of revenues and accounts receivables are derived from a few major customers. For the three months ended June 30, 2023, two customers individually accounted for 32% and 18% of the Company’s total net sales, and for the three months ended June 30, 2022, two customers individually accounted for 24% and 17% of the Company’s total net sales. Two customers accounted for 72% and 46% of the Company’s accounts receivable balance as of June 30, 2023 and March 31, 2023, respectively.

 

Accounts Receivable

 

Accounts receivable balances are recorded at the invoiced amount and do not accrue interest. Credit is extended base on evaluation of the customer’s financial condition. Collateral is not required. The allowance for credit losses reflects management’s best estimate of expected credit losses inherent in the accounts receivable balance. Management determines the allowances based on historical experience, specifically identified nonpaying customers and other currently available evidence, including the likelihood of each customer not being able to pay, due to the Company’s small customer and recurring customer base. Management reviews its customer account balances monthly with a focus on significant individual past due balances over 90 days. All other balances are reviewed on a pooled basis. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. The Company does not have any off-balance sheet credit exposure related to its customers or otherwise.

 

Revenue Recognition

 

The Company records revenue based on the five-step model which includes: (1) identifying the contract with the customer; (2) identifying the performance obligations in the contract; (3) determining the transaction price; (4) allocating the transaction price to the performance obligations; and (5) recognizing revenue when the performance obligations are satisfied. Substantially all of the Company’s revenue is generated by fulfilling orders for the purchase of its microalgal dietary supplements to retailers, wholesalers, or direct to consumers via online channels, with each order considered to be a distinct performance obligation. These orders may be formal purchase orders, verbal phone orders, e-mail orders or orders received online. Shipping and handling activities for which the Company is responsible under the terms and conditions of the order are not accounted for as performance obligations but as fulfillment costs. These activities are required to fulfill the Company’s promise to transfer the goods and are expensed when revenue is recognized. 

 

Revenue is measured as the net amount of consideration expected to be received in exchange for fulfilling a performance obligation. The Company has elected to exclude sales, use and similar taxes from the measurement of the transaction price.  The amount of consideration expected to be received and revenue recognized includes estimates of variable consideration, which includes costs for trade promotion programs, coupons, returns and early payment discounts.  Such estimates are calculated using historical averages adjusted for any expected changes due to current business conditions and experience. The Company reviews and updates these estimates at the end of each reporting period and the impact of any adjustments are recognized in the period the adjustments are identified. In assessing whether collection of consideration from a customer is probable, the Company considers the customer's ability and intent to pay that amount of consideration when it is due. Payment of invoices is due as specified in the underlying customer agreement, typically 30 days from the invoice date, which occurs on the date of transfer of control of the products to the customer. Revenue is recognized at the point in time that control of the ordered products is transferred to the customer. Generally, this occurs when the product is delivered, or in some cases, picked up from one of the Company’s distribution centers by the customer. Revenue from extraction services is recognized when control is transferred upon completion of the extraction process.

 

Customer contract liabilities consist of customer deposits received in advance of fulfilling an order and are shown separately on the consolidated balance sheets. During the three months ended June 30, 2023 and 2022, the Company recognized $16,000 and $91,000, respectively, of revenue from deposits that were included in contract liabilities as of March 31, 2023 and 2022, respectively. The Company’s contracts have a duration of one year or less and therefore, the Company has elected the practical expedient of not disclosing revenues allocated to partially unsatisfied performance obligations.

 

Disaggregation of Revenue

 

The following table represents revenue disaggregated by major product line and extraction services for the:

 

($ in thousands)

 

Three Months
Ended

June 30,

2023

  

Three Months
Ended

June 30,

2022

 

Packaged sales

        

Astaxanthin packaged

 $2,809  $3,524 

Spirulina packaged

  1,574   1,511 

Total packaged sales

  4,383   5,035 
         

Bulk sales

        

Astaxanthin bulk

  299   494 

Spirulina bulk

  363   1,093 

Total bulk sales

  662   1,587 
         

Contract extraction and R&D services revenue

  101   94 

Total net sales

 $5,146  $6,716 

 

Recently Accounting Pronouncements

 

In June 2016, the FASB issued ASU 2016-13,Financial Instruments Credit Losses” (“Topic 326”), which was subsequently amended in November 2018 through ASU 2018-19,Codification Improvements to Topic 326, Financial Instruments Credit Losses” (“CECL”). CECL requires entities to estimate lifetime expected credit losses for trade and other receivables, net investment in leases, financing receivables, debt securities and other instruments, which will result in earlier recognition of credit losses. The guidance is effective for interim and annual periods beginning after December 15, 2022. The Company adopted this standard as of April 1, 2023, however, due to the relatively short-term nature of its accounts receivable and history of limited bad debt expense, the impact of this guidance was not significant to the Company’s consolidated financial statements and related disclosure. The Company will continue to evaluate the impact of CECL going forward.

  

XML 20 R9.htm IDEA: XBRL DOCUMENT v3.23.2
Note 3 - Inventories
3 Months Ended
Jun. 30, 2023
Notes to Financial Statements  
Inventory Disclosure [Text Block]

3.

INVENTORIES

 

Inventories are stated at the lower of cost or net realizable value. Cost is determined by the first-in, first-out method. Inventories consist of the following as of:

 

  

June 30,

2023

  

March 31,

2023

 
  

(in thousands)

 

Raw materials

 $1,736  $1,887 

Work in process

  1,872   2,049 

Finished goods

  6,574   6,502 

Supplies

  324   269 

Inventories

 $10,506  $10,707 

 

The Company recognizes abnormal production costs, including fixed cost variances from normal production capacity, fixed production overhead costs, idle facilities, freight handling costs and spoilage, as an expense in the period incurred, without adjusting overhead absorption rates. Normal production capacity is defined as the production expected to be achieved over a number of periods or seasons under normal circumstances, taking into account the loss of capacity resulting from planned maintenance. The Company expensed abnormal productions costs of $133,000 and $0 to cost of sales for the three months ended June 30, 2023 and 2022, respectively.

 

Beginning in fiscal year 2021 through fiscal year 2023, cultivation of astaxanthin was completed in the first six months of the fiscal year during the most productive months of the year due to the best growing conditions, compared to year-round production in the prior fiscal years. In fiscal year 2024, cultivation of astaxanthin will be year-round in order to manage staffing constraints. The Company calculates total production costs for the year based on normal capacity of production expected to be achieved in a year under normal circumstances. These costs are then allocated into inventory based on the period of production, not including abnormal production costs. Allocating fixed and overhead costs requires management’s judgement to determine when production is outside of the normal range of expected variation in production.

 

Other non-inventoriable fixed costs of $189,000 and $35,000 were expensed to cost of sales for the three months ended June 30, 2023 and 2022, respectively.

  

XML 21 R10.htm IDEA: XBRL DOCUMENT v3.23.2
Note 4 - Equipment and Leasehold Improvements
3 Months Ended
Jun. 30, 2023
Notes to Financial Statements  
Property, Plant and Equipment Disclosure [Text Block]

4.

EQUIPMENT AND LEASEHOLD IMPROVEMENTS

 

Equipment and leasehold improvements consist of the following as of:

 

  

June 30,

2023

  

March 31,

2023

 
  

(in thousands)

 

Equipment

 $21,711  $21,649 

Leasehold improvements

  15,064   15,038 

Furniture and fixtures

  407   407 
   37,182   37,094 

Less accumulated depreciation and amortization

  (26,354

)

  (25,947

)

Construction-in-progress

  237   219 

Equipment and leasehold improvements, net

 $11,065  $11,366 

 

Management has determined that no asset impairment existed as of June 30, 2023. Depreciation and amortization expense were approximately $407,000 and $417,000 for the three months ended June 30, 2023 and 2022, respectively.

 

XML 22 R11.htm IDEA: XBRL DOCUMENT v3.23.2
Note 5 - Line of Credit and Long-term Debt
3 Months Ended
Jun. 30, 2023
Notes to Financial Statements  
Debt Disclosure [Text Block]

5.

LINE OF CREDIT AND LONG-TERM DEBT

 

Total debt consists of the following as of:

 

  

June 30,

2023

  

March 31,

2023

 
  

(in thousands)

 

Line of credit

 $1,770  $1,540 

Line of credit – related party

  750   500 

Long-term debt

  3,402   3,461 

Long-term debt - related party

  1,000   1,000 

Unamortized debt issuance costs

  (89

)

  (92

)

Less current maturities

  (5,833

)

  (5,409

)

Total long-term debt, net of current maturities

 $1,000  $1,000 

 

Line of Credit and Term Loans

 

On August 30, 2016, the Credit Agreement, which the Company entered into with the Bank on June 3, 2016, became effective after the Company and the Bank received the necessary approvals from the State of Hawaii to secure the lien on the Company’s leasehold property in Kona, Hawaii. The Credit Agreement allows the Company to borrow up to $2,000,000 on a revolving basis. Borrowings under the Credit Agreement bear interest at the Wall Street Journal prime rate (8.25% at June 30, 2023 and 8.0% at March 31, 2023) plus 2%, floating, provided that at no time shall the annual interest rate be less than 5.25%.

 

At June 30, 2023 and March 31, 2023, the outstanding balance under the Credit Agreement was $1,770,000 and $1,540,000, respectively, was included in current liabilities on the Condensed Consolidated Balance Sheets. The line of credit, which is subject to annual renewal, was renewed on August 30, 2022 and will be subject to renewal upon expiration on August 30, 2023.

 

The Credit Agreement grants the Bank the following security interests in the Company’s property: (a) a lien on the Company’s leasehold interest in its Kona facility; (b) an assignment of the Company’s interest in leases and rents on its Kona facility; and (c) a security interest in all fixtures, furnishings and equipment related to or used by the Company at the Kona facility. Each security interest is further subject to the terms of the Credit Agreement.

 

In 2012, the Company executed a loan agreement with a lender providing for $5,500,000 in aggregate credit facilities (the “2012 Loan”) secured by substantially all the Company’s assets, including a mortgage on the Company's interest in its lease at the National Energy Laboratory of Hawaii Authority, pursuant to a Term Loan Agreement dated August 14, 2012 (the “2012 Loan Agreement”). The 2012 Loan is evidenced by promissory notes in the amounts of $2,250,000 and $3,250,000, the repayment of which is partially guaranteed under the provisions of a United States Department of Agriculture (“USDA”) Rural Development Guarantee program. The proceeds of the 2012 Loan were used to acquire processing equipment and leasehold improvements at its Kona, Hawaii facility.

 

The provisions of the 2012 Loan required the payment of interest only for the first 12 months of the term; thereafter, and until its maturity on August 14, 2032, the obligation fully amortizes over nineteen (19) years. Interest on the 2012 Loan accrues on the outstanding principal balance at an annual variable rate equal to the published Wall Street Journal prime rate (8.0% and 7.5% at June 30, 2023 and March 31, 2023, respectively) plus 1.0% and is adjustable on the first day of each calendar quarter and fixed for that quarter, provided that at no time shall the annual interest rate be less than 5.5%. The balance under the 2012 Loan was $3,402,000 and $3,461,000 at June 30, 2023 and March 31, 2023, respectively, and was included in current maturities of long-term debt in the debt table above. See Loan Covenants, Violations and Waiver below.

 

The 2012 Loan included a one-time origination and guaranty fees totaling $214,500 and an annual renewal fee payable in the amount of 0.25% of the USDA guaranteed portion of the outstanding principal balance as of December 31 of each year, beginning December 31, 2012. The USDA has guaranteed 80% of all amounts owing under the 2012 Loan. The balance in unamortized debt issuance costs was $89,000 and $92,000 at June 30, 2023 and March 31, 2023, respectively, and was included in current maturities of long-term debt in the debt table above. See Loan Covenants, Violations and Waiver below.

 

Loan Covenants, Violation and Waiver

 

The Company’s Credit Agreement and the 2012 Loan are subject to annual debt service and other financial covenants, including covenants which require the Company to meet key financial ratios and customary affirmative and negative covenants.  As of March 31, 2023, the Company was not in compliance with the required debt service coverage ratio, however, was in compliance with the two other covenants. Due to this violation, the Bank would be contractually entitled to require immediate repayment of the outstanding term loans and the outstanding line of credit balance. However, on June 22, 2023, the Bank issued the Company a letter waiving the covenant violation as of March 31, 2023, and implemented an immediate freeze on any and all further advances of the Credit Agreement through the maturity date, with an outstanding balance in the amount of $1,770,000 as of June 21, 2023. The next remeasurement date will be March 31, 2024.

 

Line of Credit and Debt Related Party

 

In April 2019, the Company obtained a loan in the amount of $1,500,000 and the interest was payable quarterly.  The loan was originally due in April 2021. In April 2021, the Company amended the loan, which extended the expiration to April 2024, converted $500,000 into the Revolver, adjusted the interest rate to reflect a floor of 5%, and granted a security interest in substantially all of the Company’s personal property assets, subject to limited exceptions. Concurrently, with the amendment and conversion of the original loan, the Company repaid in cash the principal amount of $500,000 plus accrued interest to date of $1,900 (see Note 12).  In December 2022, the Company amended the loan to extend the expiration to April 2025 and increase the Revolver to $1,000,000. At both June 30, 2023 and March 31, 2023, the balance under this loan was $1,000,000, which was included in long-term debt in the debt table above. At June 30, 2023 and March 31, 2023, the balance under the Revolver was $750,000 and $500,000, respectively, which was included in line of credit – related party in the debt table above. Interest accrues on the outstanding principal balance and the Revolver at an annual variable rate equal to the published Wall Street Journal prime rate (8.0% and 7.5% at June 30, 2023 and March 31, 2023, respectively) plus 1.0% and is adjustable on the first day of each calendar quarter and fixed for that quarter, provided that at no time shall the annual interest rate be less than 5.0%.

 

Future principal payments under the loans at June 30, 2023 are as follows:

 

Fiscal year payments due

 

(in thousands)

 

Remainder of 2024

 $3,402 

2026

  1,000 

Total principal payments

 $4,402 

  

XML 23 R12.htm IDEA: XBRL DOCUMENT v3.23.2
Note 6 - Operating Leases
3 Months Ended
Jun. 30, 2023
Notes to Financial Statements  
Lessee, Operating Leases [Text Block]

6.

OPERATING LEASES

 

The Company leases facilities, equipment and land under non-cancelable operating leases expiring through 2037. One of its facility leases contains price escalations and a renewal option for five years. Right-of-use assets represent the right to use an underlying asset for the lease term and lease liabilities represent the obligation to make lease payments arising from the lease. Right-of-use assets and liabilities were recognized at April 1, 2019 based on the present value of lease payments over the lease term, using the Bank’s incremental borrowing rate based on the information available at recognition, and the Company has elected to exclude non-lease components. The Company also leases two 84-month solar leases for two of its buildings, which are included in the right-of-use assets and liabilities. At June 30, 2023, the weighted average remaining lease terms of all operating leases was 9.6 years, the weighted average discount rate was 7.3%, and for the three months ended June 30, 2023 and 2022, the operating lease costs were $203,000 and $171,000, respectively.

 

Supplemental balance sheet information related to leases consist of the following as of:

 

Operating leases

Balance Sheet Classification

 

June 30, 2023

  

March 31, 2023

 
   

(in thousands)

 

Right-of-use assets

Operating lease right-of-use assets

 $6,149  $6,149 

Accumulated lease amortization

Operating lease right-of-use assets

  (1,493

)

  (1,373

)

          

Total right-of-use assets

 $4,656  $4,776 
          

Current lease liabilities

Operating lease obligations

 $494  $483 

Non-current lease liabilities

Long-term operating lease obligations

  4,146   4,275 
          

Total lease liabilities

 $4,640  $4,758 

 

Maturities of lease liabilities at June 30, 2023 are as follows:

 

Payments

 

(in thousands)

 

Remainder of 2024

 $609 

2025

  817 

2026

  794 

2027

  801 

2028

  591 

Thereafter

  2,854 

Total undiscounted lease payments

  6,466 

Less: present value discount

  (1,826

)

Total lease liability balance

 $4,640 

  

XML 24 R13.htm IDEA: XBRL DOCUMENT v3.23.2
Note 7 - Accrued Expenses
3 Months Ended
Jun. 30, 2023
Notes to Financial Statements  
Accounts Payable and Accrued Liabilities Disclosure [Text Block]

7.

ACCRUED EXPENSES

 

Accrued expenses consist of the following as of:

 

   

June 30, 2023

   

March 31, 2023

 
   

(in thousands)

 

Bonus and profit sharing

  $ 143     $ 143  

Wages

    79       215  

Vacation

    384       393  

Interest and legal

    47       30  

Other accrued expenses

    168       320  

Total accrued expenses

  $ 821     $ 1,101  

  

XML 25 R14.htm IDEA: XBRL DOCUMENT v3.23.2
Note 8 - Commitments and Contingencies
3 Months Ended
Jun. 30, 2023
Notes to Financial Statements  
Commitments and Contingencies Disclosure [Text Block]

8.

COMMITMENTS AND CONTINGENCIES

 

From time to time, the Company may be involved in litigation and investigations relating to claims and matters arising out of its operations in the normal course of business. There were no significant legal matters outstanding at June 30, 2023.

  

XML 26 R15.htm IDEA: XBRL DOCUMENT v3.23.2
Note 9 - Share-based Compensation
3 Months Ended
Jun. 30, 2023
Notes to Financial Statements  
Share-Based Payment Arrangement [Text Block]

9.

SHARE-BASED COMPENSATION

 

The Company has share-based compensation plans, which are more fully described in Note 10, Share-Based Compensation, to the Consolidated Financial Statements included in the Company’s annual report on Form 10-K for the fiscal year ended March 31, 2023 as filed with the SEC on June 27, 2023.

 

As of June 30, 2023, the Company had two equity-based compensation plans: the 2016 Equity Incentive Plan (the “2016 Plan”) and the 2014 Independent Director Stock Option and Restricted Stock Grant Plan and Amendment (the “2014 Directors Plan”). The Company has also issued stock options, which remain outstanding as of June 30, 2023, under an equity-based compensation plan which has expired according to its terms: the 2004 Independent Director Stock Option and Stock Grant Plan (the “2004 Directors Plan”). This plan allowed the Company to award stock options and shares of restricted common stock to eligible employees, certain outside consultants and independent directors. No additional awards will be issued under the 2004 Directors Plan.

 

The following table presents shares authorized, available for future grant and outstanding under each of the Company’s plans:

 

  

As of June 30, 2023

 
  

Authorized

  

Available

  

Outstanding

 
             

2016 Plan

  1,300,000   873,737   310,756 

2014 Directors Plan

  650,000   205,534   12,000 

2004 Directors Plan

        6,000 

Total

  1,950,000   1,079,271   328,756 

 

Stock Options

 

All stock option grants made under the equity-based compensation plans were issued at exercise prices no less than the Company’s closing stock price on the date of grant. Options under the 2016 Plan, 2004 Directors Plan and 2014 Directors Plan were determined by the Board of Directors or the Compensation Committee of the Board of Directors in accordance with the provisions of the respective plans.  The terms of each option grant include vesting, exercise, and other conditions set forth in a Stock Option Agreement evidencing each grant. No option can have a life in excess of ten (10) years. The Company records compensation expense for employee stock options based on the estimated fair value of the options on the date of grant using the Black-Scholes option-pricing model. The model requires various assumptions, including a risk-free interest rate, the expected term of the options, the expected stock price volatility over the expected term of the options, and the expected dividend yield. Compensation expense for employee stock options is recognized ratably over the vesting term. Compensation expense recognized for options issued under all Plans was $26,000 and $17,000 for the three months ended June 30, 2023 and 2022, respectively.

 

A summary of option activity under the Company’s stock plans for the three months ended June 30, 2023 is presented below: 

 

Option Activity

 

Shares

  

Weighted
Average
Exercise

Price

  

Weighted

Average
Remaining
Contractual
Term (in
years)

  

Aggregate
Intrinsic
Value

 

Outstanding at March 31, 2023

  253,000  $2.88   7.5  $ 

Outstanding at June 30, 2023

  253,000  $2.88   7.2  $ 

Exercisable at June 30, 2023

  144,666  $2.97   6.8  $ 

 

The aggregate intrinsic value in the table above is before applicable income taxes and represents the excess amount over the exercise price optionees would have received if all options had been exercised on the last business day of the period indicated, based on the Company’s closing stock price of $0.86 and $0.88 at June 30, 2023 and March 31, 2023, respectively.

 

A summary of the Company’s non-vested options for the three months ended June 30, 2023 is presented below:

 

Nonvested Options

 

Shares

  

Weighted
Average
Grant-Date
Fair Value

 

Nonvested at March 31, 2023

  141,667  $1.55 

Vested

  (33,333

)

  1.77 

Nonvested at June 30, 2023

  108,334  $1.48 

 

As of June 30, 2023, total unrecognized stock-based compensation expense related to all unvested stock options was $103,000, which is expected to be expensed over a weighted average period of 1.4 years.

 

Restricted Stock 

 

To reduce the Company’s ongoing cash expenses, the Nominating and Corporate Governance Committee of the Board of Directors adopted a resolution allowing each director to elect to receive his or her quarterly director fees in the form of restricted stock in lieu of cash. Two Board members elected to receive shares of restricted stock in lieu of cash for the third fiscal quarter of 2023. On April 3, 2023, 17,672 shares of fully vested restricted stock were issue to the two Board members. For the three months ended June 30, 2023, there was no compensation expense related to the issuance of this stock, as it was earned and recognized in fiscal year 2023 in the amount of $15,500.

 

Restricted Stock Units (RSUs) 

 

RSUs are service-based awards granted to eligible employees under the 2016 Plan. Compensation expense recognized for RSUs issued under the 2016 Plan was $21,000 and $5,000 for the three months ended June 30, 2023 and 2022, respectively.

 

The following table summarizes information related to awarded RSUs:

 

Nonvested Restricted Stock Units

 

Shares

  

Weighted
Average
Grant Price

 

Nonvested restricted stock units at March 31, 2023

  70,334  $3.04 

Granted

  7,900   0.94 

Vested

  (2,278

)

  2.39 

Forfeited

  (200

)

  0.94 

Nonvested restricted stock units at June 30, 2023

  75,756  $2.85 

 

As of June 30, 2023, total unrecognized stock-based compensation expense related to unvested restricted stock units was $114,000, which is expected to be expensed over a weighted average period of 2.1 years.

  

XML 27 R16.htm IDEA: XBRL DOCUMENT v3.23.2
Note 10 - Income Taxes
3 Months Ended
Jun. 30, 2023
Notes to Financial Statements  
Income Tax Disclosure [Text Block]

10.

INCOME TAXES

 

The Company utilizes its estimated annual effective tax rate to determine its provision or benefit for income taxes for interim periods. The income tax provision or benefit is computed by multiplying the estimated annual effective tax rate by the year-to-date pre-tax book income (loss). The Company recorded no income tax expense and $3,000 of income tax expense for the three months ended June 30, 2023 and 2022, respectively. The Company’s effective tax rate was (0.7%) for the three months ended June 30, 2022. The effective tax rates differ from the statutory rate of 21% as a result of state taxes (net of federal benefit) and the net change in valuation allowance against the net deferred tax asset the Company believes is not more likely than not to be realized.  The Company continues to carry a full valuation allowance on its net deferred tax assets.

 

The Company is subject to taxation in the United States and eight state jurisdictions. The preparation of tax returns requires management to interpret the applicable tax laws and regulations in effect in such jurisdictions, which could affect the amount of tax paid by the Company. Management, in consultation with its tax advisors, files its tax returns based on interpretations that are believed to be reasonable under the circumstances. The income tax returns, however, are subject to routine reviews by the various taxing authorities.  As part of these reviews, a taxing authority may disagree with respect to the tax positions taken by management (“uncertain tax positions”) and therefore may require the Company to pay additional taxes. Management evaluates the requirement for additional tax accruals, including interest and penalties, which the Company could incur as a result of the ultimate resolution of its uncertain tax positions. Management reviews and updates the accrual for uncertain tax positions as more definitive information becomes available from taxing authorities, completion of tax audits, expiration of statute of limitations, or upon occurrence of other events.

 

As of June 30, 2023 and 2022, there was no liability for income tax associated with unrecognized tax benefits. The Company recognizes accrued interest related to unrecognized tax benefits as well as any related penalties in interest income or expense in its Consolidated Condensed Statements of Operations, which is consistent with the recognition of these items in prior reporting periods.

 

With few exceptions, the Company is no longer subject to U.S. federal, state, local, and non-U.S. income tax examination by tax authorities for tax years before 2019. 

  

XML 28 R17.htm IDEA: XBRL DOCUMENT v3.23.2
Note 11 - Earnings Per Share
3 Months Ended
Jun. 30, 2023
Notes to Financial Statements  
Earnings Per Share [Text Block]

11.

EARNINGS PER SHARE

 

Basic earnings (loss) per share is computed on the basis of the weighted average number of common shares outstanding. Diluted earnings (loss) per share is computed on the basis of the weighted average number of common shares outstanding plus the potentially dilutive effect of outstanding stock options using the treasury stock method.

 

Reconciliations between the numerator and the denominator of the basic and diluted (loss) income per share computations for the three months ended June 30, 2023 and 2022 are as follows:

 

  

Three Months Ended June 30, 2023

 
  

Net Loss

  

Shares

  

Per Share

 
  

(Numerator)

  

(Denominator)

  

Amount

 
  

(in thousands)

     

Basic and diluted loss per share

 $(1,369

)

  6,290  $(0.22

)

 

  

Three Months Ended June 30, 2022

 
  

Net Loss

  

Shares

  

Per Share

 
  

(Numerator)

  

(Denominator)

  

Amount

 
  

(in thousands)

     

Basic and diluted loss per share

 $(472

)

  6,204  $(0.08

)

 

Basic and diluted per share amounts are the same in periods of a net loss because common share equivalents are anti-dilutive when a net loss is recorded. Diluted earnings per share does not include the impact of common stock options and restricted stock units totaling 3,000 and 12,000 for the three months ended June 30, 2023 and 2022, respectively, as the effect of their inclusion would be anti-dilutive. Restricted stock units become dilutive within the period granted and remain dilutive until the units vest and are then included in the calculation of basic earnings per share.

  

XML 29 R18.htm IDEA: XBRL DOCUMENT v3.23.2
Note 12 - Related Party Transactions and Balances
3 Months Ended
Jun. 30, 2023
Notes to Financial Statements  
Related Party Transactions Disclosure [Text Block]

12.

RELATED PARTY TRANSACTIONS 

 

In April 2019, the Company obtained an unsecured subordinated loan from Skywords in the principal amount of $1,500,000 pursuant to a Promissory Note (the "Skywords Note”) executed by the Company in favor of Skywords. Skywords is controlled by the Company’s Chairman of the Board of Directors and largest stockholder. The Skywords Note bore interest at a rate of 1% plus the prime rate (as published by the Wall Street Journal), which was recalculated and payable on a quarterly basis. The principal amount and any accrued and unpaid interest were due and payable on April 12, 2021. The proceeds of the Skywords Note were used to pay down accounts payable and for general operating capital purposes.

 

On April 12, 2021, the Company entered into an Amended and Restated Promissory Note (the “Skywords Amended Note”) with Skywords. The Company and Skywords agreed to amend, restate, replace and otherwise modify without novation, the Skywords Note in order to convert $500,000 of the outstanding principal amount into revolving loans that may be prepaid and reborrowed from time to time in principal amounts not to exceed $500,000, extend the maturity date by three years, adjust the interest rate to reflect a floor of 5% and secure Skywords’ interest by granting a security interest in substantially all of the Company’s personal property assets, subject to limited exceptions (the “Collateral”). On April 12, 2021, concurrently with the conversion, the Company repaid in cash to Skywords, the principal amount of $500,000 plus accrued interest to date of $1,900. The Skywords Amended Note bears interest at a rate of 1% plus the prime rate (as published by the Wall Street Journal), which will be recalculated and payable on a quarterly basis, provided that at no time shall the annual interest rate be less than 5%. The Company may prepay the Skywords Amended Note at any time without penalty.

 

On April 12, 2021, in connection with the grant of a security interest in the Collateral, the Company also entered into an Intercreditor and Subordination Agreement with the Bank and Skywords. The Company is indebted to the Bank pursuant to two Term Loans and a Credit Agreement, each of which granted the Bank a security interest in substantially all of the Company’s personal property assets. The Bank’s security interest in the Company’s personal property assets ranks senior to Skywords’ security interest in the Collateral, and the Intercreditor and Subordination Agreement generally governs the relationship between the Bank and Skywords as secured lenders to the Company and includes customary terms.

 

On December 14, 2022, the Company entered into a First Amendment (the “Amendment”) to the Skywords Amended Note. The Amendment extends the maturity date to April 12, 2025 and increases the revolving amount that the Company may borrow from time to time under the Skywords Note from $500,000 to $1,000,000. All other terms of the Skywords Note remain the same.

 

At both June 30, 2023 and March 31, 2023, the Skywords Note principal balance was $1,000,000, and was included in long-term debt on the Condensed Consolidated Balance Sheets. At June 30, 2023 and March 31, 2023, the balance on the Revolver was $750,000 and $500,000, respectively, and was included in line of credit – related party on the Condensed Consolidated Balance Sheets. At June 30, 2023 and March 31, 2023, the interest rates were 8.0% and 7.5%, respectively.

 

On June 30, 2023, the Company and Skywords executed a letter of intent to commence drafting and negotiating a definitive Second Agreement to the Amended and Restate Promissory Note, dated as of April 12, 2021, as amended on December 14, 2022, to which the revolving amount that the Company may borrow from time to time would increase from $1,000,000 to $2,000,000, with all other terms of the Amendment remaining the same. Entry into this Second Amendment is subject to the completion of definitive documentation and the other terms and conditions specified in the letter of intent.  On August 10, 2023, the Company received approval from First Foundation Bank and the USDA to move forward with the Second Agreement.

XML 30 R19.htm IDEA: XBRL DOCUMENT v3.23.2
Note 13 - Subsequent Events
3 Months Ended
Jun. 30, 2023
Notes to Financial Statements  
Subsequent Events [Text Block]

13.

SUBSEQUENT EVENTS

 

On August 10, 2023, the Company was notified by Nasdaq that the Company is not in compliance with Nasdaq's Listing Rule 5550(a)(2), as the minimum bid price of the Company's common stock had been below $1.00 per share for 30 consecutive business days.  Under Nasdaq's rules, the notification of noncompliance had no immediate effect on the listing or trading of the Company's common stock on Nasdaq under the symbol "CYAN".  Under Nasdaq's rule, the Company was given 180 days, or until February 6, 2024, to achieve compliance with the minimum bid price requirement.  To regain compliance, the minimum bid price of the Company's stock must meet or exceed $1.00 per share for a minimum of ten consecutive business days prior to the expiration of the 180-day grace period.  Failure to regain compliance during this period could result in delisting.

 

The Company had no additional subsequent events, other than those mentioned above and in Note 12 regarding the Bank and USDA approval.

XML 31 R20.htm IDEA: XBRL DOCUMENT v3.23.2
Note 2 - Significant Accounting Policies (Tables)
3 Months Ended
Jun. 30, 2023
Notes Tables  
Disaggregation of Revenue [Table Text Block]

($ in thousands)

 

Three Months
Ended

June 30,

2023

  

Three Months
Ended

June 30,

2022

 

Packaged sales

        

Astaxanthin packaged

 $2,809  $3,524 

Spirulina packaged

  1,574   1,511 

Total packaged sales

  4,383   5,035 
         

Bulk sales

        

Astaxanthin bulk

  299   494 

Spirulina bulk

  363   1,093 

Total bulk sales

  662   1,587 
         

Contract extraction and R&D services revenue

  101   94 

Total net sales

 $5,146  $6,716 
XML 32 R21.htm IDEA: XBRL DOCUMENT v3.23.2
Note 3 - Inventories (Tables)
3 Months Ended
Jun. 30, 2023
Notes Tables  
Schedule of Inventory, Current [Table Text Block]
  

June 30,

2023

  

March 31,

2023

 
  

(in thousands)

 

Raw materials

 $1,736  $1,887 

Work in process

  1,872   2,049 

Finished goods

  6,574   6,502 

Supplies

  324   269 

Inventories

 $10,506  $10,707 
XML 33 R22.htm IDEA: XBRL DOCUMENT v3.23.2
Note 4 - Equipment and Leasehold Improvements (Tables)
3 Months Ended
Jun. 30, 2023
Notes Tables  
Property, Plant and Equipment [Table Text Block]
  

June 30,

2023

  

March 31,

2023

 
  

(in thousands)

 

Equipment

 $21,711  $21,649 

Leasehold improvements

  15,064   15,038 

Furniture and fixtures

  407   407 
   37,182   37,094 

Less accumulated depreciation and amortization

  (26,354

)

  (25,947

)

Construction-in-progress

  237   219 

Equipment and leasehold improvements, net

 $11,065  $11,366 
XML 34 R23.htm IDEA: XBRL DOCUMENT v3.23.2
Note 5 - Line of Credit and Long-term Debt (Tables)
3 Months Ended
Jun. 30, 2023
Notes Tables  
Schedule of Long-Term Debt Instruments [Table Text Block]
  

June 30,

2023

  

March 31,

2023

 
  

(in thousands)

 

Line of credit

 $1,770  $1,540 

Line of credit – related party

  750   500 

Long-term debt

  3,402   3,461 

Long-term debt - related party

  1,000   1,000 

Unamortized debt issuance costs

  (89

)

  (92

)

Less current maturities

  (5,833

)

  (5,409

)

Total long-term debt, net of current maturities

 $1,000  $1,000 
Schedule of Maturities of Long-Term Debt [Table Text Block]

Fiscal year payments due

 

(in thousands)

 

Remainder of 2024

 $3,402 

2026

  1,000 

Total principal payments

 $4,402 
XML 35 R24.htm IDEA: XBRL DOCUMENT v3.23.2
Note 6 - Operating Leases (Tables)
3 Months Ended
Jun. 30, 2023
Notes Tables  
Schedule of Supplement Balance Sheet Information for Operating Lease [Table Text Block]

Operating leases

Balance Sheet Classification

 

June 30, 2023

  

March 31, 2023

 
   

(in thousands)

 

Right-of-use assets

Operating lease right-of-use assets

 $6,149  $6,149 

Accumulated lease amortization

Operating lease right-of-use assets

  (1,493

)

  (1,373

)

          

Total right-of-use assets

 $4,656  $4,776 
          

Current lease liabilities

Operating lease obligations

 $494  $483 

Non-current lease liabilities

Long-term operating lease obligations

  4,146   4,275 
          

Total lease liabilities

 $4,640  $4,758 
Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]

Payments

 

(in thousands)

 

Remainder of 2024

 $609 

2025

  817 

2026

  794 

2027

  801 

2028

  591 

Thereafter

  2,854 

Total undiscounted lease payments

  6,466 

Less: present value discount

  (1,826

)

Total lease liability balance

 $4,640 
XML 36 R25.htm IDEA: XBRL DOCUMENT v3.23.2
Note 7 - Accrued Expenses (Tables)
3 Months Ended
Jun. 30, 2023
Notes Tables  
Schedule of Accrued Liabilities [Table Text Block]
   

June 30, 2023

   

March 31, 2023

 
   

(in thousands)

 

Bonus and profit sharing

  $ 143     $ 143  

Wages

    79       215  

Vacation

    384       393  

Interest and legal

    47       30  

Other accrued expenses

    168       320  

Total accrued expenses

  $ 821     $ 1,101  
XML 37 R26.htm IDEA: XBRL DOCUMENT v3.23.2
Note 9 - Share-based Compensation (Tables)
3 Months Ended
Jun. 30, 2023
Notes Tables  
Schedule of Share-based Compensation Shares Authorized Available and Outstanding by Plan [Table Text Block]
  

As of June 30, 2023

 
  

Authorized

  

Available

  

Outstanding

 
             

2016 Plan

  1,300,000   873,737   310,756 

2014 Directors Plan

  650,000   205,534   12,000 

2004 Directors Plan

        6,000 

Total

  1,950,000   1,079,271   328,756 
Share-Based Payment Arrangement, Option, Activity [Table Text Block]

Option Activity

 

Shares

  

Weighted
Average
Exercise

Price

  

Weighted

Average
Remaining
Contractual
Term (in
years)

  

Aggregate
Intrinsic
Value

 

Outstanding at March 31, 2023

  253,000  $2.88   7.5  $ 

Outstanding at June 30, 2023

  253,000  $2.88   7.2  $ 

Exercisable at June 30, 2023

  144,666  $2.97   6.8  $ 
Schedule of Nonvested Share Activity [Table Text Block]

Nonvested Options

 

Shares

  

Weighted
Average
Grant-Date
Fair Value

 

Nonvested at March 31, 2023

  141,667  $1.55 

Vested

  (33,333

)

  1.77 

Nonvested at June 30, 2023

  108,334  $1.48 
Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]

Nonvested Restricted Stock Units

 

Shares

  

Weighted
Average
Grant Price

 

Nonvested restricted stock units at March 31, 2023

  70,334  $3.04 

Granted

  7,900   0.94 

Vested

  (2,278

)

  2.39 

Forfeited

  (200

)

  0.94 

Nonvested restricted stock units at June 30, 2023

  75,756  $2.85 
XML 38 R27.htm IDEA: XBRL DOCUMENT v3.23.2
Note 11 - Earnings Per Share (Tables)
3 Months Ended
Jun. 30, 2023
Notes Tables  
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
  

Three Months Ended June 30, 2023

 
  

Net Loss

  

Shares

  

Per Share

 
  

(Numerator)

  

(Denominator)

  

Amount

 
  

(in thousands)

     

Basic and diluted loss per share

 $(1,369

)

  6,290  $(0.22

)

  

Three Months Ended June 30, 2022

 
  

Net Loss

  

Shares

  

Per Share

 
  

(Numerator)

  

(Denominator)

  

Amount

 
  

(in thousands)

     

Basic and diluted loss per share

 $(472

)

  6,204  $(0.08

)

XML 39 R28.htm IDEA: XBRL DOCUMENT v3.23.2
Note 1 - Organization and Basis of Presentation (Details Textual) - USD ($)
3 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 22, 2023
Mar. 31, 2023
Apr. 30, 2019
Aug. 30, 2016
Cash and Cash Equivalents, at Carrying Value $ 648,000     $ 974,000    
Working Capital (Deficit) 4,380,000     5,393,000    
Line of Credit, Current 1,770,000     1,540,000    
Lines of Credit, Related Party, Current 750,000     500,000    
Long-term Debt and Capital Lease Obligations, Current and Noncurrent 3,402,000          
Net Cash Provided by (Used in) Operating Activities (596,000) $ (1,299,000)        
Proceeds from Lines of Credit, Related Parties 250,000 $ 0        
Unsecured Subordinated Loan From Skywords [Member]            
Debt Instrument, Face Amount 1,000,000     1,000,000 $ 1,500,000  
First Foundation Bank [Member]            
Proceeds from Lines of Credit 1,770,000          
First Foundation Bank [Member] | Revolving Credit Facility [Member]            
Line of Credit Facility, Maximum Borrowing Capacity       2,000,000   $ 2,000,000
Line of Credit, Current 1,770,000   $ 1,770,000 1,540,000    
Related Party 1 [Member] | Revolving Credit Facility [Member]            
Line of Credit Facility, Maximum Borrowing Capacity 1,000,000     1,000,000    
Lines of Credit, Related Party, Current 750,000     $ 500,000    
Proceeds from Lines of Credit, Related Parties 750,000          
Related Party 1 [Member] | Revolving Credit Facility [Member] | Maximum [Member]            
Line of Credit Facility, Maximum Borrowing Capacity $ 2,000,000          
XML 40 R29.htm IDEA: XBRL DOCUMENT v3.23.2
Note 2 - Significant Accounting Policies (Details Textual)
3 Months Ended 12 Months Ended
Jun. 30, 2023
USD ($)
Jun. 30, 2022
USD ($)
Mar. 31, 2023
Contract with Customer, Liability, Revenue Recognized $ 16,000 $ 91,000  
Customer Concentration Risk [Member] | Revenue Benchmark [Member]      
Number of Major Customers 2 2 2
Customer Concentration Risk [Member] | Revenue Benchmark [Member] | Customer Number 1 [Member]      
Concentration Risk, Percentage 32.00% 24.00%  
Customer Concentration Risk [Member] | Revenue Benchmark [Member] | Customer Number 2 [Member]      
Concentration Risk, Percentage 18.00% 17.00%  
Customer Concentration Risk [Member] | Accounts Receivable [Member]      
Number of Major Customers 2    
Customer Concentration Risk [Member] | Accounts Receivable [Member] | Two Customers [Member]      
Concentration Risk, Percentage 72.00%   46.00%
XML 41 R30.htm IDEA: XBRL DOCUMENT v3.23.2
Note 2 - Significant Accounting Policies - Revenue By Product (Details) - USD ($)
$ in Thousands
3 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Net sales $ 5,146 $ 6,716
Packaged Astaxanthin [Member]    
Net sales 2,809 3,524
Packaged Spirulina [Member]    
Net sales 1,574 1,511
Packaged Products [Member]    
Net sales 4,383 5,035
Bulk Astaxanthin [Member]    
Net sales 299 494
Bulk Spirulina [Member]    
Net sales 363 1,093
Bulk Products [Member]    
Net sales 662 1,587
Contract Extraction and R&D Services [Member]    
Net sales $ 101 $ 94
XML 42 R31.htm IDEA: XBRL DOCUMENT v3.23.2
Note 3 - Inventories (Details Textual) - USD ($)
3 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Inventory Abnormal Production Costs $ 133,000 $ 0
Non Inventoriable Fixed Costs $ 189,000 $ 35,000
XML 43 R32.htm IDEA: XBRL DOCUMENT v3.23.2
Note 3 - Inventories - Components of Inventory (Details) - USD ($)
$ in Thousands
Jun. 30, 2023
Mar. 31, 2023
Raw materials $ 1,736 $ 1,887
Work in process 1,872 2,049
Finished goods 6,574 6,502
Supplies 324 269
Inventories $ 10,506 $ 10,707
XML 44 R33.htm IDEA: XBRL DOCUMENT v3.23.2
Note 4 - Equipment and Leasehold Improvements (Details Textual) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Asset Impairment Charges     $ 0
Depreciation, Depletion and Amortization $ 407,000 $ 417,000  
XML 45 R34.htm IDEA: XBRL DOCUMENT v3.23.2
Note 4 - Equipment and Leasehold Improvements - Components of Equipment and Leasehold Improvements (Details) - USD ($)
$ in Thousands
Jun. 30, 2023
Mar. 31, 2023
Equipment and leasehold improvements, gross $ 37,182 $ 37,094
Less accumulated depreciation and amortization (26,354) (25,947)
Construction-in-progress 237 219
Equipment and leasehold improvements, net 11,065 11,366
Equipment [Member]    
Equipment and leasehold improvements, gross 21,711 21,649
Leasehold Improvements [Member]    
Equipment and leasehold improvements, gross 15,064 15,038
Furniture and Fixtures [Member]    
Equipment and leasehold improvements, gross $ 407 $ 407
XML 46 R35.htm IDEA: XBRL DOCUMENT v3.23.2
Note 5 - Line of Credit and Long-term Debt (Details Textual) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Apr. 12, 2021
Aug. 14, 2012
Apr. 30, 2021
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Mar. 31, 2023
Mar. 31, 2020
Jun. 30, 2203
Jun. 22, 2023
Jun. 21, 2023
Dec. 14, 2022
Mar. 31, 2022
Apr. 30, 2019
Aug. 30, 2016
Line of Credit, Current       $ 1,770,000   $ 1,770,000 $ 1,540,000                
Long-term Debt and Capital Lease Obligations, Current and Noncurrent       3,402,000   3,402,000                  
Debt Issuance Costs, Current, Net       89,000   89,000 92,000                
Long-term Debt, Current Maturities, Total       5,833,000   5,833,000 5,409,000                
Interest Paid, Excluding Capitalized Interest, Operating Activities       151,000 $ 65,000                    
Lines of Credit, Related Party, Current       750,000   750,000 500,000                
Unsecured Subordinated Loan [Member]                              
Long-Term Debt, Gross       $ 1,000,000   $ 1,000,000 $ 1,000,000                
Term Loan Agreement, Maturing on August 14, 2032 [Member]                              
Debt Instrument Reference Rate       8.00%   8.00% 7.50%                
Debt Instrument, Basis Spread on Variable Rate   1.00%                          
Proceeds from Issuance of Debt   $ 5,500,000                          
Debt Instrument Interest Payment Period (Month)   12 months                          
Debt Instrument Amortization Period (Year)   19 years                          
Long-term Debt and Capital Lease Obligations, Current and Noncurrent       $ 3,402,000   $ 3,402,000 $ 3,461,000                
Debt Instrument One Time Origination and Guaranty Fees             $ 214,500                
Debt Instrument Annual Renewal Fee Payable Percentage             0.25%                
Debt Instrument Guaranteed Portion             80.00%                
Debt Covenant, Further Advances of Credit Agreement, Immediate Freeze                     $ 1,770,000        
Term Loan Agreement, Promissory Note One [Member]                              
Proceeds from Issuance of Debt   $ 2,250,000                          
Term Loan Agreement, Promissory Note Two [Member]                              
Proceeds from Issuance of Debt   $ 3,250,000                          
Skywords Note [Member]                              
Debt Instrument Reference Rate       8.00%   8.00% 7.50%                
Repayments of Long-term Debt, Total $ 500,000   $ 500,000                        
Interest Paid, Excluding Capitalized Interest, Operating Activities 1,900   1,900                        
Skywords Note [Member] | Unsecured Subordinated Loan [Member]                              
Debt Instrument, Face Amount               $ 1,500,000           $ 1,500,000  
Long-term Debt, Current Maturities, Total     $ 500,000                        
Long-Term Debt, Gross       $ 1,000,000   $ 1,000,000             $ 1,000,000    
Skywords Amended Note [Member]                              
Debt Instrument, Face Amount $ 500,000                     $ 1,000,000      
Debt Instrument, Floor Interest Rate 5.00%   5.00%                        
Minimum [Member] | Term Loan Agreement, Maturing on August 14, 2032 [Member]                              
Debt Instrument, Interest Rate During Period   5.50%                          
Prime Rate [Member] | Skywords Note [Member]                              
Debt Instrument, Basis Spread on Variable Rate     1.00%                        
Prime Rate [Member] | Skywords Note [Member] | Unsecured Subordinated Loan [Member]                              
Debt Instrument, Basis Spread on Variable Rate               1.00%              
Prime Rate [Member] | Skywords Amended Note [Member]                              
Debt Instrument, Basis Spread on Variable Rate 1.00%                            
Prime Rate [Member] | Minimum [Member] | Skywords Note [Member]                              
Debt Instrument, Interest Rate During Period     5.00%                        
First Foundation Bank [Member] | Minimum [Member]                              
Debt Instrument, Interest Rate, Stated Percentage       5.25%   5.25%                  
First Foundation Bank [Member] | Revolving Credit Facility [Member]                              
Line of Credit Facility, Maximum Borrowing Capacity             $ 2,000,000               $ 2,000,000
Line of Credit, Current       $ 1,770,000   $ 1,770,000 $ 1,540,000     $ 1,770,000          
First Foundation Bank [Member] | Revolving Credit Facility [Member] | Prime Rate [Member]                              
Debt Instrument Reference Rate             8.00%   8.25%            
Debt Instrument, Basis Spread on Variable Rate           2.00%                  
Related Party 1 [Member] | Revolving Credit Facility [Member]                              
Line of Credit Facility, Maximum Borrowing Capacity       $ 1,000,000   $ 1,000,000 $ 1,000,000                
Debt Instrument, Interest Rate, Stated Percentage       8.00%   8.00% 7.50%                
Lines of Credit, Related Party, Current       $ 750,000   $ 750,000 $ 500,000                
XML 47 R36.htm IDEA: XBRL DOCUMENT v3.23.2
Note 5 - Line of Credit and Long-term Debt - Summary of Line of Credit and Long-term Debt (Details) - USD ($)
$ in Thousands
Jun. 30, 2023
Mar. 31, 2023
Unamortized debt issuance costs $ (89) $ (92)
Less current maturities (5,833) (5,409)
Total long-term debt, net of current maturities 1,000 1,000
Line of Credit Excluding Related Party [Member]    
Long-term debt 1,770 1,540
Line of Credit, Related Party [Member]    
Long-term debt 750 500
Long-term Debt, Excluding Related Party Debt [Member]    
Long-term debt 3,402 3,461
Unsecured Subordinated Loan [Member]    
Long-term debt $ 1,000 $ 1,000
XML 48 R37.htm IDEA: XBRL DOCUMENT v3.23.2
Note 5 - Line of Credit and Long-term Debt - Future Payments (Details)
$ in Thousands
Jun. 30, 2023
USD ($)
Remainder of 2024 $ 3,402
2026 1,000
Total principal payments $ 4,402
XML 49 R38.htm IDEA: XBRL DOCUMENT v3.23.2
Note 6 - Operating Leases (Details Textual)
3 Months Ended
Jun. 30, 2023
USD ($)
Jun. 30, 2022
USD ($)
Mar. 31, 2023
Operating Lease, Weighted Average Remaining Lease Term (Year) 9 years 7 months 6 days    
Operating Lease, Weighted Average Discount Rate, Percent     7.30%
Operating Lease, Expense $ 203,000 $ 171,000  
Solar Lease for Buildings [Member]      
Leases, Number of Lease Properties 2    
Lessee, Operating Lease, Term of Contract (Month) 84 months    
XML 50 R39.htm IDEA: XBRL DOCUMENT v3.23.2
Note 6 - Operating Leases - Supplemental Balance Sheet Information (Details) - USD ($)
$ in Thousands
Jun. 30, 2023
Mar. 31, 2023
Right-of-use assets $ 6,149 $ 6,149
Accumulated lease amortization (1,493) (1,373)
Total right-of-use assets 4,656 4,776
Current lease liabilities 494 483
Non-current lease liabilities 4,146 4,275
Total lease liabilities $ 4,640 $ 4,758
XML 51 R40.htm IDEA: XBRL DOCUMENT v3.23.2
Note 6 - Operating Leases - Operating Leases Maturities (Details) - USD ($)
$ in Thousands
Jun. 30, 2023
Mar. 31, 2023
Remainder of 2024 $ 609  
2025 817  
2026 794  
2027 801  
2028 591  
Thereafter 2,854  
Total undiscounted lease payments 6,466  
Less: present value discount (1,826)  
Total lease liability balance $ 4,640 $ 4,758
XML 52 R41.htm IDEA: XBRL DOCUMENT v3.23.2
Note 7 - Accrued Expenses - Components of Accrued Expenses (Details) - USD ($)
$ in Thousands
Jun. 30, 2023
Mar. 31, 2023
Bonus and profit sharing $ 143 $ 143
Wages 79 215
Vacation 384 393
Interest and legal 47 30
Other accrued expenses 168 320
Total accrued expenses $ 821 $ 1,101
XML 53 R42.htm IDEA: XBRL DOCUMENT v3.23.2
Note 9 - Share-based Compensation (Details Textual)
3 Months Ended 12 Months Ended
Apr. 03, 2023
shares
Jun. 30, 2023
USD ($)
$ / shares
shares
Jun. 30, 2022
USD ($)
Mar. 31, 2023
USD ($)
$ / shares
Number of Shareholder Approved Share-based Compensation Plans   2    
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant (in shares) | shares   1,079,271    
Share-Based Payment Arrangement, Option [Member]        
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount   $ 103,000    
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Year)   1 year 4 months 24 days    
Share-Based Payment Arrangement, Option [Member] | Employees [Member]        
Share-Based Payment Arrangement, Expense   $ 26,000 $ 17,000  
Share Price (in dollars per share) | $ / shares   $ 0.86   $ 0.88
Share-Based Payment Arrangement, Option [Member] | Maximum [Member]        
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period (Year)   10 years    
Restricted Stock [Member] | Two Board Members [Member] | Share-Based Payment Arrangement, Nonemployee [Member]        
Share-Based Payment Arrangement, Expense   $ 0   $ 15,500
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares) | shares 17,672      
Restricted Stock Units (RSUs) [Member]        
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares) | shares   7,900    
Restricted Stock Units (RSUs) [Member] | Employees [Member]        
Share-Based Payment Arrangement, Expense   $ 21,000 $ 5,000  
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount   $ 114,000    
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Year)   2 years 1 month 6 days    
The 2004 Directors Plan [Member]        
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant (in shares) | shares   0    
XML 54 R43.htm IDEA: XBRL DOCUMENT v3.23.2
Note 9 - Share-based Compensation - Shares Authorized, Available for Future Grant and Outstanding Under Each Plan (Details)
Jun. 30, 2023
shares
Authorized (in shares) 1,950,000
Available (in shares) 1,079,271
Outstanding (in shares) 328,756
The 2016 Plan [Member]  
Authorized (in shares) 1,300,000
Available (in shares) 873,737
Outstanding (in shares) 310,756
2014 Directors Plan [Member]  
Authorized (in shares) 650,000
Available (in shares) 205,534
Outstanding (in shares) 12,000
The 2004 Directors Plan [Member]  
Available (in shares) 0
Outstanding (in shares) 6,000
XML 55 R44.htm IDEA: XBRL DOCUMENT v3.23.2
Note 9 - Share-based Compensation - Summary of Option Activity Under Stock Plans (Details) - USD ($)
3 Months Ended 12 Months Ended
Jun. 30, 2023
Mar. 31, 2023
Outstanding (in shares) 253,000  
Outstanding, weighted average exercise price (in dollars per share) $ 2.88  
Outstanding, weighted average remaining contractual term (Year) 7 years 2 months 12 days 7 years 6 months
Outstanding, aggregate intrinsic value $ 0  
Outstanding (in shares) 253,000 253,000
Outstanding, weighted average exercise price (in dollars per share) $ 2.88 $ 2.88
Exercisable (in shares) 144,666  
Exercisable, weighted average exercise price (in dollars per share) $ 2.97  
Exercisable, weighted average remaining contractual term (Year) 6 years 9 months 18 days  
Exercisable, aggregate intrinsic value $ 0  
XML 56 R45.htm IDEA: XBRL DOCUMENT v3.23.2
Note 9 - Share-based Compensation - Summary of Non-vested Options (Details)
3 Months Ended
Jun. 30, 2023
$ / shares
shares
Nonvested (in shares) | shares 141,667
Nonvested (in dollars per share) | $ / shares $ 1.55
Vested (in shares) | shares (33,333)
Vested (in dollars per share) | $ / shares $ 1.77
Nonvested (in shares) | shares 108,334
Nonvested (in dollars per share) | $ / shares $ 1.48
XML 57 R46.htm IDEA: XBRL DOCUMENT v3.23.2
Note 9 - Share-based Compensation - Restricted Stock Units (Details) - Restricted Stock Units (RSUs) [Member]
3 Months Ended
Jun. 30, 2023
$ / shares
shares
Nonvested restricted stock units (in shares) | shares 70,334
Nonvested restricted stock units, weighted average grant price (in dollars per share) | $ / shares $ 3.04
Granted (in shares) | shares 7,900
Granted, weighted average grant price (in dollars per share) | $ / shares $ 0.94
Vested (in shares) | shares (2,278)
Vested, weighted average grant price (in dollars per share) | $ / shares $ 2.39
Forfeited (in shares) | shares (200)
Forfeited, weighted average grant price (in dollars per share) | $ / shares $ 0.94
Nonvested restricted stock units (in shares) | shares 75,756
Nonvested restricted stock units, weighted average grant price (in dollars per share) | $ / shares $ 2.85
XML 58 R47.htm IDEA: XBRL DOCUMENT v3.23.2
Note 10 - Income Taxes (Details Textual) - USD ($)
3 Months Ended 12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Mar. 31, 2023
Dec. 31, 2022
Income Tax Expense (Benefit) $ 0 $ 3,000    
Effective Income Tax Rate Reconciliation, Percent   0.70%    
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent     21.00%  
Unrecognized Tax Benefits $ 0     $ 0
XML 59 R48.htm IDEA: XBRL DOCUMENT v3.23.2
Note 11 - Earnings Per Share (Details Textual) - shares
3 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Common Stock Options and Restricted Stock Units [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares) 3,000 12,000
XML 60 R49.htm IDEA: XBRL DOCUMENT v3.23.2
Note 11 - Earnings Per Share - Summary of Reconciliations Between the Numerator and the Denominator of the Basic and Diluted Earnings Per Share Computations (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
3 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Net loss $ (1,369) $ (472)
Basic (in shares) 6,290 6,204
Basic (in dollars per share) $ (0.22) $ (0.08)
XML 61 R50.htm IDEA: XBRL DOCUMENT v3.23.2
Note 12 - Related Party Transactions and Balances (Details Textual) - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended
Apr. 12, 2021
Apr. 30, 2021
Jun. 30, 2023
Jun. 30, 2022
Mar. 31, 2020
Mar. 31, 2023
Dec. 14, 2022
Apr. 30, 2019
Interest Paid, Excluding Capitalized Interest, Operating Activities     $ 151,000 $ 65,000        
Lines of Credit, Related Party, Current     750,000     $ 500,000    
Revolving Credit Facility [Member] | Related Party 1 [Member]                
Line of Credit Facility, Maximum Borrowing Capacity     1,000,000     1,000,000    
Lines of Credit, Related Party, Current     $ 750,000     $ 500,000    
Debt Instrument, Interest Rate, Stated Percentage     8.00%     7.50%    
Revolving Credit Facility [Member] | Related Party 1 [Member] | Maximum [Member]                
Line of Credit Facility, Maximum Borrowing Capacity     $ 2,000,000          
Conversion of Skywords Note Into Revolving Loans [Member]                
Debt Conversion, Original Debt, Amount $ 500,000              
Skywords Note [Member]                
Repayments of Long-term Debt, Total 500,000 $ 500,000            
Interest Paid, Excluding Capitalized Interest, Operating Activities 1,900 $ 1,900            
Skywords Note [Member] | Prime Rate [Member]                
Debt Instrument, Basis Spread on Variable Rate   1.00%            
Skywords Note [Member] | Unsecured Subordinated Loan [Member]                
Debt Instrument, Face Amount         $ 1,500,000     $ 1,500,000
Skywords Note [Member] | Unsecured Subordinated Loan [Member] | Prime Rate [Member]                
Debt Instrument, Basis Spread on Variable Rate         1.00%      
Skywords Amended Note [Member]                
Debt Instrument, Face Amount $ 500,000           $ 1,000,000  
Debt Instrument, Term (Year) 3 years              
Debt Instrument, Floor Interest Rate 5.00% 5.00%            
Skywords Amended Note [Member] | Prime Rate [Member]                
Debt Instrument, Basis Spread on Variable Rate 1.00%              
XML 62 R51.htm IDEA: XBRL DOCUMENT v3.23.2
Note 13 - Subsequent Events (Details Textual)
Aug. 10, 2023
$ / shares
Subsequent Event [Member]  
Nasdaq Minimum Bid Price (in dollars per share) $ 1.00
XML 63 cyan20230630_10q_htm.xml IDEA: XBRL DOCUMENT 0000768408 2023-04-01 2023-06-30 0000768408 2023-08-04 0000768408 2023-06-30 0000768408 2023-03-31 0000768408 2022-04-01 2022-06-30 0000768408 us-gaap:CommonStockMember 2023-03-31 0000768408 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0000768408 us-gaap:RetainedEarningsMember 2023-03-31 0000768408 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0000768408 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0000768408 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0000768408 us-gaap:CommonStockMember 2023-06-30 0000768408 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0000768408 us-gaap:RetainedEarningsMember 2023-06-30 0000768408 us-gaap:CommonStockMember 2022-03-31 0000768408 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0000768408 us-gaap:RetainedEarningsMember 2022-03-31 0000768408 2022-03-31 0000768408 us-gaap:CommonStockMember 2022-04-01 2022-06-30 0000768408 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0000768408 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0000768408 us-gaap:CommonStockMember 2022-06-30 0000768408 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0000768408 us-gaap:RetainedEarningsMember 2022-06-30 0000768408 2022-06-30 0000768408 us-gaap:RevolvingCreditFacilityMember cyan:FirstFoundationBankMember 2023-03-31 0000768408 us-gaap:RevolvingCreditFacilityMember cyan:FirstFoundationBankMember 2023-06-22 0000768408 us-gaap:RevolvingCreditFacilityMember cyan:RelatedParty1Member 2023-06-30 0000768408 us-gaap:RevolvingCreditFacilityMember cyan:RelatedParty1Member 2023-03-31 0000768408 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember cyan:RelatedParty1Member 2023-06-30 0000768408 cyan:UnsecuredSubordinatedLoanFromSkywordsMember 2019-04-30 0000768408 cyan:UnsecuredSubordinatedLoanFromSkywordsMember 2023-06-30 0000768408 cyan:UnsecuredSubordinatedLoanFromSkywordsMember 2023-03-31 0000768408 cyan:FirstFoundationBankMember 2023-04-01 2023-06-30 0000768408 us-gaap:RevolvingCreditFacilityMember cyan:RelatedParty1Member 2023-04-01 2023-06-30 0000768408 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-04-01 2023-06-30 0000768408 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-04-01 2023-03-31 0000768408 cyan:CustomerNumber1Member us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-04-01 2023-06-30 0000768408 cyan:CustomerNumber2Member us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-04-01 2023-06-30 0000768408 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-04-01 2022-06-30 0000768408 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-04-01 2023-06-30 0000768408 cyan:CustomerNumber1Member us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-04-01 2022-06-30 0000768408 cyan:CustomerNumber2Member us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-04-01 2022-06-30 0000768408 cyan:TwoCustomersMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-04-01 2023-06-30 0000768408 cyan:TwoCustomersMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-04-01 2023-03-31 0000768408 cyan:PackagedAstaxanthinMember 2023-04-01 2023-06-30 0000768408 cyan:PackagedAstaxanthinMember 2022-04-01 2022-06-30 0000768408 cyan:PackagedSpirulinaMember 2023-04-01 2023-06-30 0000768408 cyan:PackagedSpirulinaMember 2022-04-01 2022-06-30 0000768408 cyan:PackagedProductsMember 2023-04-01 2023-06-30 0000768408 cyan:PackagedProductsMember 2022-04-01 2022-06-30 0000768408 cyan:BulkAstaxanthinMember 2023-04-01 2023-06-30 0000768408 cyan:BulkAstaxanthinMember 2022-04-01 2022-06-30 0000768408 cyan:BulkSpirulinaMember 2023-04-01 2023-06-30 0000768408 cyan:BulkSpirulinaMember 2022-04-01 2022-06-30 0000768408 cyan:BulkProductsMember 2023-04-01 2023-06-30 0000768408 cyan:BulkProductsMember 2022-04-01 2022-06-30 0000768408 cyan:ContractExtractionAndRDServicesMember 2023-04-01 2023-06-30 0000768408 cyan:ContractExtractionAndRDServicesMember 2022-04-01 2022-06-30 0000768408 us-gaap:EquipmentMember 2023-06-30 0000768408 us-gaap:EquipmentMember 2023-03-31 0000768408 us-gaap:LeaseholdImprovementsMember 2023-06-30 0000768408 us-gaap:LeaseholdImprovementsMember 2023-03-31 0000768408 us-gaap:FurnitureAndFixturesMember 2023-06-30 0000768408 us-gaap:FurnitureAndFixturesMember 2023-03-31 0000768408 2023-01-01 2023-06-30 0000768408 cyan:LineOfCreditExcludingRelatedPartyMember 2023-06-30 0000768408 cyan:LineOfCreditExcludingRelatedPartyMember 2023-03-31 0000768408 cyan:LineOfCreditRelatedPartyMember 2023-06-30 0000768408 cyan:LineOfCreditRelatedPartyMember 2023-03-31 0000768408 cyan:LongtermDebtExcludingRelatedPartyDebtMember 2023-06-30 0000768408 cyan:LongtermDebtExcludingRelatedPartyDebtMember 2023-03-31 0000768408 cyan:UnsecuredSubordinatedLoanMember 2023-06-30 0000768408 cyan:UnsecuredSubordinatedLoanMember 2023-03-31 0000768408 us-gaap:RevolvingCreditFacilityMember cyan:FirstFoundationBankMember 2016-08-30 0000768408 us-gaap:RevolvingCreditFacilityMember cyan:FirstFoundationBankMember us-gaap:PrimeRateMember 2203-06-30 0000768408 us-gaap:RevolvingCreditFacilityMember cyan:FirstFoundationBankMember us-gaap:PrimeRateMember 2023-03-31 0000768408 us-gaap:RevolvingCreditFacilityMember cyan:FirstFoundationBankMember us-gaap:PrimeRateMember 2023-01-01 2023-06-30 0000768408 srt:MinimumMember cyan:FirstFoundationBankMember 2023-06-30 0000768408 us-gaap:RevolvingCreditFacilityMember cyan:FirstFoundationBankMember 2023-06-30 0000768408 cyan:TermLoanAgreementMaturingOnAugust142032Member 2012-08-13 2012-08-14 0000768408 cyan:TermLoanAgreementPromissoryNoteOneMember 2012-08-13 2012-08-14 0000768408 cyan:TermLoanAgreementPromissoryNoteTwoMember 2012-08-13 2012-08-14 0000768408 cyan:TermLoanAgreementMaturingOnAugust142032Member 2023-06-30 0000768408 cyan:TermLoanAgreementMaturingOnAugust142032Member 2023-03-31 0000768408 srt:MinimumMember cyan:TermLoanAgreementMaturingOnAugust142032Member 2012-08-13 2012-08-14 0000768408 cyan:TermLoanAgreementMaturingOnAugust142032Member 2022-04-01 2023-03-31 0000768408 cyan:TermLoanAgreementMaturingOnAugust142032Member 2023-06-21 0000768408 cyan:SkywordsNoteMember cyan:UnsecuredSubordinatedLoanMember 2019-04-30 0000768408 cyan:SkywordsNoteMember cyan:UnsecuredSubordinatedLoanMember 2021-04-30 0000768408 cyan:SkywordsAmendedNoteMember 2021-04-30 0000768408 cyan:SkywordsNoteMember 2021-04-01 2021-04-30 0000768408 cyan:SkywordsNoteMember cyan:UnsecuredSubordinatedLoanMember 2023-06-30 0000768408 cyan:SkywordsNoteMember cyan:UnsecuredSubordinatedLoanMember 2022-03-31 0000768408 cyan:SkywordsNoteMember 2023-06-30 0000768408 cyan:SkywordsNoteMember 2023-03-31 0000768408 cyan:SkywordsNoteMember us-gaap:PrimeRateMember 2021-04-01 2021-04-30 0000768408 srt:MinimumMember cyan:SkywordsNoteMember us-gaap:PrimeRateMember 2021-04-01 2021-04-30 0000768408 cyan:SolarLeaseForBuildingsMember 2023-06-30 0000768408 cyan:The2004DirectorsPlanMember 2023-06-30 0000768408 cyan:The2016PlanMember 2023-06-30 0000768408 cyan:The2014DirectorsPlanMember 2023-06-30 0000768408 srt:MaximumMember us-gaap:EmployeeStockOptionMember 2023-04-01 2023-06-30 0000768408 cyan:EmployeesMember us-gaap:EmployeeStockOptionMember 2023-04-01 2023-06-30 0000768408 cyan:EmployeesMember us-gaap:EmployeeStockOptionMember 2022-04-01 2022-06-30 0000768408 2022-04-01 2023-03-31 0000768408 cyan:EmployeesMember us-gaap:EmployeeStockOptionMember 2023-06-30 0000768408 cyan:EmployeesMember us-gaap:EmployeeStockOptionMember 2023-03-31 0000768408 us-gaap:EmployeeStockOptionMember 2023-06-30 0000768408 us-gaap:EmployeeStockOptionMember 2023-04-01 2023-06-30 0000768408 cyan:TwoBoardMembersMember us-gaap:RestrictedStockMember us-gaap:ShareBasedPaymentArrangementNonemployeeMember 2023-04-03 2023-04-03 0000768408 cyan:TwoBoardMembersMember us-gaap:RestrictedStockMember us-gaap:ShareBasedPaymentArrangementNonemployeeMember 2023-04-01 2023-06-30 0000768408 cyan:TwoBoardMembersMember us-gaap:RestrictedStockMember us-gaap:ShareBasedPaymentArrangementNonemployeeMember 2022-04-01 2023-03-31 0000768408 cyan:EmployeesMember us-gaap:RestrictedStockUnitsRSUMember 2023-04-01 2023-06-30 0000768408 cyan:EmployeesMember us-gaap:RestrictedStockUnitsRSUMember 2022-04-01 2022-06-30 0000768408 us-gaap:RestrictedStockUnitsRSUMember 2023-03-31 0000768408 us-gaap:RestrictedStockUnitsRSUMember 2023-04-01 2023-06-30 0000768408 us-gaap:RestrictedStockUnitsRSUMember 2023-06-30 0000768408 cyan:EmployeesMember us-gaap:RestrictedStockUnitsRSUMember 2023-06-30 0000768408 2022-12-31 0000768408 cyan:CommonStockOptionsAndRestrictedStockUnitsMember 2023-04-01 2023-06-30 0000768408 cyan:CommonStockOptionsAndRestrictedStockUnitsMember 2022-04-01 2022-06-30 0000768408 cyan:SkywordsNoteMember cyan:UnsecuredSubordinatedLoanMember 2020-03-31 0000768408 cyan:SkywordsNoteMember cyan:UnsecuredSubordinatedLoanMember us-gaap:PrimeRateMember 2019-04-01 2020-03-31 0000768408 cyan:ConversionOfSkywordsNoteIntoRevolvingLoansMember 2021-04-12 2021-04-12 0000768408 cyan:SkywordsAmendedNoteMember 2021-04-12 0000768408 cyan:SkywordsAmendedNoteMember 2021-04-12 2021-04-12 0000768408 cyan:SkywordsNoteMember 2021-04-12 2021-04-12 0000768408 cyan:SkywordsAmendedNoteMember us-gaap:PrimeRateMember 2021-04-12 2021-04-12 0000768408 cyan:SkywordsAmendedNoteMember 2022-12-14 0000768408 us-gaap:SubsequentEventMember 2023-08-10 shares iso4217:USD iso4217:USD shares pure utr:M utr:Y 0000768408 Cyanotech Corp false --03-31 Q1 2023 11000 64000 0.01 0.01 10000000 10000000 0 0 0 0 0.02 0.02 50000000 50000000 6291086 6291086 6271971 6271971 1000000 2 2 2 P19Y 1000000 2 2 P10Y 0 500000 P3Y 1000000 10-Q true 2023-06-30 false 0-14602 NV 91-1206026 73-4460 Queen Kaahumanu Hwy. #102 Kailua-Kona HI 96740 808 326-1353 Common Stock, $0.02 par value per share CYAN NASDAQ Yes Yes Non-accelerated Filer true false false 6308010 648000 974000 1794000 1331000 10506000 10707000 378000 484000 13326000 13496000 11065000 11366000 4656000 4776000 85000 90000 29132000 29728000 1721000 1021000 821000 1101000 77000 89000 494000 483000 1770000 1540000 750000 500000 3313000 3369000 8946000 8103000 1000000 1000000 4146000 4275000 0 3000 14092000 13381000 0 0 126000 125000 33917000 33856000 -19003000 -17634000 15040000 16347000 29132000 29728000 5146000 6716000 3614000 4398000 1532000 2318000 1274000 1329000 1276000 1168000 191000 246000 2741000 2743000 -1209000 -425000 160000 44000 -1369000 -469000 0 3000 -1369000 -472000 -0.22 -0.08 -0.22 -0.08 6290000 6204000 6290000 6204000 6271971 125000 33856000 -17634000 16347000 17672 1000 15000 0 16000 2278 0 -1000 0 -1000 835 -0 -0 -0 -0 0 47000 0 47000 0 0 -1369000 -1369000 6291086 126000 33917000 -19003000 15040000 6202223 124000 33557000 -14194000 19487000 2277 0 -3000 0 -3000 857 0 0 0 0 0 22000 0 22000 0 0 -472000 -472000 6203643 124000 33576000 -14666000 19034000 -1369000 -472000 407000 417000 10000 13000 120000 105000 47000 22000 11000 0 474000 -463000 -201000 1233000 -104000 -168000 744000 -509000 -264000 -75000 -12000 -85000 -118000 -110000 -3000 -3000 -596000 -1299000 150000 376000 -150000 -376000 230000 0 250000 0 59000 174000 1000 3000 420000 -177000 -326000 -1852000 974000 2589000 648000 737000 151000 65000 0 0 <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"><tbody><tr style="vertical-align: top;"><td style="width: 45pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b><em style="font: inherit;">1.</em></b></p> </td><td style="width: auto;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>ORGANIZATION AND BASIS OF PRESENTATION</b></p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:45pt;">Cyanotech Corporation (the “Company”), located in Kailua-Kona, Hawaii, was incorporated in the state of Nevada on <em style="font: inherit;"> March 3, 1983, </em>and is listed on the NASDAQ Capital Market under the symbol “CYAN”. The Company is engaged in the production of natural products derived from microalgae for the nutritional supplements market.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:45pt;">The Company is an agricultural company that produces high value natural products derived from microalgae grown in complex and intricate open-pond agricultural systems on the Kona coast of Hawaii.  The Company's products include <i>Hawaiian Spirulina Pacifica</i>®, a superfood with numerous benefits, including boosting the immune system and overall cellular health; and <i>BioAstin</i>®<i> Hawaiian Astaxanthin</i>®, a powerful antioxidant shown to support and maintain the body's natural inflammatory response.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:45pt;">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information pursuant to the instructions to Form <em style="font: inherit;">10</em>-Q and Regulation S-<em style="font: inherit;">X</em> of the Securities and Exchange Commission (“SEC”). These interim condensed consolidated financial statements are unaudited and, in the opinion of management, include all adjustments (consisting of normal recurring adjustments and accruals) necessary to present fairly the Condensed Consolidated Balance Sheets, Condensed Consolidated Statements of Operations, Condensed Consolidated Statements of Stockholders’ Equity and Condensed Consolidated Statements of Cash Flows for the periods presented in accordance with GAAP.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:45pt;">Accordingly, they do <em style="font: inherit;">not</em> include all of the information and notes required by GAAP for complete financial statements. The results of operations for the interim periods are <em style="font: inherit;">not</em> necessarily indicative of the results to be expected for the full fiscal year. The Condensed Consolidated Balance Sheet as of <em style="font: inherit;"> March </em><em style="font: inherit;">31,</em> <em style="font: inherit;">2023</em> was derived from the audited consolidated financial statements. These condensed consolidated financial statements and notes should be read in conjunction with the Company’s audited consolidated financial statements for the year ended <em style="font: inherit;"> March </em><em style="font: inherit;">31,</em> <em style="font: inherit;">2023,</em> contained in the Company’s annual report on Form <em style="font: inherit;">10</em>-K as filed with the SEC on <em style="font: inherit;"> June 27, 2023. </em></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Liquidity and Going Concern</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:45pt;">The accompanying condensed consolidated financial statements as of and for the <em style="font: inherit;">three</em> months ended <em style="font: inherit;"> June 30, 2023 </em>and <em style="font: inherit;">2022,</em> and as of <em style="font: inherit;"> March 31, 2023, </em>have been prepared assuming the Company will continue as a going concern. The going concern assumption contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The Company sustained operating losses and negative cash flows from operation for these same periods. Further, as discussed below, the Company was <em style="font: inherit;">not</em> in compliance with a debt covenant requirement at <em style="font: inherit;"> March 31, 2023 </em>and First Foundation Bank (the “Bank”) instituted a freeze on additional advances from the Revolving Credit Agreement (“Credit Agreement”). These conditions raise substantial doubt about the Company’s ability to continue as a going concern. The condensed consolidated financial statements do <em style="font: inherit;">not</em> include any adjustments to the carrying amounts and classification of assets, liabilities, and reported expense that <em style="font: inherit;"> may </em>be necessary if the Company was unable to continue as a going concern.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:45pt;">As of <em style="font: inherit;"> June 30, 2023, </em>the Company had cash of $648,000 and working capital of $4,380,000 compared to $974,000 and $5,393,000, respectively, as of <em style="font: inherit;"> March 31, 2023. </em>The Company has a Credit Agreement with the Bank that provided for borrowings up to $2,000,000 on a revolving basis, however, as part of the covenant waiver at <em style="font: inherit;"> March 31, 2023, </em>the borrowings under this line of credit were frozen at the outstanding balance on <em style="font: inherit;"> June 22, 2023, </em>at $1,770,000. As of <em style="font: inherit;"> March 31, 2023, </em>the Company had outstanding borrowings of $1,540,000 on the line of credit.  The line of credit is subject to renewal on <em style="font: inherit;"> August 30, 2023, </em>and the Company intends to renew or replace it with another line of credit on or before the expiration date.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:45pt;">The Company also has a loan facility with a related party that allows the Company to borrow up to $1,000,000 on a revolving basis (the “Revolver”). At <em style="font: inherit;"> June 30, 2023 </em>and <em style="font: inherit;"> March 31, 2023, </em>the Company had $750,000 and $500,000, respectively, outstanding borrowings on the Revolver, which were included in line of credit – related party on the Condensed Consolidated Balance Sheets. The Revolver expires on <em style="font: inherit;"> April 12, 2025 (</em>see Notes <em style="font: inherit;">5</em> and <em style="font: inherit;">12</em>). On <em style="font: inherit;"> June 30, 2023, </em>the Company and Skywords Family Foundation, Inc. (“Skywords”) executed a letter of intent to commence drafting and negotiating a definitive Second Agreement to the Amended and Restate Promissory Note, dated as of <em style="font: inherit;"> April 12, 2021, </em>as amended on <em style="font: inherit;"> December 14, 2022, </em>to which the revolving amount that the Company <em style="font: inherit;"> may </em>borrow from time to time would increase from $1,000,000 to $2,000,000, with all other terms of the Amendment remaining the same.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:45pt;">As of <em style="font: inherit;"> June 30, 2023, </em>the Company had $3,402,000 of debt (“Term Loans”) payable to the Bank that require the payment of principal and interest monthly through <em style="font: inherit;"> August 2032. </em>Pursuant to the Term Loans and the Credit Agreement, the Company is subject to annual financial covenants, customary affirmative and negative covenants and certain subjective acceleration clauses. As of <em style="font: inherit;"> March 31, 2023, </em>the Company debt service coverage ratio fell short of the Bank’s annual requirement. On <em style="font: inherit;"> June 22, 2023, </em>the Bank provided the Company with a letter waiving the covenant violation as of <em style="font: inherit;"> March 31, 2023, </em>but noting that the Bank reserved its right to declare a default in the future if any covenants remain out of compliance at applicable measurement dates. In addition, the Bank’s letter implemented an immediate freeze on any and all further advances of the Credit Agreement through the maturity date.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:45pt;">In <em style="font: inherit;"> April 2019, </em>the Company obtained a loan in the amount of $1,500,000 from a related party. The proceeds were used to pay down accounts payable and for general operating capital purposes. On <em style="font: inherit;"> April 12, 2021 </em>and <em style="font: inherit;"> December 14, 2022, </em>the Company amended this loan (see Notes <em style="font: inherit;">5</em> and <em style="font: inherit;">12</em>). As of both <em style="font: inherit;"> June 30, 2023 </em>and <em style="font: inherit;"> March 31, 2023, </em>the Company had $1,000,000 outstanding on the related party note. The loan matures on <em style="font: inherit;"> April 12, 2025.</em></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:45pt;">The Company continues to experience a loss from operations resulting in net cash outflows from operating activities of $596,000 for the <em style="font: inherit;">three</em> months ended <em style="font: inherit;"> June 30, 2023. </em>The impacts from the macroeconomic environment continued to lead to lower sales across all of the Company's products.  Since the <em style="font: inherit;">second</em> quarter of fiscal year <em style="font: inherit;">2023,</em> the Company drew a net of $1,770,000 on its line of credit and $750,000 on the Revolver.  To address the resulting cash flow challenges, the Company continues to monitor cost savings initiatives implemented in fiscal year <em style="font: inherit;">2023,</em> including stopping or slowing production of inventory in alignment with current customer demand, maintaining a reduced headcount and compensation, primarily through attrition and furloughs, respectively, and eliminating certain discretionary selling, general and administrative expenses.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:45pt;">Funds generated by operating activities and available cash are the Company’s most significant sources of liquidity for working capital requirements, debt service and funding of maintenance levels of capital expenditures.  The Company has developed its operating plan to produce the cash flows necessary to meet all financing requirements.  Although the Company has a history of either being in compliance with debt covenants, or obtaining the necessary waivers, execution of it operating plan is dependent on many factors, some of which are <em style="font: inherit;">not</em> within the control of the Company. However, <em style="font: inherit;">no</em> assurances can be provided that the Company will achieve its operating plan and cash flow projections for this fiscal year or its projected consolidated financial position as of <em style="font: inherit;"> June 30, 2024. </em>Such estimates are subject to change based on future results and such change could cause future results to vary significantly from expected results.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> 648000 4380000 974000 5393000 2000000 1770000 1540000 1000000 750000 500000 1000000 2000000 3402000 1500000 1000000 -596000 1770000 750000 <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"><tbody><tr style="vertical-align: top;"><td style="width: 45pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b><em style="font: inherit;">2.</em></b></p> </td><td style="width: auto;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>SIGNIFICANT ACCOUNTING POLICIES</b></p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Consolidation</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 45pt;">The accompanying condensed consolidated financial statements include the accounts of Cyanotech Corporation and its wholly owned subsidiary, Nutrex Hawaii, Inc. (“Nutrex Hawaii” or “Nutrex”, collectively the “Company”). All intercompany balances and transactions have been eliminated in consolidation.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Use of Estimates</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:45pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosures of any contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the periods reported.  Management reviews these estimates and assumptions periodically and reflects the effect of revisions in the period that they are determined to be necessary.  Actual results could differ from those estimates and assumptions.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Cash </b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:45pt;">Cash primarily consists of cash on hand and cash in bank deposits.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Concentration Risk</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:45pt;">A significant portion of revenues and accounts receivables are derived from a few major customers. For the <em style="font: inherit;">three</em> months ended <em style="font: inherit;"> June 30, 2023, </em><span style="-sec-ix-hidden:c101694426"><span style="-sec-ix-hidden:c101694434">two</span></span> customers individually accounted for 32% and 18% of the Company’s total net sales, and for the <em style="font: inherit;">three</em> months ended <em style="font: inherit;"> June 30, 2022, </em><span style="-sec-ix-hidden:c101694430">two</span> customers individually accounted for 24% and 17% of the Company’s total net sales. Two customers accounted for 72% and 46% of the Company’s accounts receivable balance as of <em style="font: inherit;"> June 30, 2023 </em>and <em style="font: inherit;"> March 31, 2023, </em>respectively.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Accounts Receivable</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:45pt;">Accounts receivable balances are recorded at the invoiced amount and do <em style="font: inherit;">not</em> accrue interest. Credit is extended base on evaluation of the customer’s financial condition. Collateral is <em style="font: inherit;">not</em> required. The allowance for credit losses reflects management’s best estimate of expected credit losses inherent in the accounts receivable balance. Management determines the allowances based on historical experience, specifically identified nonpaying customers and other currently available evidence, including the likelihood of each customer <em style="font: inherit;">not</em> being able to pay, due to the Company’s small customer and recurring customer base. Management reviews its customer account balances monthly with a focus on significant individual past due balances over <em style="font: inherit;">90</em> days. All other balances are reviewed on a pooled basis. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. The Company does <em style="font: inherit;">not</em> have any off-balance sheet credit exposure related to its customers or otherwise.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Revenue Recognition</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:45pt;">The Company records revenue based on the <em style="font: inherit;">five</em>-step model which includes: (<em style="font: inherit;">1</em>) identifying the contract with the customer; (<em style="font: inherit;">2</em>) identifying the performance obligations in the contract; (<em style="font: inherit;">3</em>) determining the transaction price; (<em style="font: inherit;">4</em>) allocating the transaction price to the performance obligations; and (<em style="font: inherit;">5</em>) recognizing revenue when the performance obligations are satisfied. Substantially all of the Company’s revenue is generated by fulfilling orders for the purchase of its microalgal dietary supplements to retailers, wholesalers, or direct to consumers via online channels, with each order considered to be a distinct performance obligation. These orders <em style="font: inherit;"> may </em>be formal purchase orders, verbal phone orders, e-mail orders or orders received online. Shipping and handling activities for which the Company is responsible under the terms and conditions of the order are <em style="font: inherit;">not</em> accounted for as performance obligations but as fulfillment costs. These activities are required to fulfill the Company’s promise to transfer the goods and are expensed when revenue is recognized. </p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:45pt;">Revenue is measured as the net amount of consideration expected to be received in exchange for fulfilling a performance obligation. The Company has elected to exclude sales, use and similar taxes from the measurement of the transaction price.  The amount of consideration expected to be received and revenue recognized includes estimates of variable consideration, which includes costs for trade promotion programs, coupons, returns and early payment discounts.  Such estimates are calculated using historical averages adjusted for any expected changes due to current business conditions and experience. The Company reviews and updates these estimates at the end of each reporting period and the impact of any adjustments are recognized in the period the adjustments are identified. In assessing whether collection of consideration from a customer is probable, the Company considers the customer's ability and intent to pay that amount of consideration when it is due. Payment of invoices is due as specified in the underlying customer agreement, typically <em style="font: inherit;">30</em> days from the invoice date, which occurs on the date of transfer of control of the products to the customer. Revenue is recognized at the point in time that control of the ordered products is transferred to the customer. Generally, this occurs when the product is delivered, or in some cases, picked up from <em style="font: inherit;">one</em> of the Company’s distribution centers by the customer. Revenue from extraction services is recognized when control is transferred upon completion of the extraction process.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:45pt;">Customer contract liabilities consist of customer deposits received in advance of fulfilling an order and are shown separately on the consolidated balance sheets. During the <em style="font: inherit;">three</em> months ended <em style="font: inherit;"> June 30, 2023 </em>and <em style="font: inherit;">2022,</em> the Company recognized $16,000 and $91,000, respectively, of revenue from deposits that were included in contract liabilities as of <em style="font: inherit;"> March 31, 2023 </em>and <em style="font: inherit;">2022,</em> respectively. The Company’s contracts have a duration of <em style="font: inherit;">one</em> year or less and therefore, the Company has elected the practical expedient of <em style="font: inherit;">not</em> disclosing revenues allocated to partially unsatisfied performance obligations.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Disaggregation of Revenue</i></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:45pt;">The following table represents revenue disaggregated by major product line and extraction services for the:</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;"><tbody><tr style="vertical-align: bottom;"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 70%; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">($ in thousands)</p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Three Months</b><br/> <b>Ended</b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>June 30, </b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>2023</b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Three Months</b><br/> <b>Ended</b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>June 30, </b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>2022</b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Packaged sales</p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 9pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Astaxanthin packaged</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">2,809</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">3,524</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 9pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Spirulina packaged</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">1,574</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">1,511</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 36pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 36pt;">Total packaged sales</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">4,383</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">5,035</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Bulk sales</p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 9pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Astaxanthin bulk</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">299</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">494</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 9pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Spirulina bulk</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">363</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">1,093</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 36pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 36pt;">Total bulk sales</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">662</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">1,587</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Contract extraction and R&amp;D services revenue</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">101</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">94</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 36pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 36pt;">Total net sales</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">5,146</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">6,716</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Recently Accounting Pronouncements</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:45pt;">In <em style="font: inherit;"> June 2016, </em>the FASB issued ASU <em style="font: inherit;">2016</em>-<em style="font: inherit;">13,</em> “<i>Financial Instruments </i>–<i> Credit Losses</i>” (“Topic <em style="font: inherit;">326”</em>), which was subsequently amended in <em style="font: inherit;"> November 2018 </em>through ASU <em style="font: inherit;">2018</em>-<em style="font: inherit;">19,</em> “<i>Codification Improvements to Topic <em style="font: inherit;">326,</em> Financial Instruments </i>–<i> Credit Losses</i>” (“CECL”). CECL requires entities to estimate lifetime expected credit losses for trade and other receivables, net investment in leases, financing receivables, debt securities and other instruments, which will result in earlier recognition of credit losses. The guidance is effective for interim and annual periods beginning after <em style="font: inherit;"> December 15, 2022. </em>The Company adopted this standard as of <em style="font: inherit;"> April 1, 2023, </em>however, due to the relatively short-term nature of its accounts receivable and history of limited bad debt expense, the impact of this guidance was <em style="font: inherit;">not</em> significant to the Company’s consolidated financial statements and related disclosure. The Company will continue to evaluate the impact of CECL going forward.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">  </p> 0.32 0.18 2 0.24 0.17 0.72 0.46 16000 91000 <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;"><tbody><tr style="vertical-align: bottom;"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 70%; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">($ in thousands)</p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Three Months</b><br/> <b>Ended</b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>June 30, </b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>2023</b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Three Months</b><br/> <b>Ended</b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>June 30, </b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>2022</b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Packaged sales</p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 9pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Astaxanthin packaged</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">2,809</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">3,524</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 9pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Spirulina packaged</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">1,574</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">1,511</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 36pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 36pt;">Total packaged sales</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">4,383</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">5,035</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Bulk sales</p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 9pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Astaxanthin bulk</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">299</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">494</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 9pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Spirulina bulk</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">363</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">1,093</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 36pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 36pt;">Total bulk sales</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">662</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">1,587</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Contract extraction and R&amp;D services revenue</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">101</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">94</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 36pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 36pt;">Total net sales</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">5,146</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">6,716</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> </tbody></table> 2809000 3524000 1574000 1511000 4383000 5035000 299000 494000 363000 1093000 662000 1587000 101000 94000 5146000 6716000 <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"><tbody><tr style="vertical-align: top;"><td style="width: 45pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b><em style="font: inherit;">3.</em></b></p> </td><td style="width: auto;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>INVENTORIES</b></p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:45pt;">Inventories are stated at the lower of cost or net realizable value. Cost is determined by the <em style="font: inherit;">first</em>-in, <em style="font: inherit;">first</em>-out method. Inventories consist of the following as of:</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;"><tbody><tr style="vertical-align: bottom;"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>June 30, </b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>2023</b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>March 31, </b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>2023</b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom;"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>(in thousands)</b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 70%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Raw materials</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">1,736</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">1,887</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Work in process</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">1,872</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">2,049</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Finished goods</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">6,574</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">6,502</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Supplies</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">324</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">269</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 9pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Inventories</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">10,506</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">10,707</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:45pt;">The Company recognizes abnormal production costs, including fixed cost variances from normal production capacity, fixed production overhead costs, idle facilities, freight handling costs and spoilage, as an expense in the period incurred, without adjusting overhead absorption rates. Normal production capacity is defined as the production expected to be achieved over a number of periods or seasons under normal circumstances, taking into account the loss of capacity resulting from planned maintenance. The Company expensed abnormal productions costs of $133,000 and $0 to cost of sales for the <em style="font: inherit;">three</em> months ended <em style="font: inherit;"> June 30, 2023 </em>and <em style="font: inherit;">2022,</em> respectively.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:45pt;">Beginning in fiscal year <em style="font: inherit;">2021</em> through fiscal year <em style="font: inherit;">2023,</em> cultivation of astaxanthin was completed in the <em style="font: inherit;">first</em> <em style="font: inherit;">six</em> months of the fiscal year during the most productive months of the year due to the best growing conditions, compared to year-round production in the prior fiscal years. In fiscal year <em style="font: inherit;">2024,</em> cultivation of astaxanthin will be year-round in order to manage staffing constraints. The Company calculates total production costs for the year based on normal capacity of production expected to be achieved in a year under normal circumstances. These costs are then allocated into inventory based on the period of production, <em style="font: inherit;">not</em> including abnormal production costs. Allocating fixed and overhead costs requires management’s judgement to determine when production is outside of the normal range of expected variation in production.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:45pt;">Other non-inventoriable fixed costs of $189,000 and $35,000 were expensed to cost of sales for the <em style="font: inherit;">three</em> months ended <em style="font: inherit;"> June 30, 2023 </em>and <em style="font: inherit;">2022,</em> respectively.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">  </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;"><tbody><tr style="vertical-align: bottom;"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>June 30, </b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>2023</b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>March 31, </b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>2023</b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom;"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>(in thousands)</b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 70%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Raw materials</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">1,736</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">1,887</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Work in process</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">1,872</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">2,049</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Finished goods</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">6,574</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">6,502</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Supplies</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">324</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">269</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 9pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Inventories</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">10,506</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">10,707</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> </tbody></table> 1736000 1887000 1872000 2049000 6574000 6502000 324000 269000 10506000 10707000 133000 0 189000 35000 <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"><tbody><tr style="vertical-align: top;"><td style="width: 45pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b><em style="font: inherit;">4.</em></b></p> </td><td style="width: auto;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>EQUIPMENT AND LEASEHOLD IMPROVEMENTS</b></p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:45pt;">Equipment and leasehold improvements consist of the following as of:</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;"><tbody><tr style="vertical-align: bottom;"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>June 30, </b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>2023</b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>March 31, </b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>2023</b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom;"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>(in thousands)</b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 70%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Equipment</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">21,711</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">21,649</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Leasehold improvements</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">15,064</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">15,038</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Furniture and fixtures</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">407</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">407</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">37,182</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">37,094</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Less accumulated depreciation and amortization</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">(26,354</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">(25,947</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</p> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Construction-in-progress</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">237</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">219</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 9pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Equipment and leasehold improvements, net</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">11,065</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">11,366</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:45pt;">Management has determined that no asset impairment existed as of <em style="font: inherit;"> June 30, 2023. </em>Depreciation and amortization expense were approximately $407,000 and $417,000 for the <em style="font: inherit;">three</em> months ended <em style="font: inherit;"> June 30, 2023 </em>and <em style="font: inherit;">2022,</em> respectively.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;"><tbody><tr style="vertical-align: bottom;"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>June 30, </b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>2023</b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>March 31, </b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>2023</b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom;"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>(in thousands)</b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 70%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Equipment</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">21,711</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">21,649</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Leasehold improvements</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">15,064</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">15,038</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Furniture and fixtures</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">407</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">407</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">37,182</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">37,094</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Less accumulated depreciation and amortization</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">(26,354</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">(25,947</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</p> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Construction-in-progress</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">237</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">219</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 9pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Equipment and leasehold improvements, net</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">11,065</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">11,366</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> </tbody></table> 21711000 21649000 15064000 15038000 407000 407000 37182000 37094000 26354000 25947000 237000 219000 11065000 11366000 0 407000 417000 <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"><tbody><tr style="vertical-align: top;"><td style="width: 45pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b><em style="font: inherit;">5.</em></b></p> </td><td style="width: auto;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>LINE OF CREDIT AND LONG-TERM DEBT </b></p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:45pt;">Total debt consists of the following as of:</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;"><tbody><tr style="vertical-align: bottom;"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>June 30, </b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>2023</b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>March 31, </b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>2023</b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom;"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>(in thousands)</b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 70%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Line of credit</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">1,770</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">1,540</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Line of credit – related party</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">750</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">500</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Long-term debt</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">3,402</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">3,461</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Long-term debt - related party</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">1,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">1,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Unamortized debt issuance costs</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">(89</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">(92</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</p> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Less current maturities</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(5,833</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(5,409</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</p> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 9pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Total long-term debt, net of current maturities</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">1,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">1,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><i>Line of Credit and Term Loans</i></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:45pt;">On <em style="font: inherit;"> August 30, 2016, </em>the Credit Agreement, which the Company entered into with the Bank on <em style="font: inherit;"> June 3, 2016, </em>became effective after the Company and the Bank received the necessary approvals from the State of Hawaii to secure the lien on the Company’s leasehold property in Kona, Hawaii. The Credit Agreement allows the Company to borrow up to $2,000,000 on a revolving basis. Borrowings under the Credit Agreement bear interest at the Wall Street Journal prime rate (8.25% at <em style="font: inherit;"> June 30, 2023 </em>and 8.0% at <em style="font: inherit;"> March 31, 2023) </em>plus 2%, floating, provided that at <em style="font: inherit;">no</em> time shall the annual interest rate be less than 5.25%.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:45pt;">At <em style="font: inherit;"> June 30, 2023 </em>and <em style="font: inherit;"> March 31, 2023, </em>the outstanding balance under the Credit Agreement was $1,770,000 and $1,540,000, respectively, was included in current liabilities on the Condensed Consolidated Balance Sheets. The line of credit, which is subject to annual renewal, was renewed on <em style="font: inherit;"> August 30, 2022 </em>and will be subject to renewal upon expiration on <em style="font: inherit;"> August 30, 2023.</em></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:45pt;">The Credit Agreement grants the Bank the following security interests in the Company’s property: (a) a lien on the Company’s leasehold interest in its Kona facility; (b) an assignment of the Company’s interest in leases and rents on its Kona facility; and (c) a security interest in all fixtures, furnishings and equipment related to or used by the Company at the Kona facility. Each security interest is further subject to the terms of the Credit Agreement.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:45pt;">In <em style="font: inherit;">2012,</em> the Company executed a loan agreement with a lender providing for $5,500,000 in aggregate credit facilities (the <em style="font: inherit;">“2012</em> Loan”) secured by substantially all the Company’s assets, including a mortgage on the Company's interest in its lease at the National Energy Laboratory of Hawaii Authority, pursuant to a Term Loan Agreement dated <em style="font: inherit;"> August </em><em style="font: inherit;">14,</em> <em style="font: inherit;">2012</em> (the <em style="font: inherit;">“2012</em> Loan Agreement”). The <em style="font: inherit;">2012</em> Loan is evidenced by promissory notes in the amounts of $2,250,000 and $3,250,000, the repayment of which is partially guaranteed under the provisions of a United States Department of Agriculture (“USDA”) Rural Development Guarantee program. The proceeds of the <em style="font: inherit;">2012</em> Loan were used to acquire processing equipment and leasehold improvements at its Kona, Hawaii facility.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:45pt;">The provisions of the <em style="font: inherit;">2012</em> Loan required the payment of interest only for the <em style="font: inherit;">first</em> 12 months of the term; thereafter, and until its maturity on <em style="font: inherit;"> August </em><em style="font: inherit;">14,</em> <em style="font: inherit;">2032,</em> the obligation fully amortizes over <span style="-sec-ix-hidden:c101694601">nineteen</span> (<em style="font: inherit;">19</em>) years. Interest on the <em style="font: inherit;">2012</em> Loan accrues on the outstanding principal balance at an annual variable rate equal to the published Wall Street Journal prime rate (8.0% and 7.5% at <em style="font: inherit;"> June 30, 2023 </em>and <em style="font: inherit;"> March </em><em style="font: inherit;">31,</em> <em style="font: inherit;">2023,</em> respectively) plus 1.0% and is adjustable on the <em style="font: inherit;">first</em> day of each calendar quarter and fixed for that quarter, provided that at <em style="font: inherit;">no</em> time shall the annual interest rate be less than 5.5%. The balance under the <em style="font: inherit;">2012</em> Loan was $3,402,000 and $3,461,000 at <em style="font: inherit;"> June 30, 2023 </em>and <em style="font: inherit;"> March </em><em style="font: inherit;">31,</em> <em style="font: inherit;">2023,</em> respectively, and was included in current maturities of long-term debt in the debt table above. See Loan Covenants, Violations and Waiver below.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:45pt;">The <em style="font: inherit;">2012</em> Loan included a <em style="font: inherit;">one</em>-time origination and guaranty fees totaling $214,500 and an annual renewal fee payable in the amount of 0.25% of the USDA guaranteed portion of the outstanding principal balance as of <em style="font: inherit;"> December </em><em style="font: inherit;">31</em> of each year, beginning <em style="font: inherit;"> December </em><em style="font: inherit;">31,</em> <em style="font: inherit;">2012.</em> The USDA has guaranteed 80% of all amounts owing under the <em style="font: inherit;">2012</em> Loan. The balance in unamortized debt issuance costs was $89,000 and $92,000 at <em style="font: inherit;"> June 30, 2023 </em>and <em style="font: inherit;"> March 31, 2023, </em>respectively, and was included in current maturities of long-term debt in the debt table above. See Loan Covenants, Violations and Waiver below.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Loan Covenants, Violation and Waiver</i></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:45pt;">The Company’s Credit Agreement and the <em style="font: inherit;">2012</em> Loan are subject to annual debt service and other financial covenants, including covenants which require the Company to meet key financial ratios and customary affirmative and negative covenants.  As of <em style="font: inherit;"> March 31, 2023, </em>the Company was <em style="font: inherit;">not</em> in compliance with the required debt service coverage ratio, however, was in compliance with the <em style="font: inherit;">two</em> other covenants. Due to this violation, the Bank would be contractually entitled to require immediate repayment of the outstanding term loans and the outstanding line of credit balance. However, on <em style="font: inherit;"> June 22, 2023, </em>the Bank issued the Company a letter waiving the covenant violation as of <em style="font: inherit;"> March 31, 2023, </em>and implemented an immediate freeze on any and all further advances of the Credit Agreement through the maturity date, with an outstanding balance in the amount of $1,770,000 as of <em style="font: inherit;"> June 21, 2023. </em>The next remeasurement date will be <em style="font: inherit;"> March 31, 2024.</em></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Line of Credit and Debt </i>–<i> Related Party</i></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:45pt;">In <em style="font: inherit;"> April 2019, </em>the Company obtained a loan in the amount of $1,500,000 and the interest was payable quarterly.  The loan was originally due in <em style="font: inherit;"> April 2021. </em>In <em style="font: inherit;"> April 2021, </em>the Company amended the loan, which extended the expiration to <em style="font: inherit;"> April 2024, </em>converted $500,000 into the Revolver, adjusted the interest rate to reflect a floor of 5%, and granted a security interest in substantially all of the Company’s personal property assets, subject to limited exceptions. Concurrently, with the amendment and conversion of the original loan, the Company repaid in cash the principal amount of $500,000 plus accrued interest to date of $1,900 (see Note <em style="font: inherit;">12</em>).  In <em style="font: inherit;"> December 2022, </em>the Company amended the loan to extend the expiration to <em style="font: inherit;"> April 2025 </em>and increase the Revolver to $1,000,000. At both <em style="font: inherit;"> June 30, 2023 </em>and <em style="font: inherit;"> March 31, 2023, </em>the balance under this loan was $1,000,000, which was included in long-term debt in the debt table above. At <em style="font: inherit;"> June 30, 2023 </em>and <em style="font: inherit;"> March 31, 2023, </em>the balance under the Revolver was $750,000 and $500,000, respectively, which was included in line of credit – related party in the debt table above. Interest accrues on the outstanding principal balance and the Revolver at an annual variable rate equal to the published Wall Street Journal prime rate (8.0% and 7.5% at <em style="font: inherit;"> June 30, 2023 </em>and <em style="font: inherit;"> March </em><em style="font: inherit;">31,</em> <em style="font: inherit;">2023,</em> respectively) plus 1.0% and is adjustable on the <em style="font: inherit;">first</em> day of each calendar quarter and fixed for that quarter, provided that at <em style="font: inherit;">no</em> time shall the annual interest rate be less than 5.0%.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:45pt;">Future principal payments under the loans at <em style="font: inherit;"> June 30, 2023 </em>are as follows:</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;"><tbody><tr style="vertical-align: bottom;"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 85%; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Fiscal year payments due</b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>(in thousands)</b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Remainder of 2024</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">3,402</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2026</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">1,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 9pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Total principal payments</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">4,402</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">  </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;"><tbody><tr style="vertical-align: bottom;"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>June 30, </b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>2023</b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>March 31, </b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>2023</b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom;"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>(in thousands)</b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 70%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Line of credit</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">1,770</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">1,540</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Line of credit – related party</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">750</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">500</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Long-term debt</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">3,402</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">3,461</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Long-term debt - related party</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">1,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">1,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Unamortized debt issuance costs</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">(89</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">(92</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</p> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Less current maturities</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(5,833</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(5,409</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</p> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 9pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Total long-term debt, net of current maturities</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">1,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">1,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> </tbody></table> 1770000 1540000 750000 500000 3402000 3461000 1000000 1000000 89000 92000 5833000 5409000 1000000 1000000 2000000 0.0825 0.080 0.02 0.0525 1770000 1540000 5500000 2250000 3250000 P12M 0.080 0.075 0.010 0.055 3402000 3461000 214500 0.0025 0.80 89000 92000 1770000 1500000 500000 0.05 500000 1900 1000000 1000000 750000 500000 0.080 0.075 0.010 0.050 <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;"><tbody><tr style="vertical-align: bottom;"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 85%; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Fiscal year payments due</b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>(in thousands)</b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Remainder of 2024</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">3,402</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2026</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">1,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 9pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Total principal payments</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">4,402</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> </tbody></table> 3402000 1000000 4402000 <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"><tbody><tr style="vertical-align: top;"><td style="width: 45pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b><em style="font: inherit;">6.</em></b></p> </td><td style="width: auto;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>OPERATING LEASES</b></p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:45pt;">The Company leases facilities, equipment and land under non-cancelable operating leases expiring through <em style="font: inherit;">2037.</em> One of its facility leases contains price escalations and a renewal option for <em style="font: inherit;">five</em> years. Right-of-use assets represent the right to use an underlying asset for the lease term and lease liabilities represent the obligation to make lease payments arising from the lease. Right-of-use assets and liabilities were recognized at <em style="font: inherit;"> April 1, 2019 </em>based on the present value of lease payments over the lease term, using the Bank’s incremental borrowing rate based on the information available at recognition, and the Company has elected to exclude non-lease components. The Company also leases <span style="-sec-ix-hidden:c101694686">two</span> 84-month solar leases for <em style="font: inherit;">two</em> of its buildings, which are included in the right-of-use assets and liabilities. At <em style="font: inherit;"> June 30, 2023, </em>the weighted average remaining lease terms of all operating leases was 9.6 years, the weighted average discount rate was 7.3%, and for the <em style="font: inherit;">three</em> months ended <em style="font: inherit;"> June 30, 2023 </em>and <em style="font: inherit;">2022,</em> the operating lease costs were $203,000 and $171,000, respectively.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:45pt;">Supplemental balance sheet information related to leases consist of the following as of:</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;"><tbody><tr style="vertical-align: bottom;"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 35.7%; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Operating leases</b></p> </td><td style="text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 34.3%; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Balance Sheet Classification</b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>June 30, 2023</b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>March 31, 2023</b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom;"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>(in thousands)</b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Right-of-use assets</p> </td><td style="text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><em style="font: inherit;">Operating lease right-of-use assets</em></p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">6,149</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">6,149</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Accumulated lease amortization</p> </td><td style="text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><em style="font: inherit;">Operating lease right-of-use assets</em></p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">(1,493</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">(1,373</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</p> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td> </td><td> </td><td style="padding-bottom: 1px;"> </td><td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="padding-bottom: 1px;"> </td><td style="padding-bottom: 1px;"> </td><td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td colspan="2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 9pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;"><em style="font: inherit;">Total right-of-use assets</em></p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">4,656</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">4,776</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Current lease liabilities</p> </td><td style="text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><em style="font: inherit;">Operating lease obligations</em></p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">494</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">483</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Non-current lease liabilities</p> </td><td style="text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><em style="font: inherit;">Long-term operating lease obligations</em></p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">4,146</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">4,275</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td> </td><td> </td><td style="padding-bottom: 1px;"> </td><td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="padding-bottom: 1px;"> </td><td style="padding-bottom: 1px;"> </td><td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td colspan="2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 9pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;"><em style="font: inherit;">Total lease liabilities</em></p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">4,640</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">4,758</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:45pt;">Maturities of lease liabilities at <em style="font: inherit;"> June 30, 2023 </em>are as follows:</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;"><tbody><tr style="vertical-align: bottom;"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 85%; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Payments</b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b><b>(in thousands)</b></b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Remainder of 2024</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">609</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2025</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">817</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2026</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">794</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2027</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">801</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2028</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">591</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Thereafter</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">2,854</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Total undiscounted lease payments</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">6,466</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Less: present value discount</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(1,826</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</p> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 9pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Total lease liability balance</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">4,640</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">  </p> P84M P9Y7M6D 0.073 203000 171000 <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;"><tbody><tr style="vertical-align: bottom;"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 35.7%; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Operating leases</b></p> </td><td style="text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 34.3%; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Balance Sheet Classification</b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>June 30, 2023</b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>March 31, 2023</b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom;"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>(in thousands)</b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Right-of-use assets</p> </td><td style="text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><em style="font: inherit;">Operating lease right-of-use assets</em></p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">6,149</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">6,149</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Accumulated lease amortization</p> </td><td style="text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><em style="font: inherit;">Operating lease right-of-use assets</em></p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">(1,493</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">(1,373</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</p> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td> </td><td> </td><td style="padding-bottom: 1px;"> </td><td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="padding-bottom: 1px;"> </td><td style="padding-bottom: 1px;"> </td><td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td colspan="2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 9pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;"><em style="font: inherit;">Total right-of-use assets</em></p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">4,656</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">4,776</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Current lease liabilities</p> </td><td style="text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><em style="font: inherit;">Operating lease obligations</em></p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">494</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">483</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Non-current lease liabilities</p> </td><td style="text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><em style="font: inherit;">Long-term operating lease obligations</em></p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">4,146</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">4,275</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td> </td><td> </td><td style="padding-bottom: 1px;"> </td><td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="padding-bottom: 1px;"> </td><td style="padding-bottom: 1px;"> </td><td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td colspan="2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 9pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;"><em style="font: inherit;">Total lease liabilities</em></p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">4,640</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">4,758</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> </tbody></table> 6149000 6149000 1493000 1373000 4656000 4776000 494000 483000 4146000 4275000 4640000 4758000 <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;"><tbody><tr style="vertical-align: bottom;"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 85%; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Payments</b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b><b>(in thousands)</b></b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Remainder of 2024</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">609</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2025</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">817</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2026</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">794</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2027</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">801</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2028</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">591</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Thereafter</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">2,854</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Total undiscounted lease payments</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">6,466</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Less: present value discount</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(1,826</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</p> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 9pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Total lease liability balance</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">4,640</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> </tbody></table> 609000 817000 794000 801000 591000 2854000 6466000 1826000 4640000 <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"> <tbody> <tr style="vertical-align: top;"> <td style="width: 45pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b><em style="font: inherit;">7.</em></b></p> </td> <td style="width: auto;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>ACCRUED EXPENSES</b></p> </td> </tr> </tbody> </table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:45pt;">Accrued expenses consist of the following as of:</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;"> <tbody> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>June 30, 2023</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>March 31, 2023</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>(in thousands)</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 70%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Bonus and profit sharing</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">143</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">143</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Wages</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">79</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">215</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Vacation</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">384</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">393</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Interest and legal</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">47</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">30</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Other accrued expenses</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">168</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">320</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 9pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Total accrued expenses</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">821</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">1,101</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> </tbody> </table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">  </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;"> <tbody> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>June 30, 2023</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>March 31, 2023</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>(in thousands)</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 70%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Bonus and profit sharing</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">143</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">143</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Wages</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">79</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">215</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Vacation</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">384</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">393</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Interest and legal</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">47</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">30</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Other accrued expenses</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">168</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">320</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 9pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Total accrued expenses</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">821</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">1,101</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> </tbody> </table> 143000 143000 79000 215000 384000 393000 47000 30000 168000 320000 821000 1101000 <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"> <tbody> <tr style="vertical-align: top;"> <td style="width: 45pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b><em style="font: inherit;">8.</em></b></p> </td> <td style="width: auto;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>COMMITMENTS AND CONTINGENCIES</b></p> </td> </tr> </tbody> </table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:45pt;">From time to time, the Company <em style="font: inherit;"> may </em>be involved in litigation and investigations relating to claims and matters arising out of its operations in the normal course of business. There were <em style="font: inherit;">no</em> significant legal matters outstanding at <em style="font: inherit;"> June 30, 2023.</em></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">  </p> <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"><tbody><tr style="vertical-align: top;"><td style="width: 45pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b><em style="font: inherit;">9.</em></b></p> </td><td style="width: auto;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>SHARE-BASED COMPENSATION</b></p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:45pt;">The Company has share-based compensation plans, which are more fully described in Note <em style="font: inherit;">10,</em> Share-Based Compensation, to the Consolidated Financial Statements included in the Company’s annual report on Form <em style="font: inherit;">10</em>-K for the fiscal year ended <em style="font: inherit;"> March 31, 2023 </em>as filed with the SEC on <em style="font: inherit;"> June 27, 2023.</em></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:45pt;">As of <em style="font: inherit;"> June 30, 2023, </em>the Company had <span style="-sec-ix-hidden:c101694743">two</span> equity-based compensation plans: the <em style="font: inherit;">2016</em> Equity Incentive Plan (the <em style="font: inherit;">“2016</em> Plan”) and the <em style="font: inherit;">2014</em> Independent Director Stock Option and Restricted Stock Grant Plan and Amendment (the <em style="font: inherit;">“2014</em> Directors Plan”). The Company has also issued stock options, which remain outstanding as of <em style="font: inherit;"> June 30, 2023, </em>under an equity-based compensation plan which has expired according to its terms: the <em style="font: inherit;">2004</em> Independent Director Stock Option and Stock Grant Plan (the <em style="font: inherit;">“2004</em> Directors Plan”). This plan allowed the Company to award stock options and shares of restricted common stock to eligible employees, certain outside consultants and independent directors. No additional awards will be issued under the <em style="font: inherit;">2004</em> Directors Plan.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:45pt;">The following table presents shares authorized, available for future grant and outstanding under each of the Company’s plans:</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;"><tbody><tr style="vertical-align: bottom;"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td colspan="10" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>As of June 30, 2023</b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom;"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Authorized</b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Available</b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Outstanding</b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom;"><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 55%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2016 Plan</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">1,300,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">873,737</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">310,756</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2014 Directors Plan</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">650,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">205,534</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">12,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2004 Directors Plan</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;"><em style="font: inherit;">—</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;"><em style="font: inherit;">—</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">6,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Total</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">1,950,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">1,079,271</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">328,756</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Stock Options</i></b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:45pt;">All stock option grants made under the equity-based compensation plans were issued at exercise prices <em style="font: inherit;">no</em> less than the Company’s closing stock price on the date of grant. Options under the <em style="font: inherit;">2016</em> Plan, <em style="font: inherit;">2004</em> Directors Plan and <em style="font: inherit;">2014</em> Directors Plan were determined by the Board of Directors or the Compensation Committee of the Board of Directors in accordance with the provisions of the respective plans.  The terms of each option grant include vesting, exercise, and other conditions set forth in a Stock Option Agreement evidencing each grant. <em style="font: inherit;">No</em> option can have a life in excess of <span style="-sec-ix-hidden:c101694758">ten</span> (<em style="font: inherit;">10</em>) years. The Company records compensation expense for employee stock options based on the estimated fair value of the options on the date of grant using the Black-Scholes option-pricing model. The model requires various assumptions, including a risk-free interest rate, the expected term of the options, the expected stock price volatility over the expected term of the options, and the expected dividend yield. Compensation expense for employee stock options is recognized ratably over the vesting term. Compensation expense recognized for options issued under all Plans was $26,000 and $17,000 for the <em style="font: inherit;">three</em> months ended <em style="font: inherit;"> June 30, 2023 </em>and <em style="font: inherit;">2022,</em> respectively.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:45pt;">A summary of option activity under the Company’s stock plans for the <em style="font: inherit;">three</em> months ended <em style="font: inherit;"> June 30, 2023 </em>is presented below: </p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;"><tbody><tr style="vertical-align: bottom;"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 52%; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Option Activity</b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Shares</b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Weighted</b><br/> <b>Average</b><br/> <b>Exercise</b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Price</b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Weighted</b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Average</b><br/> <b>Remaining</b><br/> <b>Contractual</b><br/> <b>Term (in</b><br/> <b>years)</b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Aggregate</b><br/> <b>Intrinsic</b><br/> <b>Value</b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Outstanding at March 31, 2023</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">253,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">2.88</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">7.5</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 9%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">—</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Outstanding at June 30, 2023</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">253,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">2.88</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">7.2</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 9%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">—</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Exercisable at June 30, 2023</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">144,666</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">2.97</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">6.8</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 9%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">—</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:45pt;">The aggregate intrinsic value in the table above is before applicable income taxes and represents the excess amount over the exercise price optionees would have received if all options had been exercised on the last business day of the period indicated, based on the Company’s closing stock price of $0.86 and $0.88 at <em style="font: inherit;"> June 30, 2023 </em>and <em style="font: inherit;"> March 31, 2023, </em>respectively.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:45pt;">A summary of the Company’s non-vested options for the <em style="font: inherit;">three</em> months ended <em style="font: inherit;"> June 30, 2023 </em>is presented below:</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;"><tbody><tr style="vertical-align: bottom;"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 70%; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Nonvested Options</b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Shares</b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Weighted</b><br/> <b>Average</b><br/> <b>Grant-Date</b><br/> <b>Fair Value</b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 9pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Nonvested at March 31, 2023</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">141,667</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">1.55</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 9pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Vested</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(33,333</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">1.77</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 9pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Nonvested at June 30, 2023</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">108,334</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">1.48</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:45pt;">As of <em style="font: inherit;"> June 30, 2023, </em>total unrecognized stock-based compensation expense related to all unvested stock options was $103,000, which is expected to be expensed over a weighted average period of 1.4 years.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Restricted Stock</i></b> </p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:46pt;">To reduce the Company’s ongoing cash expenses, the Nominating and Corporate Governance Committee of the Board of Directors adopted a resolution allowing each director to elect to receive his or her quarterly director fees in the form of restricted stock in lieu of cash. Two Board members elected to receive shares of restricted stock in lieu of cash for the <em style="font: inherit;">third</em> fiscal quarter of <em style="font: inherit;">2023.</em> On <em style="font: inherit;"> April 3, 2023, </em>17,672 shares of fully vested restricted stock were issue to the <em style="font: inherit;">two</em> Board members. For the <em style="font: inherit;">three</em> months ended <em style="font: inherit;"> June 30, 2023, </em>there was no compensation expense related to the issuance of this stock, as it was earned and recognized in fiscal year <em style="font: inherit;">2023</em> in the amount of $15,500.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Restricted Stock Units (</i></b>“<b><i>RSUs</i></b>”<b><i>)</i></b> </p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:45pt;">RSUs are service-based awards granted to eligible employees under the <em style="font: inherit;">2016</em> Plan. Compensation expense recognized for RSUs issued under the <em style="font: inherit;">2016</em> Plan was $21,000 and $5,000 for the <em style="font: inherit;">three</em> months ended <em style="font: inherit;"> June 30, 2023 </em>and <em style="font: inherit;">2022,</em> respectively.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:45pt;">The following table summarizes information related to awarded RSUs:</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;"><tbody><tr style="vertical-align: bottom;"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 70%; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Nonvested Restricted Stock Units</b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Shares</b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Weighted</b><br/> <b>Average</b><br/> <b>Grant Price</b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Nonvested restricted stock units at March 31, 2023</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">70,334</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">3.04</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 18pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 18pt;">Granted</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">7,900</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">0.94</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 18pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 18pt;">Vested</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">(2,278</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">2.39</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 18pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 18pt;">Forfeited</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(200</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">0.94</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Nonvested restricted stock units at June 30, 2023</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">75,756</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">2.85</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:45pt;">As of <em style="font: inherit;"> June 30, 2023, </em>total unrecognized stock-based compensation expense related to unvested restricted stock units was $114,000, which is expected to be expensed over a weighted average period of 2.1 years.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">  </p> 0 <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;"><tbody><tr style="vertical-align: bottom;"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td colspan="10" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>As of June 30, 2023</b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom;"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Authorized</b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Available</b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Outstanding</b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom;"><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 55%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2016 Plan</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">1,300,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">873,737</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">310,756</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2014 Directors Plan</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">650,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">205,534</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">12,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2004 Directors Plan</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;"><em style="font: inherit;">—</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;"><em style="font: inherit;">—</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">6,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Total</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">1,950,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">1,079,271</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">328,756</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> </tbody></table> 1300000 873737 310756 650000 205534 12000 6000 1950000 1079271 328756 26000 17000 <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;"><tbody><tr style="vertical-align: bottom;"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 52%; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Option Activity</b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Shares</b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Weighted</b><br/> <b>Average</b><br/> <b>Exercise</b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Price</b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Weighted</b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Average</b><br/> <b>Remaining</b><br/> <b>Contractual</b><br/> <b>Term (in</b><br/> <b>years)</b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Aggregate</b><br/> <b>Intrinsic</b><br/> <b>Value</b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Outstanding at March 31, 2023</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">253,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">2.88</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">7.5</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 9%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">—</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Outstanding at June 30, 2023</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">253,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">2.88</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">7.2</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 9%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">—</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Exercisable at June 30, 2023</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">144,666</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">2.97</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">6.8</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 9%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">—</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> </tbody></table> 253000 2.88 P7Y6M 0 253000 2.88 P7Y2M12D 0 144666 2.97 P6Y9M18D 0 0.86 0.88 <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;"><tbody><tr style="vertical-align: bottom;"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 70%; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Nonvested Options</b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Shares</b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Weighted</b><br/> <b>Average</b><br/> <b>Grant-Date</b><br/> <b>Fair Value</b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 9pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Nonvested at March 31, 2023</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">141,667</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">1.55</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 9pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Vested</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(33,333</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">1.77</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 9pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Nonvested at June 30, 2023</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">108,334</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">1.48</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> </tbody></table> 141667 1.55 33333 1.77 108334 1.48 103000 P1Y4M24D 17672 0 15500 21000 5000 <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;"><tbody><tr style="vertical-align: bottom;"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 70%; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Nonvested Restricted Stock Units</b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Shares</b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Weighted</b><br/> <b>Average</b><br/> <b>Grant Price</b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Nonvested restricted stock units at March 31, 2023</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">70,334</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">3.04</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 18pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 18pt;">Granted</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">7,900</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">0.94</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 18pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 18pt;">Vested</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">(2,278</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">2.39</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 18pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 18pt;">Forfeited</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(200</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">0.94</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Nonvested restricted stock units at June 30, 2023</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">75,756</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">2.85</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> </tbody></table> 70334 3.04 7900 0.94 2278 2.39 200 0.94 75756 2.85 114000 P2Y1M6D <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"><tbody><tr style="vertical-align: top;"><td style="width: 45pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b><em style="font: inherit;">10.</em></b></p> </td><td style="width: auto;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>INCOME TAXES </b></p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:45pt;">The Company utilizes its estimated annual effective tax rate to determine its provision or benefit for income taxes for interim periods. The income tax provision or benefit is computed by multiplying the estimated annual effective tax rate by the year-to-date pre-tax book income (loss). The Company recorded no income tax expense and $3,000 of income tax expense for the <em style="font: inherit;">three</em> months ended <em style="font: inherit;"> June 30, 2023 </em>and <em style="font: inherit;">2022,</em> respectively. The Company’s effective tax rate was (0.7%) for the <em style="font: inherit;">three</em> months ended <em style="font: inherit;"> June 30, 2022. </em>The effective tax rates differ from the statutory rate of 21% as a result of state taxes (net of federal benefit) and the net change in valuation allowance against the net deferred tax asset the Company believes is <em style="font: inherit;">not</em> more likely than <em style="font: inherit;">not</em> to be realized.  The Company continues to carry a full valuation allowance on its net deferred tax assets.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:45pt;">The Company is subject to taxation in the United States and <em style="font: inherit;">eight</em> state jurisdictions. The preparation of tax returns requires management to interpret the applicable tax laws and regulations in effect in such jurisdictions, which could affect the amount of tax paid by the Company. Management, in consultation with its tax advisors, files its tax returns based on interpretations that are believed to be reasonable under the circumstances. The income tax returns, however, are subject to routine reviews by the various taxing authorities.  As part of these reviews, a taxing authority <em style="font: inherit;"> may </em>disagree with respect to the tax positions taken by management (“uncertain tax positions”) and therefore <em style="font: inherit;"> may </em>require the Company to pay additional taxes. Management evaluates the requirement for additional tax accruals, including interest and penalties, which the Company could incur as a result of the ultimate resolution of its uncertain tax positions. Management reviews and updates the accrual for uncertain tax positions as more definitive information becomes available from taxing authorities, completion of tax audits, expiration of statute of limitations, or upon occurrence of other events.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:45pt;">As of <em style="font: inherit;"> June 30, 2023 </em>and <em style="font: inherit;">2022,</em> there was no liability for income tax associated with unrecognized tax benefits. The Company recognizes accrued interest related to unrecognized tax benefits as well as any related penalties in interest income or expense in its Consolidated Condensed Statements of Operations, which is consistent with the recognition of these items in prior reporting periods.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:45pt;">With few exceptions, the Company is <em style="font: inherit;">no</em> longer subject to U.S. federal, state, local, and non-U.S. income tax examination by tax authorities for tax years before <em style="font: inherit;">2019.</em> </p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">  </p> 0 3000 0.007 0.21 0 <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"><tbody><tr style="vertical-align: top;"><td style="width: 45pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b><em style="font: inherit;">11.</em></b></p> </td><td style="width: auto;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>EARNINGS PER SHARE</b></p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:45pt;">Basic earnings (loss) per share is computed on the basis of the weighted average number of common shares outstanding. Diluted earnings (loss) per share is computed on the basis of the weighted average number of common shares outstanding plus the potentially dilutive effect of outstanding stock options using the treasury stock method.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:45pt;">Reconciliations between the numerator and the denominator of the basic and diluted (loss) income per share computations for the <em style="font: inherit;">three</em> months ended <em style="font: inherit;"> June 30, 2023 </em>and <em style="font: inherit;">2022</em> are as follows:</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;"><tbody><tr style="vertical-align: bottom;"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td colspan="10" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Three Months Ended June 30, 2023</b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom;"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Net Loss</b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Shares</b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Per Share</b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom;"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>(Numerator)</b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>(Denominator)</b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Amount</b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom;"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>(in thousands)</b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b> </b></td><td style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b> </b></td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b> </b></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 55%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Basic and diluted loss per share</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(1,369</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">6,290</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(0.22</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;"><tbody><tr style="vertical-align: bottom;"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td colspan="10" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Three Months Ended June 30, 2022</b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom;"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Net Loss</b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Shares</b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Per Share</b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom;"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>(Numerator)</b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>(Denominator)</b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Amount</b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom;"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>(in thousands)</b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b> </b></td><td style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b> </b></td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b> </b></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 55%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Basic and diluted loss per share</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(472</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">6,204</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(0.08</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:45pt;">Basic and diluted per share amounts are the same in periods of a net loss because common share equivalents are anti-dilutive when a net loss is recorded. Diluted earnings per share does <em style="font: inherit;">not</em> include the impact of common stock options and restricted stock units totaling 3,000 and 12,000 for the <em style="font: inherit;">three</em> months ended <em style="font: inherit;"> June 30, 2023 </em>and <em style="font: inherit;">2022,</em> respectively, as the effect of their inclusion would be anti-dilutive. Restricted stock units become dilutive within the period granted and remain dilutive until the units vest and are then included in the calculation of basic earnings per share.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">  </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;"><tbody><tr style="vertical-align: bottom;"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td colspan="10" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Three Months Ended June 30, 2023</b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom;"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Net Loss</b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Shares</b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Per Share</b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom;"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>(Numerator)</b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>(Denominator)</b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Amount</b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom;"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>(in thousands)</b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b> </b></td><td style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b> </b></td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b> </b></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 55%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Basic and diluted loss per share</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(1,369</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">6,290</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(0.22</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</p> </td></tr> </tbody></table> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;"><tbody><tr style="vertical-align: bottom;"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td colspan="10" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Three Months Ended June 30, 2022</b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom;"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Net Loss</b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Shares</b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Per Share</b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom;"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>(Numerator)</b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>(Denominator)</b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Amount</b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom;"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>(in thousands)</b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b> </b></td><td style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b> </b></td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b> </b></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 55%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Basic and diluted loss per share</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(472</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">6,204</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(0.08</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</p> </td></tr> </tbody></table> -1369000 6290000 -0.22 -472000 6204000 -0.08 3000 12000 <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"><tbody><tr style="vertical-align: top;"><td style="width: 45pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b><em style="font: inherit;">12.</em></b></p> </td><td style="width: auto;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>RELATED PARTY TRANSACTIONS</b> </p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:45pt;">In <em style="font: inherit;"> April 2019, </em>the Company obtained an unsecured subordinated loan from Skywords in the principal amount of $1,500,000 pursuant to a Promissory Note (the "Skywords Note”) executed by the Company in favor of Skywords. Skywords is controlled by the Company’s Chairman of the Board of Directors and largest stockholder. The Skywords Note bore interest at a rate of 1% plus the prime rate (as published by the Wall Street Journal), which was recalculated and payable on a quarterly basis. The principal amount and any accrued and unpaid interest were due and payable on <em style="font: inherit;"> April 12, 2021. </em>The proceeds of the Skywords Note were used to pay down accounts payable and for general operating capital purposes.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:45pt;">On <em style="font: inherit;"> April 12, 2021, </em>the Company entered into an Amended and Restated Promissory Note (the “Skywords Amended Note”) with Skywords. The Company and Skywords agreed to amend, restate, replace and otherwise modify without novation, the Skywords Note in order to convert $500,000 of the outstanding principal amount into revolving loans that <em style="font: inherit;"> may </em>be prepaid and reborrowed from time to time in principal amounts <em style="font: inherit;">not</em> to exceed <span style="-sec-ix-hidden:c101694879">$500,000,</span> extend the maturity date by <span style="-sec-ix-hidden:c101694880">three</span> years, adjust the interest rate to reflect a floor of 5% and secure Skywords’ interest by granting a security interest in substantially all of the Company’s personal property assets, subject to limited exceptions (the “Collateral”). On <em style="font: inherit;"> April 12, 2021, </em>concurrently with the conversion, the Company repaid in cash to Skywords, the principal amount of $500,000 plus accrued interest to date of $1,900. The Skywords Amended Note bears interest at a rate of 1% plus the prime rate (as published by the Wall Street Journal), which will be recalculated and payable on a quarterly basis, provided that at <em style="font: inherit;">no</em> time shall the annual interest rate be less than 5%. The Company <em style="font: inherit;"> may </em>prepay the Skywords Amended Note at any time without penalty.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:45pt;">On <em style="font: inherit;"> April 12, 2021, </em>in connection with the grant of a security interest in the Collateral, the Company also entered into an Intercreditor and Subordination Agreement with the Bank and Skywords. The Company is indebted to the Bank pursuant to <em style="font: inherit;">two</em> Term Loans and a Credit Agreement, each of which granted the Bank a security interest in substantially all of the Company’s personal property assets. The Bank’s security interest in the Company’s personal property assets ranks senior to Skywords’ security interest in the Collateral, and the Intercreditor and Subordination Agreement generally governs the relationship between the Bank and Skywords as secured lenders to the Company and includes customary terms.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:45pt;">On <em style="font: inherit;"> December 14, 2022, </em>the Company entered into a First Amendment (the “Amendment”) to the Skywords Amended Note. The Amendment extends the maturity date to <em style="font: inherit;"> April 12, 2025 </em>and increases the revolving amount that the Company <em style="font: inherit;"> may </em>borrow from time to time under the Skywords Note from $500,000 to $1,000,000. All other terms of the Skywords Note remain the same.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:45pt;">At both <em style="font: inherit;"> June 30, 2023 </em>and <em style="font: inherit;"> March 31, 2023, </em>the Skywords Note principal balance was <span style="-sec-ix-hidden:c101694890">$1,000,000,</span> and was included in long-term debt on the Condensed Consolidated Balance Sheets. At <em style="font: inherit;"> June 30, 2023 </em>and <em style="font: inherit;"> March 31, 2023, </em>the balance on the Revolver was $750,000 and $500,000, respectively, and was included in line of credit – related party on the Condensed Consolidated Balance Sheets. At <em style="font: inherit;"> June 30, 2023 </em>and <em style="font: inherit;"> March 31, 2023, </em>the interest rates were 8.0% and 7.5%, respectively.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:45pt;">On <em style="font: inherit;"> June 30, 2023, </em>the Company and Skywords executed a letter of intent to commence drafting and negotiating a definitive Second Agreement to the Amended and Restate Promissory Note, dated as of <em style="font: inherit;"> April 12, 2021, </em>as amended on <em style="font: inherit;"> December 14, 2022, </em>to which the revolving amount that the Company <em style="font: inherit;"> may </em>borrow from time to time would increase from $1,000,000 to $2,000,000, with all other terms of the Amendment remaining the same. Entry into this Second Amendment is subject to the completion of definitive documentation and the other terms and conditions specified in the letter of intent.  On <em style="font: inherit;"> August 10, 2023, </em>the Company received approval from First Foundation Bank and the USDA to move forward with the Second Agreement.</p> 1500000 0.01 500000 0.05 500000 1900 0.01 0.05 500000 1000000 750000 500000 0.080 0.075 1000000 2000000 <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"><tbody><tr style="vertical-align: top;"><td style="width: 45pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b><em style="font: inherit;">13.</em></b></p> </td><td style="width: auto;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>SUBSEQUENT EVENTS</b></p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:45pt;">On <em style="font: inherit;"> August 10, 2023, </em>the Company was notified by Nasdaq that the Company is <em style="font: inherit;">not</em> in compliance with Nasdaq's Listing Rule <em style="font: inherit;">5550</em>(a)(<em style="font: inherit;">2</em>), as the minimum bid price of the Company's common stock had been below $1.00 per share for <em style="font: inherit;">30</em> consecutive business days.  Under Nasdaq's rules, the notification of noncompliance had <em style="font: inherit;">no</em> immediate effect on the listing or trading of the Company's common stock on Nasdaq under the symbol "CYAN".  Under Nasdaq's rule, the Company was given <em style="font: inherit;">180</em> days, or until <em style="font: inherit;"> February 6, 2024, </em>to achieve compliance with the minimum bid price requirement.  To regain compliance, the minimum bid price of the Company's stock must meet or exceed $1.00 per share for a minimum of <em style="font: inherit;">ten</em> consecutive business days prior to the expiration of the <em style="font: inherit;">180</em>-day grace period.  Failure to regain compliance during this period could result in delisting.</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:45pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:45pt;">The Company had <em style="font: inherit;">no</em> additional subsequent events, other than those mentioned above and in Note <em style="font: inherit;">12</em> regarding the Bank and USDA approval.</p> 1.00 1.00 EXCEL 64 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 65 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 66 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 67 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.2 html 131 236 1 false 48 0 false 6 false false R1.htm 000 - Document - Document And Entity Information Sheet http://www.cyanotech.com/20230630/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Condensed Consolidated Balance Sheets (Current Period Unaudited) Sheet http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited Condensed Consolidated Balance Sheets (Current Period Unaudited) Statements 2 false false R3.htm 002 - Statement - Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) Sheet http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited-parentheticals Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) Statements 3 false false R4.htm 003 - Statement - Condensed Consolidated Statements of Operations (Unaudited) Sheet http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-operations-unaudited Condensed Consolidated Statements of Operations (Unaudited) Statements 4 false false R5.htm 004 - Statement - Consolidated Statements of Stockholders' Equity (Unaudited) Sheet http://www.cyanotech.com/20230630/role/statement-consolidated-statements-of-stockholders-equity-unaudited Consolidated Statements of Stockholders' Equity (Unaudited) Statements 5 false false R6.htm 005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 006 - Disclosure - Note 1 - Organization and Basis of Presentation Sheet http://www.cyanotech.com/20230630/role/statement-note-1-organization-and-basis-of-presentation Note 1 - Organization and Basis of Presentation Notes 7 false false R8.htm 007 - Disclosure - Note 2 - Significant Accounting Policies Sheet http://www.cyanotech.com/20230630/role/statement-note-2-significant-accounting-policies Note 2 - Significant Accounting Policies Notes 8 false false R9.htm 008 - Disclosure - Note 3 - Inventories Sheet http://www.cyanotech.com/20230630/role/statement-note-3-inventories Note 3 - Inventories Notes 9 false false R10.htm 009 - Disclosure - Note 4 - Equipment and Leasehold Improvements Sheet http://www.cyanotech.com/20230630/role/statement-note-4-equipment-and-leasehold-improvements Note 4 - Equipment and Leasehold Improvements Notes 10 false false R11.htm 010 - Disclosure - Note 5 - Line of Credit and Long-term Debt Sheet http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt Note 5 - Line of Credit and Long-term Debt Notes 11 false false R12.htm 011 - Disclosure - Note 6 - Operating Leases Sheet http://www.cyanotech.com/20230630/role/statement-note-6-operating-leases Note 6 - Operating Leases Notes 12 false false R13.htm 012 - Disclosure - Note 7 - Accrued Expenses Sheet http://www.cyanotech.com/20230630/role/statement-note-7-accrued-expenses Note 7 - Accrued Expenses Notes 13 false false R14.htm 013 - Disclosure - Note 8 - Commitments and Contingencies Sheet http://www.cyanotech.com/20230630/role/statement-note-8-commitments-and-contingencies Note 8 - Commitments and Contingencies Notes 14 false false R15.htm 014 - Disclosure - Note 9 - Share-based Compensation Sheet http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation Note 9 - Share-based Compensation Notes 15 false false R16.htm 015 - Disclosure - Note 10 - Income Taxes Sheet http://www.cyanotech.com/20230630/role/statement-note-10-income-taxes Note 10 - Income Taxes Notes 16 false false R17.htm 016 - Disclosure - Note 11 - Earnings Per Share Sheet http://www.cyanotech.com/20230630/role/statement-note-11-earnings-per-share Note 11 - Earnings Per Share Notes 17 false false R18.htm 017 - Disclosure - Note 12 - Related Party Transactions and Balances Sheet http://www.cyanotech.com/20230630/role/statement-note-12-related-party-transactions-and-balances Note 12 - Related Party Transactions and Balances Notes 18 false false R19.htm 018 - Disclosure - Note 13 - Subsequent Events Sheet http://www.cyanotech.com/20230630/role/statement-note-13-subsequent-events Note 13 - Subsequent Events Notes 19 false false R20.htm 019 - Disclosure - Note 2 - Significant Accounting Policies (Tables) Sheet http://www.cyanotech.com/20230630/role/statement-note-2-significant-accounting-policies-tables Note 2 - Significant Accounting Policies (Tables) Tables http://www.cyanotech.com/20230630/role/statement-note-2-significant-accounting-policies 20 false false R21.htm 020 - Disclosure - Note 3 - Inventories (Tables) Sheet http://www.cyanotech.com/20230630/role/statement-note-3-inventories-tables Note 3 - Inventories (Tables) Tables http://www.cyanotech.com/20230630/role/statement-note-3-inventories 21 false false R22.htm 021 - Disclosure - Note 4 - Equipment and Leasehold Improvements (Tables) Sheet http://www.cyanotech.com/20230630/role/statement-note-4-equipment-and-leasehold-improvements-tables Note 4 - Equipment and Leasehold Improvements (Tables) Tables http://www.cyanotech.com/20230630/role/statement-note-4-equipment-and-leasehold-improvements 22 false false R23.htm 022 - Disclosure - Note 5 - Line of Credit and Long-term Debt (Tables) Sheet http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt-tables Note 5 - Line of Credit and Long-term Debt (Tables) Tables http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt 23 false false R24.htm 023 - Disclosure - Note 6 - Operating Leases (Tables) Sheet http://www.cyanotech.com/20230630/role/statement-note-6-operating-leases-tables Note 6 - Operating Leases (Tables) Tables http://www.cyanotech.com/20230630/role/statement-note-6-operating-leases 24 false false R25.htm 024 - Disclosure - Note 7 - Accrued Expenses (Tables) Sheet http://www.cyanotech.com/20230630/role/statement-note-7-accrued-expenses-tables Note 7 - Accrued Expenses (Tables) Tables http://www.cyanotech.com/20230630/role/statement-note-7-accrued-expenses 25 false false R26.htm 025 - Disclosure - Note 9 - Share-based Compensation (Tables) Sheet http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-tables Note 9 - Share-based Compensation (Tables) Tables http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation 26 false false R27.htm 026 - Disclosure - Note 11 - Earnings Per Share (Tables) Sheet http://www.cyanotech.com/20230630/role/statement-note-11-earnings-per-share-tables Note 11 - Earnings Per Share (Tables) Tables http://www.cyanotech.com/20230630/role/statement-note-11-earnings-per-share 27 false false R28.htm 027 - Disclosure - Note 1 - Organization and Basis of Presentation (Details Textual) Sheet http://www.cyanotech.com/20230630/role/statement-note-1-organization-and-basis-of-presentation-details-textual Note 1 - Organization and Basis of Presentation (Details Textual) Details http://www.cyanotech.com/20230630/role/statement-note-1-organization-and-basis-of-presentation 28 false false R29.htm 028 - Disclosure - Note 2 - Significant Accounting Policies (Details Textual) Sheet http://www.cyanotech.com/20230630/role/statement-note-2-significant-accounting-policies-details-textual Note 2 - Significant Accounting Policies (Details Textual) Details http://www.cyanotech.com/20230630/role/statement-note-2-significant-accounting-policies-tables 29 false false R30.htm 029 - Disclosure - Note 2 - Significant Accounting Policies - Revenue By Product (Details) Sheet http://www.cyanotech.com/20230630/role/statement-note-2-significant-accounting-policies-revenue-by-product-details Note 2 - Significant Accounting Policies - Revenue By Product (Details) Details 30 false false R31.htm 030 - Disclosure - Note 3 - Inventories (Details Textual) Sheet http://www.cyanotech.com/20230630/role/statement-note-3-inventories-details-textual Note 3 - Inventories (Details Textual) Details http://www.cyanotech.com/20230630/role/statement-note-3-inventories-tables 31 false false R32.htm 031 - Disclosure - Note 3 - Inventories - Components of Inventory (Details) Sheet http://www.cyanotech.com/20230630/role/statement-note-3-inventories-components-of-inventory-details Note 3 - Inventories - Components of Inventory (Details) Details 32 false false R33.htm 032 - Disclosure - Note 4 - Equipment and Leasehold Improvements (Details Textual) Sheet http://www.cyanotech.com/20230630/role/statement-note-4-equipment-and-leasehold-improvements-details-textual Note 4 - Equipment and Leasehold Improvements (Details Textual) Details http://www.cyanotech.com/20230630/role/statement-note-4-equipment-and-leasehold-improvements-tables 33 false false R34.htm 033 - Disclosure - Note 4 - Equipment and Leasehold Improvements - Components of Equipment and Leasehold Improvements (Details) Sheet http://www.cyanotech.com/20230630/role/statement-note-4-equipment-and-leasehold-improvements-components-of-equipment-and-leasehold-improvements-details Note 4 - Equipment and Leasehold Improvements - Components of Equipment and Leasehold Improvements (Details) Details 34 false false R35.htm 034 - Disclosure - Note 5 - Line of Credit and Long-term Debt (Details Textual) Sheet http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt-details-textual Note 5 - Line of Credit and Long-term Debt (Details Textual) Details http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt-tables 35 false false R36.htm 035 - Disclosure - Note 5 - Line of Credit and Long-term Debt - Summary of Line of Credit and Long-term Debt (Details) Sheet http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt-summary-of-line-of-credit-and-longterm-debt-details Note 5 - Line of Credit and Long-term Debt - Summary of Line of Credit and Long-term Debt (Details) Details 36 false false R37.htm 036 - Disclosure - Note 5 - Line of Credit and Long-term Debt - Future Payments (Details) Sheet http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt-future-payments-details Note 5 - Line of Credit and Long-term Debt - Future Payments (Details) Details 37 false false R38.htm 037 - Disclosure - Note 6 - Operating Leases (Details Textual) Sheet http://www.cyanotech.com/20230630/role/statement-note-6-operating-leases-details-textual Note 6 - Operating Leases (Details Textual) Details http://www.cyanotech.com/20230630/role/statement-note-6-operating-leases-tables 38 false false R39.htm 038 - Disclosure - Note 6 - Operating Leases - Supplemental Balance Sheet Information (Details) Sheet http://www.cyanotech.com/20230630/role/statement-note-6-operating-leases-supplemental-balance-sheet-information-details Note 6 - Operating Leases - Supplemental Balance Sheet Information (Details) Details 39 false false R40.htm 039 - Disclosure - Note 6 - Operating Leases - Operating Leases Maturities (Details) Sheet http://www.cyanotech.com/20230630/role/statement-note-6-operating-leases-operating-leases-maturities-details Note 6 - Operating Leases - Operating Leases Maturities (Details) Details 40 false false R41.htm 040 - Disclosure - Note 7 - Accrued Expenses - Components of Accrued Expenses (Details) Sheet http://www.cyanotech.com/20230630/role/statement-note-7-accrued-expenses-components-of-accrued-expenses-details Note 7 - Accrued Expenses - Components of Accrued Expenses (Details) Details 41 false false R42.htm 041 - Disclosure - Note 9 - Share-based Compensation (Details Textual) Sheet http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-details-textual Note 9 - Share-based Compensation (Details Textual) Details http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-tables 42 false false R43.htm 042 - Disclosure - Note 9 - Share-based Compensation - Shares Authorized, Available for Future Grant and Outstanding Under Each Plan (Details) Sheet http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-shares-authorized-available-for-future-grant-and-outstanding-under-each-plan-details Note 9 - Share-based Compensation - Shares Authorized, Available for Future Grant and Outstanding Under Each Plan (Details) Details 43 false false R44.htm 043 - Disclosure - Note 9 - Share-based Compensation - Summary of Option Activity Under Stock Plans (Details) Sheet http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-summary-of-option-activity-under-stock-plans-details Note 9 - Share-based Compensation - Summary of Option Activity Under Stock Plans (Details) Details 44 false false R45.htm 044 - Disclosure - Note 9 - Share-based Compensation - Summary of Non-vested Options (Details) Sheet http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-summary-of-nonvested-options-details Note 9 - Share-based Compensation - Summary of Non-vested Options (Details) Details 45 false false R46.htm 045 - Disclosure - Note 9 - Share-based Compensation - Restricted Stock Units (Details) Sheet http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-restricted-stock-units-details Note 9 - Share-based Compensation - Restricted Stock Units (Details) Details 46 false false R47.htm 046 - Disclosure - Note 10 - Income Taxes (Details Textual) Sheet http://www.cyanotech.com/20230630/role/statement-note-10-income-taxes-details-textual Note 10 - Income Taxes (Details Textual) Details http://www.cyanotech.com/20230630/role/statement-note-10-income-taxes 47 false false R48.htm 047 - Disclosure - Note 11 - Earnings Per Share (Details Textual) Sheet http://www.cyanotech.com/20230630/role/statement-note-11-earnings-per-share-details-textual Note 11 - Earnings Per Share (Details Textual) Details http://www.cyanotech.com/20230630/role/statement-note-11-earnings-per-share-tables 48 false false R49.htm 048 - Disclosure - Note 11 - Earnings Per Share - Summary of Reconciliations Between the Numerator and the Denominator of the Basic and Diluted Earnings Per Share Computations (Details) Sheet http://www.cyanotech.com/20230630/role/statement-note-11-earnings-per-share-summary-of-reconciliations-between-the-numerator-and-the-denominator-of-the-basic-and-diluted-earnings-per-share-computations-details Note 11 - Earnings Per Share - Summary of Reconciliations Between the Numerator and the Denominator of the Basic and Diluted Earnings Per Share Computations (Details) Details 49 false false R50.htm 049 - Disclosure - Note 12 - Related Party Transactions and Balances (Details Textual) Sheet http://www.cyanotech.com/20230630/role/statement-note-12-related-party-transactions-and-balances-details-textual Note 12 - Related Party Transactions and Balances (Details Textual) Details http://www.cyanotech.com/20230630/role/statement-note-12-related-party-transactions-and-balances 50 false false R51.htm 050 - Disclosure - Note 13 - Subsequent Events (Details Textual) Sheet http://www.cyanotech.com/20230630/role/statement-note-13-subsequent-events-details-textual Note 13 - Subsequent Events (Details Textual) Details http://www.cyanotech.com/20230630/role/statement-note-13-subsequent-events 51 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 32 fact(s) appearing in ix:hidden were eligible for transformation: cyan:DebtInstrumentAmortizationPeriod, cyan:LeasesNumberOfLeaseProperties, cyan:NumberOfMajorCustomers, cyan:NumberOfShareholderApprovedSharebasedCompensationPlans, dei:EntityRegistrantName, us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent, us-gaap:CommonStockParOrStatedValuePerShare, us-gaap:CommonStockSharesAuthorized, us-gaap:CommonStockSharesIssued, us-gaap:CommonStockSharesOutstanding, us-gaap:DebtInstrumentCarryingAmount, us-gaap:DebtInstrumentFaceAmount, us-gaap:DebtInstrumentTerm, us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity, us-gaap:PreferredStockParOrStatedValuePerShare, us-gaap:PreferredStockSharesAuthorized, us-gaap:PreferredStockSharesIssued, us-gaap:PreferredStockSharesOutstanding, us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod, us-gaap:UnrecognizedTaxBenefits - cyan20230630_10q.htm 8, 13, 14, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45 cyan20230630_10q.htm cyan-20230630.xsd cyan-20230630_cal.xml cyan-20230630_def.xml cyan-20230630_lab.xml cyan-20230630_pre.xml ex_553360.htm ex_553361.htm ex_553362.htm ex_553363.htm http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 true true JSON 70 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "cyan20230630_10q.htm": { "axisCustom": 0, "axisStandard": 20, "baseTaxonomies": { "http://fasb.org/us-gaap/2023": 446, "http://xbrl.sec.gov/dei/2023": 29 }, "contextCount": 131, "dts": { "calculationLink": { "local": [ "cyan-20230630_cal.xml" ] }, "definitionLink": { "local": [ "cyan-20230630_def.xml" ] }, "inline": { "local": [ "cyan20230630_10q.htm" ] }, "labelLink": { "local": [ "cyan-20230630_lab.xml" ] }, "presentationLink": { "local": [ "cyan-20230630_pre.xml" ] }, "schema": { "local": [ "cyan-20230630.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/currency/2023/currency-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/exch/2023/exch-2023.xsd", "https://xbrl.sec.gov/naics/2023/naics-2023.xsd", "https://xbrl.sec.gov/sic/2023/sic-2023.xsd", "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd" ] } }, "elementCount": 372, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2023": 27, "http://www.cyanotech.com/20230630": 6, "http://xbrl.sec.gov/dei/2023": 6, "total": 39 }, "keyCustom": 27, "keyStandard": 209, "memberCustom": 30, "memberStandard": 18, "nsprefix": "cyan", "nsuri": "http://www.cyanotech.com/20230630", "report": { "R1": { "firstAnchor": { "ancestors": [ "b", "p", "div", "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "d_2023-04-01_2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000 - Document - Document And Entity Information", "menuCat": "Cover", "order": "1", "role": "http://www.cyanotech.com/20230630/role/statement-document-and-entity-information", "shortName": "Document And Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "b", "p", "div", "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "d_2023-04-01_2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "d_2023-04-01_2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "009 - Disclosure - Note 4 - Equipment and Leasehold Improvements", "menuCat": "Notes", "order": "10", "role": "http://www.cyanotech.com/20230630/role/statement-note-4-equipment-and-leasehold-improvements", "shortName": "Note 4 - Equipment and Leasehold Improvements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "d_2023-04-01_2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "d_2023-04-01_2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "010 - Disclosure - Note 5 - Line of Credit and Long-term Debt", "menuCat": "Notes", "order": "11", "role": "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt", "shortName": "Note 5 - Line of Credit and Long-term Debt", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "d_2023-04-01_2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "d_2023-04-01_2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "011 - Disclosure - Note 6 - Operating Leases", "menuCat": "Notes", "order": "12", "role": "http://www.cyanotech.com/20230630/role/statement-note-6-operating-leases", "shortName": "Note 6 - Operating Leases", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "d_2023-04-01_2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "d_2023-04-01_2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "012 - Disclosure - Note 7 - Accrued Expenses", "menuCat": "Notes", "order": "13", "role": "http://www.cyanotech.com/20230630/role/statement-note-7-accrued-expenses", "shortName": "Note 7 - Accrued Expenses", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "d_2023-04-01_2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "d_2023-04-01_2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "013 - Disclosure - Note 8 - Commitments and Contingencies", "menuCat": "Notes", "order": "14", "role": "http://www.cyanotech.com/20230630/role/statement-note-8-commitments-and-contingencies", "shortName": "Note 8 - Commitments and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "d_2023-04-01_2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "d_2023-04-01_2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "014 - Disclosure - Note 9 - Share-based Compensation", "menuCat": "Notes", "order": "15", "role": "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation", "shortName": "Note 9 - Share-based Compensation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "d_2023-04-01_2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "d_2023-04-01_2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "015 - Disclosure - Note 10 - Income Taxes", "menuCat": "Notes", "order": "16", "role": "http://www.cyanotech.com/20230630/role/statement-note-10-income-taxes", "shortName": "Note 10 - Income Taxes", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "d_2023-04-01_2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "d_2023-04-01_2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "016 - Disclosure - Note 11 - Earnings Per Share", "menuCat": "Notes", "order": "17", "role": "http://www.cyanotech.com/20230630/role/statement-note-11-earnings-per-share", "shortName": "Note 11 - Earnings Per Share", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "d_2023-04-01_2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "d_2023-04-01_2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "017 - Disclosure - Note 12 - Related Party Transactions and Balances", "menuCat": "Notes", "order": "18", "role": "http://www.cyanotech.com/20230630/role/statement-note-12-related-party-transactions-and-balances", "shortName": "Note 12 - Related Party Transactions and Balances", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "d_2023-04-01_2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "d_2023-04-01_2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "018 - Disclosure - Note 13 - Subsequent Events", "menuCat": "Notes", "order": "19", "role": "http://www.cyanotech.com/20230630/role/statement-note-13-subsequent-events", "shortName": "Note 13 - Subsequent Events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "d_2023-04-01_2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "p", "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "i_2023-06-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "001 - Statement - Condensed Consolidated Balance Sheets (Current Period Unaudited)", "menuCat": "Statements", "order": "2", "role": "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited", "shortName": "Condensed Consolidated Balance Sheets (Current Period Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "i_2023-06-30", "decimals": "-3", "lang": null, "name": "us-gaap:AccountsReceivableNetCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "d_2023-04-01_2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "019 - Disclosure - Note 2 - Significant Accounting Policies (Tables)", "menuCat": "Tables", "order": "20", "role": "http://www.cyanotech.com/20230630/role/statement-note-2-significant-accounting-policies-tables", "shortName": "Note 2 - Significant Accounting Policies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "d_2023-04-01_2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "d_2023-04-01_2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "020 - Disclosure - Note 3 - Inventories (Tables)", "menuCat": "Tables", "order": "21", "role": "http://www.cyanotech.com/20230630/role/statement-note-3-inventories-tables", "shortName": "Note 3 - Inventories (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "d_2023-04-01_2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "d_2023-04-01_2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "021 - Disclosure - Note 4 - Equipment and Leasehold Improvements (Tables)", "menuCat": "Tables", "order": "22", "role": "http://www.cyanotech.com/20230630/role/statement-note-4-equipment-and-leasehold-improvements-tables", "shortName": "Note 4 - Equipment and Leasehold Improvements (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "d_2023-04-01_2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "d_2023-04-01_2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "022 - Disclosure - Note 5 - Line of Credit and Long-term Debt (Tables)", "menuCat": "Tables", "order": "23", "role": "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt-tables", "shortName": "Note 5 - Line of Credit and Long-term Debt (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "d_2023-04-01_2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "d_2023-04-01_2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "cyan:ScheduleOfSupplementBalanceSheetInformationForOperatingLeaseTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "023 - Disclosure - Note 6 - Operating Leases (Tables)", "menuCat": "Tables", "order": "24", "role": "http://www.cyanotech.com/20230630/role/statement-note-6-operating-leases-tables", "shortName": "Note 6 - Operating Leases (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "d_2023-04-01_2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "cyan:ScheduleOfSupplementBalanceSheetInformationForOperatingLeaseTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "d_2023-04-01_2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "024 - Disclosure - Note 7 - Accrued Expenses (Tables)", "menuCat": "Tables", "order": "25", "role": "http://www.cyanotech.com/20230630/role/statement-note-7-accrued-expenses-tables", "shortName": "Note 7 - Accrued Expenses (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "d_2023-04-01_2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "d_2023-04-01_2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "cyan:ScheduleOfSharebasedCompensationSharesAuthorizedAvailableAndOutstandingByPlanTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "025 - Disclosure - Note 9 - Share-based Compensation (Tables)", "menuCat": "Tables", "order": "26", "role": "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-tables", "shortName": "Note 9 - Share-based Compensation (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "d_2023-04-01_2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "cyan:ScheduleOfSharebasedCompensationSharesAuthorizedAvailableAndOutstandingByPlanTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "d_2023-04-01_2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "026 - Disclosure - Note 11 - Earnings Per Share (Tables)", "menuCat": "Tables", "order": "27", "role": "http://www.cyanotech.com/20230630/role/statement-note-11-earnings-per-share-tables", "shortName": "Note 11 - Earnings Per Share (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "d_2023-04-01_2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "p", "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "i_2023-06-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "027 - Disclosure - Note 1 - Organization and Basis of Presentation (Details Textual)", "menuCat": "Details", "order": "28", "role": "http://www.cyanotech.com/20230630/role/statement-note-1-organization-and-basis-of-presentation-details-textual", "shortName": "Note 1 - Organization and Basis of Presentation (Details Textual)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "i_2023-06-30", "decimals": "INF", "lang": null, "name": "cyan:WorkingCapitalDeficit", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "p", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "d_2023-04-01_2023-06-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ContractWithCustomerLiabilityRevenueRecognized", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "028 - Disclosure - Note 2 - Significant Accounting Policies (Details Textual)", "menuCat": "Details", "order": "29", "role": "http://www.cyanotech.com/20230630/role/statement-note-2-significant-accounting-policies-details-textual", "shortName": "Note 2 - Significant Accounting Policies (Details Textual)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "d_2023-04-01_2023-06-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ContractWithCustomerLiabilityRevenueRecognized", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R3": { "firstAnchor": null, "groupType": "statement", "isDefault": "false", "longName": "002 - Statement - Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals)", "menuCat": "Statements", "order": "3", "role": "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited-parentheticals", "shortName": "Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals)", "subGroupType": "parenthetical", "uniqueAnchor": null }, "R30": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "d_2023-04-01_2023-06-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "029 - Disclosure - Note 2 - Significant Accounting Policies - Revenue By Product (Details)", "menuCat": "Details", "order": "30", "role": "http://www.cyanotech.com/20230630/role/statement-note-2-significant-accounting-policies-revenue-by-product-details", "shortName": "Note 2 - Significant Accounting Policies - Revenue By Product (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:DisaggregationOfRevenueTableTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "d_2023-04-01_2023-06-30_ProductOrServiceAxis-PackagedAstaxanthinMember", "decimals": "-3", "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "p", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "d_2023-04-01_2023-06-30", "decimals": "INF", "first": true, "lang": null, "name": "cyan:InventoryAbnormalProductionCosts", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "030 - Disclosure - Note 3 - Inventories (Details Textual)", "menuCat": "Details", "order": "31", "role": "http://www.cyanotech.com/20230630/role/statement-note-3-inventories-details-textual", "shortName": "Note 3 - Inventories (Details Textual)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "d_2023-04-01_2023-06-30", "decimals": "INF", "first": true, "lang": null, "name": "cyan:InventoryAbnormalProductionCosts", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "i_2023-06-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InventoryRawMaterialsNetOfReserves", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "031 - Disclosure - Note 3 - Inventories - Components of Inventory (Details)", "menuCat": "Details", "order": "32", "role": "http://www.cyanotech.com/20230630/role/statement-note-3-inventories-components-of-inventory-details", "shortName": "Note 3 - Inventories - Components of Inventory (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "i_2023-06-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InventoryRawMaterialsNetOfReserves", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "p", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "d_2023-01-01_2023-06-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AssetImpairmentCharges", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "032 - Disclosure - Note 4 - Equipment and Leasehold Improvements (Details Textual)", "menuCat": "Details", "order": "33", "role": "http://www.cyanotech.com/20230630/role/statement-note-4-equipment-and-leasehold-improvements-details-textual", "shortName": "Note 4 - Equipment and Leasehold Improvements (Details Textual)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "d_2023-01-01_2023-06-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AssetImpairmentCharges", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "i_2023-06-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "033 - Disclosure - Note 4 - Equipment and Leasehold Improvements - Components of Equipment and Leasehold Improvements (Details)", "menuCat": "Details", "order": "34", "role": "http://www.cyanotech.com/20230630/role/statement-note-4-equipment-and-leasehold-improvements-components-of-equipment-and-leasehold-improvements-details", "shortName": "Note 4 - Equipment and Leasehold Improvements - Components of Equipment and Leasehold Improvements (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "i_2023-06-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "i_2023-06-30", "decimals": "-4", "first": true, "lang": null, "name": "us-gaap:LinesOfCreditCurrent", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "034 - Disclosure - Note 5 - Line of Credit and Long-term Debt (Details Textual)", "menuCat": "Details", "order": "35", "role": "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt-details-textual", "shortName": "Note 5 - Line of Credit and Long-term Debt (Details Textual)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "i_2023-03-31", "decimals": "INF", "lang": null, "name": "us-gaap:DeferredFinanceCostsCurrentNet", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "i_2023-06-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DeferredFinanceCostsNet", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "035 - Disclosure - Note 5 - Line of Credit and Long-term Debt - Summary of Line of Credit and Long-term Debt (Details)", "menuCat": "Details", "order": "36", "role": "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt-summary-of-line-of-credit-and-longterm-debt-details", "shortName": "Note 5 - Line of Credit and Long-term Debt - Summary of Line of Credit and Long-term Debt (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "i_2023-06-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DeferredFinanceCostsNet", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "i_2023-06-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "036 - Disclosure - Note 5 - Line of Credit and Long-term Debt - Future Payments (Details)", "menuCat": "Details", "order": "37", "role": "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt-future-payments-details", "shortName": "Note 5 - Line of Credit and Long-term Debt - Future Payments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "i_2023-06-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "p", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "i_2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "037 - Disclosure - Note 6 - Operating Leases (Details Textual)", "menuCat": "Details", "order": "38", "role": "http://www.cyanotech.com/20230630/role/statement-note-6-operating-leases-details-textual", "shortName": "Note 6 - Operating Leases (Details Textual)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "i_2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "cyan:ScheduleOfSupplementBalanceSheetInformationForOperatingLeaseTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "i_2023-06-30", "decimals": "-3", "first": true, "lang": null, "name": "cyan:OperatingLeaseRightofuseAssetBeforeAccumulatedAmortization", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "038 - Disclosure - Note 6 - Operating Leases - Supplemental Balance Sheet Information (Details)", "menuCat": "Details", "order": "39", "role": "http://www.cyanotech.com/20230630/role/statement-note-6-operating-leases-supplemental-balance-sheet-information-details", "shortName": "Note 6 - Operating Leases - Supplemental Balance Sheet Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "cyan:ScheduleOfSupplementBalanceSheetInformationForOperatingLeaseTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "i_2023-06-30", "decimals": "-3", "first": true, "lang": null, "name": "cyan:OperatingLeaseRightofuseAssetBeforeAccumulatedAmortization", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "d_2023-04-01_2023-06-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "003 - Statement - Condensed Consolidated Statements of Operations (Unaudited)", "menuCat": "Statements", "order": "4", "role": "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-operations-unaudited", "shortName": "Condensed Consolidated Statements of Operations (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "d_2023-04-01_2023-06-30", "decimals": "-3", "lang": null, "name": "us-gaap:CostOfGoodsAndServicesSold", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "i_2023-06-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "039 - Disclosure - Note 6 - Operating Leases - Operating Leases Maturities (Details)", "menuCat": "Details", "order": "40", "role": "http://www.cyanotech.com/20230630/role/statement-note-6-operating-leases-operating-leases-maturities-details", "shortName": "Note 6 - Operating Leases - Operating Leases Maturities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "i_2023-06-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "i_2023-06-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AccruedBonusesCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040 - Disclosure - Note 7 - Accrued Expenses - Components of Accrued Expenses (Details)", "menuCat": "Details", "order": "41", "role": "http://www.cyanotech.com/20230630/role/statement-note-7-accrued-expenses-components-of-accrued-expenses-details", "shortName": "Note 7 - Accrued Expenses - Components of Accrued Expenses (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "i_2023-06-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AccruedBonusesCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "cyan:ScheduleOfSharebasedCompensationSharesAuthorizedAvailableAndOutstandingByPlanTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "i_2023-06-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "reportCount": 1, "unitRef": "Share", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "041 - Disclosure - Note 9 - Share-based Compensation (Details Textual)", "menuCat": "Details", "order": "42", "role": "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-details-textual", "shortName": "Note 9 - Share-based Compensation (Details Textual)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "i_2023-06-30_AwardTypeAxis-EmployeeStockOptionMember", "decimals": "INF", "lang": null, "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "cyan:ScheduleOfSharebasedCompensationSharesAuthorizedAvailableAndOutstandingByPlanTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "i_2023-06-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "reportCount": 1, "unique": true, "unitRef": "Share", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "042 - Disclosure - Note 9 - Share-based Compensation - Shares Authorized, Available for Future Grant and Outstanding Under Each Plan (Details)", "menuCat": "Details", "order": "43", "role": "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-shares-authorized-available-for-future-grant-and-outstanding-under-each-plan-details", "shortName": "Note 9 - Share-based Compensation - Shares Authorized, Available for Future Grant and Outstanding Under Each Plan (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "cyan:ScheduleOfSharebasedCompensationSharesAuthorizedAvailableAndOutstandingByPlanTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "i_2023-06-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "reportCount": 1, "unique": true, "unitRef": "Share", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "i_2023-03-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unitRef": "Share", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "043 - Disclosure - Note 9 - Share-based Compensation - Summary of Option Activity Under Stock Plans (Details)", "menuCat": "Details", "order": "44", "role": "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-summary-of-option-activity-under-stock-plans-details", "shortName": "Note 9 - Share-based Compensation - Summary of Option Activity Under Stock Plans (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "d_2023-04-01_2023-06-30", "decimals": null, "lang": "en-US", "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "i_2023-03-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares", "reportCount": 1, "unique": true, "unitRef": "Share", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "044 - Disclosure - Note 9 - Share-based Compensation - Summary of Non-vested Options (Details)", "menuCat": "Details", "order": "45", "role": "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-summary-of-nonvested-options-details", "shortName": "Note 9 - Share-based Compensation - Summary of Non-vested Options (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "i_2023-03-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares", "reportCount": 1, "unique": true, "unitRef": "Share", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "i_2023-03-31_AwardTypeAxis-RestrictedStockUnitsRSUMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "Share", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "045 - Disclosure - Note 9 - Share-based Compensation - Restricted Stock Units (Details)", "menuCat": "Details", "order": "46", "role": "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-restricted-stock-units-details", "shortName": "Note 9 - Share-based Compensation - Restricted Stock Units (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "i_2023-03-31_AwardTypeAxis-RestrictedStockUnitsRSUMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "Share", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "d_2023-04-01_2023-06-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:IncomeTaxExpenseBenefit", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "046 - Disclosure - Note 10 - Income Taxes (Details Textual)", "menuCat": "Details", "order": "47", "role": "http://www.cyanotech.com/20230630/role/statement-note-10-income-taxes-details-textual", "shortName": "Note 10 - Income Taxes (Details Textual)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "d_2022-04-01_2022-06-30", "decimals": "3", "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "p", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "d_2023-04-01_2023-06-30_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis-CommonStockOptionsAndRestrictedStockUnitsMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "Share", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "047 - Disclosure - Note 11 - Earnings Per Share (Details Textual)", "menuCat": "Details", "order": "48", "role": "http://www.cyanotech.com/20230630/role/statement-note-11-earnings-per-share-details-textual", "shortName": "Note 11 - Earnings Per Share (Details Textual)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "d_2023-04-01_2023-06-30_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis-CommonStockOptionsAndRestrictedStockUnitsMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "Share", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "d_2023-04-01_2023-06-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "048 - Disclosure - Note 11 - Earnings Per Share - Summary of Reconciliations Between the Numerator and the Denominator of the Basic and Diluted Earnings Per Share Computations (Details)", "menuCat": "Details", "order": "49", "role": "http://www.cyanotech.com/20230630/role/statement-note-11-earnings-per-share-summary-of-reconciliations-between-the-numerator-and-the-denominator-of-the-basic-and-diluted-earnings-per-share-computations-details", "shortName": "Note 11 - Earnings Per Share - Summary of Reconciliations Between the Numerator and the Denominator of the Basic and Diluted Earnings Per Share Computations (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R5": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "i_2022-03-31_StatementEquityComponentsAxis-CommonStockMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:SharesOutstanding", "reportCount": 1, "unique": true, "unitRef": "Share", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "004 - Statement - Consolidated Statements of Stockholders' Equity (Unaudited)", "menuCat": "Statements", "order": "5", "role": "http://www.cyanotech.com/20230630/role/statement-consolidated-statements-of-stockholders-equity-unaudited", "shortName": "Consolidated Statements of Stockholders' Equity (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "i_2022-03-31_StatementEquityComponentsAxis-CommonStockMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:SharesOutstanding", "reportCount": 1, "unique": true, "unitRef": "Share", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "d_2023-04-01_2023-06-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InterestPaidNet", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "049 - Disclosure - Note 12 - Related Party Transactions and Balances (Details Textual)", "menuCat": "Details", "order": "50", "role": "http://www.cyanotech.com/20230630/role/statement-note-12-related-party-transactions-and-balances-details-textual", "shortName": "Note 12 - Related Party Transactions and Balances (Details Textual)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "d_2021-04-12_2021-04-12_DebtConversionByUniqueDescriptionAxis-ConversionOfSkywordsNoteIntoRevolvingLoansMember", "decimals": "INF", "lang": null, "name": "us-gaap:DebtConversionOriginalDebtAmount1", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "p", "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "i_2023-08-10_SubsequentEventTypeAxis-SubsequentEventMember", "decimals": "INF", "first": true, "lang": null, "name": "cyan:NasdaqMinimumBidPrice", "reportCount": 1, "unique": true, "unitRef": "USDPerShare", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "050 - Disclosure - Note 13 - Subsequent Events (Details Textual)", "menuCat": "Details", "order": "51", "role": "http://www.cyanotech.com/20230630/role/statement-note-13-subsequent-events-details-textual", "shortName": "Note 13 - Subsequent Events (Details Textual)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "i_2023-08-10_SubsequentEventTypeAxis-SubsequentEventMember", "decimals": "INF", "first": true, "lang": null, "name": "cyan:NasdaqMinimumBidPrice", "reportCount": 1, "unique": true, "unitRef": "USDPerShare", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "d_2023-04-01_2023-06-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)", "menuCat": "Statements", "order": "6", "role": "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited", "shortName": "Condensed Consolidated Statements of Cash Flows (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "d_2023-04-01_2023-06-30", "decimals": "-4", "lang": null, "name": "us-gaap:AmortizationOfFinancingCosts", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "d_2023-04-01_2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "006 - Disclosure - Note 1 - Organization and Basis of Presentation", "menuCat": "Notes", "order": "7", "role": "http://www.cyanotech.com/20230630/role/statement-note-1-organization-and-basis-of-presentation", "shortName": "Note 1 - Organization and Basis of Presentation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "d_2023-04-01_2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "d_2023-04-01_2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "007 - Disclosure - Note 2 - Significant Accounting Policies", "menuCat": "Notes", "order": "8", "role": "http://www.cyanotech.com/20230630/role/statement-note-2-significant-accounting-policies", "shortName": "Note 2 - Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "d_2023-04-01_2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "d_2023-04-01_2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "008 - Disclosure - Note 3 - Inventories", "menuCat": "Notes", "order": "9", "role": "http://www.cyanotech.com/20230630/role/statement-note-3-inventories", "shortName": "Note 3 - Inventories", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "cyan20230630_10q.htm", "contextRef": "d_2023-04-01_2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 48, "tag": { "cyan_AccruedInterestAndLegalLiabilitiesCurrent": { "auth_ref": [], "calculation": { "http://www.cyanotech.com/20230630/role/statement-note-7-accrued-expenses-components-of-accrued-expenses-details": { "order": 1.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents current accrued interest and legal liabilities.", "label": "Interest and legal" } } }, "localname": "AccruedInterestAndLegalLiabilitiesCurrent", "nsuri": "http://www.cyanotech.com/20230630", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-7-accrued-expenses-components-of-accrued-expenses-details" ], "xbrltype": "monetaryItemType" }, "cyan_BulkAstaxanthinMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Refers to information regarding bulk Astaxanthin.", "label": "Bulk Astaxanthin [Member]" } } }, "localname": "BulkAstaxanthinMember", "nsuri": "http://www.cyanotech.com/20230630", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-2-significant-accounting-policies-revenue-by-product-details" ], "xbrltype": "domainItemType" }, "cyan_BulkProductsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Refers to information regarding bulk products.", "label": "Bulk Products [Member]" } } }, "localname": "BulkProductsMember", "nsuri": "http://www.cyanotech.com/20230630", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-2-significant-accounting-policies-revenue-by-product-details" ], "xbrltype": "domainItemType" }, "cyan_BulkSpirulinaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Refers to information regarding bulk Spirulina.", "label": "Bulk Spirulina [Member]" } } }, "localname": "BulkSpirulinaMember", "nsuri": "http://www.cyanotech.com/20230630", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-2-significant-accounting-policies-revenue-by-product-details" ], "xbrltype": "domainItemType" }, "cyan_CommonStockOptionsAndRestrictedStockUnitsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents common stock options and restricted stock units.", "label": "Common Stock Options and Restricted Stock Units [Member]" } } }, "localname": "CommonStockOptionsAndRestrictedStockUnitsMember", "nsuri": "http://www.cyanotech.com/20230630", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-11-earnings-per-share", "http://www.cyanotech.com/20230630/role/statement-note-11-earnings-per-share-details-textual" ], "xbrltype": "domainItemType" }, "cyan_ContractExtractionAndRDServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents Contract extraction and R&D services.", "label": "Contract Extraction and R&D Services [Member]" } } }, "localname": "ContractExtractionAndRDServicesMember", "nsuri": "http://www.cyanotech.com/20230630", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-2-significant-accounting-policies-revenue-by-product-details" ], "xbrltype": "domainItemType" }, "cyan_ConversionOfSkywordsNoteIntoRevolvingLoansMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents convert Skywords Note into revolving loans.", "label": "Conversion of Skywords Note Into Revolving Loans [Member]" } } }, "localname": "ConversionOfSkywordsNoteIntoRevolvingLoansMember", "nsuri": "http://www.cyanotech.com/20230630", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-12-related-party-transactions-and-balances", "http://www.cyanotech.com/20230630/role/statement-note-12-related-party-transactions-and-balances-details-textual" ], "xbrltype": "domainItemType" }, "cyan_CustomerNumber1Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information pertaining to customer number 1 accounting for a percentage of accounts receivable.", "label": "Customer Number 1 [Member]" } } }, "localname": "CustomerNumber1Member", "nsuri": "http://www.cyanotech.com/20230630", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-2-significant-accounting-policies", "http://www.cyanotech.com/20230630/role/statement-note-2-significant-accounting-policies-details-textual" ], "xbrltype": "domainItemType" }, "cyan_CustomerNumber2Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information pertaining to customer number 2 accounting for a percentage of accounts receivable.", "label": "Customer Number 2 [Member]" } } }, "localname": "CustomerNumber2Member", "nsuri": "http://www.cyanotech.com/20230630", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-2-significant-accounting-policies", "http://www.cyanotech.com/20230630/role/statement-note-2-significant-accounting-policies-details-textual" ], "xbrltype": "domainItemType" }, "cyan_DebtCovenantFurtherAdvancesOfCreditAgreementImmediateFreeze": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents an immediate freeze on any further advances of Credit Agreement.", "label": "cyan_DebtCovenantFurtherAdvancesOfCreditAgreementImmediateFreeze", "terseLabel": "Debt Covenant, Further Advances of Credit Agreement, Immediate Freeze" } } }, "localname": "DebtCovenantFurtherAdvancesOfCreditAgreementImmediateFreeze", "nsuri": "http://www.cyanotech.com/20230630", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt-details-textual" ], "xbrltype": "monetaryItemType" }, "cyan_DebtInstrumentAmortizationPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the period over which obligation under the debt instrument fully amortizes.", "label": "cyan_DebtInstrumentAmortizationPeriod", "terseLabel": "Debt Instrument Amortization Period (Year)" } } }, "localname": "DebtInstrumentAmortizationPeriod", "nsuri": "http://www.cyanotech.com/20230630", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt-details-textual" ], "xbrltype": "durationItemType" }, "cyan_DebtInstrumentAnnualRenewalFeePayablePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the percentage of annual renewal fee payable on the debt instrument.", "label": "cyan_DebtInstrumentAnnualRenewalFeePayablePercentage", "terseLabel": "Debt Instrument Annual Renewal Fee Payable Percentage" } } }, "localname": "DebtInstrumentAnnualRenewalFeePayablePercentage", "nsuri": "http://www.cyanotech.com/20230630", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt-details-textual" ], "xbrltype": "percentItemType" }, "cyan_DebtInstrumentFloorInterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents floor interest rate for debt instrument.", "label": "cyan_DebtInstrumentFloorInterestRate", "terseLabel": "Debt Instrument, Floor Interest Rate" } } }, "localname": "DebtInstrumentFloorInterestRate", "nsuri": "http://www.cyanotech.com/20230630", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-12-related-party-transactions-and-balances-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt-details-textual" ], "xbrltype": "percentItemType" }, "cyan_DebtInstrumentGuaranteedPortion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the guaranteed portion of the debt instrument.", "label": "cyan_DebtInstrumentGuaranteedPortion", "terseLabel": "Debt Instrument Guaranteed Portion" } } }, "localname": "DebtInstrumentGuaranteedPortion", "nsuri": "http://www.cyanotech.com/20230630", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt-details-textual" ], "xbrltype": "percentItemType" }, "cyan_DebtInstrumentInterestPaymentPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the period for which interest is payable.", "label": "cyan_DebtInstrumentInterestPaymentPeriod", "terseLabel": "Debt Instrument Interest Payment Period (Month)" } } }, "localname": "DebtInstrumentInterestPaymentPeriod", "nsuri": "http://www.cyanotech.com/20230630", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt-details-textual" ], "xbrltype": "durationItemType" }, "cyan_DebtInstrumentOneTimeOriginationAndGuarantyFees": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of one-time origination and guaranty fees on the debt instrument.", "label": "cyan_DebtInstrumentOneTimeOriginationAndGuarantyFees", "terseLabel": "Debt Instrument One Time Origination and Guaranty Fees" } } }, "localname": "DebtInstrumentOneTimeOriginationAndGuarantyFees", "nsuri": "http://www.cyanotech.com/20230630", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt-details-textual" ], "xbrltype": "monetaryItemType" }, "cyan_DebtInstrumentReferenceRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the reference rate used to compute the variable rate on the debt instrument.", "label": "cyan_DebtInstrumentReferenceRate", "terseLabel": "Debt Instrument Reference Rate" } } }, "localname": "DebtInstrumentReferenceRate", "nsuri": "http://www.cyanotech.com/20230630", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt-details-textual" ], "xbrltype": "percentItemType" }, "cyan_EmployeesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Refers to information regarding employees.", "label": "Employees [Member]" } } }, "localname": "EmployeesMember", "nsuri": "http://www.cyanotech.com/20230630", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation", "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-details-textual" ], "xbrltype": "domainItemType" }, "cyan_FirstFoundationBankMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information about First Foundation Bank.", "label": "First Foundation Bank [Member]" } } }, "localname": "FirstFoundationBankMember", "nsuri": "http://www.cyanotech.com/20230630", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-1-organization-and-basis-of-presentation", "http://www.cyanotech.com/20230630/role/statement-note-1-organization-and-basis-of-presentation-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt", "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt-details-textual" ], "xbrltype": "domainItemType" }, "cyan_InventoryAbnormalProductionCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents the amount of abnormal production costs charged to cost of sales.", "label": "cyan_InventoryAbnormalProductionCosts", "terseLabel": "Inventory Abnormal Production Costs" } } }, "localname": "InventoryAbnormalProductionCosts", "nsuri": "http://www.cyanotech.com/20230630", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-3-inventories-details-textual" ], "xbrltype": "monetaryItemType" }, "cyan_LeasesNumberOfLeaseProperties": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents number of lease properties under lease agreement.", "label": "cyan_LeasesNumberOfLeaseProperties", "terseLabel": "Leases, Number of Lease Properties" } } }, "localname": "LeasesNumberOfLeaseProperties", "nsuri": "http://www.cyanotech.com/20230630", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-6-operating-leases-details-textual" ], "xbrltype": "integerItemType" }, "cyan_LineOfCreditExcludingRelatedPartyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line of Credit Excluding Related Party.", "label": "Line of Credit Excluding Related Party [Member]" } } }, "localname": "LineOfCreditExcludingRelatedPartyMember", "nsuri": "http://www.cyanotech.com/20230630", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt-summary-of-line-of-credit-and-longterm-debt-details" ], "xbrltype": "domainItemType" }, "cyan_LineOfCreditRelatedPartyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents line of credit, related party.", "label": "Line of Credit, Related Party [Member]" } } }, "localname": "LineOfCreditRelatedPartyMember", "nsuri": "http://www.cyanotech.com/20230630", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt-summary-of-line-of-credit-and-longterm-debt-details" ], "xbrltype": "domainItemType" }, "cyan_LinesOfCreditRelatedPartyCurrent": { "auth_ref": [], "calculation": { "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of lines of credit with related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).", "label": "Line of credit \u2013 related party", "terseLabel": "Lines of Credit, Related Party, Current" } } }, "localname": "LinesOfCreditRelatedPartyCurrent", "nsuri": "http://www.cyanotech.com/20230630", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited", "http://www.cyanotech.com/20230630/role/statement-note-1-organization-and-basis-of-presentation-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-12-related-party-transactions-and-balances-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt-details-textual" ], "xbrltype": "monetaryItemType" }, "cyan_LongTermDebtAndCapitalLeaseObligationsCurrentAndNoncurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of both current and noncurrent portions of long-term debt and capital lease obligations.", "label": "cyan_LongTermDebtAndCapitalLeaseObligationsCurrentAndNoncurrent", "terseLabel": "Long-term Debt and Capital Lease Obligations, Current and Noncurrent" } } }, "localname": "LongTermDebtAndCapitalLeaseObligationsCurrentAndNoncurrent", "nsuri": "http://www.cyanotech.com/20230630", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-1-organization-and-basis-of-presentation-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt-details-textual" ], "xbrltype": "monetaryItemType" }, "cyan_LongtermDebtCurrentMaturitiesExcludingLineOfCreditCurrent": { "auth_ref": [], "calculation": { "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Excludes line of credit.", "label": "Current maturities of long-term debt" } } }, "localname": "LongtermDebtCurrentMaturitiesExcludingLineOfCreditCurrent", "nsuri": "http://www.cyanotech.com/20230630", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited" ], "xbrltype": "monetaryItemType" }, "cyan_LongtermDebtExcludingRelatedPartyDebtMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information pertaining to long-term debt excluding related party debt.", "label": "Long-term Debt, Excluding Related Party Debt [Member]" } } }, "localname": "LongtermDebtExcludingRelatedPartyDebtMember", "nsuri": "http://www.cyanotech.com/20230630", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt-summary-of-line-of-credit-and-longterm-debt-details" ], "xbrltype": "domainItemType" }, "cyan_NasdaqMinimumBidPrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the minimum bid price on the NASDAQ Stock Exchange.", "label": "cyan_NasdaqMinimumBidPrice", "terseLabel": "Nasdaq Minimum Bid Price (in dollars per share)" } } }, "localname": "NasdaqMinimumBidPrice", "nsuri": "http://www.cyanotech.com/20230630", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-13-subsequent-events-details-textual" ], "xbrltype": "perShareItemType" }, "cyan_NonInventoriableFixedCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents the non-inventoriable fixed costs incurred during the period.", "label": "cyan_NonInventoriableFixedCosts", "terseLabel": "Non Inventoriable Fixed Costs" } } }, "localname": "NonInventoriableFixedCosts", "nsuri": "http://www.cyanotech.com/20230630", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-3-inventories-details-textual" ], "xbrltype": "monetaryItemType" }, "cyan_NoteToFinancialStatementDetailsTextual": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note To Financial Statement Details Textual" } } }, "localname": "NoteToFinancialStatementDetailsTextual", "nsuri": "http://www.cyanotech.com/20230630", "xbrltype": "stringItemType" }, "cyan_NotesToFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Notes To Financial Statements [Abstract]" } } }, "localname": "NotesToFinancialStatementsAbstract", "nsuri": "http://www.cyanotech.com/20230630", "xbrltype": "stringItemType" }, "cyan_NumberOfMajorCustomers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the number of major customers accounting for 10% or more of the specified concentration risk benchmark, which includes, but not limited to, sales revenue, accounts receivable, etc", "label": "cyan_NumberOfMajorCustomers", "terseLabel": "Number of Major Customers" } } }, "localname": "NumberOfMajorCustomers", "nsuri": "http://www.cyanotech.com/20230630", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-2-significant-accounting-policies-details-textual" ], "xbrltype": "integerItemType" }, "cyan_NumberOfShareholderApprovedSharebasedCompensationPlans": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the number of shareholder approved plans under which shares were available for equity based awards.", "label": "cyan_NumberOfShareholderApprovedSharebasedCompensationPlans", "terseLabel": "Number of Shareholder Approved Share-based Compensation Plans" } } }, "localname": "NumberOfShareholderApprovedSharebasedCompensationPlans", "nsuri": "http://www.cyanotech.com/20230630", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-details-textual" ], "xbrltype": "integerItemType" }, "cyan_OperatingLeaseRightofuseAssetAccumulatedAmortization": { "auth_ref": [], "calculation": { "http://www.cyanotech.com/20230630/role/statement-note-6-operating-leases-supplemental-balance-sheet-information-details": { "order": 0.0, "parentTag": "us-gaap_OperatingLeaseRightOfUseAsset", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated amortization of lessee's right to use underlying asset under operating lease.", "label": "cyan_OperatingLeaseRightofuseAssetAccumulatedAmortization", "negatedLabel": "Accumulated lease amortization" } } }, "localname": "OperatingLeaseRightofuseAssetAccumulatedAmortization", "nsuri": "http://www.cyanotech.com/20230630", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-6-operating-leases-supplemental-balance-sheet-information-details" ], "xbrltype": "monetaryItemType" }, "cyan_OperatingLeaseRightofuseAssetBeforeAccumulatedAmortization": { "auth_ref": [], "calculation": { "http://www.cyanotech.com/20230630/role/statement-note-6-operating-leases-supplemental-balance-sheet-information-details": { "order": 1.0, "parentTag": "us-gaap_OperatingLeaseRightOfUseAsset", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease, before accumulated amortization.", "label": "cyan_OperatingLeaseRightofuseAssetBeforeAccumulatedAmortization", "terseLabel": "Right-of-use assets" } } }, "localname": "OperatingLeaseRightofuseAssetBeforeAccumulatedAmortization", "nsuri": "http://www.cyanotech.com/20230630", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-6-operating-leases-supplemental-balance-sheet-information-details" ], "xbrltype": "monetaryItemType" }, "cyan_PackagedAstaxanthinMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Refers to information regarding packaged Astaxanthin.", "label": "Packaged Astaxanthin [Member]" } } }, "localname": "PackagedAstaxanthinMember", "nsuri": "http://www.cyanotech.com/20230630", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-2-significant-accounting-policies-revenue-by-product-details" ], "xbrltype": "domainItemType" }, "cyan_PackagedProductsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Refers to information regarding the packaged products.", "label": "Packaged Products [Member]" } } }, "localname": "PackagedProductsMember", "nsuri": "http://www.cyanotech.com/20230630", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-2-significant-accounting-policies-revenue-by-product-details" ], "xbrltype": "domainItemType" }, "cyan_PackagedSpirulinaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Refers to information regarding packaged Spirulina.", "label": "Packaged Spirulina [Member]" } } }, "localname": "PackagedSpirulinaMember", "nsuri": "http://www.cyanotech.com/20230630", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-2-significant-accounting-policies-revenue-by-product-details" ], "xbrltype": "domainItemType" }, "cyan_ProceedsFromLinesOfCreditRelatedParties": { "auth_ref": [], "calculation": { "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a line of credit made with related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth.", "label": "Net draws on line of credit \u2013 related party", "terseLabel": "Proceeds from Lines of Credit, Related Parties" } } }, "localname": "ProceedsFromLinesOfCreditRelatedParties", "nsuri": "http://www.cyanotech.com/20230630", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited", "http://www.cyanotech.com/20230630/role/statement-note-1-organization-and-basis-of-presentation-details-textual" ], "xbrltype": "monetaryItemType" }, "cyan_RelatedParty1Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents related party from loan agreement.", "label": "Related Party 1 [Member]" } } }, "localname": "RelatedParty1Member", "nsuri": "http://www.cyanotech.com/20230630", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-1-organization-and-basis-of-presentation", "http://www.cyanotech.com/20230630/role/statement-note-1-organization-and-basis-of-presentation-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-12-related-party-transactions-and-balances", "http://www.cyanotech.com/20230630/role/statement-note-12-related-party-transactions-and-balances-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt", "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt-details-textual" ], "xbrltype": "domainItemType" }, "cyan_ScheduleOfSharebasedCompensationSharesAuthorizedAvailableAndOutstandingByPlanTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of shares authorized, available for future grant and outstanding under each stock-based compensation plan.", "label": "Schedule of Share-based Compensation Shares Authorized Available and Outstanding by Plan [Table Text Block]" } } }, "localname": "ScheduleOfSharebasedCompensationSharesAuthorizedAvailableAndOutstandingByPlanTableTextBlock", "nsuri": "http://www.cyanotech.com/20230630", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-tables" ], "xbrltype": "textBlockItemType" }, "cyan_ScheduleOfSupplementBalanceSheetInformationForOperatingLeaseTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of supplemental balance sheet information for operating lease.", "label": "Schedule of Supplement Balance Sheet Information for Operating Lease [Table Text Block]" } } }, "localname": "ScheduleOfSupplementBalanceSheetInformationForOperatingLeaseTableTextBlock", "nsuri": "http://www.cyanotech.com/20230630", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-6-operating-leases-tables" ], "xbrltype": "textBlockItemType" }, "cyan_SharebasedCompensationArrangementBySharebasedPaymentAwardNumberOfSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of options and equity instrument other than options outstanding.", "label": "cyan_SharebasedCompensationArrangementBySharebasedPaymentAwardNumberOfSharesOutstanding", "terseLabel": "Outstanding (in shares)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardNumberOfSharesOutstanding", "nsuri": "http://www.cyanotech.com/20230630", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-shares-authorized-available-for-future-grant-and-outstanding-under-each-plan-details" ], "xbrltype": "sharesItemType" }, "cyan_SkywordsAmendedNoteMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information related to Skywords Amended Note.", "label": "Skywords Amended Note [Member]" } } }, "localname": "SkywordsAmendedNoteMember", "nsuri": "http://www.cyanotech.com/20230630", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-12-related-party-transactions-and-balances", "http://www.cyanotech.com/20230630/role/statement-note-12-related-party-transactions-and-balances-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt", "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt-details-textual" ], "xbrltype": "domainItemType" }, "cyan_SkywordsNoteMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information pertaining to the Skywords Note.", "label": "Skywords Note [Member]" } } }, "localname": "SkywordsNoteMember", "nsuri": "http://www.cyanotech.com/20230630", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-12-related-party-transactions-and-balances", "http://www.cyanotech.com/20230630/role/statement-note-12-related-party-transactions-and-balances-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt", "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt-details-textual" ], "xbrltype": "domainItemType" }, "cyan_SolarLeaseForBuildingsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents solar lease for buildings.", "label": "Solar Lease for Buildings [Member]" } } }, "localname": "SolarLeaseForBuildingsMember", "nsuri": "http://www.cyanotech.com/20230630", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-6-operating-leases", "http://www.cyanotech.com/20230630/role/statement-note-6-operating-leases-details-textual" ], "xbrltype": "domainItemType" }, "cyan_StockIssuedDuringPeriodSharesDirectorStockgrants": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the number of shares issued during the period with respect to director stock grants.", "label": "Issuances of common stock to Directors in lieu of cash (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesDirectorStockgrants", "nsuri": "http://www.cyanotech.com/20230630", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-consolidated-statements-of-stockholders-equity-unaudited" ], "xbrltype": "sharesItemType" }, "cyan_StockIssuedDuringPeriodValueDirectorStockgrants": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the value of stock issued during the period with respect to director stock grants.", "label": "Issuances of common stock to Directors in lieu of cash" } } }, "localname": "StockIssuedDuringPeriodValueDirectorStockgrants", "nsuri": "http://www.cyanotech.com/20230630", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-consolidated-statements-of-stockholders-equity-unaudited" ], "xbrltype": "monetaryItemType" }, "cyan_TermLoanAgreementMaturingOnAugust142032Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the term loan agreement that are maturing on august 14, 2032.", "label": "Term Loan Agreement, Maturing on August 14, 2032 [Member]" } } }, "localname": "TermLoanAgreementMaturingOnAugust142032Member", "nsuri": "http://www.cyanotech.com/20230630", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt", "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt-details-textual" ], "xbrltype": "domainItemType" }, "cyan_TermLoanAgreementPromissoryNoteOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Term loan agreement, promissory note one [member]", "label": "Term Loan Agreement, Promissory Note One [Member]" } } }, "localname": "TermLoanAgreementPromissoryNoteOneMember", "nsuri": "http://www.cyanotech.com/20230630", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt", "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt-details-textual" ], "xbrltype": "domainItemType" }, "cyan_TermLoanAgreementPromissoryNoteTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Term loan agreement, promissory note two [member]", "label": "Term Loan Agreement, Promissory Note Two [Member]" } } }, "localname": "TermLoanAgreementPromissoryNoteTwoMember", "nsuri": "http://www.cyanotech.com/20230630", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt", "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt-details-textual" ], "xbrltype": "domainItemType" }, "cyan_The2004DirectorsPlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The 2004 directors plan.", "label": "The 2004 Directors Plan [Member]" } } }, "localname": "The2004DirectorsPlanMember", "nsuri": "http://www.cyanotech.com/20230630", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation", "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-shares-authorized-available-for-future-grant-and-outstanding-under-each-plan-details" ], "xbrltype": "domainItemType" }, "cyan_The2014DirectorsPlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the \"2014 Directors Plan.\"", "label": "2014 Directors Plan [Member]" } } }, "localname": "The2014DirectorsPlanMember", "nsuri": "http://www.cyanotech.com/20230630", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-shares-authorized-available-for-future-grant-and-outstanding-under-each-plan-details" ], "xbrltype": "domainItemType" }, "cyan_The2016PlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the 2016 Cyanotech Equity Incentive Plan (the \u201c2016 Plan\u201d).", "label": "The 2016 Plan [Member]" } } }, "localname": "The2016PlanMember", "nsuri": "http://www.cyanotech.com/20230630", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-shares-authorized-available-for-future-grant-and-outstanding-under-each-plan-details" ], "xbrltype": "domainItemType" }, "cyan_TwoBoardMembersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents two board members.", "label": "Two Board Members [Member]" } } }, "localname": "TwoBoardMembersMember", "nsuri": "http://www.cyanotech.com/20230630", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation", "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-details-textual" ], "xbrltype": "domainItemType" }, "cyan_TwoCustomersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information pertaining to two customers accounting for a percentage of accounts receivables.", "label": "Two Customers [Member]" } } }, "localname": "TwoCustomersMember", "nsuri": "http://www.cyanotech.com/20230630", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-2-significant-accounting-policies", "http://www.cyanotech.com/20230630/role/statement-note-2-significant-accounting-policies-details-textual" ], "xbrltype": "domainItemType" }, "cyan_UnsecuredSubordinatedLoanFromSkywordsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the unsecured subordinated loan from Skywords Family Foundation, Inc.", "label": "Unsecured Subordinated Loan From Skywords [Member]" } } }, "localname": "UnsecuredSubordinatedLoanFromSkywordsMember", "nsuri": "http://www.cyanotech.com/20230630", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-1-organization-and-basis-of-presentation", "http://www.cyanotech.com/20230630/role/statement-note-1-organization-and-basis-of-presentation-details-textual" ], "xbrltype": "domainItemType" }, "cyan_UnsecuredSubordinatedLoanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information pertaining to the unsecured subordinated loan.", "label": "Unsecured Subordinated Loan [Member]" } } }, "localname": "UnsecuredSubordinatedLoanMember", "nsuri": "http://www.cyanotech.com/20230630", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-12-related-party-transactions-and-balances", "http://www.cyanotech.com/20230630/role/statement-note-12-related-party-transactions-and-balances-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt", "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt-summary-of-line-of-credit-and-longterm-debt-details" ], "xbrltype": "domainItemType" }, "cyan_WorkingCapitalDeficit": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The difference between the current assets and current liabilities that is used as a financial metric for operating liquidity.", "label": "cyan_WorkingCapitalDeficit", "terseLabel": "Working Capital (Deficit)" } } }, "localname": "WorkingCapitalDeficit", "nsuri": "http://www.cyanotech.com/20230630", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-1-organization-and-basis-of-presentation-details-textual" ], "xbrltype": "monetaryItemType" }, "cyan_statement-statement-note-11-earnings-per-share-summary-of-reconciliations-between-the-numerator-and-the-denominator-of-the-basic-and-diluted-earnings-per-share-computations-details": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 11 - Earnings Per Share - Summary of Reconciliations Between the Numerator and the Denominator of the Basic and Diluted Earnings Per Share Computations (Details)" } } }, "localname": "statement-statement-note-11-earnings-per-share-summary-of-reconciliations-between-the-numerator-and-the-denominator-of-the-basic-and-diluted-earnings-per-share-computations-details", "nsuri": "http://www.cyanotech.com/20230630", "xbrltype": "stringItemType" }, "cyan_statement-statement-note-11-earnings-per-share-tables": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 11 - Earnings Per Share" } } }, "localname": "statement-statement-note-11-earnings-per-share-tables", "nsuri": "http://www.cyanotech.com/20230630", "xbrltype": "stringItemType" }, "cyan_statement-statement-note-2-significant-accounting-policies-revenue-by-product-details": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 2 - Significant Accounting Policies - Revenue By Product (Details)" } } }, "localname": "statement-statement-note-2-significant-accounting-policies-revenue-by-product-details", "nsuri": "http://www.cyanotech.com/20230630", "xbrltype": "stringItemType" }, "cyan_statement-statement-note-2-significant-accounting-policies-tables": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 2 - Significant Accounting Policies" } } }, "localname": "statement-statement-note-2-significant-accounting-policies-tables", "nsuri": "http://www.cyanotech.com/20230630", "xbrltype": "stringItemType" }, "cyan_statement-statement-note-3-inventories-components-of-inventory-details": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 3 - Inventories - Components of Inventory (Details)" } } }, "localname": "statement-statement-note-3-inventories-components-of-inventory-details", "nsuri": "http://www.cyanotech.com/20230630", "xbrltype": "stringItemType" }, "cyan_statement-statement-note-3-inventories-tables": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 3 - Inventories" } } }, "localname": "statement-statement-note-3-inventories-tables", "nsuri": "http://www.cyanotech.com/20230630", "xbrltype": "stringItemType" }, "cyan_statement-statement-note-4-equipment-and-leasehold-improvements-components-of-equipment-and-leasehold-improvements-details": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 4 - Equipment and Leasehold Improvements - Components of Equipment and Leasehold Improvements (Details)" } } }, "localname": "statement-statement-note-4-equipment-and-leasehold-improvements-components-of-equipment-and-leasehold-improvements-details", "nsuri": "http://www.cyanotech.com/20230630", "xbrltype": "stringItemType" }, "cyan_statement-statement-note-4-equipment-and-leasehold-improvements-tables": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 4 - Equipment and Leasehold Improvements" } } }, "localname": "statement-statement-note-4-equipment-and-leasehold-improvements-tables", "nsuri": "http://www.cyanotech.com/20230630", "xbrltype": "stringItemType" }, "cyan_statement-statement-note-5-line-of-credit-and-longterm-debt-future-payments-details": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 5 - Line of Credit and Long-term Debt - Future Payments (Details)" } } }, "localname": "statement-statement-note-5-line-of-credit-and-longterm-debt-future-payments-details", "nsuri": "http://www.cyanotech.com/20230630", "xbrltype": "stringItemType" }, "cyan_statement-statement-note-5-line-of-credit-and-longterm-debt-summary-of-line-of-credit-and-longterm-debt-details": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 5 - Line of Credit and Long-term Debt - Summary of Line of Credit and Long-term Debt (Details)" } } }, "localname": "statement-statement-note-5-line-of-credit-and-longterm-debt-summary-of-line-of-credit-and-longterm-debt-details", "nsuri": "http://www.cyanotech.com/20230630", "xbrltype": "stringItemType" }, "cyan_statement-statement-note-5-line-of-credit-and-longterm-debt-tables": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 5 - Line of Credit and Long-term Debt" } } }, "localname": "statement-statement-note-5-line-of-credit-and-longterm-debt-tables", "nsuri": "http://www.cyanotech.com/20230630", "xbrltype": "stringItemType" }, "cyan_statement-statement-note-6-operating-leases-operating-leases-maturities-details": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 6 - Operating Leases - Operating Leases Maturities (Details)" } } }, "localname": "statement-statement-note-6-operating-leases-operating-leases-maturities-details", "nsuri": "http://www.cyanotech.com/20230630", "xbrltype": "stringItemType" }, "cyan_statement-statement-note-6-operating-leases-supplemental-balance-sheet-information-details": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 6 - Operating Leases - Supplemental Balance Sheet Information (Details)" } } }, "localname": "statement-statement-note-6-operating-leases-supplemental-balance-sheet-information-details", "nsuri": "http://www.cyanotech.com/20230630", "xbrltype": "stringItemType" }, "cyan_statement-statement-note-6-operating-leases-tables": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 6 - Operating Leases" } } }, "localname": "statement-statement-note-6-operating-leases-tables", "nsuri": "http://www.cyanotech.com/20230630", "xbrltype": "stringItemType" }, "cyan_statement-statement-note-7-accrued-expenses-components-of-accrued-expenses-details": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 7 - Accrued Expenses - Components of Accrued Expenses (Details)" } } }, "localname": "statement-statement-note-7-accrued-expenses-components-of-accrued-expenses-details", "nsuri": "http://www.cyanotech.com/20230630", "xbrltype": "stringItemType" }, "cyan_statement-statement-note-7-accrued-expenses-tables": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 7 - Accrued Expenses" } } }, "localname": "statement-statement-note-7-accrued-expenses-tables", "nsuri": "http://www.cyanotech.com/20230630", "xbrltype": "stringItemType" }, "cyan_statement-statement-note-9-sharebased-compensation-restricted-stock-units-details": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 9 - Share-based Compensation - Restricted Stock Units (Details)" } } }, "localname": "statement-statement-note-9-sharebased-compensation-restricted-stock-units-details", "nsuri": "http://www.cyanotech.com/20230630", "xbrltype": "stringItemType" }, "cyan_statement-statement-note-9-sharebased-compensation-shares-authorized-available-for-future-grant-and-outstanding-under-each-plan-details": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 9 - Share-based Compensation - Shares Authorized, Available for Future Grant and Outstanding Under Each Plan (Details)" } } }, "localname": "statement-statement-note-9-sharebased-compensation-shares-authorized-available-for-future-grant-and-outstanding-under-each-plan-details", "nsuri": "http://www.cyanotech.com/20230630", "xbrltype": "stringItemType" }, "cyan_statement-statement-note-9-sharebased-compensation-summary-of-nonvested-options-details": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 9 - Share-based Compensation - Summary of Non-vested Options (Details)" } } }, "localname": "statement-statement-note-9-sharebased-compensation-summary-of-nonvested-options-details", "nsuri": "http://www.cyanotech.com/20230630", "xbrltype": "stringItemType" }, "cyan_statement-statement-note-9-sharebased-compensation-summary-of-option-activity-under-stock-plans-details": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 9 - Share-based Compensation - Summary of Option Activity Under Stock Plans (Details)" } } }, "localname": "statement-statement-note-9-sharebased-compensation-summary-of-option-activity-under-stock-plans-details", "nsuri": "http://www.cyanotech.com/20230630", "xbrltype": "stringItemType" }, "cyan_statement-statement-note-9-sharebased-compensation-tables": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 9 - Share-based Compensation" } } }, "localname": "statement-statement-note-9-sharebased-compensation-tables", "nsuri": "http://www.cyanotech.com/20230630", "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-document-and-entity-information" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-document-and-entity-information" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-document-and-entity-information" ], "xbrltype": "gYearItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Document Information [Line Items]" } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-document-and-entity-information" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.", "label": "Document Information [Table]" } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2023", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-document-and-entity-information" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r481" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r482" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-document-and-entity-information" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-document-and-entity-information" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r479" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-document-and-entity-information" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-document-and-entity-information" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-document-and-entity-information" ], "xbrltype": "yesNoItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.", "label": "Entity [Domain]" } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited", "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited-parentheticals", "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited", "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-operations-unaudited", "http://www.cyanotech.com/20230630/role/statement-document-and-entity-information", "http://www.cyanotech.com/20230630/role/statement-note-1-organization-and-basis-of-presentation", "http://www.cyanotech.com/20230630/role/statement-note-1-organization-and-basis-of-presentation-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-10-income-taxes", "http://www.cyanotech.com/20230630/role/statement-note-10-income-taxes-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-11-earnings-per-share", "http://www.cyanotech.com/20230630/role/statement-note-11-earnings-per-share-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-11-earnings-per-share-summary-of-reconciliations-between-the-numerator-and-the-denominator-of-the-basic-and-diluted-earnings-per-share-computations-details", "http://www.cyanotech.com/20230630/role/statement-note-11-earnings-per-share-tables", "http://www.cyanotech.com/20230630/role/statement-note-12-related-party-transactions-and-balances", "http://www.cyanotech.com/20230630/role/statement-note-12-related-party-transactions-and-balances-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-13-subsequent-events", "http://www.cyanotech.com/20230630/role/statement-note-13-subsequent-events-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-2-significant-accounting-policies", "http://www.cyanotech.com/20230630/role/statement-note-2-significant-accounting-policies-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-2-significant-accounting-policies-revenue-by-product-details", "http://www.cyanotech.com/20230630/role/statement-note-2-significant-accounting-policies-tables", "http://www.cyanotech.com/20230630/role/statement-note-3-inventories", "http://www.cyanotech.com/20230630/role/statement-note-3-inventories-components-of-inventory-details", "http://www.cyanotech.com/20230630/role/statement-note-3-inventories-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-3-inventories-tables", "http://www.cyanotech.com/20230630/role/statement-note-4-equipment-and-leasehold-improvements", "http://www.cyanotech.com/20230630/role/statement-note-4-equipment-and-leasehold-improvements-components-of-equipment-and-leasehold-improvements-details", "http://www.cyanotech.com/20230630/role/statement-note-4-equipment-and-leasehold-improvements-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-4-equipment-and-leasehold-improvements-tables", "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt", "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt-future-payments-details", "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt-summary-of-line-of-credit-and-longterm-debt-details", "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt-tables", "http://www.cyanotech.com/20230630/role/statement-note-6-operating-leases", "http://www.cyanotech.com/20230630/role/statement-note-6-operating-leases-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-6-operating-leases-operating-leases-maturities-details", "http://www.cyanotech.com/20230630/role/statement-note-6-operating-leases-supplemental-balance-sheet-information-details", "http://www.cyanotech.com/20230630/role/statement-note-6-operating-leases-tables", "http://www.cyanotech.com/20230630/role/statement-note-7-accrued-expenses", "http://www.cyanotech.com/20230630/role/statement-note-7-accrued-expenses-components-of-accrued-expenses-details", "http://www.cyanotech.com/20230630/role/statement-note-7-accrued-expenses-tables", "http://www.cyanotech.com/20230630/role/statement-note-8-commitments-and-contingencies", "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation", "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-restricted-stock-units-details", "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-shares-authorized-available-for-future-grant-and-outstanding-under-each-plan-details", "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-summary-of-nonvested-options-details", "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-summary-of-option-activity-under-stock-plans-details", "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-tables" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r479" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-document-and-entity-information" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r479" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-document-and-entity-information" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-document-and-entity-information" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r483" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-document-and-entity-information" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r479" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r479" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r479" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r479" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-document-and-entity-information" ], "xbrltype": "employerIdItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited", "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited-parentheticals", "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited", "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-operations-unaudited", "http://www.cyanotech.com/20230630/role/statement-document-and-entity-information", "http://www.cyanotech.com/20230630/role/statement-note-1-organization-and-basis-of-presentation", "http://www.cyanotech.com/20230630/role/statement-note-1-organization-and-basis-of-presentation-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-10-income-taxes", "http://www.cyanotech.com/20230630/role/statement-note-10-income-taxes-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-11-earnings-per-share", "http://www.cyanotech.com/20230630/role/statement-note-11-earnings-per-share-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-11-earnings-per-share-summary-of-reconciliations-between-the-numerator-and-the-denominator-of-the-basic-and-diluted-earnings-per-share-computations-details", "http://www.cyanotech.com/20230630/role/statement-note-11-earnings-per-share-tables", "http://www.cyanotech.com/20230630/role/statement-note-12-related-party-transactions-and-balances", "http://www.cyanotech.com/20230630/role/statement-note-12-related-party-transactions-and-balances-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-13-subsequent-events", "http://www.cyanotech.com/20230630/role/statement-note-13-subsequent-events-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-2-significant-accounting-policies", "http://www.cyanotech.com/20230630/role/statement-note-2-significant-accounting-policies-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-2-significant-accounting-policies-revenue-by-product-details", "http://www.cyanotech.com/20230630/role/statement-note-2-significant-accounting-policies-tables", "http://www.cyanotech.com/20230630/role/statement-note-3-inventories", "http://www.cyanotech.com/20230630/role/statement-note-3-inventories-components-of-inventory-details", "http://www.cyanotech.com/20230630/role/statement-note-3-inventories-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-3-inventories-tables", "http://www.cyanotech.com/20230630/role/statement-note-4-equipment-and-leasehold-improvements", "http://www.cyanotech.com/20230630/role/statement-note-4-equipment-and-leasehold-improvements-components-of-equipment-and-leasehold-improvements-details", "http://www.cyanotech.com/20230630/role/statement-note-4-equipment-and-leasehold-improvements-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-4-equipment-and-leasehold-improvements-tables", "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt", "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt-future-payments-details", "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt-summary-of-line-of-credit-and-longterm-debt-details", "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt-tables", "http://www.cyanotech.com/20230630/role/statement-note-6-operating-leases", "http://www.cyanotech.com/20230630/role/statement-note-6-operating-leases-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-6-operating-leases-operating-leases-maturities-details", "http://www.cyanotech.com/20230630/role/statement-note-6-operating-leases-supplemental-balance-sheet-information-details", "http://www.cyanotech.com/20230630/role/statement-note-6-operating-leases-tables", "http://www.cyanotech.com/20230630/role/statement-note-7-accrued-expenses", "http://www.cyanotech.com/20230630/role/statement-note-7-accrued-expenses-components-of-accrued-expenses-details", "http://www.cyanotech.com/20230630/role/statement-note-7-accrued-expenses-tables", "http://www.cyanotech.com/20230630/role/statement-note-8-commitments-and-contingencies", "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation", "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-restricted-stock-units-details", "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-shares-authorized-available-for-future-grant-and-outstanding-under-each-plan-details", "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-summary-of-nonvested-options-details", "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-summary-of-option-activity-under-stock-plans-details", "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-tables" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r478" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-document-and-entity-information" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r480" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-document-and-entity-information" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-document-and-entity-information" ], "xbrltype": "tradingSymbolItemType" }, "srt_MajorCustomersAxis": { "auth_ref": [ "r175", "r459", "r510", "r553", "r554" ], "lang": { "en-us": { "role": { "label": "Customer [Axis]" } } }, "localname": "MajorCustomersAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-2-significant-accounting-policies", "http://www.cyanotech.com/20230630/role/statement-note-2-significant-accounting-policies-details-textual" ], "xbrltype": "stringItemType" }, "srt_MaximumMember": { "auth_ref": [ "r187", "r188", "r189", "r190", "r237", "r335", "r359", "r375", "r376", "r431", "r432", "r433", "r434", "r435", "r438", "r439", "r451", "r457", "r460", "r467", "r508", "r545", "r546", "r547", "r548", "r549", "r550" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-1-organization-and-basis-of-presentation", "http://www.cyanotech.com/20230630/role/statement-note-1-organization-and-basis-of-presentation-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-12-related-party-transactions-and-balances", "http://www.cyanotech.com/20230630/role/statement-note-12-related-party-transactions-and-balances-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation", "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-details-textual" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r187", "r188", "r189", "r190", "r237", "r335", "r359", "r375", "r376", "r431", "r432", "r433", "r434", "r435", "r438", "r439", "r451", "r457", "r460", "r467", "r508", "r545", "r546", "r547", "r548", "r549", "r550" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt", "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt-details-textual" ], "xbrltype": "domainItemType" }, "srt_NameOfMajorCustomerDomain": { "auth_ref": [ "r175", "r459", "r510", "r553", "r554" ], "lang": { "en-us": { "role": { "label": "Customer [Domain]" } } }, "localname": "NameOfMajorCustomerDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-2-significant-accounting-policies", "http://www.cyanotech.com/20230630/role/statement-note-2-significant-accounting-policies-details-textual" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r173", "r337", "r353", "r354", "r355", "r356", "r357", "r358", "r440", "r458", "r466", "r488", "r504", "r505", "r510", "r553" ], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-2-significant-accounting-policies-revenue-by-product-details" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r173", "r337", "r353", "r354", "r355", "r356", "r357", "r358", "r440", "r458", "r466", "r488", "r504", "r505", "r510", "r553" ], "lang": { "en-us": { "role": { "label": "Product and Service [Domain]" } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-2-significant-accounting-policies-revenue-by-product-details" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r187", "r188", "r189", "r190", "r236", "r237", "r265", "r266", "r267", "r334", "r335", "r359", "r375", "r376", "r431", "r432", "r433", "r434", "r435", "r438", "r439", "r451", "r457", "r460", "r467", "r470", "r502", "r508", "r546", "r547", "r548", "r549", "r550" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-1-organization-and-basis-of-presentation", "http://www.cyanotech.com/20230630/role/statement-note-1-organization-and-basis-of-presentation-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-12-related-party-transactions-and-balances", "http://www.cyanotech.com/20230630/role/statement-note-12-related-party-transactions-and-balances-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt", "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation", "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-details-textual" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r187", "r188", "r189", "r190", "r236", "r237", "r265", "r266", "r267", "r334", "r335", "r359", "r375", "r376", "r431", "r432", "r433", "r434", "r435", "r438", "r439", "r451", "r457", "r460", "r467", "r470", "r502", "r508", "r546", "r547", "r548", "r549", "r550" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-1-organization-and-basis-of-presentation", "http://www.cyanotech.com/20230630/role/statement-note-1-organization-and-basis-of-presentation-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-12-related-party-transactions-and-balances", "http://www.cyanotech.com/20230630/role/statement-note-12-related-party-transactions-and-balances-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt", "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation", "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-details-textual" ], "xbrltype": "domainItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r500", "r542" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation", "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-details-textual" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Title of Individual [Domain]" } } }, "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation", "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-details-textual" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.", "label": "Accounts Payable and Accrued Liabilities Disclosure [Text Block]" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-7-accrued-expenses" ], "xbrltype": "textBlockItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r11", "r465" ], "calculation": { "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableMember": { "auth_ref": [ "r436" ], "lang": { "en-us": { "role": { "documentation": "Due from customers or clients for goods or services that have been delivered or sold.", "label": "Accounts Receivable [Member]" } } }, "localname": "AccountsReceivableMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-2-significant-accounting-policies", "http://www.cyanotech.com/20230630/role/statement-note-2-significant-accounting-policies-details-textual" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r176", "r177" ], "calculation": { "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts receivable, net of allowance for credit losses of $11 as of June 30, 2023 and $64 as of March 31, 2023" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedBonusesCurrent": { "auth_ref": [ "r15" ], "calculation": { "http://www.cyanotech.com/20230630/role/statement-note-7-accrued-expenses-components-of-accrued-expenses-details": { "order": 4.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for incentive compensation awarded to employees and directors or earned by them based on the terms of one or more relevant arrangements. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Bonus and profit sharing" } } }, "localname": "AccruedBonusesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-7-accrued-expenses-components-of-accrued-expenses-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r15" ], "calculation": { "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 }, "http://www.cyanotech.com/20230630/role/statement-note-7-accrued-expenses-components-of-accrued-expenses-details": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued expenses", "totalLabel": "Total accrued expenses" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited", "http://www.cyanotech.com/20230630/role/statement-note-7-accrued-expenses-components-of-accrued-expenses-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedSalariesCurrent": { "auth_ref": [ "r15", "r443" ], "calculation": { "http://www.cyanotech.com/20230630/role/statement-note-7-accrued-expenses-components-of-accrued-expenses-details": { "order": 3.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Wages" } } }, "localname": "AccruedSalariesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-7-accrued-expenses-components-of-accrued-expenses-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedVacationCurrent": { "auth_ref": [ "r15", "r38" ], "calculation": { "http://www.cyanotech.com/20230630/role/statement-note-7-accrued-expenses-components-of-accrued-expenses-details": { "order": 2.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for unused vacation time owed to employees based on the entity's vacation benefit given to its employees. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Vacation" } } }, "localname": "AccruedVacationCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-7-accrued-expenses-components-of-accrued-expenses-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r34", "r106", "r347" ], "calculation": { "http://www.cyanotech.com/20230630/role/statement-note-4-equipment-and-leasehold-improvements-components-of-equipment-and-leasehold-improvements-details": { "order": 1.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "negatedLabel": "Less accumulated depreciation and amortization" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-4-equipment-and-leasehold-improvements-components-of-equipment-and-leasehold-improvements-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r58", "r465", "r556" ], "calculation": { "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r274", "r275", "r276", "r373", "r496", "r497", "r498", "r537", "r558" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-consolidated-statements-of-stockholders-equity-unaudited" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.", "label": "Shares withheld for tax payments", "negatedTerseLabel": "Shares withheld for tax payments" } } }, "localname": "AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-consolidated-statements-of-stockholders-equity-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "auth_ref": [ "r42", "r43", "r240" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.", "label": "Share-based compensation expense" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-consolidated-statements-of-stockholders-equity-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net loss to net cash (used in) provided by operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited" ], "xbrltype": "stringItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r269", "r277" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "us-gaap_AllocatedShareBasedCompensationExpense", "terseLabel": "Share-Based Payment Arrangement, Expense" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-details-textual" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": { "auth_ref": [ "r111", "r178", "r182" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.", "label": "Accounts receivable, allowance for doubtful accounts" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited-parentheticals" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfFinancingCosts": { "auth_ref": [ "r68", "r222", "r317", "r492" ], "calculation": { "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense attributable to debt issuance costs.", "label": "Amortization of debt issue costs and other assets" } } }, "localname": "AmortizationOfFinancingCosts", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r154" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares)" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-11-earnings-per-share-details-textual" ], "xbrltype": "sharesItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "auth_ref": [ "r28" ], "lang": { "en-us": { "role": { "documentation": "Information by type of antidilutive security.", "label": "Antidilutive Securities [Axis]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-11-earnings-per-share", "http://www.cyanotech.com/20230630/role/statement-note-11-earnings-per-share-details-textual" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "auth_ref": [ "r28" ], "lang": { "en-us": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.", "label": "Antidilutive Securities, Name [Domain]" } } }, "localname": "AntidilutiveSecuritiesNameDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-11-earnings-per-share", "http://www.cyanotech.com/20230630/role/statement-note-11-earnings-per-share-details-textual" ], "xbrltype": "domainItemType" }, "us-gaap_AssetImpairmentCharges": { "auth_ref": [ "r3", "r33" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.", "label": "us-gaap_AssetImpairmentCharges", "terseLabel": "Asset Impairment Charges" } } }, "localname": "AssetImpairmentCharges", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-4-equipment-and-leasehold-improvements-details-textual" ], "xbrltype": "monetaryItemType" }, "us-gaap_Assets": { "auth_ref": [ "r88", "r108", "r130", "r159", "r167", "r171", "r179", "r191", "r192", "r193", "r194", "r195", "r196", "r197", "r198", "r199", "r295", "r297", "r308", "r341", "r397", "r465", "r477", "r506", "r507", "r543" ], "calculation": { "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "us-gaap_Assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r102", "r113", "r130", "r179", "r191", "r192", "r193", "r194", "r195", "r196", "r197", "r198", "r199", "r295", "r297", "r308", "r465", "r506", "r507", "r543" ], "calculation": { "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited": { "order": 0.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "us-gaap_AssetsCurrent", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited" ], "xbrltype": "stringItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r243", "r244", "r245", "r246", "r247", "r248", "r249", "r250", "r251", "r252", "r253", "r254", "r255", "r256", "r257", "r258", "r259", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r267", "r268" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation", "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-restricted-stock-units-details" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": { "auth_ref": [ "r53", "r76", "r77" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Business Description and Basis of Presentation [Text Block]" } } }, "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-1-organization-and-basis-of-presentation" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r24", "r104", "r441" ], "calculation": { "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash", "terseLabel": "Cash and Cash Equivalents, at Carrying Value" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited", "http://www.cyanotech.com/20230630/role/statement-note-1-organization-and-basis-of-presentation-details-textual" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "auth_ref": [ "r24", "r73", "r127" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "periodEndLabel": "Cash at end of period", "periodStartLabel": "Cash at beginning of period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r1", "r73" ], "calculation": { "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "totalLabel": "Net decrease in cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r20", "r50", "r342", "r384" ], "calculation": { "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and contingencies" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r82", "r185", "r186", "r437", "r503" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-8-commitments-and-contingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r468", "r469", "r470", "r472", "r473", "r474", "r475", "r496", "r497", "r537", "r555", "r558" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-consolidated-statements-of-stockholders-equity-unaudited" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r57" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common stock, par value (in dollars per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited-parentheticals" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r57", "r385" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common stock, shares authorized (in shares)" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited-parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r57" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common stock, shares issued (in shares)" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited-parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r6", "r57", "r385", "r403", "r558", "r559" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common stock, shares outstanding (in shares)" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited-parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r57", "r344", "r465" ], "calculation": { "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common stock of $0.02 par value, authorized 50,000,000 shares; issued and outstanding 6,291,086 shares at June 30, 2023 and 6,271,971 shares at March 31, 2023" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r29", "r31", "r44", "r45", "r175", "r436" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.", "label": "Concentration Risk Benchmark [Domain]" } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-2-significant-accounting-policies", "http://www.cyanotech.com/20230630/role/statement-note-2-significant-accounting-policies-details-textual" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r29", "r31", "r44", "r45", "r175", "r365", "r436" ], "lang": { "en-us": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-2-significant-accounting-policies", "http://www.cyanotech.com/20230630/role/statement-note-2-significant-accounting-policies-details-textual" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r29", "r31", "r44", "r45", "r175", "r436", "r485" ], "lang": { "en-us": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk Type [Axis]" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-2-significant-accounting-policies", "http://www.cyanotech.com/20230630/role/statement-note-2-significant-accounting-policies-details-textual" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r29", "r31", "r44", "r45", "r175" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "us-gaap_ConcentrationRiskPercentage1", "terseLabel": "Concentration Risk, Percentage" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-2-significant-accounting-policies-details-textual" ], "xbrltype": "percentItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r29", "r31", "r44", "r45", "r175", "r436" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.", "label": "Concentration Risk Type [Domain]" } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-2-significant-accounting-policies", "http://www.cyanotech.com/20230630/role/statement-note-2-significant-accounting-policies-details-textual" ], "xbrltype": "domainItemType" }, "us-gaap_ConstructionInProgressGross": { "auth_ref": [ "r81" ], "calculation": { "http://www.cyanotech.com/20230630/role/statement-note-4-equipment-and-leasehold-improvements-components-of-equipment-and-leasehold-improvements-details": { "order": 0.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.", "label": "Construction-in-progress" } } }, "localname": "ConstructionInProgressGross", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-4-equipment-and-leasehold-improvements-components-of-equipment-and-leasehold-improvements-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityCurrent": { "auth_ref": [ "r230", "r231", "r234" ], "calculation": { "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited": { "order": 0.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.", "label": "us-gaap_ContractWithCustomerLiabilityCurrent", "terseLabel": "Customer deposits" } } }, "localname": "ContractWithCustomerLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": { "auth_ref": [ "r235" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.", "label": "us-gaap_ContractWithCustomerLiabilityRevenueRecognized", "terseLabel": "Contract with Customer, Liability, Revenue Recognized" } } }, "localname": "ContractWithCustomerLiabilityRevenueRecognized", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-2-significant-accounting-policies-details-textual" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfGoodsAndServicesSold": { "auth_ref": [ "r70", "r337" ], "calculation": { "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-operations-unaudited": { "order": 0.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.", "label": "Cost of sales" } } }, "localname": "CostOfGoodsAndServicesSold", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-operations-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_CreditFacilityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Axis]" } } }, "localname": "CreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-1-organization-and-basis-of-presentation", "http://www.cyanotech.com/20230630/role/statement-note-1-organization-and-basis-of-presentation-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-12-related-party-transactions-and-balances", "http://www.cyanotech.com/20230630/role/statement-note-12-related-party-transactions-and-balances-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt", "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt-details-textual" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Domain]" } } }, "localname": "CreditFacilityDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-1-organization-and-basis-of-presentation", "http://www.cyanotech.com/20230630/role/statement-note-1-organization-and-basis-of-presentation-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-12-related-party-transactions-and-balances", "http://www.cyanotech.com/20230630/role/statement-note-12-related-party-transactions-and-balances-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt", "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt-details-textual" ], "xbrltype": "domainItemType" }, "us-gaap_CustomerConcentrationRiskMember": { "auth_ref": [ "r30", "r175" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.", "label": "Customer Concentration Risk [Member]" } } }, "localname": "CustomerConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-2-significant-accounting-policies", "http://www.cyanotech.com/20230630/role/statement-note-2-significant-accounting-policies-details-textual" ], "xbrltype": "domainItemType" }, "us-gaap_DebtConversionByUniqueDescriptionAxis": { "auth_ref": [ "r26", "r27" ], "lang": { "en-us": { "role": { "documentation": "Information by description of debt issuances converted in a noncash or part noncash transaction.", "label": "Debt Conversion Description [Axis]" } } }, "localname": "DebtConversionByUniqueDescriptionAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-12-related-party-transactions-and-balances", "http://www.cyanotech.com/20230630/role/statement-note-12-related-party-transactions-and-balances-details-textual" ], "xbrltype": "stringItemType" }, "us-gaap_DebtConversionNameDomain": { "auth_ref": [ "r26", "r27" ], "lang": { "en-us": { "role": { "documentation": "The name of the original debt issue that has been converted in a noncash (or part noncash) transaction during the accounting period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Debt Conversion, Name [Domain]" } } }, "localname": "DebtConversionNameDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-12-related-party-transactions-and-balances", "http://www.cyanotech.com/20230630/role/statement-note-12-related-party-transactions-and-balances-details-textual" ], "xbrltype": "domainItemType" }, "us-gaap_DebtConversionOriginalDebtAmount1": { "auth_ref": [ "r26", "r27" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "us-gaap_DebtConversionOriginalDebtAmount1", "terseLabel": "Debt Conversion, Original Debt, Amount" } } }, "localname": "DebtConversionOriginalDebtAmount1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-12-related-party-transactions-and-balances-details-textual" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r83", "r129", "r200", "r206", "r207", "r208", "r209", "r210", "r211", "r216", "r223", "r224", "r225" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Debt Disclosure [Text Block]" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r9", "r54", "r55", "r89", "r90", "r132", "r201", "r202", "r203", "r204", "r205", "r207", "r212", "r213", "r214", "r215", "r217", "r218", "r219", "r220", "r221", "r222", "r318", "r452", "r453", "r454", "r455", "r456", "r493" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-1-organization-and-basis-of-presentation", "http://www.cyanotech.com/20230630/role/statement-note-1-organization-and-basis-of-presentation-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-12-related-party-transactions-and-balances", "http://www.cyanotech.com/20230630/role/statement-note-12-related-party-transactions-and-balances-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt", "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt-details-textual" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.", "label": "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1", "terseLabel": "Debt Instrument, Basis Spread on Variable Rate" } } }, "localname": "DebtInstrumentBasisSpreadOnVariableRate1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-12-related-party-transactions-and-balances-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt-details-textual" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentCarryingAmount": { "auth_ref": [ "r9", "r90", "r226" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.", "label": "us-gaap_DebtInstrumentCarryingAmount", "terseLabel": "Long-Term Debt, Gross", "verboseLabel": "Long-term debt" } } }, "localname": "DebtInstrumentCarryingAmount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt-summary-of-line-of-credit-and-longterm-debt-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r47", "r49", "r201", "r318", "r453", "r454" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "us-gaap_DebtInstrumentFaceAmount", "terseLabel": "Debt Instrument, Face Amount" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-1-organization-and-basis-of-presentation-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-12-related-party-transactions-and-balances-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt-details-textual" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateDuringPeriod": { "auth_ref": [ "r17", "r47", "r219" ], "lang": { "en-us": { "role": { "documentation": "The average effective interest rate during the reporting period.", "label": "us-gaap_DebtInstrumentInterestRateDuringPeriod", "terseLabel": "Debt Instrument, Interest Rate During Period" } } }, "localname": "DebtInstrumentInterestRateDuringPeriod", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt-details-textual" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r17", "r202" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "us-gaap_DebtInstrumentInterestRateStatedPercentage", "terseLabel": "Debt Instrument, Interest Rate, Stated Percentage" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-12-related-party-transactions-and-balances-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt-details-textual" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r18", "r132", "r201", "r202", "r203", "r204", "r205", "r207", "r212", "r213", "r214", "r215", "r217", "r218", "r219", "r220", "r221", "r222", "r318", "r452", "r453", "r454", "r455", "r456", "r493" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.", "label": "Debt Instrument, Name [Domain]" } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-1-organization-and-basis-of-presentation", "http://www.cyanotech.com/20230630/role/statement-note-1-organization-and-basis-of-presentation-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-12-related-party-transactions-and-balances", "http://www.cyanotech.com/20230630/role/statement-note-12-related-party-transactions-and-balances-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt", "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt-details-textual" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "us-gaap_DebtInstrumentTerm", "terseLabel": "Debt Instrument, Term (Year)" } } }, "localname": "DebtInstrumentTerm", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-12-related-party-transactions-and-balances-details-textual" ], "xbrltype": "durationItemType" }, "us-gaap_DeferredFinanceCostsCurrentNet": { "auth_ref": [ "r48" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt issuance costs classified as current. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.", "label": "us-gaap_DeferredFinanceCostsCurrentNet", "terseLabel": "Debt Issuance Costs, Current, Net" } } }, "localname": "DeferredFinanceCostsCurrentNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt-details-textual" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFinanceCostsNet": { "auth_ref": [ "r48", "r509" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.", "label": "us-gaap_DeferredFinanceCostsNet", "negatedTerseLabel": "Unamortized debt issuance costs" } } }, "localname": "DeferredFinanceCostsNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt-summary-of-line-of-credit-and-longterm-debt-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r3", "r163" ], "calculation": { "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation and amortization", "terseLabel": "Depreciation, Depletion and Amortization" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited", "http://www.cyanotech.com/20230630/role/statement-note-4-equipment-and-leasehold-improvements-details-textual" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "auth_ref": [ "r510" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table Text Block]" } } }, "localname": "DisaggregationOfRevenueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-2-significant-accounting-policies-tables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "auth_ref": [ "r238", "r242", "r270", "r271", "r273", "r461" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for share-based payment arrangement.", "label": "Share-Based Payment Arrangement [Text Block]" } } }, "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureTextBlockAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "us-gaap_DisclosureTextBlockAbstract", "terseLabel": "Notes to Financial Statements" } } }, "localname": "DisclosureTextBlockAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-1-organization-and-basis-of-presentation", "http://www.cyanotech.com/20230630/role/statement-note-10-income-taxes", "http://www.cyanotech.com/20230630/role/statement-note-11-earnings-per-share", "http://www.cyanotech.com/20230630/role/statement-note-12-related-party-transactions-and-balances", "http://www.cyanotech.com/20230630/role/statement-note-13-subsequent-events", "http://www.cyanotech.com/20230630/role/statement-note-2-significant-accounting-policies", "http://www.cyanotech.com/20230630/role/statement-note-3-inventories", "http://www.cyanotech.com/20230630/role/statement-note-4-equipment-and-leasehold-improvements", "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt", "http://www.cyanotech.com/20230630/role/statement-note-6-operating-leases", "http://www.cyanotech.com/20230630/role/statement-note-7-accrued-expenses", "http://www.cyanotech.com/20230630/role/statement-note-8-commitments-and-contingencies", "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net loss per share:" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-operations-unaudited" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r120", "r138", "r139", "r140", "r141", "r142", "r147", "r149", "r151", "r152", "r153", "r157", "r306", "r307", "r338", "r351", "r448" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Basic (in dollars per share)" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-operations-unaudited", "http://www.cyanotech.com/20230630/role/statement-note-11-earnings-per-share-summary-of-reconciliations-between-the-numerator-and-the-denominator-of-the-basic-and-diluted-earnings-per-share-computations-details" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r120", "r138", "r139", "r140", "r141", "r142", "r149", "r151", "r152", "r153", "r157", "r306", "r307", "r338", "r351", "r448" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Diluted (in dollars per share)" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-operations-unaudited" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r146", "r154", "r155", "r156" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-11-earnings-per-share" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "auth_ref": [ "r282" ], "lang": { "en-us": { "role": { "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "terseLabel": "Effective Income Tax Rate Reconciliation, Percent" } } }, "localname": "EffectiveIncomeTaxRateContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-10-income-taxes-details-textual" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r131", "r282", "r291" ], "lang": { "en-us": { "role": { "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).", "label": "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "terseLabel": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent" } } }, "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-10-income-taxes-details-textual" ], "xbrltype": "percentItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "auth_ref": [ "r272" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.", "label": "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "terseLabel": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-details-textual" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "auth_ref": [ "r272" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "terseLabel": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Year)" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-details-textual" ], "xbrltype": "durationItemType" }, "us-gaap_EmployeeStockOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.", "label": "Share-Based Payment Arrangement, Option [Member]" } } }, "localname": "EmployeeStockOptionMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation", "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-details-textual" ], "xbrltype": "domainItemType" }, "us-gaap_EquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tangible personal property used to produce goods and services.", "label": "Equipment [Member]" } } }, "localname": "EquipmentMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-4-equipment-and-leasehold-improvements-components-of-equipment-and-leasehold-improvements-details" ], "xbrltype": "domainItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r6", "r100", "r116", "r117", "r118", "r133", "r134", "r135", "r137", "r143", "r145", "r158", "r180", "r181", "r229", "r274", "r275", "r276", "r287", "r288", "r299", "r300", "r301", "r302", "r303", "r304", "r305", "r309", "r310", "r311", "r312", "r313", "r314", "r325", "r360", "r361", "r362", "r373", "r426" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-consolidated-statements-of-stockholders-equity-unaudited" ], "xbrltype": "domainItemType" }, "us-gaap_FurnitureAndFixturesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.", "label": "Furniture and Fixtures [Member]" } } }, "localname": "FurnitureAndFixturesMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-4-equipment-and-leasehold-improvements-components-of-equipment-and-leasehold-improvements-details" ], "xbrltype": "domainItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r71", "r407" ], "calculation": { "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-operations-unaudited": { "order": 2.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and administrative" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-operations-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_GranteeStatusAxis": { "auth_ref": [ "r239", "r241", "r243", "r244", "r245", "r246", "r247", "r248", "r249", "r250", "r251", "r252", "r253", "r254", "r255", "r256", "r257", "r258", "r259", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r267", "r268" ], "lang": { "en-us": { "role": { "documentation": "Information by status of recipient to whom award is granted.", "label": "Grantee Status [Axis]" } } }, "localname": "GranteeStatusAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation", "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-details-textual" ], "xbrltype": "stringItemType" }, "us-gaap_GranteeStatusDomain": { "auth_ref": [ "r239", "r241", "r243", "r244", "r245", "r246", "r247", "r248", "r249", "r250", "r251", "r252", "r253", "r254", "r255", "r256", "r257", "r258", "r259", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r267", "r268" ], "lang": { "en-us": { "role": { "documentation": "Status of recipient to whom award is granted.", "label": "Grantee Status [Domain]" } } }, "localname": "GranteeStatusDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation", "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-details-textual" ], "xbrltype": "domainItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r69", "r130", "r159", "r166", "r170", "r172", "r179", "r191", "r192", "r193", "r194", "r195", "r196", "r197", "r198", "r199", "r308", "r450", "r506" ], "calculation": { "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-operations-unaudited": { "order": 0.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "us-gaap_GrossProfit", "totalLabel": "Gross profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-operations-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r0", "r66", "r92", "r159", "r166", "r170", "r172", "r339", "r349", "r450" ], "calculation": { "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-operations-unaudited": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "totalLabel": "Loss before income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-operations-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r131", "r279", "r283", "r285", "r286", "r289", "r292", "r293", "r294", "r369" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-10-income-taxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r95", "r99", "r144", "r145", "r164", "r281", "r290", "r352" ], "calculation": { "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-operations-unaudited": { "order": 0.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income tax expense", "terseLabel": "Income Tax Expense (Benefit)" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-operations-unaudited", "http://www.cyanotech.com/20230630/role/statement-note-10-income-taxes-details-textual" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxesPaidNet": { "auth_ref": [ "r25" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.", "label": "Income taxes" } } }, "localname": "IncomeTaxesPaidNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "auth_ref": [ "r2" ], "calculation": { "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "us-gaap_IncreaseDecreaseInAccountsPayable", "terseLabel": "Accounts payable" } } }, "localname": "IncreaseDecreaseInAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r2" ], "calculation": { "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "us-gaap_IncreaseDecreaseInAccountsReceivable", "negatedTerseLabel": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedLiabilities": { "auth_ref": [ "r2" ], "calculation": { "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.", "label": "us-gaap_IncreaseDecreaseInAccruedLiabilities", "terseLabel": "Accrued expenses" } } }, "localname": "IncreaseDecreaseInAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": { "auth_ref": [ "r336", "r491" ], "calculation": { "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.", "label": "us-gaap_IncreaseDecreaseInContractWithCustomerLiability", "terseLabel": "Customer deposits" } } }, "localname": "IncreaseDecreaseInContractWithCustomerLiability", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDeferredLiabilities": { "auth_ref": [ "r2" ], "calculation": { "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Change during the period in carrying value for all deferred liabilities due within one year or operating cycle.", "label": "Deferred rent and other liabilities" } } }, "localname": "IncreaseDecreaseInDeferredLiabilities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r2" ], "calculation": { "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "us-gaap_IncreaseDecreaseInInventories", "negatedTerseLabel": "Inventories" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net (increase) decrease in assets:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": { "auth_ref": [ "r487", "r491" ], "calculation": { "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in obligation for operating lease.", "label": "Operating lease obligations" } } }, "localname": "IncreaseDecreaseInOperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net increase (decrease) in liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingLiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "auth_ref": [ "r2" ], "calculation": { "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.", "label": "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "negatedLabel": "Prepaid expenses and other assets" } } }, "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r48", "r94", "r119", "r162", "r316", "r411", "r476", "r557" ], "calculation": { "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-operations-unaudited": { "order": 0.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "us-gaap_InterestExpense", "negatedLabel": "Interest expense, net" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-operations-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r123", "r125", "r126" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest", "terseLabel": "Interest Paid, Excluding Capitalized Interest, Operating Activities" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited", "http://www.cyanotech.com/20230630/role/statement-note-12-related-party-transactions-and-balances-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt-details-textual" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryDisclosureTextBlock": { "auth_ref": [ "r184" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.", "label": "Inventory Disclosure [Text Block]" } } }, "localname": "InventoryDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-3-inventories" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryFinishedGoodsNetOfReserves": { "auth_ref": [ "r79", "r444" ], "calculation": { "http://www.cyanotech.com/20230630/role/statement-note-3-inventories-components-of-inventory-details": { "order": 3.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.", "label": "Finished goods" } } }, "localname": "InventoryFinishedGoodsNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-3-inventories-components-of-inventory-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r112", "r442", "r465" ], "calculation": { "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://www.cyanotech.com/20230630/role/statement-note-3-inventories-components-of-inventory-details": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventories", "totalLabel": "Inventories" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited", "http://www.cyanotech.com/20230630/role/statement-note-3-inventories-components-of-inventory-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryRawMaterialsNetOfReserves": { "auth_ref": [ "r79", "r446" ], "calculation": { "http://www.cyanotech.com/20230630/role/statement-note-3-inventories-components-of-inventory-details": { "order": 1.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.", "label": "Raw materials" } } }, "localname": "InventoryRawMaterialsNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-3-inventories-components-of-inventory-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventorySuppliesNetOfReserves": { "auth_ref": [ "r32", "r447" ], "calculation": { "http://www.cyanotech.com/20230630/role/statement-note-3-inventories-components-of-inventory-details": { "order": 2.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of products used directly or indirectly in the manufacturing or production process, which may or may not become part of the final product. May also include items used in the storage, presentation or transportation of physical goods.", "label": "Supplies" } } }, "localname": "InventorySuppliesNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-3-inventories-components-of-inventory-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWorkInProcessNetOfReserves": { "auth_ref": [ "r79", "r445" ], "calculation": { "http://www.cyanotech.com/20230630/role/statement-note-3-inventories-components-of-inventory-details": { "order": 0.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.", "label": "Work in process" } } }, "localname": "InventoryWorkInProcessNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-3-inventories-components-of-inventory-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseContractualTermAxis": { "auth_ref": [ "r486" ], "lang": { "en-us": { "role": { "documentation": "Information by contractual term of lease arrangement.", "label": "Lease Contractual Term [Axis]" } } }, "localname": "LeaseContractualTermAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-6-operating-leases", "http://www.cyanotech.com/20230630/role/statement-note-6-operating-leases-details-textual" ], "xbrltype": "stringItemType" }, "us-gaap_LeaseContractualTermDomain": { "auth_ref": [ "r486" ], "lang": { "en-us": { "role": { "documentation": "Contractual term of lease arrangement.", "label": "Lease Contractual Term [Domain]" } } }, "localname": "LeaseContractualTermDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-6-operating-leases", "http://www.cyanotech.com/20230630/role/statement-note-6-operating-leases-details-textual" ], "xbrltype": "domainItemType" }, "us-gaap_LeaseholdImprovementsMember": { "auth_ref": [ "r81" ], "lang": { "en-us": { "role": { "documentation": "Additions or improvements to assets held under a lease arrangement.", "label": "Leasehold Improvements [Member]" } } }, "localname": "LeaseholdImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-4-equipment-and-leasehold-improvements-components-of-equipment-and-leasehold-improvements-details" ], "xbrltype": "domainItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "auth_ref": [ "r541" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.", "label": "Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]" } } }, "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-6-operating-leases-tables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "auth_ref": [ "r324" ], "calculation": { "http://www.cyanotech.com/20230630/role/statement-note-6-operating-leases-operating-leases-maturities-details": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.", "label": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "totalLabel": "Total undiscounted lease payments" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-6-operating-leases-operating-leases-maturities-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": { "auth_ref": [ "r324" ], "calculation": { "http://www.cyanotech.com/20230630/role/statement-note-6-operating-leases-operating-leases-maturities-details": { "order": 4.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive", "terseLabel": "Thereafter" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-6-operating-leases-operating-leases-maturities-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r324" ], "calculation": { "http://www.cyanotech.com/20230630/role/statement-note-6-operating-leases-operating-leases-maturities-details": { "order": 3.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "terseLabel": "Remainder of 2024" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-6-operating-leases-operating-leases-maturities-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": { "auth_ref": [ "r324" ], "calculation": { "http://www.cyanotech.com/20230630/role/statement-note-6-operating-leases-operating-leases-maturities-details": { "order": 5.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive", "terseLabel": "2028" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-6-operating-leases-operating-leases-maturities-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [ "r324" ], "calculation": { "http://www.cyanotech.com/20230630/role/statement-note-6-operating-leases-operating-leases-maturities-details": { "order": 0.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "terseLabel": "2027" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-6-operating-leases-operating-leases-maturities-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r324" ], "calculation": { "http://www.cyanotech.com/20230630/role/statement-note-6-operating-leases-operating-leases-maturities-details": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "terseLabel": "2026" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-6-operating-leases-operating-leases-maturities-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r324" ], "calculation": { "http://www.cyanotech.com/20230630/role/statement-note-6-operating-leases-operating-leases-maturities-details": { "order": 2.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "terseLabel": "2025" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-6-operating-leases-operating-leases-maturities-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r324" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.", "label": "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "negatedLabel": "Less: present value discount" } } }, "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-6-operating-leases-operating-leases-maturities-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseTermOfContract": { "auth_ref": [ "r540" ], "lang": { "en-us": { "role": { "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "us-gaap_LesseeOperatingLeaseTermOfContract", "terseLabel": "Lessee, Operating Lease, Term of Contract (Month)" } } }, "localname": "LesseeOperatingLeaseTermOfContract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-6-operating-leases-details-textual" ], "xbrltype": "durationItemType" }, "us-gaap_LesseeOperatingLeasesTextBlock": { "auth_ref": [ "r319" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.", "label": "Lessee, Operating Leases [Text Block]" } } }, "localname": "LesseeOperatingLeasesTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-6-operating-leases" ], "xbrltype": "textBlockItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r14", "r130", "r179", "r191", "r192", "r193", "r194", "r195", "r196", "r197", "r198", "r199", "r296", "r297", "r298", "r308", "r383", "r449", "r477", "r506", "r543", "r544" ], "calculation": { "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "us-gaap_Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r62", "r91", "r346", "r465", "r494", "r501", "r538" ], "calculation": { "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "us-gaap_LiabilitiesAndStockholdersEquity", "totalLabel": "Total liabilities and stockholders\u2019 equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r16", "r103", "r130", "r179", "r191", "r192", "r193", "r194", "r195", "r196", "r197", "r198", "r199", "r296", "r297", "r298", "r308", "r465", "r506", "r543", "r544" ], "calculation": { "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "us-gaap_LiabilitiesCurrent", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityAxis": { "auth_ref": [ "r13", "r493" ], "lang": { "en-us": { "role": { "documentation": "Information by name of lender, which may be a single entity (for example, but not limited to, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit.", "label": "Lender Name [Axis]" } } }, "localname": "LineOfCreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-1-organization-and-basis-of-presentation", "http://www.cyanotech.com/20230630/role/statement-note-1-organization-and-basis-of-presentation-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-12-related-party-transactions-and-balances", "http://www.cyanotech.com/20230630/role/statement-note-12-related-party-transactions-and-balances-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt", "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt-details-textual" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityLenderDomain": { "auth_ref": [ "r13", "r493" ], "lang": { "en-us": { "role": { "documentation": "Identification of the lender, which may be a single entity (for example, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit, including a letter of credit facility.", "label": "Line of Credit Facility, Lender [Domain]" } } }, "localname": "LineOfCreditFacilityLenderDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-1-organization-and-basis-of-presentation", "http://www.cyanotech.com/20230630/role/statement-note-1-organization-and-basis-of-presentation-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-12-related-party-transactions-and-balances", "http://www.cyanotech.com/20230630/role/statement-note-12-related-party-transactions-and-balances-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt", "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt-details-textual" ], "xbrltype": "domainItemType" }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "auth_ref": [ "r13" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.", "label": "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity", "terseLabel": "Line of Credit Facility, Maximum Borrowing Capacity" } } }, "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-1-organization-and-basis-of-presentation-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-12-related-party-transactions-and-balances-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt-details-textual" ], "xbrltype": "monetaryItemType" }, "us-gaap_LinesOfCreditCurrent": { "auth_ref": [ "r54", "r89" ], "calculation": { "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The carrying value as of the balance sheet date of the current portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.", "label": "Line of credit", "terseLabel": "Line of Credit, Current" } } }, "localname": "LinesOfCreditCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited", "http://www.cyanotech.com/20230630/role/statement-note-1-organization-and-basis-of-presentation-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt-details-textual" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebt": { "auth_ref": [ "r9", "r90", "r213", "r227", "r453", "r454", "r552" ], "calculation": { "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt-future-payments-details": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.", "label": "us-gaap_LongTermDebt", "totalLabel": "Total principal payments" } } }, "localname": "LongTermDebt", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt-future-payments-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtCurrent": { "auth_ref": [ "r109" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation.", "label": "us-gaap_LongTermDebtCurrent", "negatedTerseLabel": "Less current maturities", "terseLabel": "Long-term Debt, Current Maturities, Total" } } }, "localname": "LongTermDebtCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt-summary-of-line-of-credit-and-longterm-debt-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": { "auth_ref": [ "r5", "r132", "r218" ], "calculation": { "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt-future-payments-details": { "order": 0.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree", "terseLabel": "2026" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt-future-payments-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear": { "auth_ref": [ "r495" ], "calculation": { "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt-future-payments-details": { "order": 1.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year.", "label": "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear", "terseLabel": "Remainder of 2024" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt-future-payments-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtNoncurrent": { "auth_ref": [ "r110" ], "calculation": { "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.", "label": "Long-term debt, less current maturities", "terseLabel": "Total long-term debt, net of current maturities" } } }, "localname": "LongTermDebtNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited", "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt-summary-of-line-of-credit-and-longterm-debt-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-term debt.", "label": "Long-Term Debt, Type [Axis]" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-12-related-party-transactions-and-balances", "http://www.cyanotech.com/20230630/role/statement-note-12-related-party-transactions-and-balances-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt", "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt-summary-of-line-of-credit-and-longterm-debt-details" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r18", "r35" ], "lang": { "en-us": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Long-Term Debt, Type [Domain]" } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-12-related-party-transactions-and-balances", "http://www.cyanotech.com/20230630/role/statement-note-12-related-party-transactions-and-balances-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt", "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt-summary-of-line-of-credit-and-longterm-debt-details" ], "xbrltype": "domainItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r124" ], "calculation": { "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "totalLabel": "Net cash provided by (used in) financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CASH FLOWS FROM FINANCING ACTIVITIES:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r124" ], "calculation": { "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited": { "order": 0.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "totalLabel": "Net cash used in investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CASH FLOWS FROM INVESTING ACTIVITIES:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r73", "r74", "r75" ], "calculation": { "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "terseLabel": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash used in operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited", "http://www.cyanotech.com/20230630/role/statement-note-1-organization-and-basis-of-presentation-details-textual" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CASH FLOWS FROM OPERATING ACTIVITIES:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r67", "r75", "r93", "r101", "r114", "r115", "r118", "r130", "r136", "r138", "r139", "r140", "r141", "r144", "r145", "r150", "r159", "r166", "r170", "r172", "r179", "r191", "r192", "r193", "r194", "r195", "r196", "r197", "r198", "r199", "r307", "r308", "r350", "r405", "r424", "r425", "r450", "r476", "r506" ], "calculation": { "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-operations-unaudited": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net loss", "terseLabel": "Net income (loss)", "totalLabel": "Net loss" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited", "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-operations-unaudited", "http://www.cyanotech.com/20230630/role/statement-consolidated-statements-of-stockholders-equity-unaudited", "http://www.cyanotech.com/20230630/role/statement-note-11-earnings-per-share-summary-of-reconciliations-between-the-numerator-and-the-denominator-of-the-basic-and-diluted-earnings-per-share-computations-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-operations-unaudited": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "us-gaap_OperatingExpenses", "totalLabel": "Total operating expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-operations-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating expenses:" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-operations-unaudited" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r159", "r166", "r170", "r172", "r450" ], "calculation": { "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-operations-unaudited": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "us-gaap_OperatingIncomeLoss", "totalLabel": "Loss from operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-operations-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseExpense": { "auth_ref": [ "r539" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating lease expense. Excludes sublease income.", "label": "us-gaap_OperatingLeaseExpense", "terseLabel": "Operating Lease, Expense" } } }, "localname": "OperatingLeaseExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-6-operating-leases-details-textual" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r321" ], "calculation": { "http://www.cyanotech.com/20230630/role/statement-note-6-operating-leases-supplemental-balance-sheet-information-details": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "us-gaap_OperatingLeaseLiability", "terseLabel": "Total lease liability balance", "totalLabel": "Total lease liabilities" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-6-operating-leases-operating-leases-maturities-details", "http://www.cyanotech.com/20230630/role/statement-note-6-operating-leases-supplemental-balance-sheet-information-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r321" ], "calculation": { "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited": { "order": 6.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 }, "http://www.cyanotech.com/20230630/role/statement-note-6-operating-leases-supplemental-balance-sheet-information-details": { "order": 1.0, "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating lease obligations, current portion", "terseLabel": "Current lease liabilities" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited", "http://www.cyanotech.com/20230630/role/statement-note-6-operating-leases-supplemental-balance-sheet-information-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r321" ], "calculation": { "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 }, "http://www.cyanotech.com/20230630/role/statement-note-6-operating-leases-supplemental-balance-sheet-information-details": { "order": 0.0, "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Long-term operating lease obligations", "terseLabel": "Non-current lease liabilities" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited", "http://www.cyanotech.com/20230630/role/statement-note-6-operating-leases-supplemental-balance-sheet-information-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r320" ], "calculation": { "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://www.cyanotech.com/20230630/role/statement-note-6-operating-leases-supplemental-balance-sheet-information-details": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating lease right-of-use assets, net", "totalLabel": "Total right-of-use assets" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited", "http://www.cyanotech.com/20230630/role/statement-note-6-operating-leases-supplemental-balance-sheet-information-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": { "auth_ref": [ "r492" ], "calculation": { "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited": { "order": 0.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease.", "label": "Amortization of operating leases right-of-use assets" } } }, "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r323", "r464" ], "lang": { "en-us": { "role": { "documentation": "Weighted average discount rate for operating lease calculated at point in time.", "label": "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent", "terseLabel": "Operating Lease, Weighted Average Discount Rate, Percent" } } }, "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-6-operating-leases-details-textual" ], "xbrltype": "percentItemType" }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r322", "r464" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1", "terseLabel": "Operating Lease, Weighted Average Remaining Lease Term (Year)" } } }, "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-6-operating-leases-details-textual" ], "xbrltype": "durationItemType" }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "auth_ref": [ "r15" ], "calculation": { "http://www.cyanotech.com/20230630/role/statement-note-7-accrued-expenses-components-of-accrued-expenses-details": { "order": 0.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.", "label": "us-gaap_OtherAccruedLiabilitiesCurrent", "terseLabel": "Other accrued expenses" } } }, "localname": "OtherAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-7-accrued-expenses-components-of-accrued-expenses-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r107" ], "calculation": { "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesNoncurrent": { "auth_ref": [ "r19" ], "calculation": { "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited": { "order": 0.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.", "label": "Other long-term liabilities" } } }, "localname": "OtherLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForCapitalImprovements": { "auth_ref": [ "r72" ], "calculation": { "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited": { "order": 0.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for acquisition of or capital improvements to properties held for investment (operating, managed, leased) or for use.", "label": "us-gaap_PaymentsForCapitalImprovements", "negatedLabel": "Investment in equipment and leasehold improvements" } } }, "localname": "PaymentsForCapitalImprovements", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": { "auth_ref": [ "r122" ], "calculation": { "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.", "label": "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation", "negatedLabel": "Taxes paid related to net share settlement of restricted stock units" } } }, "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r511", "r512", "r513", "r514", "r515", "r516", "r517", "r518", "r519", "r520", "r521", "r522", "r523", "r524", "r525", "r526", "r527", "r528", "r529", "r530", "r531", "r532", "r533", "r534", "r535", "r536" ], "lang": { "en-us": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation", "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-shares-authorized-available-for-future-grant-and-outstanding-under-each-plan-details" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [ "r511", "r512", "r513", "r514", "r515", "r516", "r517", "r518", "r519", "r520", "r521", "r522", "r523", "r524", "r525", "r526", "r527", "r528", "r529", "r530", "r531", "r532", "r533", "r534", "r535", "r536" ], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement.", "label": "Plan Name [Domain]" } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation", "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-shares-authorized-available-for-future-grant-and-outstanding-under-each-plan-details" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r56", "r228" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred stock, par value (in dollars per share)" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited-parentheticals" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r56", "r385" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred, authorized shares (in shares)" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited-parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r56", "r228" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred, issued shares (in shares)" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited-parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r56", "r385", "r403", "r558", "r559" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred outstanding, shares (in shares)" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited-parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r56", "r343", "r465" ], "calculation": { "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred stock of $0.01 par value, authorized 10,000,000 shares; no shares issued and outstanding" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r489" ], "calculation": { "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited": { "order": 0.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepaid expenses and other current assets" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrimeRateMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate charged by financial institutions to their most creditworthy borrowers.", "label": "Prime Rate [Member]" } } }, "localname": "PrimeRateMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-12-related-party-transactions-and-balances", "http://www.cyanotech.com/20230630/role/statement-note-12-related-party-transactions-and-balances-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt", "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt-details-textual" ], "xbrltype": "domainItemType" }, "us-gaap_ProceedsFromIssuanceOfDebt": { "auth_ref": [ "r490" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.", "label": "us-gaap_ProceedsFromIssuanceOfDebt", "terseLabel": "Proceeds from Issuance of Debt" } } }, "localname": "ProceedsFromIssuanceOfDebt", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt-details-textual" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromLinesOfCredit": { "auth_ref": [ "r22", "r493" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.", "label": "us-gaap_ProceedsFromLinesOfCredit", "terseLabel": "Proceeds from Lines of Credit" } } }, "localname": "ProceedsFromLinesOfCredit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-1-organization-and-basis-of-presentation-details-textual" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromRepaymentsOfLinesOfCredit": { "auth_ref": [], "calculation": { "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited": { "order": 0.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The net cash inflow or cash outflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with either short term or long term maturity that is collateralized (backed by pledge, mortgage or other lien in the entity's assets).", "label": "Net draws (payments) on line of credit" } } }, "localname": "ProceedsFromRepaymentsOfLinesOfCredit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-4-equipment-and-leasehold-improvements-components-of-equipment-and-leasehold-improvements-details" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "auth_ref": [ "r80", "r96", "r97", "r98" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property, Plant and Equipment Disclosure [Text Block]" } } }, "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-4-equipment-and-leasehold-improvements" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r81", "r105", "r348" ], "calculation": { "http://www.cyanotech.com/20230630/role/statement-note-4-equipment-and-leasehold-improvements-components-of-equipment-and-leasehold-improvements-details": { "order": 2.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Equipment and leasehold improvements, gross" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-4-equipment-and-leasehold-improvements-components-of-equipment-and-leasehold-improvements-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r4", "r340", "r348", "r465" ], "calculation": { "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://www.cyanotech.com/20230630/role/statement-note-4-equipment-and-leasehold-improvements-components-of-equipment-and-leasehold-improvements-details": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "us-gaap_PropertyPlantAndEquipmentNet", "terseLabel": "Equipment and leasehold improvements, net", "totalLabel": "Equipment and leasehold improvements, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited", "http://www.cyanotech.com/20230630/role/statement-note-4-equipment-and-leasehold-improvements-components-of-equipment-and-leasehold-improvements-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table Text Block]" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-4-equipment-and-leasehold-improvements-tables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r81" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.", "label": "Long-Lived Tangible Asset [Domain]" } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-4-equipment-and-leasehold-improvements-components-of-equipment-and-leasehold-improvements-details" ], "xbrltype": "domainItemType" }, "us-gaap_ProvisionForDoubtfulAccounts": { "auth_ref": [ "r121", "r183" ], "calculation": { "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.", "label": "Provision for doubtful accounts" } } }, "localname": "ProvisionForDoubtfulAccounts", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r326", "r327", "r328", "r329", "r330", "r370", "r371", "r372", "r408", "r409", "r410", "r429", "r430" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions Disclosure [Text Block]" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-12-related-party-transactions-and-balances" ], "xbrltype": "textBlockItemType" }, "us-gaap_RepaymentsOfLongTermDebt": { "auth_ref": [ "r23", "r367" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.", "label": "us-gaap_RepaymentsOfLongTermDebt", "terseLabel": "Repayments of Long-term Debt, Total" } } }, "localname": "RepaymentsOfLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-12-related-party-transactions-and-balances-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt-details-textual" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfSecuredDebt": { "auth_ref": [ "r23" ], "calculation": { "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to repay long-term debt that is wholly or partially secured by collateral. Excludes repayments of tax exempt secured debt.", "label": "us-gaap_RepaymentsOfSecuredDebt", "negatedLabel": "Principal payments on long-term debt" } } }, "localname": "RepaymentsOfSecuredDebt", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r52", "r278", "r551" ], "calculation": { "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-operations-unaudited": { "order": 0.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research and development" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-operations-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedStockMember": { "auth_ref": [ "r28" ], "lang": { "en-us": { "role": { "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.", "label": "Restricted Stock [Member]" } } }, "localname": "RestrictedStockMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation", "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-details-textual" ], "xbrltype": "domainItemType" }, "us-gaap_RestrictedStockUnitsRSUMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.", "label": "Restricted Stock Units (RSUs) [Member]" } } }, "localname": "RestrictedStockUnitsRSUMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation", "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-restricted-stock-units-details" ], "xbrltype": "domainItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r59", "r86", "r345", "r363", "r364", "r368", "r386", "r465" ], "calculation": { "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited": { "order": 0.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated undistributed earnings (deficit).", "label": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r100", "r133", "r134", "r135", "r137", "r143", "r145", "r180", "r181", "r274", "r275", "r276", "r287", "r288", "r299", "r301", "r302", "r304", "r305", "r360", "r362", "r373", "r558" ], "lang": { "en-us": { "role": { "documentation": "Accumulated undistributed earnings (deficit).", "label": "Retained Earnings [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-consolidated-statements-of-stockholders-equity-unaudited" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r160", "r161", "r165", "r168", "r169", "r173", "r174", "r175", "r232", "r233", "r337" ], "calculation": { "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-operations-unaudited": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Net sales" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-operations-unaudited", "http://www.cyanotech.com/20230630/role/statement-note-2-significant-accounting-policies-revenue-by-product-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevolvingCreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.", "label": "Revolving Credit Facility [Member]" } } }, "localname": "RevolvingCreditFacilityMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-1-organization-and-basis-of-presentation", "http://www.cyanotech.com/20230630/role/statement-note-1-organization-and-basis-of-presentation-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-12-related-party-transactions-and-balances", "http://www.cyanotech.com/20230630/role/statement-note-12-related-party-transactions-and-balances-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt", "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt-details-textual" ], "xbrltype": "domainItemType" }, "us-gaap_SalesRevenueNetMember": { "auth_ref": [ "r175", "r484" ], "lang": { "en-us": { "role": { "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.", "label": "Revenue Benchmark [Member]" } } }, "localname": "SalesRevenueNetMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-2-significant-accounting-policies", "http://www.cyanotech.com/20230630/role/statement-note-2-significant-accounting-policies-details-textual" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of accrued liabilities.", "label": "Schedule of Accrued Liabilities [Table Text Block]" } } }, "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-7-accrued-expenses-tables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDebtInstrumentsTextBlock": { "auth_ref": [ "r18", "r36", "r37", "r46", "r47", "r49", "r51", "r84", "r85", "r453", "r455", "r495" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.", "label": "Schedule of Long-Term Debt Instruments [Table Text Block]" } } }, "localname": "ScheduleOfDebtInstrumentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt-tables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r499" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-11-earnings-per-share-tables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "auth_ref": [ "r10", "r63", "r64", "r65" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "Schedule of Inventory, Current [Table Text Block]" } } }, "localname": "ScheduleOfInventoryCurrentTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-3-inventories-tables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.", "label": "Schedule of Maturities of Long-Term Debt [Table Text Block]" } } }, "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt-tables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock": { "auth_ref": [ "r41" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock units.", "label": "Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]" } } }, "localname": "ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-tables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock": { "auth_ref": [ "r41" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the changes in outstanding nonvested shares.", "label": "Schedule of Nonvested Share Activity [Table Text Block]" } } }, "localname": "ScheduleOfNonvestedShareActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-tables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r7", "r8", "r40" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-tables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SellingAndMarketingExpense": { "auth_ref": [], "calculation": { "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-operations-unaudited": { "order": 1.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.", "label": "Sales and marketing" } } }, "localname": "SellingAndMarketingExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-operations-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r2" ], "calculation": { "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "us-gaap_ShareBasedCompensation", "terseLabel": "Share-based compensation expense" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "auth_ref": [ "r259" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.", "label": "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "negatedLabel": "Forfeited (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-restricted-stock-units-details" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "auth_ref": [ "r259" ], "lang": { "en-us": { "role": { "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.", "label": "Forfeited, weighted average grant price (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-restricted-stock-units-details" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "auth_ref": [ "r257" ], "lang": { "en-us": { "role": { "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Granted (in shares)", "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-restricted-stock-units-details" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r257" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Granted, weighted average grant price (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-restricted-stock-units-details" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "auth_ref": [ "r254", "r255" ], "lang": { "en-us": { "role": { "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.", "label": "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "periodEndLabel": "Nonvested restricted stock units (in shares)", "periodStartLabel": "Nonvested restricted stock units (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-restricted-stock-units-details" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [ "r254", "r255" ], "lang": { "en-us": { "role": { "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.", "label": "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "periodEndLabel": "Nonvested restricted stock units, weighted average grant price (in dollars per share)", "periodStartLabel": "Nonvested restricted stock units, weighted average grant price (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-restricted-stock-units-details" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "auth_ref": [ "r258" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.", "label": "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "negatedLabel": "Vested (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-restricted-stock-units-details" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r258" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.", "label": "Vested, weighted average grant price (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-restricted-stock-units-details" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": { "auth_ref": [ "r463" ], "lang": { "en-us": { "role": { "documentation": "Number of shares authorized for issuance under share-based payment arrangement.", "label": "Authorized (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-shares-authorized-available-for-future-grant-and-outstanding-under-each-plan-details" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": { "auth_ref": [ "r39" ], "lang": { "en-us": { "role": { "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.", "label": "Available (in shares)", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-shares-authorized-available-for-future-grant-and-outstanding-under-each-plan-details" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "auth_ref": [ "r248" ], "lang": { "en-us": { "role": { "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.", "label": "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "terseLabel": "Exercisable (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-summary-of-option-activity-under-stock-plans-details" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "auth_ref": [ "r248" ], "lang": { "en-us": { "role": { "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.", "label": "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "terseLabel": "Exercisable, weighted average exercise price (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-summary-of-option-activity-under-stock-plans-details" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "auth_ref": [ "r39" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.", "label": "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "terseLabel": "Outstanding, aggregate intrinsic value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-summary-of-option-activity-under-stock-plans-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r246", "r247" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "periodEndLabel": "Outstanding (in shares)", "periodStartLabel": "Outstanding (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-summary-of-option-activity-under-stock-plans-details" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r246", "r247" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "periodEndLabel": "Outstanding, weighted average exercise price (in dollars per share)", "periodStartLabel": "Outstanding, weighted average exercise price (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-summary-of-option-activity-under-stock-plans-details" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r243", "r244", "r245", "r246", "r247", "r248", "r249", "r250", "r251", "r252", "r253", "r254", "r255", "r256", "r257", "r258", "r259", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r267", "r268" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Award Type [Domain]" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation", "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-restricted-stock-units-details" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedPaymentArrangementNonemployeeMember": { "auth_ref": [ "r239", "r243", "r244", "r245", "r246", "r247", "r248", "r249", "r250", "r251", "r252", "r253", "r254", "r255", "r256", "r257", "r258", "r259", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r267", "r268" ], "lang": { "en-us": { "role": { "documentation": "Recipient, of award granted under share-based payment arrangement, over whom grantor does not exercise nor has right to exercise sufficient control to establish employer-employee relationship based on law of pertinent jurisdiction. Excludes nonemployee director treated as employee when acting as member of board of directors, if elected by grantor's shareholders or appointed to board position to be filled by shareholder election when existing term expires.", "label": "Share-Based Payment Arrangement, Nonemployee [Member]" } } }, "localname": "ShareBasedPaymentArrangementNonemployeeMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation", "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-details-textual" ], "xbrltype": "domainItemType" }, "us-gaap_SharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single share of a number of saleable stocks of a company.", "label": "us-gaap_SharePrice", "terseLabel": "Share Price (in dollars per share)" } } }, "localname": "SharePrice", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-details-textual" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": { "auth_ref": [ "r462" ], "lang": { "en-us": { "role": { "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period (Year)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-details-textual" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": { "auth_ref": [ "r39" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.", "label": "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1", "terseLabel": "Exercisable, aggregate intrinsic value" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-summary-of-option-activity-under-stock-plans-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": { "auth_ref": [ "r39" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1", "terseLabel": "Exercisable, weighted average remaining contractual term (Year)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-summary-of-option-activity-under-stock-plans-details" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of non-vested options outstanding.", "label": "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares", "periodEndLabel": "Nonvested (in shares)", "periodStartLabel": "Nonvested (in shares)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-summary-of-nonvested-options-details" ], "xbrltype": "sharesItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average grant-date fair value of non-vested options outstanding.", "label": "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue", "periodEndLabel": "Nonvested (in dollars per share)", "periodStartLabel": "Nonvested (in dollars per share)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-summary-of-nonvested-options-details" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r87" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "terseLabel": "Outstanding, weighted average remaining contractual term (Year)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-summary-of-option-activity-under-stock-plans-details" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of options vested.", "label": "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares", "negatedTerseLabel": "Vested (in shares)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-summary-of-nonvested-options-details" ], "xbrltype": "sharesItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average grant-date fair value of options vested.", "label": "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue", "terseLabel": "Vested (in dollars per share)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-summary-of-nonvested-options-details" ], "xbrltype": "perShareItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "us-gaap_SharesOutstanding", "periodEndLabel": "Balance (in shares)", "periodStartLabel": "Balance (in shares)" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-consolidated-statements-of-stockholders-equity-unaudited" ], "xbrltype": "sharesItemType" }, "us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.", "label": "us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation", "negatedLabel": "Shares withheld for tax payments (in shares)" } } }, "localname": "SharesPaidForTaxWithholdingForShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-consolidated-statements-of-stockholders-equity-unaudited" ], "xbrltype": "sharesItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r76", "r128" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies [Text Block]" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-2-significant-accounting-policies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r6", "r21", "r100", "r116", "r117", "r118", "r133", "r134", "r135", "r137", "r143", "r145", "r158", "r180", "r181", "r229", "r274", "r275", "r276", "r287", "r288", "r299", "r300", "r301", "r302", "r303", "r304", "r305", "r309", "r310", "r311", "r312", "r313", "r314", "r325", "r360", "r361", "r362", "r373", "r426" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-consolidated-statements-of-stockholders-equity-unaudited" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [ "r133", "r134", "r135", "r158", "r337", "r366", "r374", "r377", "r378", "r379", "r380", "r381", "r382", "r385", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r398", "r399", "r400", "r401", "r402", "r404", "r406", "r407", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r420", "r421", "r422", "r423", "r426", "r471" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited", "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited-parentheticals", "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited", "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-operations-unaudited", "http://www.cyanotech.com/20230630/role/statement-consolidated-statements-of-stockholders-equity-unaudited", "http://www.cyanotech.com/20230630/role/statement-note-1-organization-and-basis-of-presentation", "http://www.cyanotech.com/20230630/role/statement-note-1-organization-and-basis-of-presentation-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-10-income-taxes", "http://www.cyanotech.com/20230630/role/statement-note-10-income-taxes-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-11-earnings-per-share", "http://www.cyanotech.com/20230630/role/statement-note-11-earnings-per-share-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-11-earnings-per-share-summary-of-reconciliations-between-the-numerator-and-the-denominator-of-the-basic-and-diluted-earnings-per-share-computations-details", "http://www.cyanotech.com/20230630/role/statement-note-11-earnings-per-share-tables", "http://www.cyanotech.com/20230630/role/statement-note-12-related-party-transactions-and-balances", "http://www.cyanotech.com/20230630/role/statement-note-12-related-party-transactions-and-balances-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-13-subsequent-events", "http://www.cyanotech.com/20230630/role/statement-note-13-subsequent-events-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-2-significant-accounting-policies", "http://www.cyanotech.com/20230630/role/statement-note-2-significant-accounting-policies-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-2-significant-accounting-policies-revenue-by-product-details", "http://www.cyanotech.com/20230630/role/statement-note-2-significant-accounting-policies-tables", "http://www.cyanotech.com/20230630/role/statement-note-3-inventories", "http://www.cyanotech.com/20230630/role/statement-note-3-inventories-components-of-inventory-details", "http://www.cyanotech.com/20230630/role/statement-note-3-inventories-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-3-inventories-tables", "http://www.cyanotech.com/20230630/role/statement-note-4-equipment-and-leasehold-improvements", "http://www.cyanotech.com/20230630/role/statement-note-4-equipment-and-leasehold-improvements-components-of-equipment-and-leasehold-improvements-details", "http://www.cyanotech.com/20230630/role/statement-note-4-equipment-and-leasehold-improvements-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-4-equipment-and-leasehold-improvements-tables", "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt", "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt-future-payments-details", "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt-summary-of-line-of-credit-and-longterm-debt-details", "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt-tables", "http://www.cyanotech.com/20230630/role/statement-note-6-operating-leases", "http://www.cyanotech.com/20230630/role/statement-note-6-operating-leases-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-6-operating-leases-operating-leases-maturities-details", "http://www.cyanotech.com/20230630/role/statement-note-6-operating-leases-supplemental-balance-sheet-information-details", "http://www.cyanotech.com/20230630/role/statement-note-6-operating-leases-tables", "http://www.cyanotech.com/20230630/role/statement-note-7-accrued-expenses", "http://www.cyanotech.com/20230630/role/statement-note-7-accrued-expenses-components-of-accrued-expenses-details", "http://www.cyanotech.com/20230630/role/statement-note-7-accrued-expenses-tables", "http://www.cyanotech.com/20230630/role/statement-note-8-commitments-and-contingencies", "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation", "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-restricted-stock-units-details", "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-shares-authorized-available-for-future-grant-and-outstanding-under-each-plan-details", "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-summary-of-nonvested-options-details", "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-summary-of-option-activity-under-stock-plans-details", "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-tables" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r133", "r134", "r135", "r158", "r337", "r366", "r374", "r377", "r378", "r379", "r380", "r381", "r382", "r385", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r398", "r399", "r400", "r401", "r402", "r404", "r406", "r407", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r420", "r421", "r422", "r423", "r426", "r471" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited", "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited-parentheticals", "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited", "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-operations-unaudited", "http://www.cyanotech.com/20230630/role/statement-consolidated-statements-of-stockholders-equity-unaudited", "http://www.cyanotech.com/20230630/role/statement-note-1-organization-and-basis-of-presentation", "http://www.cyanotech.com/20230630/role/statement-note-1-organization-and-basis-of-presentation-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-10-income-taxes", "http://www.cyanotech.com/20230630/role/statement-note-10-income-taxes-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-11-earnings-per-share", "http://www.cyanotech.com/20230630/role/statement-note-11-earnings-per-share-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-11-earnings-per-share-summary-of-reconciliations-between-the-numerator-and-the-denominator-of-the-basic-and-diluted-earnings-per-share-computations-details", "http://www.cyanotech.com/20230630/role/statement-note-11-earnings-per-share-tables", "http://www.cyanotech.com/20230630/role/statement-note-12-related-party-transactions-and-balances", "http://www.cyanotech.com/20230630/role/statement-note-12-related-party-transactions-and-balances-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-13-subsequent-events", "http://www.cyanotech.com/20230630/role/statement-note-13-subsequent-events-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-2-significant-accounting-policies", "http://www.cyanotech.com/20230630/role/statement-note-2-significant-accounting-policies-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-2-significant-accounting-policies-revenue-by-product-details", "http://www.cyanotech.com/20230630/role/statement-note-2-significant-accounting-policies-tables", "http://www.cyanotech.com/20230630/role/statement-note-3-inventories", "http://www.cyanotech.com/20230630/role/statement-note-3-inventories-components-of-inventory-details", "http://www.cyanotech.com/20230630/role/statement-note-3-inventories-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-3-inventories-tables", "http://www.cyanotech.com/20230630/role/statement-note-4-equipment-and-leasehold-improvements", "http://www.cyanotech.com/20230630/role/statement-note-4-equipment-and-leasehold-improvements-components-of-equipment-and-leasehold-improvements-details", "http://www.cyanotech.com/20230630/role/statement-note-4-equipment-and-leasehold-improvements-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-4-equipment-and-leasehold-improvements-tables", "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt", "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt-future-payments-details", "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt-summary-of-line-of-credit-and-longterm-debt-details", "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt-tables", "http://www.cyanotech.com/20230630/role/statement-note-6-operating-leases", "http://www.cyanotech.com/20230630/role/statement-note-6-operating-leases-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-6-operating-leases-operating-leases-maturities-details", "http://www.cyanotech.com/20230630/role/statement-note-6-operating-leases-supplemental-balance-sheet-information-details", "http://www.cyanotech.com/20230630/role/statement-note-6-operating-leases-tables", "http://www.cyanotech.com/20230630/role/statement-note-7-accrued-expenses", "http://www.cyanotech.com/20230630/role/statement-note-7-accrued-expenses-components-of-accrued-expenses-details", "http://www.cyanotech.com/20230630/role/statement-note-7-accrued-expenses-tables", "http://www.cyanotech.com/20230630/role/statement-note-8-commitments-and-contingencies", "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation", "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-restricted-stock-units-details", "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-shares-authorized-available-for-future-grant-and-outstanding-under-each-plan-details", "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-summary-of-nonvested-options-details", "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-summary-of-option-activity-under-stock-plans-details", "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-tables" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross": { "auth_ref": [ "r6", "r86" ], "lang": { "en-us": { "role": { "documentation": "Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.", "label": "Issuances of vested shares of restricted stock (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardGross", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-consolidated-statements-of-stockholders-equity-unaudited" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross": { "auth_ref": [ "r6", "r56", "r57", "r86" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate value of stock related to Restricted Stock Awards issued during the period.", "label": "Issuances of vested shares of restricted stock" } } }, "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardGross", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-consolidated-statements-of-stockholders-equity-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r57", "r60", "r61", "r78", "r387", "r403", "r427", "r428", "r465", "r477", "r494", "r501", "r538", "r558" ], "calculation": { "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited": { "order": 0.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.", "label": "us-gaap_StockholdersEquity", "periodEndLabel": "Balance", "periodStartLabel": "Balance", "totalLabel": "Total stockholders\u2019 equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited", "http://www.cyanotech.com/20230630/role/statement-consolidated-statements-of-stockholders-equity-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders\u2019 equity:" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r315", "r332" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-13-subsequent-events", "http://www.cyanotech.com/20230630/role/statement-note-13-subsequent-events-details-textual" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r315", "r332" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-13-subsequent-events", "http://www.cyanotech.com/20230630/role/statement-note-13-subsequent-events-details-textual" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r315", "r332" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Domain]" } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-13-subsequent-events", "http://www.cyanotech.com/20230630/role/statement-note-13-subsequent-events-details-textual" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r331", "r333" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-13-subsequent-events" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited" ], "xbrltype": "stringItemType" }, "us-gaap_TableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "us-gaap_TableTextBlock", "terseLabel": "Notes Tables" } } }, "localname": "TableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-11-earnings-per-share-tables", "http://www.cyanotech.com/20230630/role/statement-note-2-significant-accounting-policies-tables", "http://www.cyanotech.com/20230630/role/statement-note-3-inventories-tables", "http://www.cyanotech.com/20230630/role/statement-note-4-equipment-and-leasehold-improvements-tables", "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt-tables", "http://www.cyanotech.com/20230630/role/statement-note-6-operating-leases-tables", "http://www.cyanotech.com/20230630/role/statement-note-7-accrued-expenses-tables", "http://www.cyanotech.com/20230630/role/statement-note-9-sharebased-compensation-tables" ], "xbrltype": "stringItemType" }, "us-gaap_UnrecognizedTaxBenefits": { "auth_ref": [ "r280", "r284" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrecognized tax benefits.", "label": "us-gaap_UnrecognizedTaxBenefits", "terseLabel": "Unrecognized Tax Benefits" } } }, "localname": "UnrecognizedTaxBenefits", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-10-income-taxes-details-textual" ], "xbrltype": "monetaryItemType" }, "us-gaap_VariableRateAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of variable rate.", "label": "Variable Rate [Axis]" } } }, "localname": "VariableRateAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-12-related-party-transactions-and-balances", "http://www.cyanotech.com/20230630/role/statement-note-12-related-party-transactions-and-balances-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt", "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt-details-textual" ], "xbrltype": "stringItemType" }, "us-gaap_VariableRateDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.", "label": "Variable Rate [Domain]" } } }, "localname": "VariableRateDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-note-12-related-party-transactions-and-balances", "http://www.cyanotech.com/20230630/role/statement-note-12-related-party-transactions-and-balances-details-textual", "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt", "http://www.cyanotech.com/20230630/role/statement-note-5-line-of-credit-and-longterm-debt-details-textual" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r148", "r153" ], "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Diluted (in shares)" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-operations-unaudited" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Shares used in calculation of net loss per share:" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-operations-unaudited" ], "xbrltype": "stringItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r147", "r153" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Basic (in shares)" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.cyanotech.com/20230630/role/statement-condensed-consolidated-statements-of-operations-unaudited", "http://www.cyanotech.com/20230630/role/statement-note-11-earnings-per-share-summary-of-reconciliations-between-the-numerator-and-the-denominator-of-the-basic-and-diluted-earnings-per-share-computations-details" ], "xbrltype": "sharesItemType" } }, "unitCount": 6 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a),20,24)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(5))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(c))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r146": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "https://asc.fasb.org//260/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479344/326-20-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r184": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "330", "URI": "https://asc.fasb.org//330/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.24)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r238": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "https://asc.fasb.org//718/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-1D", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-5", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(l)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.F)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "https://asc.fasb.org//1943274/2147482916/730-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r279": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "https://asc.fasb.org//740/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "10B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-10B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)(i)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)(iii)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)(iv)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(i)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-20", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r319": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org//842-20/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.BB)", "Topic": "330", "URI": "https://asc.fasb.org//1943274/2147480581/330-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(3)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(4)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r326": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "https://asc.fasb.org//850/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r331": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "https://asc.fasb.org//855/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "912", "URI": "https://asc.fasb.org//1943274/2147482312/912-310-45-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(19))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(21))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(22))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8)(b))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(11))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-5", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-17(Column A))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-17(Column B))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-17(Column C))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-17(Column D))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-17(Column E))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-17(Column F))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(e)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(f)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "710", "URI": "https://asc.fasb.org//1943274/2147483070/710-10-25-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(14))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(15))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(16)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(17))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(19))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(2)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(2)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(3)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(3)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(3)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(e))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(8))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(e))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-05(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-05(4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Subparagraph": "(b)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(e))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-12", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(9))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(1)(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(4)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-13", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(e)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Topic": "954", "URI": "https://asc.fasb.org//1943274/2147481027/954-310-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-20", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-8", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(5))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "12A", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-1A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479589/842-20-55-53", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479401/944-30-55-2", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(b)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "55", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r478": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r479": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r480": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r481": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r482": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r483": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4H", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-13", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r503": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org//450/tableOfContent", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "https://asc.fasb.org//1943274/2147481283/985-20-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r523": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r524": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r53": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "https://asc.fasb.org//205/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r531": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r550": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r551": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "730", "Topic": "912", "URI": "https://asc.fasb.org//1943274/2147482517/912-730-25-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r552": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r553": { "Name": "Accounting Standards Codification", "Paragraph": "2B", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r554": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r555": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r556": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(18))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r557": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Subparagraph": "(i)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r558": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(4)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r559": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(c))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(8))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r76": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org//235/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r77": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "https://asc.fasb.org//275/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.BB)", "Topic": "330", "URI": "https://asc.fasb.org//1943274/2147480581/330-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r80": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "360", "URI": "https://asc.fasb.org//360/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r82": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org//440/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r83": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "https://asc.fasb.org//470/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" } }, "version": "2.2" } ZIP 71 0001437749-23-023314-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001437749-23-023314-xbrl.zip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end